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A B S T R A C T
Background
Helicobacter pylori (H pylori) infection has been implicated in a number of malignancies and non-malignant conditions including
peptic ulcers, non-ulcer dyspepsia, recurrent peptic ulcer bleeding, unexplained iron deficiency anaemia, idiopathic thrombocytopaenia
purpura, and colorectal adenomas. The confirmatory diagnosis of H pylori is by endoscopic biopsy, followed by histopathological
examination using haemotoxylin and eosin (H & E) stain or special stains such as Giemsa stain and Warthin-Starry stain. Special stains
are more accurate than H & E stain. There is significant uncertainty about the diagnostic accuracy of non-invasive tests for diagnosis
of H pylori.
Objectives
To compare the diagnostic accuracy of urea breath test, serology, and stool antigen test, used alone or in combination, for diagnosis of
H pylori infection in symptomatic and asymptomatic people, so that eradication therapy for H pylori can be started.
Search methods
We searched MEDLINE, Embase, the Science Citation Index and the National Institute for Health Research Health Technology
Assessment Database on 4March 2016. We screened references in the included studies to identify additional studies. We also conducted
citation searches of relevant studies, most recently on 4 December 2016. We did not restrict studies by language or publication status,
or whether data were collected prospectively or retrospectively.
Selection criteria
We included diagnostic accuracy studies that evaluated at least one of the index tests (urea breath test using isotopes such as 13C or
14C, serology and stool antigen test) against the reference standard (histopathological examination using H & E stain, special stains or
immunohistochemical stain) in people suspected of having H pylori infection.
Data collection and analysis
Two review authors independently screened the references to identify relevant studies and independently extracted data. We assessed the
methodological quality of studies using the QUADAS-2 tool. We performed meta-analysis by using the hierarchical summary receiver
operating characteristic (HSROC) model to estimate and compare SROC curves. Where appropriate, we used bivariate or univariate
logistic regression models to estimate summary sensitivities and specificities.
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Main results
We included 101 studies involving 11,003 participants, of which 5839 participants (53.1%) had H pylori infection. The prevalence
of H pylori infection in the studies ranged from 15.2% to 94.7%, with a median prevalence of 53.7% (interquartile range 42.0% to
66.5%). Most of the studies (57%) included participants with dyspepsia and 53 studies excluded participants who recently had proton
pump inhibitors or antibiotics.There was at least an unclear risk of bias or unclear applicability concern for each study.
Of the 101 studies, 15 compared the accuracy of two index tests and two studies compared the accuracy of three index tests. Thirty-four
studies (4242 participants) evaluated serology; 29 studies (2988 participants) evaluated stool antigen test; 34 studies (3139 participants)
evaluated urea breath test-13C; 21 studies (1810 participants) evaluated urea breath test-14C; and two studies (127 participants)
evaluated urea breath test but did not report the isotope used. The thresholds used to define test positivity and the staining techniques
used for histopathological examination (reference standard) varied between studies. Due to sparse data for each threshold reported, it
was not possible to identify the best threshold for each test.
Using data from 99 studies in an indirect test comparison, there was statistical evidence of a difference in diagnostic accuracy between
urea breath test-13C, urea breath test-14C, serology and stool antigen test (P = 0.024). The diagnostic odds ratios for urea breath test-
13C, urea breath test-14C, serology, and stool antigen test were 153 (95% confidence interval (CI) 73.7 to 316), 105 (95% CI 74.0 to
150), 47.4 (95% CI 25.5 to 88.1) and 45.1 (95% CI 24.2 to 84.1). The sensitivity (95% CI) estimated at a fixed specificity of 0.90
(median from studies across the four tests), was 0.94 (95% CI 0.89 to 0.97) for urea breath test-13C, 0.92 (95% CI 0.89 to 0.94) for
urea breath test-14C, 0.84 (95% CI 0.74 to 0.91) for serology, and 0.83 (95% CI 0.73 to 0.90) for stool antigen test. This implies that
on average, given a specificity of 0.90 and prevalence of 53.7% (median specificity and prevalence in the studies), out of 1000 people
tested forH pylori infection, there will be 46 false positives (people without H pylori infection who will be diagnosed as having H pylori
infection). In this hypothetical cohort, urea breath test-13C, urea breath test-14C, serology, and stool antigen test will give 30 (95% CI
15 to 58), 42 (95% CI 30 to 58), 86 (95% CI 50 to 140), and 89 (95% CI 52 to 146) false negatives respectively (people with H pylori
infection for whom the diagnosis of H pylori will be missed).
Direct comparisons were based on few head-to-head studies. The ratios of diagnostic odds ratios (DORs) were 0.68 (95% CI 0.12 to
3.70; P = 0.56) for urea breath test-13C versus serology (seven studies), and 0.88 (95% CI 0.14 to 5.56; P = 0.84) for urea breath test-
13C versus stool antigen test (seven studies). The 95% CIs of these estimates overlap with those of the ratios of DORs from the indirect
comparison. Data were limited or unavailable for meta-analysis of other direct comparisons.
Authors’ conclusions
In people without a history of gastrectomy and those who have not recently had antibiotics or proton ,pump inhibitors, urea breath tests
had high diagnostic accuracy while serology and stool antigen tests were less accurate for diagnosis of Helicobacter pylori infection.This
is based on an indirect test comparison (with potential for bias due to confounding), as evidence from direct comparisons was limited
or unavailable. The thresholds used for these tests were highly variable and we were unable to identify specific thresholds that might be
useful in clinical practice.
We need further comparative studies of high methodological quality to obtain more reliable evidence of relative accuracy between the
tests. Such studies should be conducted prospectively in a representative spectrum of participants and clearly reported to ensure low
risk of bias. Most importantly, studies should prespecify and clearly report thresholds used, and should avoid inappropriate exclusions.
P L A I N L A N G U A G E S U M M A R Y
Accuracy of different non-invasive methods for identifying Helicobacter pylori
Why is it important to know whether someone has Helicobacter pylori?
Helicobacter pylori (H pylori) is a type of bacteria which may be present in the stomach of some people. H pylori is believed to cause a
number of cancers, including stomach cancer, pancreatic cancer, and throat cancer.H pylori is also linked with other diseases including
stomach ulcers, heart burn, and a bloated feeling. If H pylori is found in an individual, appropriate treatment can be started.
What is the aim of this review?
To compare the accuracy of three different types of test for H pylori. These are: urea breath tests, blood tests (the specific blood test is
called serology), and stool tests (in faeces).
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What was studied in this review?
There are two types of urea breath test which use two different forms of carbon known as 13C and 14C, as well as multiple versions of
serology and stool tests.
What are the main results of the review?
We found 101 studies which included 11,003 people who were tested for H pylori. Of these 11,003 participants, 5839 (53.1%) had
H pylori infection. All the studies used one of the three tests listed above and compared these test results with the diagnosis given by
endoscopic biopsy. Endoscopic biopsy involves obtaining tissue from the stomach using a thin flexible tube introduced through the
mouth and testing for the presence of H pylori under the microscope. It is currently the most accurate available test, however it causes
physical discomfort to the patient, with associated risks for harm. This is in contrast to the alternative non-invasive tests in this review
which are significantly less uncomfortable and have minimal or no risk of harm, making them desirable alternatives if they can be
shown to be as accurate at diagnosing H pylori as endoscopic biopsy. Most of the studies included participants with heart burn or similar
problems in the stomach and excluded participants who had previously undergone partial removal of the stomach and those having
treatment for H pylori.
Thirty-four studies (4242 participants) used serology; 29 studies (2988 participants) used stool antigen test; 34 studies (3139 partici-
pants) used urea breath test-13C; 21 studies (1810 participants) used urea breath test-14C; and two studies (127 participants) used urea
breath test but did not report the type of carbon used. Studies varied in the limit they used before saying a test was positive forH pylori
infection and the type of stains used to examine the biopsy material. When we looked at all the data we found that urea breath tests
were more accurate than blood and stool tests. The results mean that, on average, if 1000 people are tested, there will be 46 people
without H pylori who will be misdiagnosed as having H pylori. Also, there will be 30, 42, 86, and 89 people with H pylori infection for
whom the diagnosis of H pylori infection will be missed by urea breath test-13C, urea breath test-14C, serology, and stool antigen test,
respectively. When we looked at the seven studies which compared urea breath test-13C and serology, or urea breath test-13C and stool
antigen tests in the same participants, the results were uncertain and we cannot tell which test is more accurate.
How reliable are the results of the studies?
Except for one study, all the studies were of poor methodological quality, which makes their results unreliable.
Who do the results of this review apply to?
These results apply to children and adults with suspected H pylori infection, but only in those who have not previously undergone
stomach operations and those who have not recently had antibiotics or treatment for H pylori infection.
What are the implications of this review?
Urea breath tests, blood tests, and stool tests may be suitable for identifying whether someone hasH pylori infection. However, the level
of the result of urea breath test, blood test, or stool test which should be used to make a diagnosis of H pylori infection remains unclear.
How up-to-date is the review?
We performed a thorough literature search for studies reporting the accuracy of these different tests until 4 March 2016.
B A C K G R O U N D
Helicobacter pylori (H pylori) is a gram negative spiral bacterium
(NCBI 2014). Approximately 13% to 81% of people have H py-
lori infection (Peleteiro 2014). Prevalence of the bacterium varies
according to age (generally increasing with age, although infection
rates tend to fall among older age groups in some Latin Ameri-
can and Northeast Asian countries); region (lower infection rates
are seen in Australia and the UK, while higher rates are reported
in Chile, China, Japan, Korea, and Latvia); race (more prevalent
amongst Afrocarribeans compared to white people); and socioe-
conomic class (more common in poorer settings) (Graham 1991;
Laszewicz 2014; Muhsen 2012; Peleteiro 2014).
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Based on observational studies, H pylori infection has been im-
plicated in a number of malignancies, including gastric cancer,
premalignant lesions of the stomach (atrophic gastritis and in-
testinal metaplasia), gastric lymphoma, pancreatic cancer, colorec-
tal cancer, and laryngeal cancer (Huang 1998; Huang 2003; Wu
2013; Xiao 2013; Xue 2001; Zhuo 2008). However, H pylori is
associated with a lower incidence of oesophageal adenocarcinomas
(Islami 2008). H pylori is also associated with a number of non-
malignant conditions, including peptic ulcers, non-ulcer dyspep-
sia, recurrent peptic ulcer bleeding, unexplained iron deficiency
anaemia, idiopathic thrombocytopaenia purpura, and colorectal
adenomas (DuBois 2005; Franchini 2007; Gisbert 2004b; Huang
2002; Jaakkimainen 1999; Wu 2013).
Although a number of pathogenic factors such as cytotoxin-asso-
ciated gene A (CagA), vacuolating cytotoxin A (VacA), and blood
group antigen binding adhesin (BabA) are associated with in-
creased virulence of H pylori (Huang 2003; Malfertheiner 2012),
detection of these pathogenic factors currently has no role in the
management of H pylori infection (Malfertheiner 2012). The rec-
ommended initial treatment for H pylori infection is with a com-
bination of a proton pump inhibitor, clarithromycin, and amox-
icillin or metronidazole (triple therapy) in regions with low resis-
tance to clarithromycin (< 20% resistance rate in the area), and
the triple therapy along with bismuth (quadruple therapy) in re-
gions with high resistance to clarithromycin (> 20% resistance
rate in the area) (Malfertheiner 2012). If this results in failure
of eradication, bismuth-quadruple therapy or levofloxacin-triple
therapy (replacement of clarithromycin with levofloxacin in the
classical triple therapy) when triple therapy was used as the initial
treatment and levofloxacin-triple therapy when bismuth quadru-
ple therapy was used as the initial treatment is recommended
(Malfertheiner 2012). If even this treatment fails to eradicate H
pylori, then further treatment should be based on antibiotic sus-
ceptibility (Malfertheiner 2012). Eradication of H pylori might
lead to a decrease in malignant and non-malignant conditions as-
sociated withH pylori infection. Adverse events related toH pylori
treatment include taste disturbance, diarrhoea, nausea, headache,
skin rash, abdominal pain, dizziness, bloating, myalgias (muscle
pain), and constipation (Ye 2014).
A glossary of terms is included in Appendix 1.
Target condition being diagnosed
Helicobacter pylori infection.
Index test(s)
Urea breath test
The urea breath test is based on the presence of urease enzyme in
live H pylori which breaks down urea into ammonia and carbon
dioxide (McNulty 2005; Ricci 2007). After ingestion of urea la-
belled with either 13C or 14C, breath samples are collected for up
to 30 minutes by exhaling into a carbon dioxide-trapping agent
(Ricci 2007). The urea breath test is performed by the clinician
or the clinician’s assistant. The thresholds used include the per-
centage of carbon recovered during the collection time or counts
per minute (Ferwana 2015). Threshold levels above 4% or 5% are
commonly used to diagnose H pylori infection (Ferwana 2015).
A wide range of threshold counts per minute, ranging from more
than 25 counts per minute to 1000 counts per minute, have been
used for diagnosis of H pylori infection (Ferwana 2015).
Serology
These tests are based on circulating antibodies to H pylori. There
are three main methods for these tests: the enzyme-linked im-
munosorbent assay (ELISA) test, latex agglutination tests, and
Western blotting (Ricci 2007). Of these, ELISA is the most com-
monly used method. Total immunoglobulin, immunoglobulin
subtypes, and antibody response to specific antigens can all be
tested. Since they do not require any special equipment, they can
be easily performed (Ricci 2007). However, serology may be pos-
itive because of the presence of active infection at the time of the
test, previous infection, or because of non-specific cross-reacting
antibodies (McNulty 2005). Tests that use whole blood (rather
than serum) and other bedside tests (using a bedside centrifuge)
are also available, although these whole-blood tests and bedside
serum tests are generally considered unreliable (Ricci 2007). Rou-
tine serum tests are performed by the laboratory technician and
interpreted by the clinician. The bedside serum tests and whole-
blood tests are performed by the clinician or the clinician’s assis-
tant. Different researchers evaluating the prevalence of H pylori
have used different thresholds to define the positivity of serology,
for example Lindsetmo 2008 used a titre ≥ 300 while Granberg
1993 used a titre ≥ 500.
Stool antigen tests
These tests use monoclonal and polyclonal antibodies to detect the
presence of H pylori antigen in stools and activeH pylori infection
can be diagnosed (McNulty 2005; Ricci 2007). Serum tests are
performed by the laboratory technician and interpreted by the
clinician. Several thresholds have been used for other tests, for
example, an optical density of≥ 0.15,≥ 0.16, and≥ 0.19 have all
been used as thresholds for diagnosis ofH pylori using monoclonal
antibodies for stool antigen tests.
Clinical pathway
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Evidence from randomised controlled trials (RCTs) showed that
screening and eradication programmes forH pylori in populations
at high risk of gastric cancer (e.g. East Asians) lowered the inci-
dence of gastric cancer (Ford 2014). The Asia-Pacific Gastric Can-
cer Consensus conference recommended that screening and eradi-
cation ofH pyloriwas advisable in populations in countries at high
risk of gastric cancer (i.e. Japan and Korea) (Talley 2008). The up-
dated EuropeanHelicobacter StudyGroup (EHSG) FourthMaas-
tricht/FlorenceConsensusConference guidelines suggest that peo-
ple should be tested for H pylori, and eradication of H pylori
(when present) has been recommended for the following condi-
tions (Malfertheiner 2012):
1. People at high risk of gastric cancer.
2. Adults with dyspepsia with a locally-determined age cut-off
point (depending on local incidence of gastric cancer in different
age groups), and without ‘alarm’ symptoms or signs associated
with an increased risk of gastric cancer such as weight loss,
dysphagia, upper gastrointestinal bleeding, abdominal mass, or
iron deficient anaemia.
3. Unexplained iron deficiency anaemia.
4. Idiopathic thrombocytopenic purpura.
5. Uninvestigated young patients with dyspepsia should also
be considered for testing for H pylori when the prevalence of H
pylori is high (≥ 20%).
The clinical pathway is shown in Figure 1.
Figure 1. Clinical pathway
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Prior test(s)
The index tests can be performed without any prior test.
Role of index test(s)
The index tests are used for screening and diagnosis of H pylori.
Alternative test(s)
Other tests used in the screening and diagnosis of H pylori in-
fection include non-invasive saliva and urine antigen-based tests
(Ricci 2007), and invasive gastric biopsy followed byCampylobac-
ter-like organism (CLO) test, culture, histology, and polymerase
chain reaction (PCR) (Van Doorn 2000). We do not include non-
invasive saliva and urine antigen-based tests in this review because
these tests are not commonly used (Ricci 2007).
Rationale
Testing for H pylori and eradication of H pylori have been recom-
mended for a number of population groups (Clinical pathway).
These tests have to be non-invasive so that a large number of peo-
ple can be tested. People with undetected H pylori continue to
be at high risk of gastric cancer or continue to have dyspepsia,
anaemia, or purpura. Overdiagnosis (false positive test results) of
H pylori means that patients are subject to unnecessary adverse
events related to eradication therapy (approximately 27% of pa-
tients receiving eradication therapy develop mild adverse events
such as bitter taste, nausea, diarrhoea, etc.). Comparing the diag-
nostic accuracy of different index tests will highlight the best test
for the diagnosis of H pylori infection.
O B J E C T I V E S
To compare the diagnostic accuracy of urea breath test, serology,
and stool antigen test, alone or in combination, for diagnosis of
H pylori infection in symptomatic and asymptomatic people, so
that eradication therapy for H pylori can be started.
Secondary objectives
To investigate the following potential sources of heterogeneity:
type of reference standard, risk of bias, publication status, prospec-
tive versus retrospective studies, symptomatic versus asymptomatic
participants, recent or current use of proton pump inhibitors or
antibiotics, different subtypes of tests, and the interval between
the index test and reference standard.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We include studies that evaluate the accuracy of the index tests
in the appropriate patient population (see Participants), regardless
of language or publication status, or whether data were collected
prospectively or retrospectively. However, we exclude reports that
describe how the diagnosis of H pylori was made in an individual
patient or group of patients, and which do not provide sufficient
diagnostic test accuracy data (i.e. the number of true positives, false
positives, false negatives, and true negatives). We also exclude case-
control studies because these are prone to bias (Whiting 2011).
Participants
Symptomatic and asymptomatic people in whom H pylori infec-
tion status is sought so that eradication therapy forH pylori can be
started. We exclude studies that included only people with acute
upper gastrointestinal bleeding because such patients are likely to
undergo endoscopy and invasive testing can be performed, if re-
quired.
Index tests
Urea breath test-14C, urea breath test-13C, serology, and stool anti-
gen test, alone or in combination. We included only initial test-
ing and excluded repeat testing (monitoring success of treatment),
since diagnostic accuracy may vary depending on the purpose of
testing (Ricci 2007).
Target conditions
H pylori infection.
Reference standards
There is no gold standard for diagnosis of H pylori infection and
the diagnosis is made by a combination of tests following en-
doscopic biopsy; endoscopic biopsy followed by histology, en-
doscopic biopsy followed by polymerase chain reaction (PCR),
and endoscopic biopsy followed by rapid urease testing all have
excellent sensitivity and specificity (Chey 2007). However, PCR
methodology is not standardised across laboratories (Chey 2007);
it is an unreliable reference standard. Endoscopic biopsy followed
by rapid urease testing has poor sensitivity following treatment
with proton pump inhibitors (Chey 2007). Endoscopic biopsy
with culture has high specificity but poor sensitivity (Chey 2007).
We therefore considered only endoscopic biopsy followed by his-
tology (using haemotoxylin and eosin (H & E) stain, special his-
tological stains such as Giemsa stain and Warthin-Starry stain, or
immunohistochemical stain) as the reference standard in this re-
view.
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Immunohistochemical stains are more accurate than special stains,
while special stains and immunohistochemical stains are thought
to have better specificity than H & E stains for diagnosis of H py-
lori infection (Laine 1997; Lee 2015b). For this reason,we consid-
ered endoscopic biopsy with histology using immunohistochem-
ical stain as the best reference standard, and endoscopic biopsy
with histology using H & E stain as the worst reference standard.
Search methods for identification of studies
We included all studies, irrespective of the language of publication
and publication status. If we found articles in languages other than
English, we obtained translations.
Electronic searches
We searched the following databases.
1. MEDLINE via OvidSP (January 1946 to 4 March 2016)
(Appendix 2).
2. Embase via OvidSP (January 1947 to 4 March 2016)
(Appendix 3).
3. Science Citation Index Expanded via Thomson Reuters
Web of Science (January 1980 to 4 March 2016) (Appendix 4).
4. National Institute for Health Research (NIHR HTA) via
Centre for Reviews and Dissemination, University of York. (
www.crd.york.ac.uk/CRDWeb/) (4 March 2016) (Appendix 5).
Searching other resources
To identify additional studies, we examined references in the in-
cluded studies to see if any might be relevant. We also searched for
articles related to the included studies by using the ’related search’
function inMEDLINE (OvidSP) and Embase (OvidSP).We con-
ducted a ’citing reference’ search (by searching articles which cited
the included articles) (Sampson 2008) in MEDLINE (OvidSP)
and Embase (OvidSP) on 4 December 2016.
Data collection and analysis
Selection of studies
Two review authors (KG and LB, SS, or AS) independently
searched the references to identify relevant studies. We obtained
the full text for references considered relevant by at least one of the
two review authors. Two review authors independently screened
the full-text papers against the inclusion criteria, resolving any dif-
ferences in study selection by discussion. We attempted to contact
study authors if there were doubts about the eligibility of a study.
Data extraction and management
Two review authors (KG and LB, SS, or AS) independently ex-
tracted the following data from each included study, using a pre-
piloted data extraction form, and resolving differences by discus-
sion.
1. First author.
2. Year of publication.
3. Study design (prospective or retrospective cohort studies;
cross-sectional studies or randomised controlled trials).
4. Inclusion and exclusion criteria for individual studies.
5. Total number of participants.
6. Number of female participants.
7. Average age of the participants.
8. Initial testing versus testing after eradication.
9. Number of people with bleeding ulcers, gastric atrophy,
lymphoma, and recent or current use of proton pump inhibitors
or antibiotics.
10. Number of symptomatic participants.
11. Tests carried out prior to the index test.
12. Description of the index test.
13. Threshold used for the index test.
14. Reference standard.
15. Number of true positives, false positives, false negatives,
and true negatives (i.e. 2 x 2 data) at each threshold reported.
If a study reported multiple index tests, we extracted the 2 x 2 data
for each index test at each threshold. For studies that reported test
accuracy for different reference standards, we extracted 2 x 2 data
for only one of the reference standards. For this purpose, due to
the accuracy of the stains, we preferred the immunohistochemical
stain over special stains, which in turn we preferred over the H &
E stain.
Although the number of uninterpretable index test results may
provide information on the applicability of the tests in clinical
practice and may affect the cost effectiveness of a test, we had
planned to exclude patients with uninterpretable index test results
from the meta-analyses. We made this decision because in clinical
practice uninterpretable index test results would result in addi-
tional testing. Nevertheless, we would have extracted and reported
such data if available from the studies.
If we suspected an overlap of participants betweenmultiple reports
due to common study authors and centres, we planned to contact
the study authors for clarification; however, this was not required,
since we could identify multiple reports of the same study using
the information provided in the reports. We sought further infor-
mation from study authors, if necessary.
Assessment of methodological quality
Two review authors independently assessed study quality using
the QUADAS-2 tool (Whiting 2006; Whiting 2011), resolving
differences by discussion. The criteria used for the assessment are
shown in Appendix 6. We considered studies classified as ’low risk
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of bias’ and ’low concern’ in all the domains of the QUADAS-2
tool as studies with high methodological quality. It must be noted
here that ’risk of bias’ refers to internal validity (i.e. whether there
were systematic errors in performing the study with respect to the
particular domain), while ’applicability concern’ refers to external
validity (i.e. whether there were concerns that the population,
index test or reference standard used in the studies matched the
review question).
Statistical analysis and data synthesis
We plotted study estimates of sensitivity and specificity on for-
est plots and in receiver operating characteristic (ROC) space
to explore between-study variation in the accuracy of each test.
We examined the thresholds reported for each test and the refer-
ence standards used. Due to between-study variation in thresh-
olds, we performed meta-analyses by using the hierarchical sum-
mary receiver operating characteristics (HSROC) model to esti-
mate SROC curves (Rutter 2001). For these analyses, if a study re-
ported test accuracy at multiple thresholds, we selected the thresh-
old used by the study authors for their primary analysis.
Prior to comparative meta-analyses of the tests, we performed
meta-analysis of each test separately for preliminary investigation
of the shape of the SROC curve of each test and to assess hetero-
geneity in test performance. We used this approach to understand
the data and to guidemodelling assumptions wemay need tomake
in the comparative meta-analysis. These preliminary analyses were
done noting the availability of comparative studies. To compare
the accuracy of the index tests, we added test type as a covariate
to the HSROCmodel (Macaskill 2013). For the indirect compar-
ison where we used all available data (i.e. not restricted to com-
parative studies), we assessed the effect of test type on the accu-
racy, threshold, and shape parameters of the HSROC model. We
also explored the effect of test type on the variance of the random
effects for accuracy and threshold. To determine the final meta-
analytic model, we used likelihood ratio tests to assess model fit.
Likelihood ratio tests were also used to determine the statistical
significance of differences in test accuracy. When SROC curves
are symmetric (i.e. HSROC model without the shape parameter),
each curve can be described using the diagnostic odds ratio (DOR)
to quantify the accuracy of the test. We used the ratio of DORs
as a summary of the relative accuracy of two tests.
Summary sensitivities and specificities can be obtained from a
HSROC model but they are not clinically interpretable here be-
cause we included studies with different thresholds. We therefore
estimated sensitivities at points on the SROC curves that corre-
spond to the lower quartile, median and upper quartile of the
specificities from the studies included in the meta-analysis. When
comparative studies that had evaluated two tests head-to-headwere
available, we performed direct comparisons of the tests (Takwoingi
2013). For these analyses, we fitted HSROC models with sym-
metric SROC curves, as the available data were insufficient for
reliable estimation of the shape of the SROC curves (Takwoingi
2017).
If there were at least two studies that reported the accuracy of a
test at the same threshold, we considered meta-analysis to obtain
summary estimates of sensitivity and specificity. Due to the small
number of studies in these analyses, we performed meta-analyses
using univariate fixed-effect or random-effects logistic regression
models, depending on the extent of heterogeneity observed in for-
est plots and in ROC space (Takwoingi 2017). When there were
only two or three studies at the same threshold, and little or no
heterogeneity observed in ROC space, we used univariate fixed-
effect logistic regression models to pool sensitivities and specifici-
ties separately. When there were two or three studies and we ob-
served heterogeneity, we did not perform meta-analysis, as ran-
dom-effects models would be more appropriate in such situations.
However, random effects cannot be reliably estimated with very
few studies.
We performed meta-analyses using the NLMIXED procedure in
SAS.
Investigations of heterogeneity
We used forest plots and scatter plots of sensitivity against speci-
ficity for preliminary investigation of potential sources of hetero-
geneity such as:
1. Type of reference standard (different histological stains).
2. Studies at low risk of bias in all the QUADAS-2 domains
versus those at unclear or high risk of bias.
3. Full-text publications versus abstracts (may provide insight
into publication bias if there is an association between the results
of a study and full publication of the study) (Eloubeidi 2001).
4. Prospective versus retrospective studies.
5. Symptomatic versus asymptomatic participants.
6. Recent or current use of proton pump inhibitors or
antibiotics, as these patients are at higher risk of false negative
results for the urea breath test and stool antigen test, with
serology being the only non-invasive test unaffected by the use of
proton pump inhibitors or antibiotics (Malfertheiner 2012;
Ricci 2007).
7. Different subtypes of tests (ELISA, latex agglutination test,
and Western blot methods of serological tests; formal serological
tests versus bedside serological tests; and monoclonal versus
polyclonal antibodies for stool antigen tests).
8. Interval between index test and reference standard.
Resolution of H pylori infection in people with H pylori infection
(usually with treatment) and infection in those without H pylori
infection may occur if there was a long interval between the
index test and reference standard.
We formally investigated heterogeneity for each test by adding a
covariate to a HSROC model (meta-regression). We used likeli-
hood ratio tests to assess the statistical significance of differences
in test accuracy by comparing models with and without the co-
variate.
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Sensitivity analyses
We planned to examine the impact of data inconsistencies on the
meta-analytic findings. For example, if test accuracy data reported
in the text of a paper differed from those in the figures, we planned
to assess the impact of using different data in sensitivity analyses;
however, we did not find such inconsistencies.
Assessment of reporting bias
Due to limited data, we were unable to formally investigate
whether test accuracy differed between studies that were published
as full texts and those available only as abstracts.
R E S U L T S
Results of the search
We identified 23,896 references through electronic searches of
MEDLINE, Embase, Science Citation Index, and NIHR HTA.
We did not identify additional references through other searches.
The flow of studies through the screening process is shown in
Figure 2. After removing 10,313 duplicates, there were 13,583 ref-
erences.Of these, we dropped11,737 irrelevant references through
reading the titles and abstracts. We could not obtain the full text
of 11 references. The quality of copies of two references was too
poor to allow translation and we were unable to obtain better
copies. We assessed the full text of the remaining 1833 references.
We excluded 1728 references (1727 studies) for reasons stated in
Appendix 7 (also see Characteristics of excluded studies below).
The remaining 107 references (101 studies) met our inclusion cri-
teria. Two references reported diagnostic accuracy data separately
for people who underwent gastrectomy and those who did not un-
dergo gastrectomy, and so we considered these subgroups as sep-
arate studies (Adamopoulos 2009a; Adamopoulos 2009b; Sheu
1998a; Sheu 1998b).
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Figure 2. Study flow diagram.
10Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Characteristics of included studies
We summarise the characteristics of the 101 included studies in
the Characteristics of included studies table. The studies included
11,003 participants, of which 5839 participants (53.1%) had H
pylori infection. The prevalence of H pylori infection ranged from
15.2% to 94.7% with a median of 53.7% (interquartile range:
42.0% to 66.5%).
Of the 101 studies, 34 evaluated urea breath test-13C; 21 evalu-
ated urea breath test-14C; two evaluated urea breath test but did
not report the isotope used; 34 evaluated serology; and 29 eval-
uated stool antigen test. Seventeen studies evaluated more than
one test. Of these, 15 evaluated two tests (Dede 2015; El-Din
2013; Eltumi 1999; Hafeez 2007; Inelmen 2004; Korstanje 2006;
Kuloglu 2008; Lahner 2004; Lottspeich 2007; Mansour-Ghanaei
2011; Ogata 2001; Soomro 2012; Vandenplas 1992; Yoshimura
2001; Yu 2001), and two evaluated three tests (Monteiro 2001a;
Salles-Montaudon 2002). Studies used different thresholds, with
15 studies reporting test accuracy at more than one threshold
(Chey 1998; Dede 2015; Delvin 1999; Formichella 2013; Ladas
2002a; Mana 2001a; Misawa 1998; Monteiro 2001a; Morales
1995; Noguera 1998; Novis 1991; Ozturk 2003; Trevisani 2005;
Weiss 1994; Yu 2001).
Eleven studies were prospective (Adamopoulos 2009a;
Adamopoulos 2009b; Al-Fadda 2000; Arikan 2004; Dede 2015;
Eltumi 1999; Fallone 1995; Kalach 1998a; Kuloglu 2008; Ogata
2001; Qadeer 2009); six studies were retrospective (Bosso 2000;
Czerwionka-Szaflarska 2007; Graham 1996a; Iqbal 2013; Mion
1994; Wardi 2012), while the remaining 84 studies did not state
whether they were prospective or retrospective studies. Six stud-
ies were published as abstracts only (Han 2012; Mohammadian
2007; Rathbone 1986; Sheu 1998a; Sheu 1998b; Thobani 1995),
and the remaining 95 were full-text publications.
Fourteen studies included only children (Argentieri 2007; Behrens
1999; Czerwionka-Szaflarska 2007; Delvin 1999; Dinler 1999;
Eltumi 1999; Hafeez 2007; Kalach 1998a; Kuloglu 2008;
Lottspeich 2007; Ogata 2001; Rafeey 2007; Vandenplas 1992;
Yoshimura 2001). Five studies clearly included only adults (Atli
2012; Chen 1991; Kamel 2011; Safe 1993; Salles-Montaudon
2002). Although not clearly specified in the remaining 82 studies,
it appeared that most or all of the participants were adults. The
mean or median age of the participants included in these stud-
ies ranged between 31 years and 85 years in the 45 studies that
reported this information. One study included only participants
without symptoms (Wang 2008). Fifty-eight studies included only
participants with symptoms, usually abdominal pain or dyspep-
sia (Adamopoulos 2009a; Adamopoulos 2009b; Aguilar 2007;
Al-Fadda 2000; Allardyce1997; Behrens1999; Bosso 2000;Ceken
2011; Chen 1991; Czerwionka-Szaflarska 2007; D’Elios 2000;
Delvin 1999; Dinler 1999; Ekesbo 2006; El-Din 2013; El-Mekki
2011; El-Nasr 2003; Eltumi 1999; Fanti 1999; Faruqui 2007;
Ferrara 1998; Germana 2001; Guo 2011; Gurbuz 2005; Hafeez
2007; Jordaan 2008; Kamel 2011; Kuloglu 2008; Ladas 2002a;
Lahner 2004; Lee 1998; Lottspeich 2007; Mansour-Ghanaei
2011; Mion 1994; Misawa 1998; Mohammadian 2007; Morales
1995; Novis 1991; Ogata 2001; Ozturk 2003; Peitz 2001; Qadeer
2009; Rafeey 2007; Rasool 2007; Rathbone 1986; Safe 1993;
Scuderi 2000; Segamwenge 2014; Selcukcan 2011; Sharbatdaran
2013; Sheu 1998a; Soomro 2012; Surveyor 1989; Thobani 1995;
Vandenplas 1992; Villalobos 1992;Weiss 1994; Yoshimura 2001).
The remaining 42 studies did not report the type of participants
included. Five studies included only participants who had previ-
ously undergone gastrectomy (Adamopoulos 2009b; Lombardo
2003; Schilling 2001; Sheu 1998b; Wardi 2012). Two stud-
ies included only participants with atrophic gastritis (Korstanje
2006; Ogata 2001). It was clear that participants who received
recent proton pump inhibitors or antibiotics were excluded from
53 studies (Ceken 2011; Chey 1998; Debongnie 1991; D’Elios
2000; Delvin 1999; Duan 1999; El-Mekki 2011; El-Nasr 2003;
Eltumi 1999; Fallone 1996; Fanti 1999; Ferrara 1998; Formichella
2013; Germana 2001; Guo 2011; Gurbuz 2005; Jekarl 2013;
Jensen 1998; Jordaan 2008; Kalach 1998a; Kim 2016; Kuloglu
2008; Ladas 2002a; Lahner 2004; Lee 1998; Lombardo 2003;
Lottspeich 2007;Mana 2001a;Mansour-Ghanaei 2011;Monteiro
2001a;Ogata 2001;Ozturk 2003; Peitz 2001; Peura 1996; Puspok
1999; Qadeer 2009; Rafeey 2007; Rasool 2007; Schilling 2001;
Segamwenge 2014; Selcukcan 2011; Sharbatdaran 2013; Shin
2009; Tiwari 2014; Trevisani 2005; Vandenplas 1992; Villalobos
1992; Wang 2008; Weiss 1994; Yan 2003; Yoshimura 2001; Yu
1999; Yu 2001). It was not clear whether such participants were
included or excluded in the remaining 48 studies.
Thirty-two studies used H & E stain as a reference stan-
dard (Aguilar 2007; Al-Fadda 2000; Arikan 2004; Atli 2012;
Behrens 1999; Ceken 2011; Chen 1991; Chey 1998; Czerwionka-
Szaflarska 2007; D’Elios 2000;Dinler 1999; Eggers 1990; El-Nasr
2003; Fallone 1996; Faruqui 2007; Graham 1996a; Gramley
1999; Gurbuz 2005; Iqbal 2013; Jordaan 2008; Kalach 1998a;
Kamel 2011; Lee 1998; Logan 1991a; Noguera 1998; Puspok
1999; Segamwenge 2014; Selcukcan 2011; Sheu 1998a; Sheu
1998b; Tiwari 2014; Yu 2001); 24 studies used special stains such
as Warthin-Starry stain, Giemsa stain, or silver stain (Argentieri
2007; Bosso 2000; El-Din 2013; Fallone 1995; Guo 2011; Hafeez
2007; Han 2012; Ivanova 2010; Kim 2016; Ladas 2002a; Lahner
2004; Mion 1994; Mohammadian 2007; Morales 1995; Novis
1991; Ozturk 2003; Peura 1996; Qadeer 2009; Schilling 2001;
Scuderi 2000; Shin 2009; Soomro 2012; Villalobos 1992; Yan
2003); two studies used immunohistochemical staining (Ekesbo
2006; Misawa 1998); and the remaining 43 studies used a com-
bination of different stains.
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The interval between the index test and reference standard was
reported only in 21 studies. The interval was less than two weeks
in 19 of the 21 studies (Adamopoulos 2009a; Adamopoulos
2009b; Bosso 2000; Debongnie 1991; Duan 1999; Fallone
1995; Fallone 1996; Formichella 2013; Gurbuz 2005; Hafeez
2007; Lahner 2004; Lee 1998; Logan 1991a; Lottspeich 2007;
Mansour-Ghanaei 2011; Mion 1994; Ozturk 2003; Peura 1996;
Safe 1993), and was between 15 days and 23 days in one study
(Dede 2015); it was within 30 days in the remaining study
(Lombardo 2003).
Characteristics of excluded studies
We excluded 1726 references (1725 studies). The reason for ex-
clusion is stated for each study in Appendix 7 and summarised
below.
• Case-control study: 17
• Not a primary research study: 147
• Erratum: 3
• Inappropriate population: 79
◦ In monitoring: 33
◦ Not in humans: 1
◦ Only in H pylori negative people: 2
◦ Only in H pylori positive people: 39
◦ Only in people with gastrointestinal bleeding: 2
◦ Selection of participants was based on the results of
other H pylori tests: 1
◦ Includes people who were being monitored for H
pylori status: 1
• Inappropriate index test: 38
• Inappropriate target condition: 4
• Inappropriate reference standards: 1182
• Lack of data: 256
◦ Insufficient diagnostic test accuracy data: 25
◦ No diagnostic accuracy data: 42
◦ Not a diagnostic test accuracy study of non-invasive H
pylori diagnosis: 188
◦ Incorrect data (correct information could not be
obtained): 1
Methodological quality of included studies
The methodological quality of the included studies is summarised
across all studies in Figure 3. None of the included studies was
of high methodological quality (i.e. low risk of bias in all the
domains). Appendix 8 shows the results for individual studies for
urea breath test-13C, urea breath test-14C, serology and the stool
antigen test, respectively.
Figure 3. Risk of bias and applicability concerns graph: review authors’ judgements about each domain
presented as percentages across included studies. For each domain, the numbers shown on the bar represent
the number of studies that were scored as high, unclear or low in terms of risk of bias or applicability concern.
Patient selection domain
In the patient selection domain, 23, 15 and 63 studies were at
low, high and unclear risk of bias, respectively. All 15 studies were
at high risk of bias because they did not include a consecutive or
random series of participants.
Twenty-five, seven and 69 studies were of low, high and unclear
applicability concern. In the 69 studies of unclear applicability
concern it was not clear whether participants similar to those seen
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in the clinical settingwhere the test is usedwere excluded, while the
seven studies of high concern clearly excluded such participants. In
these seven studies, only people who had undergone gastrectomy
or those with atrophic gastritis were included.
Index test domain
In the index test domain, studies generally had an unclear risk
of bias because it was unclear whether the index test results were
interpreted without the knowledge of the results of the reference
standard, and/or it was unclear whether a threshold was prespeci-
fied.
Urea breath test
None of the studies that evaluated the urea breath test (13C, 14C,
or unknown isotope) were at low risk of bias. The risk of bias was
unclear in the two studies that did not report the type of isotope
(Han 2012; Lombardo 2003). Of the 34 studies that evaluated
urea breath test-13C, seven (21%) had a high risk of bias while
27 (79%) had unclear risk of bias. There were 21 studies of urea
breath test-14C, 16 (76%) of which had unclear risk of bias while
five (24%) had high risk of bias.
For the two studies with unknown isotope, applicability concern
was high in one study and low in the other. Of the 34 urea breath
test-13C studies, applicability concerns were unclear for two (6%)
studies, high for six (18%) studies and low for 26 (76%) studies.
For urea breath test-14C, applicability concerns were generally low
(18/21; 86%) with only three studies having high applicability
concerns (Selcukcan 2011; Surveyor 1989; Yu 1999) .
Serology
One study (Ladas 2002a), had a low risk of bias.and another study
(Rathbone 1986), had a high risk of bias. The risk of bias for the
remaining 32 (94%) studies was unclear. Applicability concerns
were low in 19 (56%) studies and high in 15 (44%) studies.
Stool antigen test
None of the 29 studies had a high risk of bias. Most of the studies
(26/29; 90%) had an unclear risk of bias; three studies (Islam
2005; Kuloglu 2008; Sharbatdaran 2013), had a low risk of bias.
All the studies were of low applicability concern.
Reference standard domain
Two studies were at low risk of bias in the reference standard
domain (Fallone 1995; Ladas 2002a). For 27 studies, the risk of
biaswas unclear because itwas not clearwhether reference standard
results were interpreted without knowledge of the results of the
index tests. The remaining 72 studies were at high risk of bias
because the reference standard was endoscopic biopsy with H &
E stain in some or all participants.
All the studies were of low applicability concern.
Flow and timing domain
Seven studies were at low risk of bias in the flow and timing do-
main. The risk of bias was unclear for 74 studies because the inter-
val between the index test and reference standard was unclear or it
was unclear whether all participants were included in the analysis.
The remaining 20 studies were at high risk of bias because some
participants were clearly excluded from the analysis. These studies
did not report the reference standard results for the excluded par-
ticipants. None of the studies reported indeterminate results (i.e.
there were no indeterminate index test results in studies which
provided a clear participant flow and none of the exclusions were
due to indeterminate index test results).
Findings
Urea breath test-13C
The 34 studies of urea breath test-13C included 3139 participants,
of whom 1526 had H pylori infection (Figure 4). The threshold
used in six studies was either unknown (Eggers 1990; Monteiro
2001a), or unclear (Sheu 1998a; Sheu 1998b; Vandenplas 1992;
Wardi 2012). At the most commonly reported threshold of delta
over baseline > 4% (30 minutes after administration of urea), the
summary sensitivity (95%confidence interval (CI)) and specificity
(95% CI) from 10 studies (958 participants) were 0.95 (95% CI
0.79 to 0.99) and 0.95 (95% CI 0.87 to 0.98). Other thresholds
were used by a limited number of studies (Figure 5; Appendix 9).
When possible we performed meta-analysis to estimate summary
sensitivities and specificities at these common thresholds. The re-
sults are presented in Table 1.
13Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 4. Forest plot of urea breath test-13C.FN = false negative; FP = false positive; TN = true negative; TP
= true positive. The forest plot shows an estimate of sensitivity and specificity from each study and the
threshold used. Studies are sorted by threshold, sensitivity and specificity. For threshold, the number of
minutes in brackets is the time after administration of urea.
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Figure 5. Forest plot of urea breath test-13C at commonly reported thresholds. FN = false negative; FP =
false positive; TN = true negative; TP = true positive. Thresholds are shown in brackets and the number of
minutes in brackets is the time after administration of urea.
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Urea breath test-14C
Figure 6 shows the 21 studies of urea breath test-14C. The studies
included 1810 participants (involving 1018H pylori cases). Three
studies did not state the thresholds used (Selcukcan 2011; Surveyor
1989; Yu 1999). The two most commonly used thresholds were
counts per minute > 50 (10 minutes after administration of urea)
in six studies (471 participants) and disintegrations per minute
> 200 (10 minutes) in four studies (296 participants) (Table 1).
Test accuracy results for other thresholds are shown in Appendix
9. The summary sensitivity (95% CI) and specificity (95% CI) at
the counts per minute > 50 threshold were 0.89 (95% CI 0.55 to
0.98) and 0.91 (95% CI 0.79 to 0.96). For the disintegrations per
minute > 200 threshold, the summary sensitivity (95% CI) and
specificity (95% CI) were 0.95 (95% CI 0.33 to 1.00) and 0.95
(95% CI 0.80 to 0.99).
Figure 6. Forest plot of urea breath test-14C. FN = false negative; FP = false positive; TN = true negative;
TP = true positive. The forest plot shows an estimate of sensitivity and specificity from each study and the
threshold used. Studies are sorted by threshold, sensitivity and specificity. For threshold, the number of
minutes in brackets is the time after administration of urea.
Serology
Serology was evaluated in 34 studies with a total of 4242 partic-
ipants, of whom 2477 had H pylori infection (Figure 7). There
was considerable variation in the thresholds used but 14 (41%)
studies did not state the thresholds used. A threshold of > 7 units/
ml was used in two studies (Iqbal 2013; Ogata 2001), involving
97 participants, and two studies involving 234 participants (Ladas
2002a; Monteiro 2001a) used a threshold of ≥ 300 units (Table
1). The summary sensitivity (95% CI) and specificity (95% CI)
at the > 7 units/mL threshold were 0.98 (95% CI 0.74 to 1.00)
and 0.71 (95% CI 0.51 to 0.86), and 0.91 (95% CI 0.82 to 0.96)
and 0.86 (95% CI 0.72 to 0.93) for the ≥ 300 units threshold.
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Figure 7. Forest plot of serology. FN = false negative; FP = false positive; SD = standard deviation; TN = true
negative; TP = true positive. The forest plot shows an estimate of sensitivity and specificity from each study
and the threshold used. Studies are sorted by threshold, sensitivity and specificity. Other threshold is staining
of a 120kDa protein (CagA) gel band and/or at least two of five proteins between 28-33 kDa.
Stool antigen test
Twenty-nine studies assessed the stool antigen test in 2988 partic-
ipants (including 1311 H pylori cases) (Figure 8). The threshold
used was unknown in almost half of the studies (14/29, 48%).
None of the thresholds reportedwere used bymore than one study.
Summary estimates of sensitivity and specificity were therefore not
obtained at a common threshold.
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Figure 8. Forest plot of stool antigen test. FN = false negative; FP = false positive; TN = true negative; TP =
true positive; WL = wavelength. The forest plot shows an estimate of sensitivity and specificity from each
study and the threshold used. Studies are sorted by threshold, sensitivity and specificity.
Comparative accuracy of non-invasive tests for H
pylori infection
Comparison based on all studies (Indirect test comparison)
Across the four tests (urea breath test-13C, urea breath test-14C,
serology and stool antigen test) 99 studies (5694 cases; 10799 par-
ticipants) were included in this comparative meta-analysis (Figure
9). Preliminary assessment of each test separately indicated there
was no significant association between test accuracy and threshold,
and so a symmetric SROC curve is plausible for each test. Based
on these preliminary assessments, and likelihood ratio tests com-
paring different HSROC meta-regression models with covariate
terms for test type and examination of the variance parameters in
these models, the final model we fitted allowed for differences in
accuracy and threshold as random effects (i.e. unequal variances
for the random effects) with symmetric SROC curves for the tests.
Overall, there was statistical evidence of a difference in accuracy
(P = 0.024). The DORs (95% CI) for urea breath test-13C, urea
breath test-14C, serology and stool antigen test were 153 (95%
CI 73.7 to 316), 105 (95% CI 74.0 to 150), 47.4 (95% CI 25.5
to 88.1) and 45.1 (95% CI 24.2 to 84.1) respectively (Table 2).
The accuracy of urea breath tests (13C and 14C) was significantly
higher than that of serology and stool antigen test. For example,
the ratio of DORs (95%) for urea breath test-13C compared to
serology was 3.22 (95% CI 1.24 to 8.37), P = 0.017.
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Figure 9. Summary ROC plot of non-invasive tests for H pylori infection. The SROC curves for the four
tests are parallel. The curve for each test is drawn within the range of estimates of specificity from the studies
included for the test.
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Table 3 shows the clinical implications of using each of the four
tests in a hypothetical cohort of 1000 people with different levels
of prevalence ofHpylori infection. For example, given a prevalence
of 53.7% and a specificity of 0.90, 46 people who do not have
H pylori infection will be treated and urea breath test-13C, urea
breath test-14C, serology and stool antigen test will miss 30, 42,
86 and 89 people respectively who have H pylori infection.
Direct comparisons (restricted to comparative studies)
Direct comparisons were based on few studies. Table 4 shows the
number of studies (N) for each pairwise comparison and, where
meta-analysis was possible, the ratio of DORs with 95% CIs and
P value. There were no comparative studies of urea breath test-
13C and urea breath test-14C. All other comparisons were based on
seven or fewer studies. Each pair of tests were evaluated as follows:
• Urea breath test-13C versus serology (Figure 10): seven
studies (Eltumi 1999; Korstanje 2006; Monteiro 2001a; Ogata
2001; Salles-Montaudon 2002; Vandenplas 1992; Yoshimura
2001).
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Figure 10. Summary ROC plot of direct comparisons of urea breath test-13C and serology. Each summary
curve was drawn restricted to the range of specificities for each test. The size of each symbol was scaled
according to the precision of sensitivity and specificity in the study. A dotted line joins the pair of points for the
two tests from each study.
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• Urea breath test-13C versus stool antigen test (Figure 11):
seven studies (Hafeez 2007; Inelmen 2004; Lahner 2004;
Lottspeich 2007; Monteiro 2001a; Salles-Montaudon 2002; Yu
2001).
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Figure 11. Summary ROC plot of direct comparisons of urea breath test-13C and stool antigen test. Each
summary curve was drawn restricted to the range of specificities for each test. The size of each symbol was
scaled according to the precision of sensitivity and specificity in the study. A dotted line joins the pair of points
for the two tests from each study.
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• Urea breath test-14C versus serology: two studies (Dede
2015; Kuloglu 2008).
• Urea breath test-14C versus serology: one study
(Mansour-Ghanaei 2011).
• Serology versus stool antigen test: four studies (El-Din
2013; Monteiro 2001a; Salles-Montaudon 2002; Soomro 2012).
The ratios of DORs (95% CI; P value) were 0.68 (95% CI 0.12
to 3.70; P = 0.56) for urea breath test-13C versus serology, and
0.88 (95% CI 0.14 to 5.56; P = 0.84) for urea breath test-13C
versus stool antigen test. Due to paucity of data and substantial
heterogeneity observed in ROC space which precluded the use of
simpler meta-analytic models, meta-analyses were not possible for
the other two test comparisons that had more than one study. For
the single study of urea breath test-14C versus serology (Mansour-
Ghanaei 2011), both tests had similar sensitivity, but specificity
was higher for urea breath test-14C than for serology.
Investigation of heterogeneity
We were unable to investigate subtype of tests because most of the
serological tests were ELISA (17/20 (85%) studies that provided
the type of serology test) and most studies (24/29 (83%) studies)
did not report whether monoclonal or polyclonal antibodies were
used for stool antigen tests. Studies did not report the precise in-
terval between index test and reference standard (unless they were
performed on the same day), i.e. many studies did not report the
interval at all, while some reported that the tests were performed
within a few days of each other without stating the exact time in-
terval. Of those that reported the interval, only two studies had an
interval of more than two weeks (Dede 2015; Lombardo 2003).
For each of the four tests, Appendix 10 shows the number of stud-
ies in each subgroup of other factors we had planned to investigate.
Given the availability of data, we were only able to perform meta-
regression to investigate the effect of reference standard on the ac-
curacy of each test. Of the 99 studies, 42 (42%) used a combina-
tion of stains and there were few data for Immunohistochemical
stains (2/99; 2%). The analyses were therefore limited to compar-
isons of H & E stain versus special stain for each test (Appendix
11). Although the effect of reference standard was not consistent
across tests, there was no statistical evidence of a difference in test
accuracy for any of the tests. For urea breath test-14C, the DOR
for special stain was higher than for H & E stain, while for the
other tests the DOR of both types of stain were similar or higher
for H & E (Appendix 11).
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Summary of findings
What is the best non-invasive test for diagnosis of H pylori infect ion?
Population Children and adults with gastrointest inal symptoms
Setting Primary care sett ing
Index tests Urea breath test-13C, Urea breath test-14C, serology, and stool ant igen test
Threshold Various thresholds were used for each test
Role and purpose of test Screening and diagnosis of H pylori
Reference standard Endoscopic biopsy with Haemotoxylin & Eosin stain, special stains, or combinat ion of Haemotoxylin & Eosin and special stains
Quality of evidence Risk of bias was generally high or unclear with respect to the select ion of part icipants, and the conduct and interpretat ion of the index tests
and reference standard. Applicability concerns were also generally high or unclear with respect to select ion of part icipants
Limitations There was heterogeneity in thresholds and reference standards. Studies did not of ten prespecif y or clearly report thresholds used
Pre- test probability (prevalence
of Helicobacter pylori)
Median (interquart ile range) = 53.7% (42.0% to 66.5%)
Index test Number of participants (studies) Diagnostic odds ratio (95% CI) Sensitivity (95%CI) at fixed speci-
ficity of 0.901
Missed H pylori cases per 1000
people tested (95% CI)2
Urea breath test-13C 3139 part icipants
(34 studies)
153 (95%CI 73.7 to 316) 0.94 (0.89 to 0.97) 30 (15 to 58)
Urea breath test-14C 1810 part icipants
(21 studies)
105 (95%CI 74.0 to 150) 0.92 (0.89 to 0.94) 42 (30 to 58)
Serology 4242 part icipants
(34 studies)
47.4 (95%CI 25.5 to 88.1) 0.84 (0.74 to 0.91) 86 (50 to 140)
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Stool ant igen test 2988 part icipants
(29 studies)
45.1 (95%CI 24.2 to 84.1) 0.83 (0.73 to 0.90) 89 (52 to 146)
Comparison of non- invasive tests for H pylori infection
Based on an indirect comparison of the four tests using all the studies, there was stat ist ical evidence of a dif ference in diagnost ic accuracy (P = 0.024). Direct comparisons
were based on few head-to-head studies. The rat ios of diagnost ic odds rat ios (95%CI; P value) were 0.68 (95%CI 0.12 to 3.70; P = 0.56) for urea breath test-13C versus serology
(seven studies), and 0.88 (95% CI 0.14 to 5.56; P = 0.84) for urea breath test-13C versus stool ant igen test (seven studies). The 95% conf idence intervals of these est imates
overlap with those of the rat ios of diagnost ic odds rat ios f rom the indirect comparison. Data were lim ited or unavailable for meta-analysis of other direct comparisons
Conclusions
In people with no history of gastrectomy and those who have not recent ly had ant ibiot ics or proton pump inhibitors, urea breath tests had high diagnost ic accuracy while
serology and stool ant igen tests had lower accuracy to detect H pylori infect ion. Although suscept ible to bias due to confounding, this conclusion is based on evidence
f rom indirect test comparisons as evidence f rom direct comparisons was based on few studies or was unavailable. It should be noted that studies were generally of poor
methodological quality. The thresholds used for the tests were highly variable and there is current ly insuf f icient evidence to recommend specif ic thresholds for use in clinical
pract ice
1The sensit ivit ies were est imated along the SROC curves at the median specif icity across the studies included for the four
tests.
2Based on the sensit ivity est imated at the median specif icity of 0.90, and the median prevalence of 53.7% f rom the included
studies, the numbers of m issed H pylori cases were calculated using a hypothet ical cohort of 1000 people suspected of having
H pylori infect ion. The 95% CI for the number of m issed cases is f rom the 95% CI for sensit ivity. For a specif icity of 0.90 and
prevalence of 53.7%, there will be 46 false posit ives. See Table 3 for results for other values of specif icity and prevalence.
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D I S C U S S I O N
Summary of main results
We included 101 studies (11,003 participants) that evaluated the
diagnostic accuracy of different non-invasive methods for the di-
agnosis of H pylori. Of these 11,003 participants, 5839 partici-
pants (53.1%) had H pylori infection. The prevalence of H pylori
infection ranged from 15.2% to 94.7%. The median prevalence
was 53.7% (lower quartile: 42.0% and upper quartile: 66.5%).
The summary of results for urea breath test-13C, urea breath
test-14C, serology and stool antigen test is given in Summary of
findings. The studies used different thresholds and reference stan-
dards. As a result, there were few data for pooling sensitivities
and specificities at specific thresholds, and we mainly estimated
and compared SROC curves. The test comparison based on all
available data (99 studies) for the four tests showed a statistically
significant difference in diagnostic accuracy between the test (P =
0.024). There was no statistical evidence of a difference in diag-
nostic accuracy between urea breath test-13C and urea breath test-
14C, while serology and stool antigen test were inferior to both
urea breath tests. Direct comparisons are more reliable than indi-
rect comparisons, due to the potential for confounding in indirect
comparisons (Takwoingi 2013). However, we found few head-to-
head studies and meta-analysis was possible for only two pairwise
comparisons (urea breath test-13C versus serology, seven studies;
and urea breath test-13C versus stool antigen test, seven studies).
Most of the tests that used visual assessment (for example, appear-
ance of a pink-red line) were stool antigen tests, although some
serology tests also used visual assessment. Some serology and stool
antigen tests are therefore easy to use (stool antigen test is easier
to use as described below), but low diagnostic accuracy is a dis-
advantage when compared to urea breath tests. Urea breath test
is a cumbersome test and involves the use of radioisotopes; how-
ever, urea breath test-13C may be the most accurate test among
the non-invasive tests. This has implications in the screening of
individuals for H pylori as a decision has to be made regarding
the use of a cumbersome and relatively costly test but with good
diagnostic accuracy versus cheap tests that can be performed easily
but with lower diagnostic accuracy. A further decision to make
if one opts for easy-to-use tests is the threshold at which the test
should be used. For example, one can use a threshold that pro-
vides higher sensitivity (at the cost of lower specificity, necessitat-
ing endoscopic biopsy confirmation or treatment) or a threshold
that provides higher specificity (at the cost of lower sensitivity,
resulting in people with H pylori not being treated). Although at
first sight it appears that the treatment for H pylori is relatively
harmless and one would prefer a threshold at which the test has
higher sensitivity rather than higher specificity, the decision to give
antibiotics is not a straightforward one, because of the association
between unnecessary antibiotic use and development of antimi-
crobial resistance (Llor 2014). Serology and stool antigen test have
similar diagnostic test accuracy and the choice between the two
may be made based on ease of carrying out the tests. Only one
study included in this review used whole blood for performing
serology (Chey 1998). Even this test required a laboratory techni-
cian to interpret the test result (Chey 1998). So, there are no bed-
side tests available for serology testing. On the other hand, bed-
side kits with easy interpretation by colour changes are available
for stool antigen tests, making them easy to administer (Inelmen
2004; Jekarl 2013; Kuloglu 2008; Qadeer 2009; Trevisani 2005).
A cost-effectiveness study may clarify the most cost-effective non-
invasive test in people with suspectedH pylori, but it is difficult to
factor in the price of antimicrobial resistance to an individual as
the price of antimicrobial resistance is paid by future generations
(through increased mortality and decreased productivity), rather
than the individual for whom the treatment decision has to be
made (Taylor 2014).
Strengths and weaknesses of the review
We conducted a thorough literature search and included full-
text publications and abstracts without any language restrictions.
There are currently no reliable search strategies to identify diag-
nostic test accuracy studies (Beynon 2013).We did not use any di-
agnostic filter in our search strategy, thereby ensuring that studies
on the topic were identified. Two review authors independently
identified and extracted data from the studies, potentially decreas-
ing errors related to single data extraction. PCR methodology is
not standardised across laboratories and it is an unreliable refer-
ence standard (Chey 2007). Endoscopic biopsy followed by rapid
urease testing has poor sensitivity following treatment with pro-
ton pump inhibitors, and endoscopic biopsy with culture has high
specificity but poor sensitivity (Chey 2007). We used a strict ref-
erence standard (histology) which is likely to diagnose the target
condition with a high degree of accuracy. These are the major
strengths of the review.
Amajor limitation was the diversity of thresholds used in the stud-
ies. As a result, data were sparse for each threshold, which limited
estimation of summary sensitivities and specificities. Therefore
there is insufficient evidence to recommend specific thresholds for
each of the tests. Nonetheless, we were able to estimate and com-
pare SROC curves by including studies with different thresholds.
There was a high proportion of studies at high risk of bias and with
high concern regarding applicability in all the four domains of the
QUADAS-2 tool. This makes the validity and applicability of the
results questionable. The major concerns were lack of reporting
of the threshold used or when the thresholds were reported, there
was no information to judge whether the thresholds were prespec-
ified. Despite the lack of statistical evidence of an effect of type of
reference standard on test accuracy, as there were few studies for
each subgroup and other differences between studies, we cannot
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conclude that diagnostic accuracy does not depend on type of ref-
erence standard.
Comparison with other systematic reviews
We identified several relevant systematic reviews (Ferwana 2015;
Gisbert 2001; Gisbert 2004a; Loy 1996; Zhou 2014; Zhou 2017).
The findings from this review support those of Zhou 2017, and
Ferwana 2015, that urea breath test has high diagnostic accuracy
and that there was significant heterogeneity in the diagnostic ac-
curacy of the urea breath test (Zhou 2017). Our findings agree
with those of Zhou 2014 that stool antigen test has only modest
diagnostic test accuracy. The review findings are contrary to those
of Gisbert 2001, and Gisbert 2004a, which suggested that stool
antigen tests are highly accurate. This difference may be due to
the strict reference standards that we used in this review and how
we handled the issue of heterogeneity in thresholds. In agreement
with the findings of Loy 1996, the role of serology in clinical prac-
tice is uncertain, as stool antigen tests provide equivalent diagnos-
tic accuracy to serology and are easier to interpret.
Applicability of findings to the review question
This review included adults and children who underwent non-
invasive tests for the diagnosis of H pylori. Most of the studies
included only symptomatic people and so the findings of this
review are applicable only to people with symptoms. Most studies
excluded people who had previous gastrectomy and those who had
recent antibiotics or proton pump inhibitors. Hence, the findings
of this review are not applicable in these populations.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In people with no history of gastrectomy and those who have not
recently had antibiotics or proton pump inhibitors, urea breath
tests had high diagnostic accuracy while serology and stool antigen
tests had lower accuracy to detect H pylori infection. Although
susceptible to bias due to confounding, this conclusion is based on
evidence from indirect test comparisons, as evidence from direct
comparisons was based on few studies or was unavailable. There
was high or unclear risk of bias for many studies with respect to the
selection of participants, and the conduct and interpretation of the
index tests and reference standard. The thresholds used for these
tests were highly variable, thus there is insufficient evidence to
identify specific thresholds thatmight be useful in clinical practice.
Implications for research
Further comparative studies of high methodological quality are
necessary to obtain more reliable evidence of accuracy between
the tests (urea breath tests, serology, and stool antigen tests) in
people with upper gastrointestinal symptoms and people without
any symptoms suggestive of H pylori. Such studies should be con-
ducted prospectively in a representative spectrum of participants,
and be clearly reported to ensure low risk of bias. Most impor-
tantly, studies should pre-specify and clearly report the thresholds
used, should apply appropriate reference standards such as endo-
scopic biopsy with special stains, and should avoid inappropriate
exclusions.
A C K N OW L E D G E M E N T S
We thank the Cochrane Upper Gastrointestinal and Pancreatic
Diseases (UGPD) Group, and the DTA editorial team for their
advice in the preparation of this review. We thank the copy editors
for improving the readability of the review.
R E F E R E N C E S
References to studies included in this review
Adamopoulos 2009a {published data only}
Adamopoulos AB, Stergiou GS, Saklzlis GN, Tiniakos DG,
Nasothimiou EG, Sioutis DK, et al. Diagnostic value
of rapid urease test and urea breath test for Helicobacter
pylori detection in patients with Billroth ii gastrectomy:
A prospective controlled trial. Digestive and Liver Disease
2009;41(1):4–8.
Adamopoulos 2009b {published data only}
Adamopoulos AB, Stergiou GS, Saklzlis GN, Tiniakos DG,
Nasothimiou EG, Sioutis DK, et al. Diagnostic value
of rapid urease test and urea breath test for Helicobacter
pylori detection in patients with Billroth ii gastrectomy:
A prospective controlled trial. Digestive and Liver Disease
2009;41(1):4–8.
Aguilar 2007 {published data only}
Aguilar RC, Saavedra SP, Mendoza PG, Bussalleu RA, Cok
GJ, Martinez MF, et al. Study of urease test or breath
test (BT) and correlation with gastric biopsy to detect
Helicobacter pylori (hp) in dyspeptic patients at “Hospital
Nacional Cayetano Heredia hospital” (HNCH)--Lima.
Revista de Gastroenterologia del Peru 2007;27(2):172–6.
Al-Fadda 2000 {published data only}
Al-Fadda M, Powe J, Rezeig M, Al Nazer M, Alrajhi AA,
Baynton R. Comparison of carbon-14-urea breath test and
rapid urease test with gastric biopsy for identification of
28Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Helicobacter pylori. Annals of Saudi Medicine 2000;20(2):
170–2.
Allardyce 1997 {published data only}
Allardyce RA, Chapman BA, Tie ABM, Burt MJ, Yeo KJ,
Keenan JI, et al. 37 KBQ C-14-urea breath test and gastric
biopsy analyses of H-pylori infection. Australian and New
Zealand Journal of Surgery 1997;67(1):31–4.
Argentieri 2007 {published data only}
Argentieri M, Sabbi T, Pansani L, Torroni F, Francalanci P,
De Angelis P, et al. Helicobacter pylori infection in children:
Utility of culture in diagnosis and study of resistance to
metronidazole, clarithromycin and amoxicillin. Journal of
Pediatric Infectious Diseases 2007;2(3):135–9.
Arikan 2004 {published data only}
Arikan S, Kocakusak A, Barut G, Sengoz G, Yucel AF,
Gokturk K. Helicobacter pylori stool antigen test: Results
of a prospective study. Surgery Today 2004;34(4):318–22.
Atli 2012 {published data only}
Atli T, Sahin S, Arslan BU, Varli M, Yalcin AE, Aras S.
Comparison of the C14 urea breath test and histopathology
in the diagnosis of Helicobacter pylori in the elderly. Journal
of the Pakistan Medical Association 2012;62(10):1061–5.
Behrens 1999 {published data only}
∗ Behrens R, Lang T, Keller KM, Bindl L, Becker M,
Rodeck B, et al. Dual versus triple therapy of Helicobacter
pylori infection: Results of a multicentre trial. Archives of
Disease in Childhood 1999;81(1):68–70.
Behrens R, Lang T, Keller KM, Bindl L, Becker M, Rodeck
B, et al. Helicobacter pylori infection in children and
adolescents. Diagnosis and treatment. [German]. Tagliche
Praxis 2001;42(3):473–83.
Bosso 2000 {published data only}
Bosso S, Balbo L, Lerro P, Kuvidi M, Musso A, Ansaldi
N. Antigen detection in stools as a first choice for
laboratory diagnosis of Helicobacter pylori disease. Minerva
Gastroenterologica e Dietologica 2000;46(1):15–8.
Ceken 2011 {published data only}
Ceken N, Yurtsever SG, Baran N, Alper E, Buyrac Z, Unsal
B. Comparison of Helicobacter pylori antibody detection in
stool with other diagnostic tests for infection. Asian Pacific
Journal of Cancer Prevention 2011;12(4):1077–81.
Chen 1991 {published data only}
Chen CF, Lee MH, Ng JL, Lin CY, Yeh HW, Huang TW. A
rapid latex test for the serological diagnosis of Helicobacter
pylori. Chinese Journal of Gastroenterology 1991;8(4):
266–70.
Chey 1998 {published data only}
Chey WD, Murthy UK, Linscheer W, Barish C, Riff D,
Rubin H, et al. The ChemTrak Hp Chek fingerstick whole
blood serology test for the detection of Helicobacter pylori
infection. American Journal of Gastroenterology 1998;93(1):
16–9.
Czerwionka-Szaflarska 2007 {published data only}
Czerwionka-Szaflarska M, Brazowski J, Kupczyk W. Value
of urease breath test in Helicobacter pylori infection
diagnostics among children and youth. Medycyna Wieku
Rozwojowego 2007;11(2 Pt 1):97–101.
D’Elios 2000 {published data only}
D’Elios MM, Amedei A, Benagiano M, Azzurri A, Del Prete
G. Usefulness of 13C-urea breath test in the diagnosis of
gastric Helicobacter pylori infection. International Journal
of Immunopathology and Pharmacology 2000;13(1):27–30.
Debongnie 1991 {published data only}
Debongnie JC, Pauwels S, Raat A, De Meeus Y, Haot J,
Mainguet P. Quantification of Helicobacter pylori infection
in gastritis and ulcer disease using a simple and rapid
carbon-14-urea breath test. Journal of Nuclear Medicine
1991;32(6):1192–8.
Dede 2015 {published data only}
Dede F, Civen H, Dane F, Aliustaoglu M, Turhal S, Turoglu
HT, et al. Carbon-14 urea breath test: Does it work in
patients with partial gastric resection?. Annals of Nuclear
Medicine 2015;29(9):786–91.
Delvin 1999 {published data only}
Delvin EE, Brazier JL, Deslandres C, Alvarez F, Russo
P, Seidman E. Accuracy of the [13C]-urea breath test in
diagnosing Helicobacter pylori gastritis in pediatric patients.
Journal of Pediatric Gastroenterology and Nutrition 1999;28
(1):59–62.
Dinler 1999 {published data only}
Dinler G, Ozen H, Kocak N, Yuce A, Gurakan F. Detection
of Helicobacter pylori infection. American Journal of
Gastroenterology 1999;94(4):1118.
Duan 1999 {published data only}
Duan L, Duan X, Ye S, Wang J, Jin Z, Wang Z. The
diagnostic value of 13C-urea breath test in Helicobacter
pylori colonization density and the severity of gastritis.
Zhonghua Nei Ke za Zhi [Chinese Journal of Internal
Medicine] 1999;38(12):824–6.
Eggers 1990 {published data only}
Eggers RH, Kulp A, Tegeler R, Ludtke FE, Lepsien G,
Meyer B, et al. A methodological analysis of the c-13-urea
breath test for detection of Helicobacter-pylori infections
- high-sensitivity and specificity within 30-min using 75-
mg of c-13-urea. European Journal of Gastroenterology &
Hepatology 1990;2(6):437–44.
Ekesbo 2006 {published data only}
Ekesbo R, Toth E, Fork FT, Held M, Nilsson I, Wadstrom
T, et al. Chronic Helicobacter pylori infection in a
population in southern Sweden analysed by histopathology,
immunoblot and ELISA serology. European Journal of
Gastroenterology & Hepatology 2006;18(6):589–93.
El-Din 2013 {published data only}
El-Din HMA, Hashem AGM, Ragab YM, Hussein IL,
Mohamed DB, Mohamed EB. Evaluation of noninvasive
versus invasive techniques for the diagnosis of Helicobacter
pylori infection. Applied Immunohistochemistry & Molecular
Morphology 2013;21(4):326–33.
29Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
El-Mekki 2011 {published data only}
El-Mekki A, Kumar A, Alknawy B, Al-Ammari O, Moosa
R, Quli S, et al. Comparison of enzyme immunoassays
detecting Helicobacter pylori specific IgG in serum and
saliva with endoscopic and biopsy findings in patients with
dyspepsia. Indian Journal of Medical Microbiology 2011;29
(2):136–40.
El-Nasr 2003 {published data only}
El-Nasr MS, Elibiary SA, Bastawi MB, Hassan A, Shahin Y,
Hassan L, et al. Evaluation of a new enzyme immunoassay
for the detection of Helicobacter pylori in stool specimens.
Journal of the Egyptian Society of Parasitology 2003;33(3):
905–15.
Eltumi 1999 {published data only}
Eltumi M, Brueton MJ, Francis N. Diagnosis of
Helicobacter pylori gastritis in children using the 13C urea
breath test. Journal of Clinical Gastroenterology 1999;28(3):
238–40.
Epple 1997 {published data only}
Epple HJ, Kirstein FW, Bojarski C, Frege J, Fromm M,
Riecken EO, et al. 13C-urea breath test in Helicobacter
pylori diagnosis and eradication. Correlation to histology,
origin of ’false’ results, and influence of food intake.
Scandinavian Journal of Gastroenterology 1997;32(4):
308–14.
Fallone 1995 {published data only}
Fallone CA, Mitchell A, Paterson WG. Determination of
the test performance of less costly methods of Helicobacter
pylori detection. Clinical and Investigative Medicine.
Medecine Clinique et Experimentale 1995;18(3):177–85.
Fallone 1996 {published data only}
Fallone CA, Elizov M, Cleland P, Thompson JA, Wild GE,
Lough J, et al. Detection of Helicobacter pylori infection
by saliva IgG testing. American Journal of Gastroenterology
1996;91(6):1145–9.
Fanti 1999 {published data only}
Fanti L, Mezzi G, Cavallero A, Gesu G, Bonato C, Masci
E. A new simple immunoassay for detecting Helicobacter
pylori infection: Antigen in stool specimens. Digestion
1999;60(5):456–60.
Faruqui 2007 {published data only}
Faruqui AN, Majid U, Ahmed L, Khalil M, ul Hassan
M. Helicobacter pylori stool antigen test (HpSA) for the
diagnosis of gastric infection. Journal of the College of
Physicians and Surgeons Pakistan 2007;17(6):316–9.
Ferrara 1998 {published data only}
Ferrara M, Apuzzo M, Bazuro ME, Tammaro GF, Pippa
G. Serology screening for Helicobacter pylori in dyspeptic
patients. Giornale Italiano di Endoscopia Digestiva 1998;21
(1):15–22.
Formichella 2013 {published data only}
∗ Formichella L, Romberg L, Bolz C, Vieth M, Geppert
M, Gottner G, et al. A novel line immunoassay based
on recombinant virulence factors enables highly specific
and sensitive serologic diagnosis of Helicobacter pylori
infection. Clinical & Vaccine Immunology: CVI 2013;20
(11):1703–10.
Gholi MK, Kalali B, Formichella L, Gottner G, Shamsipour
F, Zarnani AH, et al. Helicobacter pylori FliD protein is a
highly sensitive and specific marker for serologic diagnosis
of H. pylori infection. International Journal of Medical
Microbiology 2013;303(8):618–23.
Germana 2001 {published data only}
∗ Germana B, Galliani E, Lecis P, Costan F. Diagnosis of
Helicobacter pylori infections using isotope-selective non
dispersive infrared spectrometry with 13C-urea breath test.
Recenti Progressi in Medicina 2001;92(2):113–6.
Germana B, Galliani EA, Lecis PE, Doglioni C, Costan F.
Isotope-selective non dispersive infrared spectrometry for
detection of Helicobacter-pylori infection with c-13-urea
breath test. Gut 1999;45(Suppl 3):A130.
Graham 1996a {published data only}
Graham DY, Evans DJ Jr, Peacock J, Baker JT, Schrier
WH. Comparison of rapid serological tests (Flexsure Hp
and Quickvue) with conventional ELISA for detection
of Helicobacter pylori infection. American Journal of
Gastroenterology 1996;91(5):942–8.
Gramley 1999 {published data only}
Gramley WA, Asghar A, Frierson HF Jr, Powell SM.
Detection of Helicobacter pylori DNA in fecal samples
from infected individuals. Journal of Clinical Microbiology
1999;37(7):2236–40.
Guo 2011 {published data only}
Guo JX, Han J, Chen L, Xu J, Liu J, Zhao J, et al. Evaluation
of the Helicobacter pylori stool antigen test. Zhonghua Shi
Yan He Lin Chuang Bing du Xue za Zhi [Chinese Journal of
Experimental and Clinical Virology] 2011;25(6):495–6.
Gurbuz 2005 {published data only}
Gurbuz AK, Ozel AM, Narin Y, Yazgan Y, Baloglu H,
Demirturk L. Is the remarkable contradiction between
histology and c-14 urea breath test in the detection of
Helicobacter pylori due to false-negative histology or false-
positive c-14 urea breath test?. Journal of International
Medical Research 2005;33(6):632–40.
Hafeez 2007 {published data only}
Hafeez A, Bilal R, Haseeb HA, Khan UF, Latif Z, Hassan
M. Comparison of diagnostic accuracy of non-invasive tests
for Helicobacter pylori infection in children. Journal of the
College of Physicians and Surgeons--Pakistan : JCPSP 2007;
17(5):261–4.
Han 2012 {published data only}
Han H, Lee S, Hwang T. The significance of positive giemsa
stain cases in negative UBT (urea breath test) patients.
Helicobacter 2012;17:117.
Inelmen 2004 {published data only}
Inelmen EM, Gasparini G, Sergi G, Enzi G. Evaluation of
Helicobacter pylori with a stool antigen assay in frail, elderly
patients. Scandinavian Journal of Gastroenterology 2005;40
(7):794–9.
∗ Inelmen EM, Maccari T, Enzi G, Gasparini G, Fuson F,
Davanzo B, et al. Helicobacter pylori infection diagnosis
30Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
in hospitalised elderly patients: The stool antigen test
(HpSA) in comparison with other methods. Aging-Clinical
& Experimental Research 2004;16(5):349–55.
Iqbal 2013 {published data only}
Iqbal S, Fatima S, Raheem A, Khan AH. Agreement between
serology and histology for detection of Helicobacter pylori
infection. Journal of the College of Physicians and Surgeons--
Pakistan : JCPSP 2013;23(10):784–6.
Islam 2005 {published data only}
Islam S, Weilert F, Babington R, Dickson G, Smith AC.
Stool antigen testing for the diagnosis and confirmation of
eradication of Helicobacter pylori infection: A prospective
blinded trial. Internal Medicine Journal 2005;35(9):526–9.
Ivanova 2010 {published data only}
Ivanova K, Marina M, Vladimirov B, Churchev J, Tersiev
I. Comparison of different methods for detection of
Helicobacter pylori infection. Problems of Infectious and
Parasitic Diseases 2010;38(1):25–7.
Jekarl 2013 {published data only}
Jekarl DW, An YJ, Lee S, Lee J, Kim Y, Park YJ, et
al. Evaluation of a newly developed rapid stool antigen
test using an immunochromatographic assay to detect
Helicobacter pylori. Japanese Journal of Infectious Diseases
2013;66(1):60–4.
Jensen 1998 {published data only}
Jensen G, Friedenberg F, Levine G, Zaeri N, Braitman LE,
Tran HD, et al. Accuracy and clinical utility of the mini-
dose c-14-urea breath test in the evaluation of Helicobacter
pylori infection. Nuclear Medicine Communications 1998;
19(8):771–5.
Jordaan 2008 {published data only}
Jordaan M, Laurens JB. Diagnosis of Helicobacter pylori
infection with the c-13-urea breath test by means of GC-MS
analysis. Journal of Separation Science 2008;31(2):329–35.
Kalach 1998a {published data only}
Kalach N, Briet F, Raymond J, Benhamou PH, Barbet P,
Bergeret M, et al. The 13Carbon urea breath test for the
noninvasive detection of Helicobacter pylori in children:
Comparison with culture and determination of minimum
analysis requirements. Journal of Pediatric Gastroenterology
& Nutrition 1998;26(3):291–6.
Kamel 2011 {published data only}
Kamel HY, Abd-Al-Atty MF, El-Banoby MH, El-Baz AA,
Sakr MA, Ahmed NS, et al. Stool antigen test in diagnosis of
Helicobacter pylori in older adults with dyspepsia. Journal
of the American Geriatrics Society 2011;59(9):1769–70.
Kim 2016 {published data only}
Kim DH, Kim HD, Park H, Choi S, Beom JW, KimWJ, et
al. New monoclonal antibody-based test for Helicobacter
pylori urease in gastric tissue. Korean Journal of Internal
Medicine 2016;31(1):40–5.
Korstanje 2006 {published data only}
Korstanje A, Van Eeden S, Offerhaus GJ, Sabbe LJ, Den
Hartog G, Biemond I, et al. The 13Carbon urea breath
test for the diagnosis of Helicobacter pylori infection in
subjects with atrophic gastritis: Evaluation in a primary care
setting. Alimentary Pharmacology & Therapeutics 2006;24
(4):643–50.
Kuloglu 2008 {published data only}
Kuloglu Z, Kansu A, Kirsaclioglu CT, Ustundag G, Aysev
D, Ensari A, et al. A rapid lateral flow stool antigen
immunoassay and (14)C-urea breath test for the diagnosis
and eradication of Helicobacter pylori infection in children.
Diagnostic Microbiology & Infectious Disease 2008;62(4):
351–6.
Ladas 2002a {published data only}
Ladas SD, Malamou H, Triantafyllou K, Varzakakos I,
Georgopoulos S, Giota G, et al. Performance of two
immunosorbent assay kits for the detection of serum
immunoglobulin G to Helicobacter pylori in untreated
Greek patients. Scandinavian Journal of Gastroenterology
2002;37(5):512–6.
Lahner 2004 {published data only}
Lahner E, Vaira D, Figura N, Pilozzi E, Pasquali A, Severi
C, et al. Role of noninvasive tests (c-13-urea breath test
and stool antigen test) as additional tools in diagnosis of
Helicobacter pylori infection in patients with atrophic body
gastritis. Helicobacter 2004;9(5):436–42.
Lee 1998 {published data only}
Lee HS, Gwee KA, Teng LY, Kang JY, Yeoh KG, Wee A, et
al. Validation of [13C]urea breath test for Helicobacter
pylori using a simple gas chromatograph-mass selective
detector. European Journal of Gastroenterology & Hepatology
1998;10(7):569–72.
Logan 1991a {published data only}
Logan RP, Polson RJ, Misiewicz JJ, Rao G, Karim NQ,
Newell D, et al. Simplified single sample 13Carbon urea
breath test for Helicobacter pylori: Comparison with
histology, culture, and ELISA serology. Gut 1991;32(12):
1461–4.
Lombardo 2003 {published data only}
Lombardo L, Masoero G, Della Monica P, Crocella L,
Ruggia O, Ravarino N, et al. Multiple sampling 13C-urea
breath test: Improvement of diagnosis in postgastrectomy
patients. Minerva Gastroenterologica e Dietologica 2003;49
(3):181–6.
Lottspeich 2007 {published data only}
Lottspeich C, Schwarzer A, Panthel M, Koletzko S,
Russmann H. Evaluation of the novel Helicobacter
pylori ClariRes real-time PCR assay for detection and
clarithromycin susceptibility testing of h.pylori in stool
specimens from symptomatic children. Journal of Clinical
Microbiology 2007;45(6):1718–22.
Luthra 1998 {published data only}
Luthra GK, DiNuzzo AR, Gourley WK, Crowe SE.
Comparison of biopsy and serological methods of diagnosis
of Helicobacter pylori infection and the potential role of
antibiotics. American Journal of Gastroenterology 1998;93
(8):1291–6.
31Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mana 2001a {published data only}
∗ Mana F, Franken PR, Ham HR, Urbain D. Cut-off point,
timing and pitfalls of the c-13-urea breath test as measured
by infrared spectrometry. Digestive and Liver Disease 2001;
33(1):30–5.
Mana F, Fried M, Ham HR, Lacor P, Vandenplas Y, Urbain
D. Evaluation of a 10 minute c-13-urea breath test for the
diagnosis of Helicobacter pylori infection, as measured by
infrared spectrometry. Gastroenterology 2000;118(4 Part 1):
A508.
Mansour-Ghanaei 2011 {published data only}
Mansour-Ghanaei F, Sanaei O, Joukar F. Clinical validation
of an office-based C-14-UBT (Heliprobe) for H. Pylori
diagnosis in Iranian dyspeptic patients. Gastroenterology
Research and Practice 2011 Jun 22 [Epub ahead of print].
[DOI: 10.1155/2011/930941
Mion 1994 {published data only}
Mion F, Delecluse HJ, Rousseau M, Berger F, Brazier
JL, Minaire Y. 13C-urea breath test for the diagnosis
of Helicobacter infection. Comparison with histology.
Gastroenterologie Clinique et Biologique 1994;18(12):
1106–11.
Misawa 1998 {published data only}
Misawa K, Kumagai T, Shimizu T, Furihata K, Ota H,
Akamatsu T, et al. A new histological procedure for re-
evaluation of the serological test for Helicobacter pylori.
European Journal of Clinical Microbiology & Infectious
Diseases 1998;17(1):14–9.
Mohammadian 2007 {published data only}
Mohammadian T, Hagh-Zare M, Aria H, Doosti M,
Paknejad M, Siavoshi F, et al. Comparison of serologic
ELISA and histopathologic findings in diagnosis of
Helicobacter pylori infection in Iran. Helicobacter 2007;12
(4):446.
Monteiro 2001a {published data only}
Monteiro L, De Mascarel A, Sarrasqueta AM, Bergey B,
Barberis C, Talby P, et al. Diagnosis of Helicobacter pylori
infection: Noninvasive methods compared to invasive
methods and evaluation of two new tests. American Journal
of Gastroenterology 2001;96(2):353–8.
Morales 1995 {published data only}
Morales EOS, Vorackova FV, Perez JDV, Alonso SS, Angeles
AA, Rivera JE, et al. Optimization of the c-14 urea breath
test for the detection of Helicobacter-pylori in dyspeptic
patients. Revista De Investigacion Clinica 1995;47(2):
109–16.
Noguera 1998 {published data only}
Noguera ECA, Hames W, Bertola S, Mothe G. Helicobacter
pylori: C-14 urea breath test in clinical practice in a general
hospital. Medicina-Buenos Aires 1998;58(1):45–50.
Novis 1991 {published data only}
Novis BH, Gabay G, Leichtmann G, Peri M, Bernheim J,
Pomeranz IS. Two point analysis 15-minute 14c-urea breath
test for diagnosing Helicobacter pylori infection. Digestion
1991;50(1):16–21.
Ogata 2001 {published data only}
Ogata SK, Kawakami E, Patricio FR, Pedroso MZ, Santos
AM. Evaluation of invasive and non-invasive methods
for the diagnosis of Helicobacter pylori infection in
symptomatic children and adolescents. Sao Paulo Medical
Journal 2001;119(2):67–71.
Ozturk 2003 {published data only}
Ozturk E, Yesilova Z, Ilgan S, Arslan N, Erdil A, Celasun
B, et al. A new, practical, low-dose 14c-urea breath test
for the diagnosis of Helicobacter pylori infection: Clinical
validation and comparison with the standard method.
European Journal of Nuclear Medicine & Molecular Imaging
2003;30(11):1457–62.
Peitz 2001 {published data only}
Peitz U, Baumann M, Tillenburg B, Borsch G, Stolte
M, Malfertheiner P, et al. Insufficient validity of a rapid
blood test for diagnosis of Helicobacter pylori infection.
Medizinische Klinik 2001;96(12):703–7.
Peura 1996 {published data only}
Peura DA, Pambianco DJ, Dye KR, Lind C, Frierson HF,
Hoffman SR, et al. Microdose c-14-urea breath test offers
diagnosis of Helicobacter pylori in 10 minutes. American
Journal of Gastroenterology 1996;91(2):233–8.
Puspok 1999 {published data only}
Puspok A, Bakos S, Oberhuber G. A new, non-invasive
method for detection of Helicobacter pylori: Validity in the
routine clinical setting. European Journal of Gastroenterology
& Hepatology 1999;11(10):1139–42.
Qadeer 2009 {published data only}
Qadeer AS, Kharal SA, Baig MF, Badvi JA, Durrani MA.
Detection of Helicobacter pylori antigen in stool. Journal of
the Liaquat University of Medical and Health Sciences 2009;8
(2):126–30.
Rafeey 2007 {published data only}
Rafeey M, Nikvash S. Detection of Helicobacter pylori
antigen in stool samples for diagnosis of infection in
children. Eastern Mediterranean Health Journal 2007;13(5):
1067–72.
Rasool 2007 {published data only}
∗ Rasool S, Abid S, Jafri W. Validity and cost comparison
of 14carbon urea breath test for diagnosis of H pylori in
dyspeptic patients. World Journal of Gastroenterology 2007;
13(6):925–9.
Rasool S, Abid S, Mumtaz K, Shah HA, Hamid S, Islam
M, et al. C-14-urea breath test: A reliable and practical test
in office-based diagnosis of Helicobacter pylori infection.
Helicobacter 2005;10(5):525.
Rathbone 1986 {published data only}
Rathbone BJ, Wyatt J, Tompkins D, Heatley RV, Losowsky
MS. Diagnostic IgG ELISA for gastric campylobacter-
pyloridis infection using serum samples. Gut 1986;27(5):
A607.
Safe 1993 {published data only}
Safe AF, Warren B, Corfield A, McNulty CA, Watson B,
Mountford RA, et al. Helicobacter-pylori infection in
32Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
elderly people - correlation between histology and serology.
Age and Ageing 1993;22(3):215–20.
Salles-Montaudon 2002 {published data only}
Salles-Montaudon N, Dertheil S, Broutet N, Gras N,
Monteiro L, De Mascarel A, et al. Detecting Helicobacter
pylori infection in hospitalized frail older patients: The
challenge. Journal of the American Geriatrics Society 2002;50
(10):1674–80.
Schilling 2001 {published data only}
Schilling D, Jakobs R, Peitz U, Sugilla M, Stolte M,
Riemann JF, et al. The diagnostic accuracy of (13)C0urea
breath test in diagnosis of Helicobacter pylori (hp) infection
in patients with partial gastric resection due to peptic ulcer
disease. Gastroenterology 1999;116(4 suppl):A304.
∗ Schilling D, Jakobs R, Peitz U, Sulliga M, Stolte M,
Riemann JF, et al. Diagnostic accuracy of c-13-urea breath
test in the diagnosis of Helicobacter pylori infection in
patients with partial gastric resection due to peptic ulcer
disease - a prospective multicenter study. Digestion 2001;63
(1):8–13.
Scuderi 2000 {published data only}
Scuderi G, Celi D, Romagnolo M, Lupi A, Alecci L,
Dramissino I, et al. Helicobacter pylori: Use of a stool
antigen detection test and a six-day triple therapy [2].
Digestive and Liver Disease 2000;32(1):71–3.
Segamwenge 2014 {published data only}
Segamwenge IL, Kagimu M, Ocama P, Opio K. The utility
of the Helicobacter pylori stool antigen test in managing
dyspepsia: An experience from a low resource setting.
African Health Sciences 2014;14(4):829–34.
Selcukcan 2011 {published data only}
Selcukcan Aydin F, Demirkiran Urganci N, Uzum Yenici
FU. Comparison of methods in diagnosis of gastritis
originated from Helicobacter pylori in pediatric age, and
use of urea breath test as a noninvasive technique in post-
treatment follow-up of the patient. Duzce Medical Journal
2011;13(1):6–14.
Sharbatdaran 2013 {published data only}
Sharbatdaran M, Kashifard M, Shefaee S, Siadati S, Jahed
B, Asgari S. Comparison of stool antigen test with gastric
biopsy for the detection of Helicobacter pylori infection.
Pakistan Journal of Medical Sciences 2013;29(1):68–71.
Sheu 1998a {published data only}
Sheu BS, Lee SC, Lin PW, Chang YC, Yang SB, Lin XZ.
Diagnostic efficacy of carbon 13 urea breath test to detect
H. pylori in patients after gastrectomy. Gut 1998;43(Suppl
2):A57.
Sheu 1998b {published data only}
Sheu BS, Lee SC, Lin PW, Chang YC, Yang SB, Lin XZ.
Diagnostic efficacy of carbon 13 urea breath test to detect
H. pylori in patients after gastrectomy. Gut 1998;43(Suppl
2):A57.
Shin 2009 {published data only}
Shin CM, Kim N, Lee HS, Lee HE, Lee SH, Park YS, et
al. Validation of diagnostic tests for Helicobacter pylori
with regard to grade of atrophic gastritis and/or intestinal
metaplasia. Helicobacter 2009;14(6):512–9.
Soomro 2012 {published data only}
∗ Soomro RA, Abro AK, Ujjan ID, Ibraheem Z, Farooq M.
Comparison of two diagnostic methods for detection of
H.pylori i.e., gastric biopsy by H&E & Giemsa and serum
anti H.pylori antibodies. Pakistan Journal of Medical and
Health Sciences 2012;6(3):552–4.
Soomro RA, Sheikh TA, Memon AI, Pathan NA, Qazi N.
Two easy and early methods for the diagnosis of H.pylori
i.e.: serum anti H.pylori antibodies and stool antigen.
Journal of the Liaquat University of Medical and Health
Sciences 2013;12(2):87–90.
Surveyor 1989 {published data only}
Surveyor I, Goodwin CS, Mullan BP, Geelhoed E, Warren
JR, Murray RN, et al. The c-14-urea breath-test for the
detection of gastric campylobacter-pylori infection. Medical
Journal of Australia 1989;151(8):435–9.
Thobani 1995 {published data only}
Thobani S, Jafri SMW, Ferrell L, Perezperez GI, Hasan SH,
Blaser MJ, et al. Detection of Helicobacter-pylori gastritis
in Pakistan - efficacy of an IgG ELISA based on a United-
States population. Gastroenterology 1995;108(4 suppl):
A241.
Tiwari 2014 {published data only}
Tiwari BP, Nistala S, Patil SP, Kalgutkar DP, Jaychandran
N, Chander H, et al. Evaluation of the c-14-urea breath
test using indigenously produced c-14-urea capsules and a
modified technique for trapping exhaled breath: A pilot
study. Nuclear Medicine Communications 2014;35(3):
325–30.
Trevisani 2005 {published data only}
Trevisani L, Sartori S, Rossi MR, Ruina M, Matarese V,
Gullini S, et al. Evaluation of a new rapid immunoassay for
the detection of Helicobacter pylori in faeces: A prospective
pilot study. Alimentary Pharmacology & Therapeutics 2005;
21(4):485–9.
Vandenplas 1992 {published data only}
Vandenplas Y, Blecker U, Devreker T, Keppens E, Nijs J,
Cadranel S, et al. Contribution of the 13C-urea breath test
to the detection of Helicobacter pylori gastritis in children.
Pediatrics 1992;90(4):608–11.
Villalobos 1992 {published data only}
Villalobos Perez JJ, Sanchez Morales EO, Vargas Vorackova
F, Sixtos Alonso S, Angeles Angeles A, Elizondo Rivera J, et
al. Usefulness of the 14c-urea marked test in the detection
of Helicobacter pylori in patients with dyspepsia. Revista de
Gastroenterologia de Mexico 1992;57(3):167–71.
Wang 2008 {published data only}
Wang XY, Yang Y, Shi RH, Ho B, Wang HD, Zhang GX.
An evaluation of a serologic test with a current infection
marker of Helicobacter pylori before and after eradication
therapy in Chinese. Helicobacter 2008;13(1):49–55.
Wardi 2012 {published data only}
Wardi J, Shalev T, Shevah O, Boaz M, Avni Y, Shirin H.
A rapid continuous-real-time c-13-urea breath test for the
33Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
detection of Helicobacter pylori in patients after partial
gastrectomy. Journal of Clinical Gastroenterology 2012;46
(4):293–6.
Weiss 1994 {published data only}
Weiss J, Mecca J, Da Silva E, Gassner D. Comparison
of PCR and other diagnostic techniques for detection of
Helicobacter pylori infection in dyspeptic patients. Journal of
Clinical Microbiology 1994;32(7):1663–8.
Yan 2003 {published data only}
Yan S, Lin Q, Song Y, Wang S. Detection of Helicobacter
pylori stool antigen by non-invasive enzyme immunoassay.
Chinese Medical Sciences Journal 2003;18(4):218–21.
Yoshimura 2001 {published data only}
Yoshimura N, Tajiri H, Sawada A, Kozaiwa K, Ida S,
Fujisawa T, et al. A c-13-urea breath test in children with
Helicobacter pylori infection: Assessment of eradication
therapy and follow-up after treatment. Journal of
Gastroenterology 2001;36(9):606–11.
Yu 1999 {published data only}
Yu WK, Chow PKH, Tan SY, Ng EH, Goh ASW, Soo KC,
et al. Five micro-curie urea breath test for the diagnosis of
Helicobacter pylori infection: Evaluation in a south-east
Asian population. Australian and New Zealand Journal of
Surgery 1999;69(1):37–40.
Yu 2001 {published data only}
Yu FJ, Wu DC, Kuo CH, Lu CY, Su YC, Lee YC, et al.
Diagnosis of Helicobacter pylori infection by stool antigen
test in southern Taiwan. Kaohsiung Journal of Medical
Sciences 2001;17(7):344–50.
References to studies awaiting assessment
Buhigas-Garcia 2008 {published data only}
Buhigas-Garcia I, Herrero-Alonso MC, Barrio-Merino A.
From laboratory to clinic: 13-c urea breath test [Test de urea
marcada con carbono 13]. Anales de Pediatria Continuada
2008;6(3):155–8. appswl.elsevier.es/watermark/ctl˙servlet?
˙f=10&pident˙articulo=80000328&pident˙usuario=0&
pcontactid=&pident˙revista=51&ty=30&accion=L&
origen=apccontinuada&web=www.apcontinuada.com&
lan=es&fichero=v6n3a328pdf001.pdf&anuncioPdf=
ERROR˙publi˙pdf ]
Fazeli 2004 {published data only}
Fazeli A, Safaei HG, Tamizifar H, Rashidi N, Medimond.
Diagnosis of Helicobacter pylori infection by salivary
immunoglobulin g. Immunology 2004: Immunodeficiency,
Infectious Diseases, Immunomodulation, and Vaccines.
12th Annual International Congress of Immunology/
4th Annual Conference of the Federation-of-Clinical-
Immunology-Societies (FOCIS); 2004 Jul 18-23; Montreal.
2004:79–82.
Fuke 2009 {published data only}
Fuke A, Kunita S, Goto K, Sugiyama F, Yagami K. Diagnosis
method based on sandwich ELISA using Helicobacter
hepaticus-specific monoclonal antibody. Journal of the
American Association for Laboratory Animal Science 2009;48
(5):634–5.
Glupczynski 1991 {published data only}
Glupczynski Y, Bourdeaux L, Vantricht L, Depre M,
Balegamire B, Devos D, et al. C-14-urea breath test (ubt),
an efficacious tool for studying Helicobacter-pylori (hp)
epidemiology in developing-countries - a study in Zaire.
Nuclear Medicine 1991;27:253–5.
Karczewska 1997 {published data only}
Karczewska E, Kacka K, Bielanski W, Plonka M, Zarzycki
D, Konturek SJ, et al. The seroprevalence of IgG antibodies
to h-pylori caga protein in asymptomatic children assessed
by helico blot 2.0 and ELISA methods. Gut 1997;41:A70.
Kushch 2014 {published data only}
Kushch I, Korenev N, Kamarchuk L, Pospelov A,
Alexandrov Y, Kamarchuk G, et al. New possibilities
in diagnosing Helicobacter pylori infection by the non-
urease products of its activity. 8th World Congress of the
World Society for Pediatric Infectious Diseases (WSPID);
2013 Nov 20-23; Cape Town. Bologna: MEDIMOND
International, 2014:89–92.
Lappas 1997 {published data only}
Lappas A, Bogdanos D, Konstantinou G, Bokolas G,
Ioannidis K, Boura P, et al. The value of the saliva-
dental plaque urease test in the diagnosis and treatment of
Helicobacter pylori infection associated with peptic ulcer
disease. Archives of Hellenic Medicine 1997;14(3):330–4.
Lee 1999a {published data only}
Lee G, Chun HJ, Lee SJ, Kim KH, Jeen YT, Song CW, et al.
Significance of c-13-urea breath test results: Delta(co2)-c-
13 as a predictor of Helicobacter pylori density and activity
of gastritis in gastric body. Gastrointestinal Endoscopy 1999;
49(4):AB191–AB.
Martin-de-Argila 1997 {published data only}
Martin-de-Argila C, Boixeda D, Canton R, Valdezate S,
Mir N, De Rafael L, et al. Usefulness of the combined
igg and iga antibody determinations for serodiagnosis
of Helicobacter pylori infection. European Journal of
Gastroenterology & Hepatology 1997;9(12):1191–6.
Mason 1997 {published data only}
Mason CL, Wong WW. The urea breath test for
Helicobacter pylori: A direct application of stable isotope
mass spectrometry. Abstracts of Papers of the American
Chemical Society 1997;213:274–CHED.
Thong-Ngam 2011 {published data only}
Thong-Ngam D, Chayanupatkul M, Vongchampa P,
Hanvivatvong O. An evaluation of a new in-house serum
and urine ELISA test for detection of Helicobacter pylori
infection in Thai population. Journal of the Medical
Association of Thailand 2011;94(8):985–90.
Tokunaga 2005a {published data only}
Tokunaga K, Tanaka A, Takahashi S. Evaluation of
diagnostic method for Helicobacter pylori infection.
Nippon Rinsho [Japanese Journal of Clinical Medicine] 2005;
63 Suppl 11:403–8.
Xu 1995 {published data only}
Xu C, Xu H, Cheng S. 14c-urea breath test in the diagnosis
of Helicobacter pylori infection in the stomach. Zhonghua
34Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Nei Ke Za Zhi [Chinese Journal of Internal Medicine] 1995;
34(4):239–42.
Additional references
Abadi 2011
Abadi ATB, Taghvaei T, Wolfram L. Inefficiency of rapid
urease test for confirmation of Helicobacter pylori. Saudi
Journal of Gastroenterology 2011;17(1):84–5.
Abdullah 1997a
Abdullah AM, Gad el Rab MO, al Ayed I, Kambal AM, al
Sohaibani M, al Mazyad AL. Helicobacter pylori infection
in children in Saudi Arabia. Tropical Gastroenterology 1997;
18(2):63–5.
Abdullah 1997b
Abdullah AM, Gad el Rab MO, al Ayed I, al Mazyad AS, al
Sanie A. Comparison of Helicobacter pylori antibody levels
in children in Riyadh. Tropical Gastroenterology 1997;18(2):
65–6.
Abdulqawi 2012
Abdulqawi K, El-Mahalaway AM, Abdelhameed A,
Abdelwahab AA. Correlation of serum antibody titres with
invasive methods for rapid detection of Helicobacter pylori
infections in symptomatic children. International Journal of
Experimental Pathology 2012;93(4):295–304.
Abu 2015
Abu Shady MM, Fathy HA, Ali A, Galal EM, Fathy GA,
Sibaii H. Comparison of serum IgG antibody test with
gastric biopsy for the detection of Helicobacter pylori
infection among Egyptian children. Macedonian Journal of
Medical Sciences 2015;3(2):303–6.
Abu-Sbeih 2014
Abu-Sbeih RS, Hawari AD, Hassawi DS, Al-Daghistani
HI. Isolation and detection of Helicobacter pylori from
patients suffering from peptic ulcer using biochemical tests
and molecular techniques. American Journal of Biochemistry
and Biotechnology 2014;10(1):58–68.
Abukhadir 1998
Abukhadir BA, Heneghan MA, Kearns M, Little CL,
McCarthy CF. Evaluation of a 20 minute C-14 urea breath
test for the diagnosis of Helicobacter pylori infection. Irish
Medical Journal 1998;91(1):23–5.
Abut 2006
Abut E, Guveli H, Kurdas OO. Diagnostic tests used for the
detection of Helicobacter pylori. Sendrom 2006;18(3):53–9.
Aceti 1989
Aceti A, Pennica A, Leri O, Caferro M, Grilli A, Celestino D,
et al. Time-resolved fluoroimmunoassay for campylobacter
pylori antibodies. Lancet 1989;2(8661):505.
Adachi 2002
Adachi K, Kawamura A, Ono M, Masuzaki K, Takashima
T, Yuki M, et al. Comparative evaluation of urine-based
and other minimally invasive methods for the diagnosis of
Helicobacter pylori infection. Journal of Gastroenterology
2002;37(9):703–8.
Adamczyk 2013
Adamczyk M, Peczek , Rudnicki C, Nawrot B, Stec-
Michalska K. The clinical significance of GastroPanel in
diagnostics of Helicobacter pylori eradication efficiency in
patients with dyspepsia with correlation of family history
of gastric cancer. Polski Merkuriusz Lekarski 2013;35(207):
141–7.
Adamek 1994
Adamek RJ, Freitag M, Labenz J, Opferkuch W, Ruhl
GH, Aygen S, et al. Modified 13C-urea breath test
in the detection of Helicobacter pylori in the gastric
mucosa. Deutsche Medizinische Wochenschrift 1994;119
(46):1569–72.
Adamek 1995
Adamek RJ, Wegener M, Labenz J. C-12 urea breath test
in Helicobacter-pylori infection of the gastric-mucosa -
reply. Deutsche Medizinische Wochenschrift 1995;120(25-
26):941–2.
Adamsson 2000
Adamsson I, Edlund C, Nord CE. Microbial ecology and
treatment of Helicobacter pylori infections: Review. Journal
of Chemotherapy 2000;12(1):5–16.
Adiloglu 2003
Adiloglu AK, Nazli C, Cicioglu-Aridogan B, Kinay O, Can
R, Ergene O. Gastroduodenal Helicobacter pylori infection
diagnosed by Helicobacter pylori stool antigen is related to
atherosclerosis. Acta Cardiologica 2003;58(4):335–9.
Adiloglu 2007
Adiloglu AK, Isler M, Goren I, Candir O, Senol A, Onal S,
et al. Quantitative correlation of Helicobacter pylori stool
antigen (HpSA) test with the severity of H. pylori-related
gastritis. Tohoku Journal of Experimental Medicine 2007;212
(2):159–67.
Agha-Amiri 1999a
Agha-Amiri K, Mainz D, Peitz U, Kahl S, Leodolter A,
Malfertheiner P. Evaluation of an enzyme immunoassay
for detecting Helicobacter pylori antigens in human stool
samples. Zeitschrift Fur Gastroenterologie 1999;37(12):
1145–9.
Agha-Amiri 1999b
Agha-Amiri K, Leodolter A, Peitz U, Malfertheiner P. How
does the Helicobacter pylori antigen concentration in stool
correlate with the urease activity in c-13-urea breath test?.
Gut 1999;45(Suppl 3):A132.
Agha-Amiri 2001
Agha-Amiri K, Peitz U, Mainz D, Kahl S, Leodolter A,
Malfertheiner P. A novel immunoassay based on monoclonal
antibodies for the detection of Helicobacter pylori antigens
in human stool. Zeitschrift Fur Gastroenterologie 2001;39
(8):555–60.
Agudo 2009a
Agudo S, Alarcón T, Urruzuno P, Lopez-Brea M. Evaluation
of two monoclonal-based antigen in stool enzyme
immunoassay for diagnosis of H.pylori infection in Spanish
children. Helicobacter 2009;14(4):341–2.
35Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Agudo 2009b
Agudo S, Alarcón T, Urruzuno P, Somodevilla A, Lopez-
Brea M. Evaluation of a monoclonal-based antigen in stool
enzyme immunoassay for diagnosis of Helicobacter pylori
infection in Spanish children. Clinical Microbiology and
Infection 2009;15:S315.
Aguemon 2004
Aguemon B, Struelens M, Deviere J, Denis O, Golstein P,
Nagy N, et al. Evaluation of stool antigen detection for
diagnosis of Helicobacter pylori infection in adults. Acta
Clinica Belgica 2004;59(5):246–50.
Aguemon 2005
Aguemon B, Struelens M, Deviere J, Denis O, Golstein
P, Salmon I, et al. Primary antibiotic resistance and
effectiveness of Helicobacter pylori triple therapy in ulcero-
inflammatory pathologies of the upper digestive tract. Acta
Gastroenterologica Belgica 2005;68(3):287–93.
Aguilar-Soto 2004
Aguilar-Soto O, Majalca-Mart ez C, León-Espinosa F,
Avila-Vargas G, Sánchez-Medina R, Figueroa SA, et al.
Comparative study between rapid urease test, imprint and
histopathological study for Helicobacter pylori diagnosis.
Revista de Gastroenterologia de Mexico 2004;69(3):136–42.
Ahmed 2005
Ahmed F, Murthy UK, Chey WD, Toskes PP, Wagner
DA. Evaluation of the Ez-HBT Helicobacter blood test
to establish Helicobacter pylori eradication. Alimentary
Pharmacology & Therapeutics 2005;22(9):875–80.
Ahuja 1998
Ahuja V, Bal CS, Sharma MP. Can the c-14 urea breath test
replace follow-up endoscopic biopsies in patients treated for
Helicobacter pylori infection?. Clinical Nuclear Medicine
1998;23(12):815–9.
Aje 2010
Aje AO, Otegbayo JA, Odaibo GN, Bojuwoye BJ.
Comparative study of stool antigen test and serology for
Helicobacter pylori among Nigerian dyspeptic patients: a
pilot study. Nigerian Journal of Clinical Practice 2010;13(2):
120–4.
Aksoy 2003
Aksoy DY, Aybar M, Ozaslan E, Kav T, Engin D, Ercis S,
et al. Evaluation of the Helicobacter pylori stool antigen
test (HpSA) for the detection of Helicobacter pylori
infection and comparison with other methods. Hepato-
Gastroenterology 2003;50(52):1047–9.
Aktepe 2011
Aktepe OC, Ciftci IH, Safak B, Uslan I, Dilek FH. Five
methods for detection of Helicobacter pylori in the Turkish
population. World Journal of Gastroenterology 2011;17(47):
5172–6.
Al-Assi 1999
Al-Assi MT, Miki K, Walsh JH, Graham DP, Asaka M,
Graham DY. Noninvasive evaluation of Helicobacter pylori
therapy: role of fasting or postprandial gastrin, pepsinogen
i, pepsinogen ii, or serum IgG antibodies. American Journal
of Gastroenterology 1999;94(9):2367–72.
Al-Humayed 2008
Al-Humayed SM, Ahmed MEK, Bello CS, Tayyar MA.
Comparison of 4 laboratory methods for detection of
Helicobacter pylori. Saudi Medical Journal 2008;29(4):
530–2.
Alam 2013
Alam El-Din HM, Hashem AGM, Ragab YM, Hussein IL,
Mohamed DB, Mohamed ECB. Evaluation of noninvasive
versus invasive techniques for the diagnosis of Helicobacter
pylori infection. Applied Immunohistochemistry and
Molecular Morphology 2013;21(4):326–33.
Alan 2014
Alan Selcuk N, Toklu T, Karaaslan I. Evaluation of
sensitivity of post-therapeutic i-131 whole body scan on
detecting Helicobacter pylori. European Journal of Nuclear
Medicine and Molecular Imaging 2014;41:S594.
Alarcón-Rivera 2011
Alarcón-Rivera G, Vázquez-Jiménez G, De la Cruz-Patiño
E, Abarca M, Leyva E, Delgado F, et al. Comparative
analysis between breath test, serological immunoassay
and rapid-urease test for detection of Helicobacter pylori
infection in Mexican patients with non-investigated
dyspepsia. Revista de Gastroenterologia de Mexico 2011;76
(4):322–9.
Alavi 1996a
Alavi A, Kroser JA, Faigel DO, Childs M, Furth EE, Alavi
A, et al. Can quantitative urea breath test for Helicobacter
pylori (hp) replace endoscopic biopsy?. Journal of Nuclear
Medicine 1996;37(5 Suppl):246 (abstract 1104).
Alavi 1996b
Alavi A, Faigel DO, Childs M, Furth EE, Goin J, Metz
DC. Comparison of 14-urea breath test for the diagnosis
of Helicobacter pylori gastritis with standard techniques.
Journal of Nuclear Medicine 1996;37(5 Suppl):114 (abstract
448).
Albrecht 2012
Albrecht P, Kotowska M, Misko E, lazowska-Przeorek I,
Karolewska-Bochenek K, Banaszkiewicz A, et al. Agreement
of monoclonal fecal test (amplified IDEA™ hp star™)
with the urease breath test, before and after the eradication
treatment of H. pylori in children. Pediatria Wspolczesna
2012;14(2):79–82.
Alcalde 1994
Alcalde M, Perez Garcia JI, Sanchez P, Lancho A, Carpintero
P, Pajares JM. Usefulness of the breath test with urea-13C
in the diagnosis of Helicobacter pylori infection. Medicina
Clinica 1994;103(10):371–3.
Alem 2002
Alem M, Alem N, Cohen H, England T, Hamedi N,
Moussazadeh M, et al. Diagnostic value of detection of IgM
antibodies to Helicobacter pylori. Experimental & Molecular
Pathology 2002;72(1):77–83.
36Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Alemohammad 1993
Alemohammad MM, Foley TJ, Cohen H. Detection of
immunoglobulin g antibodies to Helicobacter pylori in
urine by an enzyme immunoassay method. Journal of
Clinical Microbiology 1993;31(8):2174–7.
Ali 1997
Ali A, Vaira D, Stanghellini V, Menegatti M, Salardi S,
Landi F, et al. C-13 urea-breath test (UBT) with and
without a citric acid test meal for Helicobacter pylori (hp)
detection in adults and children. Gastroenterology 1997;112
(4 suppl):A56.
Ali 1998
Ali A, Vaira D, Stanghellini V, Menegatti M, Landi F,
Ricci C, et al. C-13 vs c-14 urea breath test (UBT) for
Helicobacter pylori (hp) detection. Gut 1998;43(Suppl 2):
A55–A6.
Allerberger 1996
Allerberger F, Oberhuber G, Wrba F, Puspok A, Dejaco
C, Dierich MP. Detection of Helicobacter pylori infection
using single serum specimens: Comparison of five
commercial serological tests. Hepato-Gastroenterology 1996;
43(12):1656–9.
Alpert 1989
Alpert LC, Graham DY, Evans DJ, Yoshimura HH,
Hazell SL, Evans DG, et al. Diagnostic possibilities
for campylobacter pylori infection. European Journal of
Gastroenterology & Hepatology 1989;1(1):17–26.
Altindis 2002a
Altindis M, Dilek ON. Usefulness of the Helicobacter
pylori stool antigen test for detection Helicobacter pylori
infection. Acta Gastro-Enterologica Belgica 2002;65(2):
74–6.
Altindis 2002b
Altindis M, Dilek ON. Erratum: Usefullness of the
Helicobacter pylori stool antigen test for detection
Helicobacter pylori infection (Acta Gastro-Enterologica
Belgica 2002;65:2:74-6). Acta Gastro-Enterologica Belgica
2002;65(4):246.
Altindis 2003
Altindis M, Dilek ON. Erratum: Usefullness of the
Helicobacter pylori stool antigen test for detection
Helicobacter pylori infection (Acta Gastro-Enterologica
Beljica 2002;65(2):74-6). Acta Gastro-Enterologica Belgica
2003;66(2):195.
Amendola 2002
Amendola R, Doweck J, Katz J, Racca J, Menendez G,
Schenone L, et al. A new method for detection and
eradication of Helicobacter pylori infection by stool antigens
test. Acta Gastroenterologica Latinoamericana 2002;32(2):
83–5.
Anania 2007
Anania C, Labalestra V, Neaga M, Ferrara E, Borrelli O,
Cirulli M, et al. Evaluation of a polyclonal Helicobacter
pylori stool antigen test (HpSA) for the detection of
Helicobacter pylori infection in children. Digestive and
Liver Disease 2007;39(10):A62.
Anania 2008
Anania C, Pacifico L, Olivero G, Osborn JF, Bonaiuto E,
Chiesa C. Breath tests in pediatrics. Clinica Chimica Acta
2008;397(1-2):1–12.
Andersen 1989
Andersen LP. Campylobacter pylori antibodies measured by
indirect ELISA using O-antigen. Gastroduodenal pathology
and Campylobacter pylori: European Campylobacter Pylori
Study Group ICS847. 1989:201–3.
Andersen 1998
Andersen LP, Kiilerick S, Pedersen G, Thoreson AC,
Jorgensen F, Rath J, et al. An analysis of seven different
methods to diagnose Helicobacter pylori infections.
Scandinavian Journal of Gastroenterology 1998;33(1):24–30.
Anderson 1993
Anderson G, Alemohammad MM, Foley TJ, Colletti A,
Patel A, Dooley CP. Rapid test for detection of antibodies
to Helicobacter pylori. Clinical Infectious Diseases 1993;16
(SUPPL. 4):S416–S7.
Andrews 2003
Andrews J, Marsden B, Brown D, Wong VS, Wood E,
Kelsey M. Comparison of three stool antigen tests for
Helicobocter pylori detection. Journal of Clinical Pathology
2003;56(10):769–71.
Ang 2007a
Ang CW, Krogfelt K, Herbrink P, Keijser J, Van Pelt
W, Dalby T, et al. Validation of an enzyme-linked
immunosorbent assay for the diagnosis of recent
campylobacter infections in guillain-barre and reactive
arthritis patients. Zoonoses and Public Health 2007;54:50.
Ang 2007b
Ang CW, Krogfelt K, Herbrink P, Keijser J, Van Pelt W,
Dalby T, et al. Validation of an ELISA for the diagnosis
of recent campylobacter infections in guillain-barre and
reactive arthritis patients. Clinical Microbiology & Infection
2007;13(9):915–22.
Anonymous 1989
Anonymous. 14c-urea breath test for C pylori. Gut 1989;30
(11):1656–7.
Anonymous 1996
Anonymous. Breath test for Helicobacter pylori. WHO
Drug Information 1996;10(4):187.
Anonymous 1997
Anonymous. Technical annex: Tests used to assess
Helicobacter pylori infection. Working party of the
European Helicobacter pylori study group. Gut 1997;41
Suppl 2:S10–8.
Anonymous 2000
Anonymous. A stool test for H. pylori. Hospital Practice
2000;35(4):140.
Anonymous 2002a
Anonymous. The stool antigen test for detection of
Helicobacter pylori after eradication therapy - commentary.
Annals of Internal Medicine 2002;136(4):286–7.
37Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Anonymous 2002b
Anonymous. H. pylori breath test effective. Pharmaceutical
Journal 2002;268(7196):601.
Anonymous 2004
Anonymous. Which test for Helicobacter pylori in primary
care?. Drug and Therapeutics Bulletin 2004;42(9):71–2.
Antico 2010
Antico A, Tozzoli R, Villalta D, Tonutti E, Tampoia M,
Bizzaro N. Diagnostic efficacy of a specific serological profile
for the diagnosis of chronic autoimmune gastritis. Rivista
Italiana della Medicina di Laboratorio 2010;6(3):198–204.
Antoine 1995
Antoine C, Lozniewski A, De Korwin JD, Conroy MC,
Feldmann L, Duprez A, et al. Comparative study of
four commercial serological tests for the diagnosis of
Helicobacter pylori infection. Gastroenterologie Clinique et
Biologique 1995;19(2):182–8.
Antos 2005
Antos D, Crone J, Konstantopoulos N,
Koletzko S. Evaluation of a novel rapid one-step
immunochromatographic assay for detection of monoclonal
Helicobacter pylori antigen in stool samples from children.
Journal of Clinical Microbiology 2005;43(6):2598–601.
Anwar 2012
Anwar MM, Youssef AI, Sheta MI, Zaki A, Bernaba NR, el-
Toukhi MA. Evaluation of specific biochemical indicators
of Helicobacter pylori-associated gastric cancer in Egypt.
Eastern Mediterranean Health Journal 2012;18(5):501–7.
Arboleda 2013
Arboleda RN, Schneider BG, Bravo LE, Romero-Gallo J,
Peek RM Jr, Mera RM, et al. Use of the noninvasive entero-
test in the detection of Helicobacter pylori in children
in an endemic area in Colombia. Journal of Pediatric
Gastroenterology & Nutrition 2013;57(2):192–6.
Archimandritis 2001
Archimandritis A, Giontzis A, Kourtesas D, Tzivras M,
Smilakou S, Davaris P. Diagnosis of Helicobacter pylori
infection with a stool assay: Is it useful after eradication
treatment?. American Journal of Gastroenterology 2001;96
(4):1298–9.
Arents 2001
Arents NL, Van Zwet AA, Thijs JC, De Jong A, Pool MO,
Kleibeuker JH. The accuracy of the Helicobacter pylori
stool antigen test in diagnosing H. pylori in treated and
untreated patients. European Journal of Gastroenterology &
Hepatology 2001;13(4):383–6.
Arents 2002
Arents NL, Van Zwet AA, Thijs JC, De Jong A, Pool MO,
Kleibeuker JH. The accuracy of the Helicobacter pylori
stool antigen test in diagnosing H. pylori in treated patients
- reply. European Journal of Gastroenterology & Hepatology
2002;14(1):89–90.
Arinton 2011
Arinton IG. Adjustment of cut-off values in ELISA for
detection of Helicobacter pylori infection. Acta Medica
Indonesiana 2011;43(2):88–91.
Arita 1982
Arita K, Yamauchi E, Mizuno S, Maki S. Serological
response to campylobacter jejuni infection: Enzyme-linked
immunosorbent assay (ELISA) for detection of antibodies
to campylobacter jejuni. Kansenshogaku Zasshi [The Journal
of the Japanese Association for Infectious Diseases] 1982;56(7):
566–73.
Arj 2012
Arj A, Ehteram H, Razavizadeh M. Efficacy of stool ag
test for the non-invasive diagnosis of Helicobacter pylori
infection in dyspeptic patients. Journal of Gastroenterology
and Hepatology 2012;27:420.
Arora 2003
Arora U, Aggarwal A, Singh K. Comparative evaluation of
conventional methods and ELISA based IgG antibodies
detection for diagnosis of Helicobacter pylori infection in
cases of dyspepsia. Indian Journal of Medical Microbiology
2003;21(1):46–8.
Artiko 2004
Artiko V, Obradovic V, Petrovic N, Davidovic B, Vlajkovic
M, Petrovic M, et al. Breath test (c-14-urea) in the detection
of Helicobacter pylori infection. European Journal of
Nuclear Medicine and Molecular Imaging 2004;31:S216–S7.
Asaka 1988
Asaka M, Mitani S, Yoshida J, Saito M, Meguro T. Clinical
significance of ELISA for campylobacter pylori. Nihon
Shokakibyo Gakkai Zasshi [Japanese Journal of Gastro-
enterology] 1988;85(4):950.
Asaki 1996
Asaki S, Yamagami H, Noda A, Tachikawa T, Osumi T,
Hirao Y, et al. Phase i clinical trial of 13C-urea breath test
(c-13ubt). Japanese Journal of Clinical Pharmacology and
Therapeutics 1996;27(3):607–16.
Asante 1998
Asante MA, Mendall MA, Finlayson C, Ballam L,
Northfield T. Screening dyspeptic patients for Helicobacter
pylori prior to endoscopy: Laboratory or near-patient
testing?. European Journal of Gastroenterology & Hepatology
1998;10(10):843–6.
Asfeldt 2004
Asfeldt AM, Lochen ML, Straume B, Steigen SE,
Florholmen J, Goll R, et al. Accuracy of a monoclonal
antibody-based stool antigen test in the diagnosis of
Helicobacter pylori infection. Scandinavian Journal of
Gastroenterology 2004;39(11):1073–7.
Ashraf 1999
Ashraf P, Ul Haq M, Amjad R. Assessment of 13C urea
breath test’s usefulness in the diagnosis of Helicobacter
pylori infection. Journal of the College of Physicians and
Surgeons Pakistan 1999;9(2):75–7.
Atherton 1992
Atherton JC, Hymantaylor P, Hawkey CJ, Spiller RC.
Direct comparison of c-13 and low-dose c-14 as isotopic
markers in the urea breath test for Helicobacter-pylori. Gut
1992;33(2):S5–S.
38Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Atherton 1994
Atherton JC, Spiller RC. The urea breath test for
Helicobacter pylori. Gut 1994;35(6):723–5.
Attallah 2004
Attallah AM, Ismail H, Ibrahim GG, Abdel-Raouf M,
El-Waseef AM, Abdel-Wahab M. Use of a novel enzyme
immunoassay based on detection of circulating antigen
in serum for diagnosis of Helicobacter pylori infection.
Clinical & Diagnostic Laboratory Immunology 2004;11(4):
775–9.
Attumi 2011
Attumi TA, Graham DY. Follow-up testing after treatment
of Helicobacter pylori infections: Cautions, caveats, and
recommendations. Clinical Gastroenterology and Hepatology
2011;9(5):373–5.
Aucher 1998
Aucher P, Petit ML, Mannant PR, Pezennec L, Babin P,
Fauchere JL. Use of immunoblot assay to define serum
antibody patterns associated with Helicobacter pylori
infection and with h. Pylori-related ulcers. Journal of
Clinical Microbiology 1998;36(4):931–6.
Aulia 2009
Aulia D, Manz GO, Simadibrata M. Pepsinogen
i concentration in organic dyspepsia patients at
Gastroenterology Division, Department of Internal
Medicine, Cipto Mangunkusumo Hospital. Acta Medica
Indonesiana 2009;41(3):107–14.
Auroux 1998
Auroux J, Lamarque D, Tankovic J, Benamouzig R, Mahe
S, Chaumette MT, et al. Comparison of Helicobacter pylori
gastric density by culture, histology and c-13 urea breath
test. Gastroenterologie Clinique et Biologique 1998;22(4):
407–12.
Aziz 2014
Aziz F, Sherwani SK, Akhtar SS, Kazmi SU. Development
of an in-house enzyme-linked immunosorbent assay based
on surface whole cell antigen for diagnosis of Helicobacter
pylori infection in patients with gastroduodenal ulcer
disease. World Journal of Microbiology & Biotechnology 2014;
30(1):305–15.
Bakka 2002
Bakka AS, El-Gariani AB, AbouGhrara FM, Salih BA.
Frequency of Helicobacter pylori infection in dyspeptic
patients in Libya. Saudi Medical Journal 2002;23(10):
1261–5.
Balcilar 2012
Balcilar E, Karsidag T, Tuzun S. Relaibility of Helicobacter
antigen in stool for screening. Medical Bulletin of Haseki
2012;50(3):89–92.
Ballam 1998
Ballam L, Mendall MA, Morris J, Strachan D, Whincup
P, Cook D. Western blotting (wb) is useful in the salivary
diagnosis of h-pylori infection. Gastroenterology 1998;114
(4 suppl):A64.
Ballam 2000a
Ballam LD, Mendall MA, Asante M, Morris J, Strachan
DP, Whincup PH, et al. Western blotting is useful in the
salivary diagnosis of Helicobacter pylori infection.[Erratum
appears in J Clin Pathol 2000;53(9):725]. Journal of
Clinical Pathology 2000;53(4):314–7.
Ballam 2000b
Ballam LD, Mendall MA, Asante. Erratum: Western
blotting is useful in the salivary diagnosis of Helicobacter
pylori infection (Journal of clinical pathology 2000;53:314-
7). Journal of Clinical Pathology 2000;53(9):725.
Balon 1997
Balon HR, Roff E, Dworkin HJ. Capsule-based c-14 urea
breath test for Helicobacter pylori: Early experience and
comparison with liquid-based test. Journal of Nuclear
Medicine 1997;38(5 Suppl):Abstract 1092.
Baqai 2003
Baqai R, Qureshi H, Arian G, Mehdi I. Diagnostic efficacy
of stool antigen test (HPSA), clo test and serology for the
detection of Helicobacter pylori infection. Journal of Ayub
Medical College, Abbottabad: JAMC 2003;15(4):34–6.
Baranskaia 2006
Baranskaia EK, Ivashkin VT, Lapshin AV, Stepanov EV,
Zyrianov PV. The diagnostic significance of laser 13C-
urea breath test in various Helicobacter pylori-associated
diseases. Klinicheskaia Meditsina 2006;84(8):47–50.
Barbosa 2003
Barbosa J, Dinis-Ribeiro M, Guilherme M, Filipe T, Lomba-
Viana R, Guimaraes MA, et al. Use of Helicobacter pylori-
specific antibodies in the evaluation of intestinal metaplasia
and gastric dysplasia. British Journal of Biomedical Science
2003;60(4):175–9.
Barthel 1990
Barthel JS, Everett ED. Diagnosis of campylobacter pylori
infections: The “gold standard” and the alternatives.
Reviews of Infectious Diseases 1990;12 Suppl 1:S107–14.
Baryshnikova 2009
Baryshnikova NV. Actual problems of Helicobacteriosis
diagnostics. Eksperimental’naia i Klinicheskaia
Gastroenterologiia [Experimental & Clinical Gastroenterology]
2009;2:50–6.
Baryshnikova 2012
Baryshnikova NV, Uspenskiy YP, Smirnova AS, Dmitrienko
MA, Bykov SE. Helicobacter pylori in oral cavity in patients
with chronic gastritis. Helicobacter 2012;17:90.
Baryshnikova 2013
Baryshnikova NV, Belousova LN, Smirnova AS, Tsopanova
EE, Loeva IA, Orlov OY, et al. Breath ammonium test in
diagnostic of Helicobacter pylori infection. Helicobacter
2013;18:124.
Baryshnikova 2014
Baryshnikova NV, Belousova LN, Loeva IA, Kudryavtseva
AS, Shehman AV, Yakovleva JS. Comparative analysis
of efficacy of noninvasive ammonium “helic-test” and
39Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
histological method in diagnostic of Helicobacter pylori
infection. Helicobacter 2014;19:122.
Basinska 2005
Basinska T, Wisniewska M, Chmiela M. Principle of a new
immunoassay based on electrophoretic mobility of poly
(styrene/alpha-tert-butoxy-omega-vinylbenzyl-polyglycidol)
microspheres: Application for the determination of
Helicobacter pylori igg in blood serum. Macromolecular
Bioscience 2005;5(1):70–7.
Bassler 1992
Bassler HMS, Dreher RM, Wolf K. Isolation of h. Pylori
proteins and their availability in serological tests. Immunitat
und Infektion 1992;20(3):103–6.
Basso 1999
Basso D, Stefani A, Brigato L, Navaglia F, Greco E, Zambon
CF, et al. Serum antibodies anti-h. Pylori and anti-caga:
A comparison between four different assays. Journal of
Clinical Laboratory Analysis 1999;13(4):194–8.
Bateson 1991
Bateson MC, Ching CK, Loffeld RJLF, Arends JW,
Stobberingh E. Screening for Helicobacter pylori in
dyspepsia [comment]. Lancet 1991;338(8763):393–4.
Bateson 2001
Bateson MC. Quadruple therapy for symptomatic
spontaneous duodenal ulcer disease. Postgraduate Medical
Journal 2001;77(909):447–50.
Bathe 1996
Bathe OF, Rae AJ, Zetler P, Cleator IGM. Validation of a
new saliva test for Helicobacter pylori infection. Canadian
Journal of Gastroenterology 1996;10(2):93–6.
Bauernfeind 1989
Bauernfeind A, Przyklenk B, Horl G,Otto U. Representative
campylobacter pylori antigen for IgG-ELISA and diagnostic
significance of antibody titres. Gastroduodenal pathology
and Campylobacter pylori. The first meeting of the
European Campylobacter Pylori Study Group ICS847;
1989. 1989:185–8.
Bazaz 2005
Bazaz RD, Khalaj A, Beiki D, Eftekhari M, Hosein MHAS,
Khoshayand MR. Microdose 14c urea breath test for the
diagnosis of Helicobacter pylori: A survey in Iranian
population. Daru 2005;13(1):6–10.
Bazzoli 1994
Bazzoli F, Zagari RM, Pozzato P, Fossi S, Alampi G, Sottili S,
et al. C-13-urea breath test to quantify Helicobacter-pylori
colonization of gastric-mucosa and association with severity
of inflammation. Gastroenterology 1994;106(4 suppl):A48.
Bazzoli 1995
Bazzoli F, Zagari RM, Pozzato P, Fossi S, Simoni P, Roda
A, et al. The c-13-urea breath test to evaluate the effect of
antisecretory drugs on Helicobacter-pylori. Gastroenterology
1995;108(4 suppl):A57.
Bazzoli 1996
Bazzoli F, Cecchini L, Corvaglia L, Antonia MD, Libera
MD, DeGiacomo C, et al. The c-13-urea breath test for
the diagnosis of Helicobacter pylori infection in children.
Gastroenterology 1996;110(4 Suppl):A60.
Bazzoli 1997a
Bazzoli F, Zagari RM, Festi D, Palli D, Pozzato P, Sottili
S, et al. A population based study of Helicobacter pylori
infection .2. Uprevalence by c-13-urea breath test and
association with family history of peptic ulcer and gastric
cancer. Gut 1997;41(Suppl):A106.
Bazzoli 1997b
Bazzoli F, Zagari M, Fossi S, Pozzato P, Ricciardiello L,
Mwangemi C, et al. Urea breath tests for the detection of
Helicobacter pylori infection. Helicobacter 1997;2 Suppl 1:
S34–7.
Bazzoli 1998
Bazzoli F, Zagari M, Pozzato P, Fossi S, Ricciardiello
GL, Nicolini G, et al. Diagnosis of Helicobacter pylori
infection: Non-invasive diagnostic tests. Italian Journal of
Gastroenterology & Hepatology 1998;30(suppl 3):S313–4.
Bazzoli 1999
Bazzoli F, Zagari RM, Pozzato P, Fossi S, Ricciardiello L, De
Luca L, et al. Helicobacter pylori: Optimum diagnosis and
test of cure. Journal of Chemotherapy 1999;11(6):601–5.
Bazzoli 2000
Bazzoli F, Cecchini L, Corvaglia L, Dall’Antonia M, De
Giacomo C, Fossi S, et al. Validation of the 13C-urea
breath test for the diagnosis of Helicobacter pylori infection
in children: A multicenter study. American Journal of
Gastroenterology 2000;95(3):646–50.
Befrits 1993
Befrits R, Granstrom M, Rylander M, Rubio C.
Helicobacter pylori in 205 consecutive endoscopy patients.
Scandinavian Journal of Infectious Diseases 1993;25(2):
185–91.
Beiki 2005
Beiki D, Khalaj A, Dowlatabadi R, Eftekhari M, Hossein
MHAS, Fard A, et al. Validation of 13C-urea breath test
with non dispersive isotope selective infrared spectroscopy
for the diagnosis of Helicobacter pylori infection: A survey in
Iranian population. Daru 2005;13(2):52–5.
Bekmen 2008
Bekmen N, Demiray E, Gonen C, Dolek D, Soyturk
M, Sagol O, et al. Determination of H. pylori antigenic
frequency by western blot technique in adult patients with
dyspepsia. Helicobacter 2008;13(5):452.
Bell 1987
Bell GD, Weil J, Harrison G, Morden A, Jones PH, Gant
PW, et al. 14c-urea breath analysis, a non-invasive test for
campylobacter pylori in the stomach. Lancet 1987;1(8546):
1367–8.
Bell 1991
Bell GD, Powell K, Weil J, Harrison G, Brookes S, Prosser
S. 13C-urea breath test for Helicobacter pylori infection. Gut
1991;32(5):551–2.
40Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Bellon 2004
Bellon M. The urea breath test. ANZ Nuclear Medicine
2004;35(2):104–7.
Bener 2002
Bener A, Uduman SA, Ameen A, Alwash R, Pasha MA,
Usmani MA, et al. Prevalence of Helicobacter pylori
infection among low socio-economic workers. Journal of
Communicable Diseases 2002;34(3):179–84.
Benito 1999
Benito LM, Sara S, Gisbert JP, Vasquez MA, Jimenez I,
Pajares JM. C-13-urea breath test for the diagnosis of H-
pylori infection: Are basal samples necessary?. Gut 1999;45
(Suppl 3):A125–A6.
Benjamin 2012
Benjamin YC, Feng Z, Ho KY, Christopher K, Lim LG, So
JB, et al. Risk stratification for gastric cancer using serum
pepsinogen and Helicobacter pylori serology in a Chinese
population. Gastroenterology 2012;142(5 (Suppl)):S631.
Bennedsen 1998
Bennedsen M, Lehn N, Morgner A, Bayerdorffer E,
Andersen LP. Development of a Helicobacter heilmanii
specific ELISA. Gut 1998;43(Suppl 2):A115–A6.
Bennett 2006
Bennett K, Feely J, Thornton O, Dobson M, O’Morain
CA, O’Connor HJ. Impact of Helicobacter pylori on the
management of dyspepsia in primary care. Alimentary
Pharmacology & Therapeutics 2006;24(4):637–41.
Berger 2002
Berger A. Helicobacter pylori breath tests. BMJ 2002;324
(7348):1263.
Bergey 2003
Bergey B, Marchildon P, Peacock J, Megraud F. What is the
role of serology in assessing Helicobacter pylori eradication?.
Alimentary Pharmacology & Therapeutics 2003;18(6):635–9.
Bergmann 1997
Bergmann WL. Diagnosis and therapy ofHelicobacter pylori
infections in adults. Deutsche Medizinische Wochenschrift
1997;122(11):348–9.
Berker 2003
Berker B, Soylemez F, Cengiz SD, Kose SK. Serologic assay
of Helicobacter pylori infection - is it useful in hyperemesis
gravidarum?. Journal of Reproductive Medicine 2003;48(10):
809–12.
Bermejo 2000a
Bermejo San Jose F, Boixeda de Miguel D, Gisbert JP,
Martin de Argila de Prados C, Sanz Sacristan JM, Defarges
Pons V, et al. Efficacy of four widely used techniques of
the diagnosis of Helicobacter pylori infection in gastric ulcer
disease. Revista Clinica Española 2000;200(9):475–9.
Bermejo 2000b
Bermejo F, Boixeda D, Gisbert JP, Sanz JM, Canton R,
Defarges V, et al. Concordance between noninvasive tests in
detecting Helicobacter pylori and potential use of serology for
monitoring eradication in gastric ulcer. Journal of Clinical
Gastroenterology 2000;31(2):137–41.
Bermejo 2002
Bermejo F, Boixeda D, Gisbert JP, Defarges V, Sanz JM,
Redondo C, et al. Rapid urease test utility for Helicobacter
pylori infection diagnosis in gastric ulcer disease. Hepato-
Gastroenterology 2002;49(44):572–5.
Berning 2009
Berning M, Krasz S, Schneider-Brachert W, Madisch A,
Laass MW, Knoth H, et al. Randomized multicenter study
of esomeprazole, moxifloxacin and amoxicillin for second-
line or rescue treatment of Helicobacter pylori infection -
impact of treatment duration. Gastroenterology 2009;136(5
(suppl)):A150.
Bertschinger 1992
Bertschinger P, Brunner J, Flury R, Lammer F, Jost R, Hacki
WH. Comparison of effectiveness of omeprazole/bismuth
subcitrate and triple therapy in Helicobacter pylori gastritis.
Schweizerische Medizinische Wochenschrift 1992;122(39):
1446–51.
Besherdas 2000
Besherdas K, Oben JA, Beck ER, Vicary FR, Wong VS.
What proportion of dyspeptic patients having H. pylori
breath test subsequently undergo endoscopy?. Gut 2000;46
(Suppl 2):A52.
Bessede 2011
Bessede E, Delcamp A, Sifre E, Buissonniere A, Megraud
F. New methods for detection of campylobacters in stool
samples in comparison to culture. Journal of Clinical
Microbiology 2011;49(3):941–4.
Best 1992
Best LM, Van Zanten SJOV, Bezanson GS, Haldane DJM,
Malatjalian DA. Serological detection of Helicobacter pylori
by a flow microsphere immunofluorescence assay. Journal of
Clinical Microbiology 1992;30(9):2311–7.
Best 1994
Best LM, Van Zanten SJOV, Sherman PM, Bezanson GS.
Serological detection of Helicobacter pylori antibodies in
children and their parents. Journal of Clinical Microbiology
1994;32(5):1193–6.
Beynon 2013
Beynon R, Leeflang MM, McDonald S, Eisinga A, Mitchell
RL, Whiting P, et al. Search strategies to identify diagnostic
accuracy studies in MEDLINE and EMBASE. Cochrane
Database of Systematic Reviews 2013, Issue 9. [DOI:
10.1002/14651858.MR000022.pub3
Bhewa 2007
Bhewa Y, Hilmi I, Cheah PL, Navaratnam P, Goh KL.
Evaluation of the monoclonal stool antigen test for
Helicobacter pylori in an asian population with dyspepsia.
Journal of Digestive Diseases 2007;8(4):207–10.
Bielanski 1996a
Bielanski W, Konturek SJ, Dobrzanska MJ, Pytko-
Polonczyk J, Sito E, Marshall BJ. Microdose 14c-urea breath
test in detection of Helicobacter pylori. Journal of Physiology
& Pharmacology 1996;47(1):91–100.
41Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Bielanski 1996b
Bielanski W, Pytko J, Konturek SJ, Sito E, Marshall
J. Usefulness of c-14-urea breath test in detection
of Helicobacter pylori associated gastric diseases.
Gastroenterology 1996;110(4 (suppl)):A65.
Bielanski 1996c
Bielanski W, Konturek SJ. New approach to 13C-urea
breath test: Capsule-based modification with low-dose of
13C-urea in the diagnosis of Helicobacter pylori infection.
Journal of Physiology & Pharmacology 1996;47(3):545–53.
Bielanski 1997a
Bielanski W, Plonka M, Dobrzanska M, Kaminska A,
Konturek SJ. Screening of H-pylori (HP) infection in adult
population of Krakow, Poland using modified capsulated
urea breath test. Gut 1997;41(Suppl):A37–A8.
Bielanski 1997b
Bielanski W, Dobrzanska J, Kaminska A, Plonka M, Sito E,
Konturek SJ. Validation of new low dose and low cost c-
13-urea breath test in the diagnosis for Helicobacter pylori.
Gastroenterology 1997;112(4 (suppl)):A72.
Bielanski 1998
Bielanski W, Bobrzynski A, Kostarczyk W, Karczewska E,
Gedliczka O, Konturek SJ. Usefulness of capsulated low
dose c-13-urea breath test in diagnosing h-pylori infection
in patients with upper gastrointestinal bleeding. Gut 1998;
43(Suppl 2):A54–A5.
Bielanski 1999
Bielanski W, Dobrzanska M, Jakuszewska B, Kaminska A,
Plonka M, Konturek SJ. Ethanol as confounding factor in
detection of Helicobacter pylori (HP) by c-13-urea breath
test. Gastroenterology 1999;116(4 (suppl)):A123.
Bielanski 2000
Bielanski W, Loster BW, Plonka M, Dobrzanska M,
Kaminska A, Majewski S, et al. Incidence of H-pylori (HP)
infection in Polish endoscopists and dentists: Results of
field survey with capsulated c-13-urea breath test (ubt). Gut
2000;47(Suppl 1):A50.
Biemond 1997
Biemond I, Veenendaal RA, Lamers C. Rapid diagnostic
test for antibodies to Helicobacter pylori in comparison with
the ELISA technique. Gut 1997;41(suppl):A159.
Bilal 2007
Bilal R, Khaar B, Qureshi TZ, Mirza SA, Ahmad T, Latif
Z, et al. Accuracy of non-invasive 13C-urea breath test
compared to invasive tests for Helicobacter pylori detection.
Journal of the College of Physicians & Surgeons - Pakistan
2007;17(2):84–8.
Bilardi 2002
Bilardi C, Biagini R, Dulbecco P, Iiritano E, Gambaro
C, Mele MR, et al. Stool antigen assay (HPSA) is less
reliable than urea breath test for post-treatment diagnosis
of Helicobacter pylori infection. Alimentary Pharmacology &
Therapeutics 2002;16(10):1733–8.
Billaud 1996
Billaud N, Morali A, Conroy MJ, Floquet J. Helicobacter
pylori infection in pediatric patients. A review of twenty-
three cases. Annales De Pediatrie 1996;43(4):281–7.
Bindayna 2006
Bindayna K, Al Baker W, Botta G. Detection ofHelicobacter
pylori caga gene in gastric biopsies, clinical isolates and
faeces. Indian Journal of Medical Microbiology 2006;24(3):
195–200.
Birkenfeld 2004
Birkenfeld S, Keter D, Dikman R, Shevah O, Shirin H,
Niv Y. Prevalence of Helicobacter pylori infection in health-
care personnel of primary care and gastroenterology clinics.
Journal of Clinical Gastroenterology 2004;38(1):19–23.
Bjorneklett 1989
Bjorneklett A, Fausa O, Nedenskovsorensen P, Bukholm
G, Aase S. The c-14 urea breath test in the diagnosis of
Campylobacter-pylori infection. Gastroduodenal Pathology
and Camphylobacter pylori 1989;847:65–8.
Blairon 2009
Blairon L, Souayah H, Moens C, Dediste A, Vandenberg O.
Comparison of 6 rapid assays for detection of Helicobacter
pylori antigen in stool in children with recurrent abdominal
pain - preliminary data. Clinical Microbiology and Infection
2009;15:S315.
Blancas 2004
Blancas Valencia JM. Importance of Helicobacter pylori
diagnosis. Revista de Gastroenterologia de Mexico 2004;69
(3):186–7.
Blanco 2008
Blanco S, Forne M, Lacoma A, Prat C, Cuesta MA, Latorre
I, et al. Comparison of stool antigen immunoassay methods
for detecting Helicobacter pylori infection before and after
eradication treatment. Diagnostic Microbiology & Infectious
Disease 2008;61(2):150–5.
Blanco 2009
Blanco S, Forne M, Lacoma A, Prat C, Cuesta MA,
Fuenzalida L, et al. Evaluation of a latex agglutination test
(pylogen) for the detection of Helicobacter pylori in stool
specimens. Diagnostic Microbiology & Infectious Disease
2009;63(4):349–53.
Blashenkov 2013
Blashenkov NM, Sheshenya ES, Solov’ev SM, Sachenko
VD, Gall LN, Zarutskii IV, et al. A specialized isotope mass
spectrometer for noninvasive diagnostics of Helicobacter
pylori infection in human beings. Technical Physics Letters
2013;39(5):431–4.
Bleau 1998
Bleau BL, Van Zanten SV, Best L, Hutchison D, Blevins J,
Thee D. Determination of eradication of Helicobacter pylori
(HP) by the HP stool antigen test (HPSAT). Gut 1998;43
(Suppl 2):A50.
Blecker 1992a
Blecker U, Vandenplas Y. Helicobacter pylori seropositivity
in symptom-free children. Lancet 1992;339(8808):1537.
42Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Blecker 1992b
Blecker U, Lanciers S, Peeters S, Vandenplas Y.
Helicobacter pylori infections in children. Tijdschrift voor
Kindergeneeskunde 1992;60(2):35–9.
Blecker 1993a
Blecker U, Keymolen K, Levy J, Vandenplas Y. Low
prevalence of Helicobacter pylori in the acquired
immunodeficiency syndrome. American Journal of
Gastroenterology 1993;88(8):1294.
Blecker 1993b
Blecker U, Lanciers S, Hauser B. Validation of a new
serologic test for the detection of Helicobacter pylori. Acta
Gastroenterologica Belgica 1993;56(5-6):309–14.
Blecker 1993c
Blecker U, Lanciers S, Hauser B, Vandenplas Y. Diagnosis of
Helicobacter pylori infection in adults and children by using
the malakit Helicobacter pylori, a commercially available
enzyme-linked immunosorbent assay. Journal of Clinical
Microbiology 1993;31(7):1770–3.
Blecker 1993d
Blecker U, Lanciers S, Hauser B, Vandenplas Y. Positive and
negative titres of a new serologic test for the detection of
Helicobacter pylori. European Journal of Gastroenterology &
Hepatology 1993;5(8):631–4.
Blecker 1993e
Blecker U, Vandenplas Y. Helicobacter pylori serology.
Journal of Clinical Microbiology 1993;31(1):173.
Blecker 1993f
Blecker U, Vandenplas Y, Taha AS, Russell RI. Serological
diagnosis of Helicobacter pylori. Gut 1993;34(10):1467.
Blecker 1993g
Blecker U, Hauser B, Lanciers S, Peeters S, Suys B,
Vandenplas Y. The prevalence of Helicobacter pylori-positive
serology in asymptomatic children. Journal of Pediatric
Gastroenterology and Nutrition 1993;16(3):252–6.
Blecker 1994a
Blecker U, Lanciers S, Mehta DI, Vandenplas Y. The
sensitivity and specificity of a recent generation serum
ELISA test for the detection of Helicobacter-pylori specific
IgG antibodies compared to the c-13-urea breath test.
Gastroenterology 1994;106(4 (suppl)):A54.
Blecker 1994b
Blecker U, Vandenplas Y. Usefulness of specific IgM in the
diagnosis of Helicobacter pylori infection. Pediatrics 1994;93
(2):342–3.
Blecker 1994c
Blecker U, Vandenplas Y, Blecker U, Lanciers S, Mehta DI.
Concordance between serology and 13C-urea breath test
in the diagnosis of Helicobacter pylori infection. American
Journal of Gastroenterology 1994;89(3):459.
Blecker 1994d
Blecker U, Keymolen K, Lanciers S, Bahwere P, Souayah H,
Levy J, et al. The prevalence of Helicobacter pylori positivity
in human immunodeficiency virus-infected children.
Journal of Pediatric Gastroenterology & Nutrition 1994;19
(4):417–20.
Blecker 1995a
Blecker U, Lanciers S, Hauser B, Mehta DI, Vandenplas
Y. Serology as a valid screening test for Helicobacter pylori
infection in asymptomatic subjects. Archives of Pathology &
Laboratory Medicine 1995;119(1):30–2.
Blecker 1995b
Blecker U, Lanciers S, Hauser B, De Pont SM, Vandenplas
Y. The contribution of specific immunoglobulin m
antibodies to the diagnosis of Helicobacter pylori infection in
children. European Journal of Gastroenterology & Hepatology
1995;7(10):979–83.
Blum 1997
Blum AL, Bayerdorffer E, Borsch G, Classen M, Creutzfeldt
W, Hotz J, et al. The Helicobacter revolution .2. Diagnosis
and therapy. Leber Magen Darm 1997;27(4):241–6.
Bode 1998
Bode G, Rothenbacher D, Brenner H, Adler G. Variation
in the 13C-urea breath test value by nationality in
Helicobacter pylori-infected children. Scandinavian Journal
of Gastroenterology 1998;33(5):468–72.
Bode 2000
Bode G, Hoffmeister A, Koenig W, Brenner H,
Rothenbacher D. Extent and determinants of differences in
Helicobacter pylori serology and c-13-urea breath test in an
asymptomatic sample of blood donors. Gut 2000;47(Suppl
1):A121.
Bode 2001
Bode G, Hoffmeister A, Koenig W, Brenner H,
Rothenbacher D. Characteristics of differences in
Helicobacter pylori serology and c-13-urea breath-testing in
an asymptomatic sample of blood donors. Scandinavian
Journal of Clinical & Laboratory Investigation 2001;61(8):
603–8.
Bode 2002
Bode G, Marchildon P, Peacock J, Brenner H, Rothenbacher
D. Diagnosis of Helicobacter pylori infection in children:
Comparison of a salivary immunoglobulin g antibody test
with the c-13 urea breath test. Clinical and Diagnostic
Laboratory Immunology 2002;9(2):493–5.
Bodger 1999
Bodger K, Wyatt JI, Heatley RV. Serologic screening before
endoscopy: The value of Helicobacter pylori serology, serum
recognition of the caga and vaca proteins, and serum
pepsinogen i. Scandinavian Journal of Gastroenterology
1999;34(9):856–63.
Bodhidatta 1993
Bodhidatta L, Hoge CW, Churnratanakul S, Nirdnoy
W, Sampathanukul P, Tungtaem C, et al. Diagnosis of
Helicobacter pylori infection in a developing country:
Comparison of two ELISAs and a seroprevalence study.
Journal of Infectious Diseases 1993;168(6):1549–53.
43Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Bohn 1994
Bohn I, Teufel M, Niessen KH. Helicobacter pylori causing
chronical stomach-ache in childhood. Monatsschrift fur
Kinderheilkunde 1994;142(4):269–71.
Bojko 1997
Bojko JB, Braden B, Lembcke B, Stolte M, Burlage M,
Folsch UR, et al. C-13-urea breath test correlates with the
hp corpus colonization score in Helicobacter pylori - infected
patients. Gastroenterology 1997;112(4 (suppl)):A75.
Bolton 1989a
Bolton FJ, Hutchinson DN, Hinchiliffe PM, Holt AV.
Distribution in various clinical groups of antibody to
C. pylori detected by enzyme-linked immunosorbent
assay, complement fixation and microagglutination tests.
Serodiagnosis and Immunotherapy in Infectious Disease 1989;
3(1):41–50.
Bolton 1989b
Bolton FJ, Hutchinson DN. Evaluation of three
Campylobacter pylori antigen preparations for screening sera
from patients undergoing endoscopy. Journal of Clinical
Pathology 1989;42(7):723–6.
Bolton 1997
Bolton FJ, Wareing DRA, Sails AD. Comparison of a novel
microaerobic system with three other gas-generating systems
for the recovery of Campylobacter species from human faecal
samples. European Journal of Clinical Microbiology and
Infectious Diseases 1997;16(11):839–42.
Bommelaer 2001
Bommelaer G, Des Varannes SB, Flejou JF, Matysiak T,
Poynard T, Richard A, et al. Caga status and virulence of
Helicobacter pylori strains. Results of a French multicentric
prospective study. Gastroenterologie Clinique et Biologique
2001;25(12):1084–9.
Bonamico 2004
Bonamico M, Strappini PM, Bonci E, Ferri M, Crisogianni
M, Guido M, et al. Evaluation of stool antigen test, PCR on
oral samples and serology for the noninvasive detection of
Helicobacter pylori infection in children. Helicobacter 2004;
9(1):69–76.
Bongermino 2010
Bongermino MP, Ruggero V, Cristallo V, Bonfrate L,
Santantonio M, Mola A, et al. Evaluation of non-invasive
methods for the diagnosis of Helicobacter pylori infection.
European Journal of Clinical Investigation 2010;40:67.
Booka 2005
Booka M, Okuda M, Shin K, Miyashiro E, Hayashi H,
Yamauchi K, et al. Polymerase chain reaction-restriction
fragment length polymorphism analysis of clarithromycin-
resistant Helicobacter pylori infection in children using stool
sample. Helicobacter 2005;10(3):205–13.
Bordin 2013
Bordin DS, Berezina OI, Kim VA, Orobey YA, Patrushev
NB. Diagnosis of H. pylori infection in routine clinical
practice in Russia. Helicobacter 2013;18:122.
Bornschein 2011
Bornschein J, Selgrad M, Malfertheiner P.Helicobacter pylori
- diagnosis and treatment. MMW-Fortschritte der Medizin
2011;153(38):58–61.
Borody 2012
Borody T, Wettstein A, Finlayson S, Torres M, Campbell
J, Nowak A. Diagnostic value of fundic red spots in
Helicobacter pylori (HP) infection. American Journal of
Gastroenterology 2012;107:S59.
Borody 2013
Borody TJ, Wettstein AR, Benstock S, Nowak A, Finlayson
SJ, Campbell J. Superior diagnosis of H. pylori infection
with 14c-urea helicaptm capsules versus standard pytest
capsules. Gastroenterology 2013;144(5 (suppl 1)):S214–S5.
Boudjella 2009
Boudjella MEA, Matougui N, Tebaibia A, Oumnia N,
Lahcene M, Mouffok F, et al. Evaluation of C-13-urea
breath test in determining H. pylori status after treatment:
About 197 cases. Helicobacter 2009;14(4):343.
Boukthir 2005
Boukthir S, Mazigh S, Fendri C, Kalach N, Barsaoui
S. Evaluation of a non-invasive test for detection of
Helicobacter pylori antigen in stool from children. Archives
de Pediatrie 2005;12(1):85–7.
Boyanova 2003
Boyanova L, Koumanova R, Lazarova E, Jelev C.
Helicobacter pylori and Helicobacter heilmannii in children.
A Bulgarian study. Diagnostic Microbiology & Infectious
Disease 2003;46(4):249–52.
Boyanova 2013
Boyanova L, Ilieva Y, Vladimirov B, Gergova G, Nikolov
R, Spasova Z, et al. The rate of Helicobacter pylori in adult
patients with the 13C urea breath test. General Medicine
2013;15(4):22–5.
Braden 1991
Braden B, Lembcke B, Caspary WF. Stable isotopes in
diagnosis and research. Deutsche Medizinische Wochenschrift
1991;116(45):1721–7.
Braden 1992
Braden B, Lembcke B, Caspary WF. Diagnosis of
Helicobacter-pylori. Innere Medizin 1992;19(3):103–7.
Braden 1993
Braden B, Klutz M, Lembcke B, Caspary WF. C-13 urea
breath test for Helicobacter-pylori - optimal timing of breath
sample collection. Gastroenterology 1993;104(4 (suppl)):
A45.
Braden 1994a
Braden B, Haisch M, Duan LP, Lembcke B, Caspary WF,
Hering P. Clinically feasible stable isotope technique at a
reasonable price: Analysis of 13Co2/12co2-abundance in
breath samples with a new isotope selective-nondispersive
infrared spectrometer. Zeitschrift fur Gastroenterologie 1994;
32(12):675–8.
Braden 1994b
Braden B, Duan LP, Caspary WF, Lembcke B. More
convenient 13C-urea breath test modifications still meet the
44Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
criteria for valid diagnosis of Helicobacter pylori infection.
Zeitschrift fur Gastroenterologie 1994;32(4):198–202.
Braden 1996
Braden B, Schafer F, CasparyWF, Lembcke B. Nondispersive
isotope-selective infrared spectroscopy: A new analytical
method for 13C-urea breath tests. Scandinavian Journal of
Gastroenterology 1996;31(5):442–5.
Braden 1997
Braden B, Duan LP, Caspary WF, Lembcke B. Endoscopy
is not a risk factor for Helicobacter pylori infection - but
medical practice is. Gastrointestinal Endoscopy 1997;46(4):
305–10.
Braden 1999
Braden B, Caspary WF, Lembcke B. Nondispersive infrared
spectrometry for (co2)-c-13/(co2)-c-12-measurements: A
clinically feasible analyzer for stable isotope breath tests in
gastroenterology. Zeitschrift fur Gastroenterologie 1999;37
(6):477–81.
Braden 2000a
Braden B. New faecal antigen test noninvasively
detects Helicobacter pylori infection. Biomedicine and
Pharmacotherapy 2000;54(7):416–7.
Braden 2000b
Braden B, Posselt HG, Ahrens P, Kitz R, Dietrich CF,
Caspary WF. New immunoassay in stool provides an
accurate noninvasive diagnostic method for Helicobacter
pylori screening in children. Pediatrics 2000;106(1 Pt 1):
115–7.
Braden 2000c
Braden B, Teuber G, Dietrich CF, Caspary WF, Lembcke
B. Comparison of new faecal antigen test with c-13-urea
breath test for detecting Helicobacter pylori infection and
monitoring eradication treatment: Prospective clinical
evaluation. BMJ 2000;320(7228):148.
Braden 2001a
Braden B, Gelbmann C, Dietrich CF, Caspary WF,
Scholmerich J, Lock G. Qualitative and quantitative clinical
evaluation of the laser-assisted ratio analyser for detection
of Helicobacter pylori infection by c-13-urea breath tests.
European Journal of Gastroenterology & Hepatology 2001;13
(7):807–10.
Braden 2001b
Braden B, Caspary WF. Detection of Helicobacter pylori
infection: When to perform which test?. Annals of Medicine
2001;33(2):91–7.
Braden 2007
Braden B, Lembcke B, Kuker W, Caspary WF. 13C-breath
tests: Current state of the art and future directions. Digestive
& Liver Disease 2007;39(9):795–805.
Braden 2012
Braden B. Diagnosis of Helicobacter pylori infection. BMJ
2012;344:e828.
Brandi 2006
Brandi G, Biavati B, Calabrese C, Granata M, Nannetti
A, Mattarelli P, et al. Urease-positive bacteria other than
Helicobacter pylori in human gastric juice and mucosa.
American Journal of Gastroenterology 2006;101(8):1756–61.
Bravo 1999
Bravo LE, Realpe JL, Campo C, Mera R, Correa P. Effects
of acid suppression and bismuth medications on the
performance of diagnostic tests for Helicobacter pylori
infection. American Journal of Gastroenterology 1999;94(9):
2380–3.
Bravos 2000
Bravos ED, Gilman RH. Accurate diagnosis of Helicobacter
pylori other tests. Gastroenterology Clinics of North America
2000;29(4):925–9.
Brennan 1991
Brennan DP, Kennedy NP, Keeling PWN. Serum IgG
response to Campylobacter-pylori antigens as measured by
western blotting. Irish Journal of Medical Science 1991;160
(2):64–5.
Brennan 2015a
Brennan D, Smith SM, Omorogbe JA, Holleran G, Hall
B, Hussey M, et al. Detection of Helicobacter pylori and
antibiotic resistance using a molecular genetics-based
approach in human faecal samples. Gastroenterology 2015;
148(4 (suppl)):S420.
Brennan 2015b
Brennan D, Omorogbe J, Holleran G, HusseyM, O’Morain
C, Smith S, et al. A comparison of the prevalence of
Helicobacter pylori infection and rates of antibiotic resistance
in patients undergoing gastroscopy versus the urea breath
test. Helicobacter 2015;20:100–1.
Breslin 1997
Breslin NP, Omorain CA. Noninvasive diagnosis of
Helicobacter pylori infection: A review. Helicobacter 1997;2
(3):111–7.
Breslin 1998
Breslin NP, Lee J, Buckley M, O’Morain C. Screening for
Helicobacter pylori in young dyspeptic patients referred
for investigation - endoscopy for those who test negative.
Alimentary Pharmacology and Therapeutics 1998;12(6):
577–82.
Breslin 2000
Breslin NP, Lee JM, Buckley MJ, Balbirnie E, Rice D,
O’Morain CA. Validation of serological tests forHelicobacter
pylori infection in an Irish population. Irish Journal of
Medical Science 2000;169(3):190–4.
Bretagne 1998
Bretagne JF, Caekaert A, Barthelemy P, Hepysode. Long-
term follow-up of Helicobacter pylori (HP) serology after
successful eradication: A cohort of 203 patients tested by
ELISA and heliSAL (TM) rapid blood tests. Gastroenterology
1998;114(4 (suppl)):A80.
Briedigkeit 1992
Briedigkeit H, Montag T, Spiridonow PS, Sielaff F, Wack R,
Held C, et al. Detection of Helicobacter pylori infections by
antibody determination. Zeitschrift fur Arztliche Fortbildung
(Jena) 1992;86(17):869–72.
45Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Britto 2002
Britto Gomes AT, Coelho LK, Secaf M, Pimenta Modena
JL, De Almeida Troncon LE, De Oliveira RB. Accuracy of
the 14C-urea breath test for the diagnosis of Helicobacter
pylori. Sao Paulo Medical Journal 2002;120(3):68–71.
Brmbolic 1997
Brmbolic B, Zerjav S, Bogdanov M, Dordevic M,
Radivojevic M, Stojsic Z, et al. The value of serum
IgG and IgA antibodies in the diagnosis of Helicobacter
pylori infection in dyspeptic patients. Archives of
Gastroenterohepatology 1997;16(1):12–5.
Brown 1993
Brown KE, Peura DA. Diagnosis of Helicobacter pylori
infection. Gastroenterology Clinics of North America 1993;22
(1):105–15.
Bruce 2005
Bruce M, Parkinson A, Gessner B. Does delayed testing of
urea breath test samples effect results?. Digestion 2005;71
(4):261.
Bruden 2011
Bruden DL, Bruce MG, Miernyk KM, Morris J, Hurlburt
D, Hennessy TW, et al. Diagnostic accuracy of tests for
Helicobacter pylori in an Alaska native population. World
Journal of Gastroenterology 2011;17(42):4682–8.
Bruning 2002
Bruning A, Reimann FM, Homann N, Hussein ZE,
Konecny E, Ludwig D. A novel continuous 13C-urea breath
test for detection of H. pylori infection. Gastrointestinal
Endoscopy 2002;55(5):AB190–AB.
Brunner 1989
Brunner H, Markt B, Mittermayer H, Binder L. C-14
urea breath test (UBT) for the detection and follow-up of
Campylobacter-pylori infection. Gastroduodenal Pathology
and Camphylobacter pylori 1989;847:69–71.
Buchan 2013
Buchan BW, Olson WJ, Pezewski M, Marcon MJ, Novicki
T, Uphoff TS, et al. Clinical evaluation of a real-time
PCR assay for identification of Salmonella, Shigella,
Campylobacter (Campylobacter jejuni and C. coli), and shiga
toxin-producing Escherichia coli isolates in stool specimens.
Journal of Clinical Microbiology 2013;51(12):4001–7.
Buchvald 1993
Buchvald D, Buchvaldova D. Antigens for the ELISA
test for serodiagnosis of Helicobacter pylori infection.
Ceskoslovenska Epidemiologie, Mikrobiologie, Imunologie
1993;42(1):16–21.
Buhling 2004
Buhling F, KochG,Wex T, Heimburg A, Vieth M, Leodolter
A, et al. Simultaneous detection and differentiation of
anti-Helicobacter pylori antibodies by flow microparticle
immunofluorescence assay. Clinical & Diagnostic Laboratory
Immunology 2004;11(1):131–6.
Bures 2000
Bures J, Palicka V, Kopacova M, Vorisek V, Rejchrt S, Zivny
P. Diagnosis of Helicobacter pylori with the 13C-labeled urea
breath test: Study methodology. Casopis Lekaru Ceskych
2000;139(24):776–8.
Burucoa 2013
Burucoa C, Delchier JC, Courillon-Mallet A, De Korwin
JD, Megraud F, Zerbib F, et al. Comparative evaluation
of 29 commercial Helicobacter pylori serological kits.
Helicobacter 2013;18(3):169–79.
Busro 2013
Busro VO, Bakry F, Farida A, Yuwono. Sensitivity and
specificity value of saliva Helicobacter pylori examination in
chronic gastritis patients. Hepatology International 2013;7:
S753–S4.
Butler 2000
Butler AK, Brennan SA, Neal K, Logan RPH. A multi-
centre study of the prevalence of H-pylori in urban
Nottinghamshire children using the HpSA(r) stool antigen
test. Gut 2000;47(Suppl 1):A45–A6.
Buyukbaba-Boral 2005
Buyukbaba-Boral O, Kucuker-Ang M, Aktas G, Issever
H, Ang O. HpSA fecoprevalence in patients suspected
to have Helicobacter pylori infection in Istanbul, Turkey.
International Journal of Infectious Diseases 2005;9(1):21–6.
Buzas 2001
Buzas GM, Illyes G, Szekely E, Szeles I. Six regimens for
the eradication of Helicobacter pylori (HP) in duodenal ulcer
patients: Three consecutive trials (1995-1999). Journal of
Physiology, Paris 2001;95(1-6):437–41.
Buzas 2008
Buzas GM, Szeles I. Interpretation of the 13C-urea breath
test in the choice of second- and third-line eradication of
Helicobacter pylori infection. Journal of Gastroenterology
2008;43(2):108–14.
Cacoullis 1991
Cacoullis F, Batten JJ, Logan R, Karim QN, Walker M,
Baron JH. Quantifying the extent of Helicobacter-pylori
infection with the C-13 urea breath test. Gut 1991;32(5):
A565.
Cadranel 1998
Cadranel S, Corvaglia L, Bontems P, Deprez C, Glupczynski
Y, Van Riet A, et al. Detection of Helicobacter pylori
infection in children with a standardized and simplified C-
13-urea breath test. Journal of Pediatric Gastroenterology and
Nutrition 1998;27(3):275–80.
Cagdas 2012
Cagdas U, Otag F, Tezcan S, Sezgin O, Aslan G, Emekdas
G. Detection of Helicobacter pylori and antimicrobial
resistance in gastric biopsy specimens. Mikrobiyoloji Bulteni
2012;46(3):398–409.
Caglar 1999
Caglar M, Belzberg AS, Spruston B, Sexsmith G. Time-
optimized carbon-14 breath test for Helicobacter pylori
contamination of the stomach. Clinical Nuclear Medicine
1999;24(9):674–7.
Cai 2010
Cai J, Olafsson S. Helicobacter pylori breath test in an open
access system has a high rate of potentially false negative
46Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
results. Negative result should be considered false negative
until proven otherwise. Gastroenterology 2010;138(5 (suppl
1)):S336.
Calam 1994
Calam J. Helicobacter-pylori. European Journal of Clinical
Investigation 1994;24(8):501–10.
Calvet 1999
Calvet X, Feu F, Forne M, Montserrat A, Elizalde JI, Viver
JM, et al. The evaluation of a new immunoenzyme analysis
for the detection of Helicobacter pylori infection in stool
samples. [Spanish]. Gastroenterologia Y Hepatologia 1999;
22(6):270–2.
Calvet 2002a
Calvet X, Salceda F, Sanfeliu I, Montserrat A, Brullet E,
Real J, et al. Testing a new in-office test for determination
of faecal Helicobacter pylori antigen. Medicina Clinica 2002;
118(4):126–9.
Calvet 2002b
Calvet X, Sanfeliu I, Musulen E, Mas P, Dalmau B, Gil M,
et al. Evaluation of Helicobacter pylori diagnostic methods
in patients with liver cirrhosis. Alimentary Pharmacology &
Therapeutics 2002;16(7):1283–9.
Calvet 2002c
Calvet X, Rosello M, Quesada M, Sanfeliu I, Salcerda F,
Montserrat A, et al. Diagnosis ofHelicobacter pylori infection
in dyspectic patients by stool antigen detection. Usefulness
of a new monoclonal ELISA test. Gastroenterology 2002;
122(4 (suppl)):A205–A6.
Calvet 2003
Calvet X, Quesada M, Rosello M, Salceda F, Sanfeliu
I, Dalmau B, et al. Stool antigen for the diagnosis of
Helicobacter pylori infection in cirrhosis: Comparative
usefulness of three different methods. Alimentary
Pharmacology & Therapeutics 2003;17(5):727–31.
Calvet 2005
Calvet X, Quesada M, Calvet V, Choat T, Sanfeliu I,
Segura F. Usefulness of RAPID HP StAR (TM), a new
immunochomatographic, monoclonal antigen-based fecal
test for diagnosing Helicobacter pylori infection in dyspeptic
patients. Helicobacter 2005;10(5):524.
Calvet 2009
Calvet X, SaDelgado J, Montserrat A, Lario S, Ramirez-
Lazaro MJ, Quesada M, et al. Accuracy of diagnostic tests
for Helicobacter pylori: A reappraisal. Clinical Infectious
Diseases 2009;48(10):1385–91.
Calvet 2010a
Calvet X, Lario S, Ramirez-Lazaro MJ, Montserrat A,
Quesada M, Reeves L, et al. Comparative accuracy of 3
monoclonal stool tests for diagnosis of Helicobacter pylori
infection among patients with dyspepsia. Clinical Infectious
Diseases 2010;50(3):323–8.
Calvet 2010b
Calvet X, Lario S, Ramirez-Lazaro MJ, Montserrat A,
Quesada M, Reeves L, et al. Accuracy of monoclonal stool
tests for determining cure of Helicobacter pylori infection
after treatment. Helicobacter 2010;15(3):201–5.
Calvet 2015
Calvet X. Diagnosis of Helicobacter pylori infection in the
proton pump inhibitor era. Gastroenterology Clinics of North
America 2015;44(3):507–18.
Calvo 2013
Calvo XC, Ramirez-Lazaro M, Lario S, Sanchez-Delgado
J, Montserrat A, Casalots A, et al. C13-urea breath test
skipping citric acid has low specificity for diagnosing H.
pylori infection. Helicobacter 2013;18:119–20.
Camargos 2003
Camargos Rocha AM, Aguiar Rocha G, Santos A, De
Oliveira CA, Magalhaes Queiroz DM. Accuracy of a
commercial enzyme-linked immunosorbent assay for CagA
in patients from Brazil with and without gastric carcinoma.
Journal of Clinical Microbiology 2003;41(1):447–8.
Camorlinga-Ponce 1998
Camorlinga-Ponce M, Torres J, Perez-Perez G, Leal-
Herrera Y, Gonzalez-Ortiz B, Madrazo de la Garza A, et al.
Validation of a serologic test for the diagnosis ofHelicobacter
pylori infection and the immune response to urease and
CagA in children. American Journal of Gastroenterology
1998;93(8):1264–70.
Campuzano-Maya 2007
Campuzano-Maya G. An optimized C-13-urea breath test
for the diagnosis of H. pylori infection. World Journal of
Gastroenterology 2007;13(41):5454–64.
Canard 2003
Canard JM, Ponchon T, Napoleon B, Boyer J, Dalbies
P, Escourrou J, et al. Specific roles of endoscopy and
respiratory test in the diagnosis and eradication control of
Helicobacter pylori. Acta Endoscopica 2003;33(5):810–2.
Canete 2002
Canete A, Abunaji Y, Alvarez-Calatayud G, De-Vicente M,
Gonzalez-Holguera J, Leralta M, et al. 13C-urea breath test
with 50 mg of urea: An accurate method for the diagnosis
of H. pylori infection in children. Gastroenterology 2002;
122(4 (Suppl)):A207.
Canete 2003
Canete A, Abunaji Y, Alvarez-Calatayud G, DeVicente M,
Gonzalez-Holguera JA, Leralta M, et al. Breath test using a
single 50-mg dose of C-13-urea to detect Helicobacter pylori
infection in children. Journal of Pediatric Gastroenterology
and Nutrition 2003;36(1):105–11.
Cao 2012
Cao X, Jiang J, Jia ZF, Jin MS. Serum levels of pepsinogen ii
are a useful biomarker of Helicobacter pylori-infected gastric
cancer than pepsinogen i. Journal of Gastroenterology and
Hepatology 2012;27:24.
Caporali 2003
Caporali R, Epis O, Negrini R, Scire CA, Solcia E,
Montecucco C. Salivary gland lymphocytic infiltrates and
Helicobacter pylori serology in anti-SSA/Ro positive patients
47Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
in Italy. Clinical and Experimental Rheumatology 2003;21
(2):266–7.
Capurso 2006
Capurso G, Carnuccio A, Lahner E, Panzuto F, Baccini F,
Fave GD, et al. Corpus-predominant gastritis as a risk factor
for false-negative C-13-urea breath test results. Alimentary
Pharmacology & Therapeutics 2006;24(10):1453–60.
Cardenas 2006
Cardenas VM, Dominguez DC, Puentes F, Aragaki CC,
Goodman KJ, Graham DY, et al. Rapid stool antigen
test for diagnosis of H-pylori infection in asymptomatic
children. Gastroenterology 2006;130(4 (suppl)):A570.
Cardenas 2008
Cardenas VM, Dominguez DC, Puentes FA, Aragaki CC,
Goodman KJ, Graham DY, et al. Evaluation of a novel stool
native catalase antigen test for Helicobacter pylori infection
in asymptomatic North American children. Journal of
Pediatric Gastroenterology & Nutrition 2008;46(4):399–402.
Cardinali 2003
Cardinali LDC, Rocha GA, Rocha AMC, De Moura SB,
Soares TD, Esteves AMB, et al. Evaluation of C-13 urea
breath test and Helicobacter pylori stool antigen test for
diagnosis ofH-pylori infection in children from a developing
country. Journal of Clinical Microbiology 2003;41(7):
3334–5.
Carrasco 1998
Carrasco MAV, Alonso IJ, Canto JLG, Baruque LL, Molini
PS, Gisbert JP, et al. Is fasting required to perform C-13-
urea breath test in the diagnosis of H-pylori infection?. Gut
1998;43(Suppl 2):A54.
Casellas 1999
Casellas F, Lopez J, Borruel N, Saperas E, Vergara M, De
Torres I, et al. The impact of delaying gastric emptying by
either meal substrate or drug on the C-13 -urea breath test.
American Journal of Gastroenterology 1999;94(2):369–73.
Caselli 1999
Caselli M, Zaffoni E, Trevisani L, Sartori S, Alvisi V, Plebani
M, et al. Diagnosis of Helicobacter pylori infection by HPSA
test. Lancet 1999;354(9185):1209–11.
Caspary 1995
Caspary WF. 13C-urea breath test. Patient-friendly gold
standard in the diagnosis of Helicobacter pylori infection
with long term cost control potential. Deutsche Medizinische
Wochenschrift 1995;120(27):976–8.
Casswall 1999
Casswall TH, Nilsson HO, Bergstrom M, Aleljung P,
Wadstrom T, Dahlstrom AK, et al. Evaluation of serology,
13C-urea breath test, and polymerase chain reaction of
stool samples to detect Helicobacter pylori in Bangladeshi
children. Journal of Pediatric Gastroenterology & Nutrition
1999;28(1):31–6.
Castro 2004
Castro Fernández M, Sánchez Muñoz D, García Díaz
E, Galán Jurado MV, Rodríguez Alonso C. Diagnosis
of Helicobacter pylori infection using urease rapid test
in patients with bleeding duodenal ulcer: Influence of
endoscopic signs and simultaneous corporal and antral
biopsies. Revista Espanola De Enfermedades Digestivas 2004;
96(9):599-602; 605.
Castro-Fernandez 2004
Castro-Fernández M, Sanchez-Muñoz D, García-Díaz
E, Miralles-Sanchiz J, Vargas-Romero J. Diagnosis of
Helicobacter pylori infection in patients with bleeding ulcer
disease: Rapid urease test and histology. Revista Espanola De
Enfermedades Digestivas 2004;96(6):395-8; 398-401.
Cave 1999
Cave DR, Zanten SV, Carter E, Halpern EF, Klein S, Prather
C, et al. A multicentre evaluation of the laser assisted
ratio analyser (LARA): A novel device for measurement of
13CO2 in the 13C-urea breath test for the detection of
Helicobacter pylori infection. Alimentary Pharmacology &
Therapeutics 1999;13(6):747–52.
Cevrioglu 2004
Cevrioglu AS, Altindis M, Yilmazer M, Fenkci IV,
Ellidokuz E, Kose S. Efficient and non-invasive method for
investigating Helicobacter pylori in gravida with hyperemesis
gravidarum: Helicobacter pylori stool antigen test. Journal of
Obstetrics & Gynaecology Research 2004;30(2):136–41.
Chacon 1995
Chacon EP, Correnti M, Salma N, Serrano N, Pinero
R, Cavazza ME, et al. Immunoenzymatic assay for
serodiagnosis of Helicobacter pylori infections. GEN 1995;
49(3):208–11.
Chalkias 2011
Chalkias A, Nikotian G, Koutsovasilis A, Bramis J,
Manouras A, Mystrioti D, et al. Patients with colorectal
cancer are characterized by increased concentration of fecal
Hb-Hp complex, myeloperoxidase, and secretory IgA.
American Journal of Clinical Oncology: Cancer Clinical Trials
2011;34(6):561–6.
Chang 1999
Chang MC, Wu MS, Wang HH, Wang HP, Lin JT.
Helicobacter pylori stool antigen (HPSA) test - a simple,
accurate and non-invasive test for detection of Helicobacter
pylori infection. Hepato-Gastroenterology 1999;46(25):
299–302.
Chang 2000
Chang YW, Kim KJ, Min SK, Dong SH, Kim HJ, Kim BH,
et al. Quantitative result of C-13-urea breath test does not
correlate with Helicobacter pylori density in the stomach by
assessing histopathology and grade of phenol red staining.
Gastroenterology 2000;118(4):A1221.
Chang 2002
Chang MC, Chang YT, Sun CT, WuMS, Wang HP, Lin JT.
Quantitative correlation of Helicobacter pylori stool antigen
(HPSA) test with C-13-urea breath test (C-13-UBT) by
the updated Sydney Grading System of gastritis. Hepato-
Gastroenterology 2002;49(44):576–9.
Chang 2003
Chang YW, Min SK, Kim KJ, Han YS, Lee JH, Dong SH,
et al. Delta (13)C-urea breath test value is a useful indicator
48Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
for Helicobacter pylori eradication in patients with functional
dyspepsia. Journal of Gastroenterology & Hepatology 2003;
18(6):726–31.
Chang 2012
Chang WT, Lin CC, Lin YH, Wang CC, Wang SH, Liu
YW, et al. The potential role of using C-13 urea breath test
as a routine perioperative evaluation of Helicobacter pylori
infection in living-related liver donors. Liver Transplantation
2012;18:S205–S.
Chang 2013
Chang C, Xie H, Ni Y, Ting Q, Bo Z. The clinical studies
to the diagnostic value of serum pepsinogen levels in gastric
cancer. Journal of Gastroenterology and Hepatology 2013;28:
742.
Chattopadhyay 2002
Chattopadhyay UK. Coagglutination test for rapid
noncultural diagnosis of human campylobacteriosis.
European Review for Medical and Pharmacological Sciences
2002;6(1):9–11.
Chattopadhyay 2004
Chattopadhyay S, Patra R, Ramamurthy T, Chowdhury A,
Santra A, Dhali GK, et al. Multiplex PCR assay for rapid
detection and genotyping ofHelicobacter pylori directly from
biopsy specimens. Journal of Clinical Microbiology 2004;42
(6):2821–4.
Checchi 2000
Checchi L, Felice P, Acciardi C, Ricci C, Gatta L, Polacci R,
et al. Absence of Helicobacter pylori in dental plaque assessed
by stool test. American Journal of Gastroenterology 2000;95
(10):3005–6.
Chehter 2013
Chehter EZ, Bacci MR, Fonseca FLA, Goncalves JAC,
Buchalla G, Shiraichi SAR, et al. Diagnosis of the infection
by the Helicobacter pylori through stool examination:
Method standardization in adults. Clinical Biochemistry
2013;46(15):1622–4.
Chen 1994
Chen JJ, Changchien CS, Tai DI, Chiou SS, Lee CM,
Kuo CH. Role of Helicobacter pylori in cirrhotic patients
with peptic ulcer. A serological study. Digestive Diseases &
Sciences 1994;39(7):1565–8.
Chen 1996
Chen JJ, Yang ZX, Jiang XG. A comparison of purified
urease antigen and whole cell antigen of Helicobacter
pylori by ELISA test--study on the application and
serum diagnoses of Helicobacter pylori urease diagnostic
reagent. Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua
Liuxingbingxue Zazhi 1996;17(1):44–6.
Chen 1997
Chen TS, Chang FY, Lee SD. Serodiagnosis of Helicobacter
pylori infection: Comparison and correlation between
enzyme-linked immunosorbent assay and rapid serological
test results. Journal of Clinical Microbiology 1997;35(1):
184–6.
Chen 2000
Chen X, Haruma K, Kamada T, Mihara M, Komoto K,
Yoshihara M, et al. Factors that affect results of the C-13
urea breath test in Japanese patients. Helicobacter 2000;5
(2):98–103.
Chen 2001a
Chen X, Haruma K, Kamada T, Hartori N, Yoshihara
M, Kitadai Y, et al. A low 13C-urea breath test value is
associated with increased risk of gastric cancer. Journal of
Gastroenterology 2001;36(9):601–5.
Chen 2001b
Chen TS, Chang FY, Lee SD. Extending the reading time
increases the accuracy of rapid whole blood test for diagnosis
of Helicobacter pylori infection. Journal of Gastroenterology
& Hepatology 2001;16(12):1341–5.
Chen 2002a
Chen TS, Li FY, Chang FY, Lee SD. Immunoglobulin G
antibody against Helicobacter pylori: Clinical implications
of levels found in serum. Clinical & Diagnostic Laboratory
Immunology 2002;9(5):1044–8.
Chen 2002b
Chen TS, Chang FY, Lee SD. No difference of accuracy
between capillary and venous blood in rapid whole blood
test for diagnosis of Helicobacter pylori infection. Digestive
Diseases & Sciences 2002;47(11):2519–22.
Chen 2003
Chen TS, Chang FY, Chen PC, Huang TW, Ou JT, Tsai
MH, et al. Simplified C-13-urea breath test with a new
infrared spectrometer for diagnosis of Helicobacter pylori
infection. Journal of Gastroenterology and Hepatology 2003;
18(11):1237–43.
Chen 2009a
Chen CC, Liou JM, Hsu YC, Fang JY, Wang HP, Wu MS.
Rabeprazole therapeutic trial in patients with uninvestigated
dyspepsia. Journal of Gastroenterology and Hepatology 2009;
24:A45.
Chen 2009b
Chen LW, Chang JJ, Chiu CJ, Fang KM, Chien RN, Chang
LC, et al. 14C urea breath test in patients with peptic ulcer:
The correlations with clinical factors, histology, rapid urease
test and endoscopic findings. Journal of Gastroenterology and
Hepatology 2009;24:A86.
Cheng 2004
Cheng H, Hu FL. The value of Helicobacter pylori stool
antigen immunocard stat in diagnosis of HP infection and
assessing of eradication of HP. Zhonghua Yi Xue Za Zhi
2004;84(14):1166–70.
Cherian 2008
Cherian S, Burgner DP, Carson CF, Sanfilippo FM, Cook
AG, Forbes DA. Diagnosis of Helicobacter pylori infection
in a high-prevalence pediatric population: A comparison
of 2 fecal antigen testing methods and serology. Journal of
Pediatric Gastroenterology and Nutrition 2008;47(2):130–5.
Chey 1997a
Chey WD,Woods M, Scheiman JM, Nostrant TT, DelValle
J. Lansoprazole and ranitidine affect the accuracy of the
49Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C-14-urea breath test by a pH-dependent mechanism.
American Journal of Gastroenterology 1997;92(3):446–50.
Chey 1997b
Chey WD. Proton pump inhibitors and the urea breath
test: How long is long enough?. American Journal of
Gastroenterology 1997;92(4):720–1.
Chey 1999a
Chey WD, Shaw S, Montague J, Jones M, Murthy U.
Appropriate timing of the C-14-urea breath test to establish
eradication of H-pylori infection: An interim analysis.
Gastroenterology 1999;116(4 (suppl)):A136.
Chey 1999b
Chey WD, Murthy U, Toskes P, Carpenter S, Laine L. The
13C-urea blood test accurately detects active Helicobacter
pylori infection: A United States, multicenter trial. American
Journal of Gastroenterology 1999;94(6):1522–4.
Chey 2000a
Chey WD, Metz DC, Shaw S, Kearney D, Montague J,
Murthy U. Appropriate timing of the C-14-urea breath
test to establish eradication of Helicobacter pylori infection.
American Journal of Gastroenterology 2000;95(5):1171–4.
Chey 2000b
Chey WD. Accurate diagnosis of Helicobacter pylori - C-14-
urea breath test. Gastroenterology Clinics of North America
2000;29(4):895.
Chey 2007
CheyWD,WongBC.AmericanCollege ofGastroenterology
guideline on the management of Helicobacter pylori
infection. American Journal of Gastroenterology 2007;102
(8):1808–25.
Chiang 2010
Chiang TH, Tu CH, Lee YC, Wu MS. Clinical predictors
of significant esophagogastroduodenoscopy findings for
asymptomatic subjects with positive immunochemical fecal
occult blood test and negative colonoscopy. Gastrointestinal
Endoscopy 2010;71 (5):AB357.
Chiba 1999
Chiba N, Veldhuyzen Van Zanten SJ. 13C-urea breath tests
are the noninvasive method of choice for Helicobacter pylori
detection. Canadian Journal of Gastroenterology 1999;13(8):
681–3.
Ching 1991a
Ching CK, Thompson S, Buxton C, Holgate C, Hill P,
Freeman JG, et al. Evaluation of the new Helico-G ELISA
for serological diagnosis of Helicobacter-pylori infection. Gut
1991;32(5):A570.
Ching 1991b
Ching CK. A simplified diagnostic approach to Helicobacter
pylori infection--is it adequate?. American Journal of
Gastroenterology 1991;86(9):1276–8.
Ching 1993
Ching CK, Thompson S, Buxton C, Holgate C,
Holmes GKT. Evaluation of a commercial enzyme-linked
immunosorbent assay (ELISA) kit for serological diagnosis
of Helicobacter pylori infection in a group of non-ulcer
dyspepsia sufferers. Postgraduate Medical Journal 1993;69
(812):456–60.
Chisholm 2004
Chisholm SA, Watson CL, Teare ELS, Saverymuttu S,
Owen RJ. Non-invasive diagnosis of Helicobacter pylori
infection in adult dyspeptic patients by stool antigen
detection: Does the rapid immunochromatography test
provide a reliable alternative to conventional ELISA kits?.
Journal of Medical Microbiology 2004;53(7):623–7.
Chmiela 2003
Chmiela M, Wisniewska M, Bak-Romaniszyn L, Rechcinski
T, Planeta-Malecka I, Bielanski W, et al. Serological
differentiation of Helicobacter pylori CagA(+) and CagA
(-) infections. Archivum Immunologiae et Therapiae
Experimentalis 2003;51(2):131–6.
Cho 2000
Cho HS, Kang DH, Kim EA, Park DK, Park HC, Choi
DJ, et al. The usefulness of C-13-urea breath test for
the diagnosis of Helicobacter pylori infection in operative
stomach. Gastroenterology 2000;118(4):A505.
Cho 2003
Cho YS, Kim SS, Chae HS, Han SW, Lee CD, Chung IS.
The correlation between the DOB30 value of 13C-urea
breath test and the staining pattern of endoscopic phenol
red test in the diagnosis of Helicobacter pylori infection.
Gastroenterology 2003;124(4 (Suppl)):A176.
Cho 2008
Cho YS, Chae HS, Jang SN, Kim JS, Son HS, Kim HK,
et al. Comparison of the 13C-urea breath test and the
endoscopic phenol red mucosal pH test in the quantification
of Helicobacter pylori infection loading. Korean Journal of
Internal Medicine 2008;23(3):134–9.
Choi 2010
Choi J, Kim D, Park M. A prospective evaluation of new
stool antigen test for detection of H-pylori, in comparison
with histology, rapid urease test, C-13-urea breath test, and
serology. Helicobacter 2010;15(4):359.
Choi 2011
Choi J, Kim CH, Kim D, Chung SJ, Song JH, Kang
JM, et al. Prospective evaluation of a new stool antigen
test for the detection of Helicobacter pylori, in comparison
with histology, rapid urease test, 13C-urea breath test,
and serology. Journal of Gastroenterology and Hepatology
(Australia) 2011;26(6):1053–9.
Chong 1994
Chong J, Marshall BJ, Barkin JS, McCallum RW, Reiner
DK, Hoffman SR, et al. Occupational exposure to
Helicobacter pylori for the endoscopy professional: A sera
epidemiological study. American Journal of Gastroenterology
1994;89(11):1987–92.
Chong 1995
Chong SK, Lou Q, Asnicar MA, Zimmerman SE, Croffie
JM, Lee CH, et al. Helicobacter pylori infection in recurrent
abdominal pain in childhood: Comparison of diagnostic
tests and therapy. Pediatrics 1995;96(2 Pt 1):211–5.
50Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Chou 1997
Chou CH, Sheu BS, Yang HB, Cheng PN, Shin JS, Chen
CY, et al. Clinical assessment of the bacterial load of
Helicobacter pylori on gastric mucosa by a new multi-scaled
rapid urease test. Journal of Gastroenterology and Hepatology
1997;12(1):1–6.
Christensen 1992
Christensen AH, Gjorup T, Hilden J, Fenger C, Henriksen
B, Vyberg M, et al. Observer homogeneity in the histologic
diagnosis of Helicobacter-pylori - latent class analysis, kappa-
coefficient, and repeat frequency. Scandinavian Journal of
Gastroenterology 1992;27(11):933–9.
Christie 1996
Christie JM, McNulty CA, Shepherd NA, Valori RM. Is
saliva serology useful for the diagnosis of Helicobacter pylori?
. Gut 1996;39(1):27–30.
Chua 2002
Chua TS, Fock KM, Teo EK, Ng TM. Validation of 13C-
urea breathtest for the diagnosis of Helicobacter pylori
infection in the Singapore population. Singapore Medical
Journal 2002;43(8):408–11.
Chung 2001a
Chung IK, Hong SJ, Kim EJ, Cho JY, Kim HS, Park SH,
et al. What is the best method to diagnose Helicobacter
infection in bleeding peptic ulcers?: A prospective trial.
Korean Journal of Internal Medicine 2001;16(3):147–52.
Chung 2001b
Chung AYF, Chow PKH, Yu WK, Ho JMS, Chan HS,
Wong WK, et al. Prevalence of Helicobacter pylori in gastric
cancer in a South-East Asian population by C-14-urea
breath test. ANZ Journal of Surgery 2001;71(10):574–6.
Churchill 1998
Churchill RD, Hill PG, Holmes GK. Management of
dyspepsia in primary care. Breath test is better than near
patient blood tests. BMJ 1998;316(7141):1389.
Chvalova 1990
Chvalova M, Sedlackova M, Souckova A, Soucek A, Jirasek
A. Assessment of antibodies against Campylobacter-pylori in
children and adolescents with gastroduodenal complaints.
Sbornik Lekarsky 1990;92(11-12):343–8.
Cinar 2004
Cinar K, Soykan I, Ozden A. The effect of Helicobacter
pylori eradication in patients with functional dyspepsia:
Assessment of different diagnostic tests. Turkish Journal of
Gastroenterology 2004;15(3):159–63.
Ciok 2003
Ciok J, Tacikowski T, Bujko J, Dzieniszewski J. Urea breath
test (UBT) in the diagnosis of Helicobacter pylori infection.
Gastroenterologia Polska 2003;10(3):241–6.
Cirak 2007
Cirak MY, Akyon Y, Megraud F. Diagnosis of Helicobacter
pylori. Helicobacter 2007;12 Suppl 1:4–9.
Clancy 1994
Clancy RL, Cripps AW, Taylor DC, McShane LA, Webster
VJ. Detection of antibody against Helicobacter pylori in
the saliva of patients with dyspepsia. Canadian Journal of
Gastroenterology 1994;8(7):408–12.
Clayton 1992
Clayton CL, Kleanthous H, Coates PJ, Morgan DD,
Tabaqchali S. Sensitive detection of Helicobacter-pylori
by using polymerase chain-reaction. Journal of Clinical
Microbiology 1992;30(1):192–200.
Cockburn 2001
Cockburn M, Collett J, Cox B. Validation of the saliva-
based H. pylori test, helisal, and its use in prevalence surveys.
Epidemiology & Infection 2001;126(2):191–6.
Coelho 1990
Coelho LGV, Chausson Y, Passos MCF, Sadala RU,
Costa EL, Sabino CVS, et al. C-14 urea breath test as a
noninvasive method to detect gastric Helicobacter-pylori
colonization. Gastroenterologie Clinique et Biologique 1990;
14(11):801–5.
Coelho 1997
Coelho LGV, Passos MCF, Chausson Y, Simal CJR, Aguiar
ROA, Gallo MA, et al. Standard-dose (5-mu Ci) vs mini-
dose (1-mu Ci) 14c-urea breath test for H-pylori detection.
Gastroenterology 1997;112(4 (suppl)):A92.
Coelho 1999
Coelho LG, Reber M, Passos MC, Aguiar RO, Casaes PE,
Bueno ML, et al. Application of isotope-selective non-
dispersive infrared spectrometry for the evaluation of the
13C-urea breath test: Comparison with three concordant
methods. Brazilian Journal of Medical & Biological Research
1999;32(12):1493–7.
Coelho 2003
Coelho LGV, Rocha Z, Boechat LC, Aguiar ROA, Aragao
ALA, Dias EES, et al. 13C-urea breath test for H-pylori
detection in children: Determination of the cutoff value by
graphic method, independent of gold standard comparison.
Gastroenterology 2003;124(4 (suppl)):A177.
Coelho 2009a
Coelho LGV, Coelho MCF, Oliveira SM, Santa-Cecilia EV,
Moreira MR, Bomfim IM, et al. Does low dosage of 13C-
urea keep good accuracy for diagnosis of H. pylori infection?
. Helicobacter 2009;14 (4):340.
Coelho 2009b
Coelho LG, Silva-Junior AE, Coelho MC, Santa-Cecilia EV,
Ferreira RO, Bomfim IM, et al. Does low dosage of 13C-
urea keep good accuracy for diagnosis of Helicobacter pylori
infection. Gastroenterology 2009;136(5 (Suppl)):A345.
Coelho 2011
Coelho LG, Silva AE Jr, Coelho MC, Penna FG, Ferreira
RO, Santa-Cecilia EV. Does low dose (13)C-urea breath test
maintain a satisfactory accuracy in diagnosing Helicobacter
pylori infection?. Arquivos de Gastroenterologia 2011;48(2):
104–8.
Cohen 1999
Cohen H, Rose S, Lewin DN, Retama B, Naritoku W,
Johnson C, et al. Accuracy of four commercially available
serologic tests, including two office-based tests and a
51Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
commercially available C-13 urea breath test, for diagnosis
of Helicobacter pylori. Helicobacter 1999;4(1):49–53.
Colaiocco 1999
Colaiocco Ferrante L, Papponetti M, Marcuccitti J, Neri
M, Festi D. 13C-urea breath test for Helicobacter pylori
infection: Stability of samples over time. Scandinavian
Journal of Gastroenterology 1999;34(9):942–3.
Collins 1992
Collins JSA, Bamford KB, Sloan JM, Collins BJ, Moorehead
RJ, Love AHG. Screening for Helicobacter pylori antibody
could reduce endoscopy workload in young dyspeptic
patients. European Journal of Gastroenterology and
Hepatology 1992;4(12):991–3.
Con 2007
Con SA, Con-Wong R, Con-Chin GR, Con-Chin
VG, Takeuchi H, Valerin AL, et al. Serum pepsinogen
levels, Helicobacter pylori CagA status, and cytokine gene
polymorphisms associated with gastric premalignant
lesions in Costa Rica. Cancer Epidemiology, Biomarkers &
Prevention 2007;16(12):2631–6.
Connor 1999
Connor SJ, Seow F, Ngu MC, Katelaris PH. The effect
of dosing with omeprazole on the accuracy of the C-13-
urea breath test in Helicobacter pylori-infected subjects.
Alimentary Pharmacology & Therapeutics 1999;13(10):
1287–93.
Conti-Nibali 1990
Conti-Nibali S, Baldari S, Vitulo F, Sferlazzas C, Russo
E, Tedeschi A, et al. The 14CO2 urea breath test
for Helicobacter pylori infection. Journal of Pediatric
Gastroenterology & Nutrition 1990;11(2):284–5.
Continibali 1991
Continibali S, Sferlazzas C, Fera MT, Saitta G, Tedeschi
A, Magazzu G. A simplified diagnostic-approach to
Helicobacter-pylori infection - is it adequate - reply. American
Journal of Gastroenterology 1991;86(9):1277–8.
Contreras 2006
Contreras M, Amado MAG, Rodriguez MJ, Landaez
PB, Zambrano Y, Alvarez M, et al. Validation of a fast
immunochroniatographic test for H. pylori detection in
stool. Interciencia 2006;31(2):136–9.
Coombs 2001
Coombs GW, Foster NM, Pearman JW, Forbes GM.
Detection of Helicobacter pylori antigen in faeces by enzyme
immunoassay. Pathology 2001;33(4):496–7.
Cooreman 1990
Cooreman M, Hengels KJ, Krausgrill P, Strohmeyer G.
13C-urea breath test as a noninvasive means of diagnosing
the presence of Helicobacter (Campylobacter) pylori. Deutsche
Medizinische Wochenschrift 1990;115(10):367–71.
Corti 2007
Corti RE. The accuracy of the breath test with C-urea to
diagnose Helicobacter pylori infection. Salud I Ciencia 2007;
15(5):914.
Corvaglia 1997
Corvaglia L, Bontems P, Keppens E, Vandenborre C,
DePrez C. HP infection in children: Comparison of results
with serology and C-13-urea breath test. Gut 1997;41
(suppl):A68.
Corvaglia 1999
Corvaglia L, Bontems P, Devaster JM, Heimann P,
Glupczynski Y, Keppens E, et al. Accuracy of serology and
C-13-urea breath test for detection of Helicobacter pylori in
children. Pediatric Infectious Disease Journal 1999;18(11):
976–9.
Costa 2001
Costa F, Mumolo MG, Bellini M, Romano MR, Manghetti
M, Paci A, et al. Post-treatment diagnostic accuracy of a
new enzyme immunoassay to detect Helicobacter pylori in
stools. Alimentary Pharmacology & Therapeutics 2001;15
(3):395–401.
Couturier 2014
Couturier MR, Marshall BJ, Goodman KJ, Megraud F.
Helicobacter pylori diagnostics and treatment: Could a lack
of universal consensus be the best consensus?. Clinical
Chemistry 2014;60(4):589–94.
Crabtree 1990
Crabtree JE, Shallcross TM, Wyatt JI, Heatley RV.
Validation of a commercial ELISA for serodiagnosis of
Helicobacter-pylori infection. Gut 1990;31(10):A1176.
Crabtree 1991a
Crabtree JE, Taylor JD, Shallcross TM, Wyatt JI, Rathbone
BJ, Heatley RV. Western blotting analysis of mucosal and
systemic immune-responses to Helicobacter-pylori. Gut
1991;32(5):A564.
Crabtree 1991b
Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI.
Evaluation of a commercial ELISA for serodiagnosis of
Helicobacter pylori infection. Journal of Clinical Pathology
1991;44(4):326–8.
Cremonini 2000
Cremonini F, ZoccoMA, Armuzzi A, Bartolozzi F, Santarelli
L, Ojetti V, et al. C-13 urea breath test for predicting
resistance to therapy in Helicobacter pylori infection. Gut
2000;47(Suppl 1):A117.
Cremonini 2005
Cremonini F, Bartolozzi F, Armuzzi A, ZoccoMA, Santarelli
L, Gabrielli M, et al. Can 13C urea breath test predict
resistance to therapy in Helicobacter pylori infection?.
Hepato-Gastroenterology 2005;52(64):1119–21.
Crespo 2009
Crespo Medina M, Sanchez Sanchez C, Morales JL, Huber
LB, Mendiola I. Valuation of non-invasive tests to detect
Helicobacter pylori infection in children. Acta Pediatrica
Espanola 2009;67(7):319–24.
Crispino 2013
Crispino P, Colarusso D, Minervini G, Schiava A, Tripodi
B, Cimmino G, et al. Diagnosis of Helicobacter pylori
52Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
infection: Comparison between invasive and non invasive
tests. Italian Journal of Medicine 2013;7(2S):33.
Cullen 1992
Cullen DJ, Cullen KJ, Collins BJ, Christiansen KJ, Epis J.
Serological assessment of Helicobacter pylori eradication.
Lancet 1992;340(8828):1161–2.
Cullen 2002
Cullen KP, Broderick BM, Jayaram J, Flynn B, O’Connor
HJ. Evaluation of the Helicobacter pylori stool antigen
(HPSA) test in routine clinical practice--is it patient-
friendly?. Irish Medical Journal 2002;95(10):305–6.
Cunningham 2010
Cunningham SA, Sloan LM, Nyre LM, Vetter EA,
Mandrekar J, Patel R. Three-hour molecular detection of
Campylobacter, Salmonella, Yersinia, and Shigella species in
feces with accuracy as high as that of culture. Journal of
Clinical Microbiology 2010;48(8):2929–33.
Cutler 1993
Cutler A, Schubert A, Schubert T. Role of Helicobacter
pylori serology in evaluating treatment success. Digestive
Diseases & Sciences 1993;38(12):2262–6.
Cutler 1995a
Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez GI,
Schubert TT. Accuracy of invasive and noninvasive tests
to diagnose Helicobacter pylori infection. Gastroenterology
1995;109(1):136–41.
Cutler 1995b
Cutler AF. Re - C-13 urea breath test - response. American
Journal of Gastroenterology 1995;90(11):2070.
Cutler 1996
Cutler AF, Prasad VM. Long-term follow-up of Helicobacter
pylori serology after successful eradication. American Journal
of Gastroenterology 1996;91(1):85–8.
Cutler 1997
Cutler AF. Diagnostic tests for H. pylori: A prospective
evaluation of their accuracy, without selecting a single test
as the gold standard. American Journal of Gastroenterology
1997;92(3):538–9.
Cutler 1998
Cutler AF, Miller S. Comparison of C-13 urea blood
test to C-13 urea breath test for diagnosis of H-pylori.
Gastroenterology 1998;114(4 (suppl)):A97.
Cutler 1999
Cutler AF, Toskes P. Comparison of 13C-urea blood test to
13C-urea breath test for the diagnosis of Helicobacter pylori.
American Journal of Gastroenterology 1999;94(4):959–61.
Czinn 1991
Czinn SJ, Carr HS, Speck WT. Diagnosis of gastritis caused
by Helicobacter pylori in children by means of an ELISA.
Reviews of Infectious Diseases 1991;13 Suppl 8:S700–3.
Czkwianianc 1997
Czkwianianc E, Chmiela M, Lawnik M, Planeta-Malecka
I, Rudnicka W. Serodiagnosis of Helicobacter pylori in
children with gastroduodenitis. Central-European Journal of
Immunology 1997;22(4):240–7.
Da Silva 2010
Da Silva JMK, Villares CA, Monteiro MS, Colauto C, Dos
Santos AF, Mattar R. Validation of a rapid stool antigen test
for diagnosis of Helicobacter pylori infection. Revista Do
Instituto De Medicina Tropical De Sao Paulo 2010;52(3):
125–8.
Dahlberg 1998
Dahlberg M, Schjonsby H. 13C-urea breath test as
diagnostic method in Helicobacter pylori infection. Tidsskrift
for Den Norske Laegeforening 1998;118(24):3762–5.
Daino 2015
Daino DF, Soifer L, Pedesta J, Rome J. Pilot test for
Helicobacter pylori detection with ammonia breath test. Acta
Gastroenterologica Latinoamericana 2015;45(1):12–7.
Dan 2013
Dan W, Jing W, Libo W, Hong X. Detection and analysis of
Helicobacter pylori antibodies by protein chip technology.
Journal of Gastroenterology and Hepatology 2013;28:541.
Danielli 1993
Danielli E. A fluorometric enzyme-linked-immunosorbent-
assay for serological diagnosis of Helicobacter-pylori
infection. European Journal of Gastroenterology & Hepatology
1993;5:S57–S59.
Datta 2003
Datta D, Gazzard B, Stebbing J. The diagnostic yield of
stool analysis in 525 HIV-1-infected individuals. Aids
2003;17(11):1711–3.
Datta 2005
Datta S, Chattopadhyay S, Chowdhury A, Santra A, Saha
DR, Ramamurthy T, et al. Diagnosis and genotyping of
Helicobacter pylori by polymerase chain reaction of bacterial
DNA from gastric juice. Journal of Gastroenterology and
Hepatology 2005;20(8):1253–9.
Day 2002
Day AS, Sherman PM. Accuracy of office-based
immunoassays for the diagnosis of Helicobacter pylori
infection in children. Helicobacter 2002;7(3):205–9.
Day 2003
Day AS, Veldhuyzen van Zanten S, Otley AR, Best L,
Griffiths A, Sherman PM. Use of LARA-urea breath test in
the diagnosis of Helicobacter pylori infection in children
and adolescents: A preliminary study. Canadian Journal of
Gastroenterology 2003;17(12):701–6.
De Angelis 2007
De Angelis GL, Cavallaro LG, Maffini V, Moussa AM,
Fornaroli F, Liatopoulou S, et al. Usefulness of a serological
panel test in the assessment of gastritis in symptomatic
children. Digestive Diseases 2007;25(3):206–13.
De Argila 2001
de Argila CM, Boixeda D. Practical considerations for the
diagnosis of Helicobacter pylori infection. Medicina Clinica
2001;117(10):386–91.
De Arruda 2001
De Arruda SMB, PassaroDJ, Yang S, Parsonnet J. Variability
of serologic testing for H. pylori using U.S. and Peruvian
antigens. Gastroenterology 2001;120(1):325–6.
53Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
De Boer 1995
De Boer WA. Re: 13C urea breath test. American Journal of
Gastroenterology 1995;90(11):2069–70.
De Bustillo 1998
De Bustillo EM, Tomero JAS, Sanz JC, Moreno JA,
Jimenez I, Lopez-Brea M, et al. Eradication and follow-up
of Helicobacter pylori infection in hemodialysis patients.
Nephron 1998;79(1):55–60.
De Carvalho 2003
De Carvalho Costa Cardinali L, Rocha GA, Rocha AM,
De Moura SB, De Figueiredo Soares T, Esteves AM, et al.
Evaluation of 13C urea breath test and Helicobacter pylori
stool antigen test for diagnosis of H. pylori infection in
children from a developing country. Journal of Clinical
Microbiology 2003;41(7):3334–5.
De Giacomo 1991
De Giacomo C, Lisato L, Negrini R, Licardi G, Maggiore
G. Serum immune response to Helicobacter pylori in
children: Epidemiologic and clinical applications. Journal
of Pediatrics 1991;119(2):205–10.
De Laat 2001
De Laat LE, De Boer WA, Megraud F. The CLO test as a
reference method for Helicobacter pylori infection. European
Journal of Gastroenterology & Hepatology 2001;13(10):
1269–70.
De Oliveira 1999
De Oliveira AMR, Rocha GA, De Magalhaes Queiroz
DM, Mendes EN, De Carvalho AST, Ferrari TCA, et al.
Evaluation of enzyme-linked immunosorbent assay for the
diagnosis of Helicobacter pylori infection in children from
different age groups with and without duodenal ulcer.
Journal of Pediatric Gastroenterology and Nutrition 1999;28
(2):157–61.
De Pascalis 1999
De Pascalis R, Del Pezzo M, Nardone G, Budillon G,
Lavitola A. Performance characteristics of an enzyme-
linked immunosorbent assay for determining salivary
immunoglobulin G response to Helicobacter pylori. Journal
of Clinical Microbiology 1999;37(2):430–2.
Deankanob 2006
Deankanob W, Chomvarin C, Hahnvajanawong C, Intapan
PM, Wongwajana S, Mairiang P, et al. Enzyme-linked
immunosorbent assay for serodiagnosis of Helicobacter pylori
in dyspeptic patients and volunteer blood donors. Southeast
Asian Journal of Tropical Medicine & Public Health 2006;37
(5):958–65.
Debongnie 1993
Debongnie JC, Durez P, Luyasu V. Validation of a
commercial serologic test in the diagnosis of Helicobacter-
pylori infection - clinical and epidemiologic use.
Gastroenterologie Clinique et Biologique 1993;17(2):98–102.
Dediste 2003
Dediste A, Vandenberg O, Vlaes L, Ebraert A, Douat N,
Bahwere P, et al. Evaluation of the prospect microplate
assay for detection of Campylobacter: A routine laboratory
perspective. Clinical Microbiology & Infection 2003;9(11):
1085–90.
Deguchi 2009
Deguchi R, Matsushima M, Suzuki T, Mine T, Fukuda
R, Nishina M, et al. Comparison of a monoclonal with a
polyclonal antibody-based enzyme immunoassay stool test
in diagnosing Helicobacter pylori infection after eradication
therapy. Journal of Gastroenterology 2009;44(7):713–6.
Del Pozo Garcia 2006
Del Pozo Garcia AJ, Gisbert JP. Is the string test a useful
alternative to gastroscopy with biopsy for H. pylori
identification?. Revista Espanola De Enfermedades Digestivas
2006;98(7):542–9.
Del Zompo 2014
Del Zompo F, Feliciani D, Mangiola F, D’Angelo G, Di
Rienzo T, Vanella G, et al. Gas production during lactulose
breath test is associated with Helicobacter pylori infection.
Helicobacter 2014;19:82.
Delaney 2003
Delaney BC, Holder RL, Allan TF, Kenkre JE, Hobbs
FDR. A comparison of Bayesian and maximum likelihood
methods to determine the performance of a point of care
test for Helicobacter pylori in the office setting. Medical
Decision Making 2003;23(1):21–30.
Demir 2001
Demir H, Ercis S, Kocak N, Hascelik G, Ozen H, Yuce A,
et al. Detection of Helicobacter pylori with stool antigen test
in children with gastroesophageal reflux disease. American
Journal of Gastroenterology 2001;96(6):1944.
Demiray 2006
Demiray E, Yilmaz O, Sarkis C, Soyturk M, Simsek I.
Comparison of invasive methods and two different stool
antigen tests for diagnosis of H-pylori infection in patients
with gastric bleeding. World Journal of Gastroenterology
2006;12(26):4206–10.
Demiray 2012
Demiray Gurbuz E, Gonen C, Bekmen N, Dolek D,
Soyturk M, Sagol O, et al. The diagnostic accuracy of urine
IgG antibody tests for the detection of Helicobacter pylori
infection in Turkish dyspeptic patients. Turkish Journal of
Gastroenterology 2012;23(6):753–8.
Demiray-Gurbuz 2012
Demiray-Gurbuz E, Bekmen N, Erci T, Dotan Y, Yilmaz
O. Evaluation of Helicobacter pylori stool antigen test results
required from different outpatient clinics at university
hospital. Helicobacter 2012;17:87–8.
Demirturk 2003
Demirturk L, Yazgan Y, Tarcin O, Ozel M, Diler M, Oncul
O, et al. Does N-acetyl cysteine affect the sensitivity
and specificity of Helicobacter pylori stool antigen test?.
Helicobacter 2003;8(2):120–3.
Desroches 1997
Desroches JJ, Lahaie RG, Picard M, Morais J, Dumont A,
Gaudreau C, et al. Methodological validation and clinical
usefulness of carbon-14-urea breath test for documentation
54Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
of presence and eradication of Helicobacter pylori infection.
Journal of Nuclear Medicine 1997;38(7):1141–5.
Devenish 2005
Devenish J, Brooks B, Perry K, Milnes D, Burke T, McCabe
D, et al. Validation of a monoclonal antibody-based
capture enzyme-linked immunosorbent assay for detection
of Campylobacter fetus. Clinical and Diagnostic Laboratory
Immunology 2005;12(11):1261–8.
Dewan 2000
Dewan R, Sachdev GK. Diagnosis of Helicobacter pylori
infection in primary and tertiary care centers. Indian Journal
of Gastroenterology 2000;19 Suppl 1:S11-4; discussion S5.
Dhar 1998
Dhar R, Mustafa AS, Dhar PM, Khan MS, Al-Rashidi FJS,
Al-Shamali AAA, et al. Evaluation and comparison of two
immunodiagnostic assays for Helicobacter pylori antibodies
with culture results. Diagnostic Microbiology and Infectious
Disease 1998;30(1):1–6.
Dhesi 2015
Dhesi E, White B, Chitembwe A, Alisa A, Musa S,
Besherdas K. Is there any value in performing a CLO test at
endoscopy in patients previously having a stool antigen test?
. Gut 2015;64:A78.
Di Fulvio 2003
Di Fulvio A, Ierfone N, Standoli M, Trancassini M,
Giordano A, Magni A, et al. Study of fecal antigens against
Helicobacter pylori as non-invasive test compared with the
13C-urea breath-test. Personal experience. Il Giornale di
Chirurgia 2003;24(8-9):312–4.
Di Mario 2009
Di Mario F, Gatta L, Franze A, Rugge M, Scarpignato
C, Dal Bo N, et al. Effects of H. pylori eradication on
serum pepsinogen i, ii, ratio and gastrin-17 in Italian and
immigrant patients. Helicobacter 2009;14 (4):408.
Di Mario 2010
Di Mario F. Diagnostic accuracy of serum pepsinogens and
gastrin to follow-up H. pylori infection. Helicobacter 2010;
15(4):350.
Di Rienzo 2013
Di Rienzo TA, D’Angelo G, Ojetti V, Campanale MC,
Tortora A, Cesario V, et al. 13C-urea breath test for the
diagnosis of Helicobacter pylori infection. European Review
for Medical & Pharmacological Sciences 2013;17 Suppl 2:
51–8.
Di Silvio 1998
Di Silvio M, Larisch J, Dibildox M, Almaguer I, Gitler R,
Dehesa M, et al. Breath tests as a noninvasive diagnostic
method in Helicobacter pylori infection. Revista de
Gastroenterologia de Mexico 1998;63(3):135–42.
Dietz 2001
Dietz J, Sekine S, Segal F, Kulczynski JMU, Chaves ALH,
Costa JD, et al. “Helicobacter pylori” diagnosis: Comparison
between invasive methods. Gastrenterologia Endoscopia
Digestiva 2001;20(2):36–40.
Dill 1989
Dill S, Paynejames JJ, McSwiggan D, Scrimgeour CM,
Rennie MJ, Misiewicz JJ. Sensitivity and specificity of the
C-13 urea breath test in detecting Campylobacter-pylori. Gut
1989;30(5):A752.
Dill 1990
Dill S, Payne-James JJ, Misiewicz JJ, Grimble GK,
McSwiggan D, Pathak K, et al. Evaluation of 13C-urea
breath test in the detection of Helicobacter pylori and in
monitoring the effect of tripotassium dicitratobismuthate in
non-ulcer dyspepsia. Gut 1990;31(11):1237–41.
Ding 1993
Ding SZ, Jia BQ, Liu XG. An urease enzyme linked
immunosorbent assay for detection of Helicobacter pylori
infection. Zhonghua Nei Ke Za Zhi [Chinese Journal of
Internal Medicine] 1993;32(5):298–301.
Ding 2000
Ding SL, Ring JA, Hebbard GS, Morcom JM, Young
GP. Lansoprazole but not ranitidine interferes with C-13
urea breath test detection of Helicobacter pylori infection.
Gastroenterology 2000;118(4):A1228.
Djurasinovic 2014
Djurasinovic MZ, Sokic-Milutinovic A, Filipovic B, Basara
S, Krstic M, Milosavljevic T. The role of non-invasive
assessment of the secretory function of the gastric mucosa in
dyspepsia. Helicobacter 2014;19:112.
Dmitrienko 2009
Dmitrienko M, Bykov S. Method of breath sampling for
noninvasive H. pylori analysis. Helicobacter 2009;14 (4):
341.
Dmitrienko 2011
Dmitrienko M, Bykov S, Parolova N, Karaseva G. Ammonia
breath test - transportation way of ammonia. Helicobacter
2011;16:115.
Dolek 2007
Dolek D, Soyturk M, Bekmen N, Yilmaz O, Demiray
E, Sarioglu S, et al. Urine-based ELISA testing for the
diagnosis and confirmation of eradication of Helicobacter
pylori infection. Helicobacter 2007;12(4):444.
Dominguez 2006
Dominguez J, Forne M, Blanco S, Prat C, Gali N,
Latorre I, et al. Comparison of a monoclonal with a
polyclonal antibody-based enzyme immunoassay stool
test in diagnosing Helicobacter pylori infection before and
after eradication therapy. Alimentary Pharmacology &
Therapeutics 2006;23(12):1735–40.
Dominguezmunoz 1995
Dominguezmunoz JE, Linke A, Sauerbruch T,Malfertheiner
P. How to improve the C-13-urea breath test (UBT) for the
diagnosis of Helicobacter-pylori infection. Gastroenterology
1995;108(4 (suppl)):A84.
Domínguez-Muñoz 1997
Domínguez-Muñoz JE, Leodolter A, Sauerbruch T,
Malfertheiner P. A citric acid solution is an optimal test
55Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
drink in the 13C-urea breath test for the diagnosis of
Helicobacter pylori infection. Gut 1997;40(4):459–62.
Donati 1997
Donati M, Moreno S, Storni E, Tuccia A, Poli L, Sambri V,
et al. Study of anti-Helicobacter pylori antibodies with use of
latex agglutination test. Microbiologia Medica 1997;12(3):
130–1.
Donati 2000
Donati M, Sambri V, Ranucci L, De Orsi D, Tucci A, Poli
L, et al. Recombinant CagA enzyme-linked immunosorbent
assay and western immunoblot for the detection of serum
antibodies to Helicobacter pylori. Clinical Microbiology &
Infection 2000;6(3):164–6.
Dondi 2006
Dondi E, Rapa A, Boldorini R, Fonio P, Zanetta S,
Oderda G. High accuracy of noninvasive tests to diagnose
Helicobacter pylori infection in very young children. Journal
of Pediatrics 2006;149(6):817–21.
Dong 2015
Dong FY, Ji DN, Huang RX, Zhang F, Huang YQ,
Xiang P, et al. Multiple genetic analysis system-based
antibiotic susceptibility testing in Helicobacter pylori
and high eradication rate with phenotypic resistance-
guided quadruple therapy. Medicine 2015 [Epub
ahead of print]; Vol. 94, issue 47. [DOI: 10.1097/
MD.0000000000002056
Dore 1997
Dore SP, Krupadas S, Borgonha S, Kurpad AV. The 13C
urea breath test to assess Helicobacter pylori infection in
school children. National Medical Journal of India 1997;10
(2):57–60.
Dore 2003
Dore MP, Realdi G, Sepulveda AR, Graham DY. Detection
of genomic Helicobacter pylori DNA in the blood of patients
positive for the infection. Digestive and Liver Disease 2003;
35(11):839–40.
Dore 2004
Dore MP, Negrini R, Tadeu V, Marras L, Maragkoudakis
E, Nieddu S, et al. Novel monoclonal antibody-based
Helicobacter pylori stool antigen test. Helicobacter 2004;9
(3):228–32.
Dorta 2005
Dorta G. Helicobacter pylori detection revisited. Endoscopy
2005;37(6):579-80; author reply 581-2.
Dou 2008
Dou YC, Wang JB. Detection of H. pylori infection in
patients with pancreatic cancer and clinical significance.
Journal of Jilin University Medicine Edition 2008;34(2):
317–9.
Douraghi 2013
Douraghi M, Rostami MN, Goudarzi H, Ghalavand Z.
Comparison of stool antigen immunoassay and serology for
screening for Helicobacter pylori infection in intellectually
disabled children. Microbiology and Immunology 2013;57
(11):772–7.
Doweck 1997
Doweck J, Quintana C, Barrios A, Monastra L, Lopetegui
G, Zerbo O, et al. Evaluation of sensitivity, specificity
and predictive value of six qualitative serological methods
for the detection of Helicobacter pylori antibodies. Acta
Gastroenterologica Latinoamericana 1997;27(4):259–61.
Dowlatshahi 2002
Dowlatshahi S. Effect of gastrointestinal bleeding on the
sensitivity of diagnostic tests forHelicobacter pylori infection.
Archives of Iranian Medicine 2002;5(3):201–2.
Drew 1988
Drew H, Lafrance ND, Mertz H, Hernandez J, Ravich W,
Milligan F, et al. C-14 urea breath test in Campylobacter
pyloridis gastric disorders - comparison with biopsy with
comparison and sensitivity of 20, 40, 60 and 120 minute
sampling. Clinical Nuclear Medicine 1988;13(5):394.
Drumm 1999
Drumm B, Rowland M, Imrie C. Sensitivity of urease-based
test on diagnosis of Helicobacter pylori in children and the
elderly. Gastroenterology 1999;116(6):1506.
Drzymala-Czy 2014
Drzymala-Czy S, Stawinska-Witoszynska B, Madry E,
Krzywinska-Wiewiorowska M, Szczepanik M, Walkowiak J,
et al. Non-invasive detection of Helicobacter pylori in cystic
fibrosis - the fecal test vs. the urea breath test. European
Review for Medical and Pharmacological Sciences 2014;18
(16):2343–8.
Du 2004
Du JX, Watkins T, Bravo LE, Fontham ET, Camargo
MC, Correa P, et al. 13C-urea breath test for Helicobacter
pylori in young children: Cut-off point determination by
finite mixture model. Statistics in Medicine 2004;23(13):
2049–60.
Duan 1994
Duan LP, Braden B, Lembcke B, Caspary WF. C-13-urea
breath test after breakfast still meets the criteria for valid
diagnosis of Helicobacter-pylori. Gastroenterology 1994;106
(4 (suppl)):A71.
DuBois 2005
DuBois S, Kearney DJ. Iron-deficiency anemia and
Helicobacter pylori infection: a review of the evidence.
American Journal of Gastroenterology 2005;100(2):453–9.
Duggan 1998
Duggan AE, Hardy E, Hawkey CJ. Evaluation of a new near
patient test for the detection ofHelicobacter pylori. European
Journal of Gastroenterology & Hepatology 1998;10(2):133–6.
Duggan 1999
Duggan AE, Elliott C, Logan RFA. Testing for Helicobacter
pylori infection: Validation and diagnostic yield of a near
patient test in primary care. BMJ 1999;319(7219):1236–9.
Dulbecco 2001
Dulbecco P, Gambaro C, Zentilin P, Bilardi C, Biagini
R, Savarino V. The impact of long-term ranitidine and
pantoprazole on the precision of C-13-urea breath test
56Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(UBT) in subjects infected with Helicobacter pylori.
Gastroenterology 2001;120(5 (suppl)):A578.
Dulbecco 2003
Dulbecco P, Gambaro C, Bilardi C, Zentilin P, Mele
MR, Mansi C, et al. Impact of long-term ranitidine and
pantoprazole on accuracy of 13C urea breath test. Digestive
Diseases & Sciences 2003;48(2):315–21.
Dumont 1989
Dumont A, Abramovici J, Muller C, Trolin C, Barbier
P. Diagnostic efficiency of the 14C-urea breath test in
the detection of antral Campylobacter pylori infection.
Gastroduodenal pathology and Campylobacter pylori:
European Campylobacter Pylori Study Group ICS847.
1989:73–5.
Dun 2001
Dun CDR, Blac M, Cowell DC, Penaul C, Ratcliffe
NM, Spence R, et al. Ammonia vapour in the mouth
as a diagnostic marker for Helicobacter pylori infection:
Preliminary ’proof of principle’ pharmacological
investigations. British Journal of Biomedical Science 2001;58
(2):66–75.
Durdal 2002
Durdal US, Engin D, Hascelik G. Evaluation of western
blot method for the serological diagnosis of Helicobacter
pylori infections. Mikrobiyoloji Bulteni 2002;36(2):153–60.
Dy-Limquiaco 2006
Dy-Limquiaco LA, Florendo WO, Labio ME, Banez V,
Daez ML. Validation of the new 14-carbon urea breath test
(14-C UBT) in the diagnosis of Helicobacter pylori infection.
Journal of Gastroenterology and Hepatology 2006;21:A505.
Dyrla 2015
Dyrla P, Gil J, Wojtun S, Korszun K, Kasinska E,
Mackiewicz A. Helicobacter pylori infection. Diagnosis and
treatment. Pediatria i Medycyna Rodzinna 2015;11(1):
68–74.
Ebara 2000
Ebara S, Aoyama N, Sakai T, Ikemura T, Shirasaka D,
Sakashita M, et al. A study of gastric emptying in H-pylori
negative healthy volunteers using the C-13-octanoic acid
breath test. Gastroenterology 2000;118(4):A1169.
Ebell 1998
Ebell MH. Breath test and serologic testing for Helicobacter
pylori. Journal of the American Board of Family Practice 1998;
11(2):170–1.
Edwards 1997
Edwards CN, Douglin CP, Prussia PR, Garriques SA,
Levett PN. Epidemiology of Helicobacter pylori infection in
Barbados. West Indian Medical Journal 1997;46(1):3–7.
El-Nujumi 1996
El-Nujumi A, Hilditch TE, McColl KEL. Effect of
omeprazole therapy on determination of Helicobacter pylori
status by C-14 urea breath test. Gastroenterology 1996;110
(4 (suppl)):A102.
El-Nujumi 1998
El-Nujumi A, Hilditch TE, Williams C, McColl KE.
Current or recent proton pump inhibitor therapy markedly
impairs the accuracy of the 14C urea breath test. European
Journal of Gastroenterology & Hepatology 1998;10(9):
759–64.
El-Zaatari 1995
El-Zaatari FA, Nguyen AM, Genta RM, Klein PD, Graham
DY. Determination of Helicobacter pylori status by reverse
transcription-polymerase chain reaction. Comparison with
urea breath test. Digestive Diseases & Sciences 1995;40(1):
109–13.
El-Zimaity 1998
El-Zimaity HMT, Segura AM, Genta RM, Graham DY.
Histologic assessment of Helicobacter pylori status after
therapy: Comparison of Giemsa, Diff-Quik, and Genta
stains. Modern Pathology 1998;11(3):288–91.
Elbast 1999
Elbast W, Brazier JL. Nondispersive infrared spectroscopy,
an alternative to isotope ratio mass spectrometry: Case of
the C-13 urea breath test. Analusis 1999;27(3):228–31.
Elitsur 1997
Elitsur Y, Neace C, Triest WE. Comparison between a
rapid office-based and ELISA serologic test in screening
for Helicobacter pylori in children. Helicobacter 1997;2(4):
180–4.
Elitsur 1999a
Elitsur Y, Neace C, Werthammer MC, Triest WE.
Prevalence of CagA, VacA antibodies in symptomatic and
asymptomatic children with Helicobacter pylori infection.
Helicobacter 1999;4(2):100–5.
Elitsur 1999b
Elitsur Y, Neace C. Detection of Helicobacter pylori
organisms by HP-Fast in children. Digestive Diseases and
Sciences 1999;44(6):1169–72.
Elitsur 2000
Elitsur Y, Aflak R, Neace C, Triest WE. Helicobacter pylori
serology and the diagnosis of H. pylori infection in children.
West Virginia Medical Journal 2000;96(5):564–6.
Elitsur 2004
Elitsur Y, Lawrence Z, Hill I. Stool antigen test for
diagnosis of Helicobacter pylori infection in children with
symptomatic disease: A prospective study. Journal of
Pediatric Gastroenterology & Nutrition 2004;39(1):64–7.
Elitsur 2005
Elitsur Y. Helicobacter pylori diagnostic tools: Is it in the
stool?. Journal of Pediatrics 2005;146(2):164–7.
Elitsur 2009
Elitsur Y, Tolia V, Gilger MA, Reeves-Garcia J, Schmidt-
Sommerfeld E, Opekun AR, et al. Urea breath test in
children: The United States prospective, multicenter study.
Helicobacter 2009;14(2):134–40.
Ellenrieder 1997
Ellenrieder V, Glasbrenner B, Stoffels C, Weiler S, Bode
G, Moller P, et al. Qualitative and semi-quantitative
value of a modified 13C-urea breath test for identification
of Helicobacter pylori infection. European Journal of
Gastroenterology & Hepatology 1997;9(11):1085–9.
57Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Elnujumi 1991
Elnujumi AM, Rowe P, Dorrian CA, McColl KEL. Value
of C-14 urea breath test and urease slide test (CLO test) to
diagnose Helicobacter-pylori in uremic patients. Gut 1991;
32(10):A1220.
Eloubeidi 2001
Eloubeidi MA, Wade SB, Provenzale D. Factors
associated with acceptance and full publication of GI
endoscopic research originally published in abstract form.
Gastrointestinal Endoscopy 2001;53(3):275–82.
Endtz 2000
Endtz HP, Ang CW, Van den Braak N, Luijendijk A, Jacobs
BC, De Man P, et al. Evaluation of a new commercial
immunoassay for rapid detection of Campylobacter jejuni in
stool samples. European Journal of Clinical Microbiology and
Infectious Diseases 2000;19(10):794–7.
Engberg 2003
Engberg JH, Strid MA, Molbak K, Krogfelt KA. Antibody
response following infection with Campylobacter determined
by enzyme-linked immunosorbent assay (ELISA). Ugeskrift
for Laeger 2003;165(24):2485–6.
Engstrand 1992
Engstrand L, Nguyen AM, Graham DY, el-Zaatari FA.
Reverse transcription and polymerase chain reaction
amplification of rRNA for detection of Helicobacter species.
Journal of Clinical Microbiology 1992;30(9):2295–301.
Enroth 1997a
Enroth H, Rigo R, Hulten K, Engstrand L. Diagnostic
accuracy of a rapid whole-blood test for detection of
Helicobacter pylori. Journal of Clinical Microbiology 1997;35
(10):2695–7.
Enroth 1997b
Enroth H, Engstrand L. Rapid detection of Helicobacter
pylori infection in serum and whole-blood samples. APMIS
1997;105(12):951–5.
Enroth 2002
Enroth H, Kraaz W, Rohan T, Nyren O, Engstrand L. Does
the method of Helicobacter pylori detection influence the
association with gastric cancer risk?. Scandinavian Journal of
Gastroenterology 2002;37(8):884–90.
Erzin 2004
Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican
A, et al. Comparison of two different stool antigen tests
for the primary diagnosis of Helicobacter pylori infection in
Turkish patients with dyspepsia. Helicobacter 2004;9(6):
657–62.
Erzin 2005
Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican
A, et al. Evaluation of two enzyme immunoassays for
detecting Helicobacter pylori in stool specimens of dyspeptic
patients after eradication therapy. Journal of Medical
Microbiology 2005;54(Pt 9):863–6.
Evans 1989
Evans DJ Jr, Evans DG, Graham DY, Klein PD. A sensitive
and specific serologic test for detection of Campylobacter
pylori infection. Gastroenterology 1989;96(4):1004–8.
Everts 1996
Everts B, Hamlet A, Pettersson A. A 10 minutes solid dosage
C-13-urea breath test for diagnosis of Helicobacter pylori
infection. Gastroenterology 1996;110(4 suppl):A105.
Faigel 1996a
Faigel DO, Furth EE, Childs M, Goin J, Metz DC.
Histological predictors of activeHelicobacter pylori infection.
Digestive Diseases & Sciences 1996;41(5):937–43.
Faigel 1996b
Faigel DO, Childs M, Furth EE, Alavi A, Metz DC.
New noninvasive tests for Helicobacter pylori gastritis -
comparison with tissue-based gold standard. Digestive
Diseases and Sciences 1996;41(4):740–8.
Faigel 2000
Faigel DO, Magaret N, Corless C, Lieberman DA, Fennerty
MB. Evaluation of rapid antibody tests for the diagnosis
of Helicobacter pylori infection. American Journal of
Gastroenterology 2000;95(1):72–7.
Faigel 2001
Faigel DO, Hahn M. Urea breath test for the diagnosis of
Helicobacter pylori - response. Gastrointestinal Endoscopy
2001;53(6):700–1.
Fakhrjou 2011
Fakhrjou A, Somi MH, Fattahi E, Koohbanani SS,
Shadravan S. Rapid urease test, touch cytology and
histopathologic assessment in determining infection by
Helicobacter pylori in outpatient setting. Pakistan Journal of
Biological Sciences 2011;14(12):698–702.
Falaknazi 2010
Falaknazi K, Jalalzadeh M, Vafaeimanesh J. Noninvasive
stool antigen assay for screening of Helicobacter pylori
infection and assessing success of eradication therapy in
patients on hemodialysis. Iranian Journal of Kidney Diseases
2010;4(4):317–21.
Falk 1997
Falk GW. Best tests for detecting Helicobacter pylori.
Consultant 1997;37(7):1765.
Fallone 1998
Fallone CA, Loo VG, Barkun AN. Utility of serology in
determining Helicobacter pylori eradication after therapy.
Canadian Journal of Gastroenterology 1998;12(2):117–24.
Fallone 2000
Fallone CA, Veldhuyzen van Zanten SJ, Chiba N. The urea
breath test for Helicobacter pylori infection: Taking the wind
out of the sails of endoscopy. CMAJ Canadian Medical
Association Journal 2000;162(3):371–2.
Falsafi 2005
Falsafi T, Valizadeh N, Sepehr S, Najafi M. Application of a
stool antigen test to evaluate the incidence of Helicobacter
pylori infection in children and adolescents from Tehran,
Iran. Clinical & Diagnostic Laboratory Immunology 2005;12
(9):1094–7.
Falsafi 2009
Falsafi T, Favaedi R, Mahjoub F, Najafi M. Application of
stool-PCR test for diagnosis of Helicobacter pylori infection
58Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
in children. World Journal of Gastroenterology 2009;15(4):
484–8.
Falsafi 2014
Falsafi T, Lavasani P, Basardeh I, Massarrat S, Landarani
Z. Evaluation of an Iranian home Helicobacter pylori stool
antigen ELISA kit. Jundishapur Journal of Microbiology
2014; Vol. 7, issue 6:e10629. [DOI: 10.5812/jjm.10629
Fanti 2001
Fanti L, Ieri R, Mezzi G, Testoni PA, Passaretti S,
Guslandi M. Long-term follow-up and serologic assessment
after triple therapy with omeprazole or lansoprazole of
Helicobacter-associated duodenal ulcer. Journal of Clinical
Gastroenterology 2001;32(1):45–8.
Farkkila 1996
Farkkila M. Active Campylobacter pylori infection diagnosed
by the urea breath test. Duodecim; Laaketieteellinen
Aikakauskirja 1996;112(5):349–50.
Faulde 1991
Faulde M, Putzker M, Mertes T, Sobe D. Evaluation of
an immunofluorescence assay for specific detection of
immunoglobulin-G antibodies directed againstHelicobacter-
pylori, and antigenic cross-reactivity between Helicobacter-
pylori and Campylobacter-jejuni. Journal of Clinical
Microbiology 1991;29(2):323–7.
Fayaz 2014
Fayaz F, Gachkar L, Roodsari SR, Pourkaveh B. Prevalence
of Helicobacter pylori infection in patients with down
syndrome and mental retardation. Archives of Clinical
Infectious Diseases 2014 Sep 25 [Epub ahead of print]; Vol.
9, issue 4. [ 10.5812/archcid.22064]
Fayed 2008
Fayed SB, Aref MI, Fathy HM, El Dayem SMA, Emara NA,
Maklof A, et al. Prevalence of celiac disease, Helicobacter
pylori and gastroesophageal reflux in patients with refractory
iron deficiency anemia. Journal of Tropical Pediatrics 2008;
54(1):43–53.
Fazulzyanova 2012
Fazulzyanova A, Isaeva G, Ivanovskaya K. Evaluation
of effectiveness of different methods of Helicobacter
pylori detection in patients with chronic HCV-infection.
Helicobacter 2012;17:95.
Fazzio 1995
Fazzio S, Vazquez G, Ardao G, Blanco J, Vivero E,
Gualco G, et al. Helicobacter pylori: Comparative study
of different diagnostic techniques. Acta Gastroenterologica
Latinoamericana 1995;25(5):269–76.
Feldman 1995
Feldman RA, Deeks JJ, Evans SJW. Multilaboratory
comparison of 8 commercially available Helicobacter-pylori
serology kits. European Journal of Clinical Microbiology &
Infectious Diseases 1995;14(5):428–33.
Felz 1997
Felz MW, Burke GJ, Schuman BM. Breath test diagnosis
of Helicobacter pylori in peptic ulcer disease: A noninvasive
primary care option. Journal of the American Board of Family
Practice 1997;10(6):385–9.
Ferrante 1999
Ferrante LC, Papponetti M, Marcuccitti J, Neri M, Festi
D. C-13-urea breath test for Helicobacter pylori infection:
Stability of samples over time. Scandinavian Journal of
Gastroenterology 1999;34(9):942–3.
Ferwana 2015
Ferwana M, Abdulmajeed I, Alhajiahmed A, Madani W,
Firwana B, Hasan R, et al. Accuracy of urea breath test in
Helicobacter pylori infection: Meta-analysis. World Journal
of Gastroenterology 2015;21(4):1305–14.
Festi 1999
Festi D, Marcuccitti J, Papponetti M, Colaiocco-Ferrante
L, Bonitatibua A, Di Ilio C, et al. C-13-urea breath test
for Helicobacter pylori infection: A repeatability study.
Gastroenterology 1999;116(4 (suppl)):A162.
Feteih 2009
Feteih R, Abdel-Salam M, Jamjoom H, Akbar H. Salivary
anti-Helicobacter pylori positivity among endoscopy patients
with chronic liver disease. Eastern Mediterranean Health
Journal 2009;15(6):1371–8.
Feydt-Schmidt 2002
Feydt-Schmidt A, Russmann H, Lehn N, Fischer A, Antoni
I, Stork D, et al. Fluorescence in situ hybridization vs.
Epsilometer test for detection of clarithromycin-susceptible
and clarithromycin-resistant Helicobacter pylori strains in
gastric biopsies from children. Alimentary Pharmacology &
Therapeutics 2002;16(12):2073–9.
Figura 1994
Figura N, Oderda G, Verdiani S. Evaluation of a commercial
ELISA kit for the serological diagnosis of Helicobacter pylori
infection. New Microbiologica 1994;17(4):319–25.
Figura 2005
Figura N, Santucci A, Lahner E, Mini R, Bernardini
G, Vaira D, et al. Western blotting for the diagnosis of
Helicobacter pylori infection in patients with atrophic body
gastritis. Helicobacter 2005;10(5):521.
Figura 2014
Figura N, Marini L, Macchiarelli R, Moretti E. Latex
agglutination test for detection of H. pylori in gastric
biopsies. Helicobacter 2014;19:125.
Finderle 2013
Finderle P, Suhadolc K, Osredkar J. Determination of
Helicobacter pylori antigen in stool in comparison to breath
test. Biochimica Clinica 2013;37:S665.
Floch 2012
Floch P, Goret J, Bessede E, Lehours P, Megraud F.
Evaluation of the positive predictive value of a rapid
immunochromatographic test to detect Campylobacter in
stools. Gut Pathogens 2012 Dec 4; Vol. 4, issue 1:17.
[10.1186/1757–4749–4–17]
Foertsch 2010
Foertsch S, Neumann H, Vieth M, Guldi DM, Neurath
MF, Kuth R. Development of a new electrochemical device
for rapid Helicobacter pylori detection. Gastroenterology
2010;138(5 (suppl 1)):S512.
59Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Folwaczny 1999
Folwaczny C, Reichardt B, Klauser A, Klose J, Blendinger
C, Wiebecke B, et al. Accuracy of C-13-urea breath test for
diagnosis of Helicobacter pylori infection in clinical routine.
Gastroenterology 1999;116(4 (suppl)):A164.
Fontana 2000
Fontana C, Pietroiusti A, Mastino A, Pistoia ES, Marino D,
Magrini A, et al. Comparison of an enzyme immunoassay
versus a rapid latex test for serodiagnosis of Helicobacter
pylori infection. European Journal of Clinical Microbiology &
Infectious Diseases 2000;19(3):239–40.
Ford 2014
Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P.
Helicobacter pylori eradication therapy to prevent gastric
cancer in healthy asymptomatic infected individuals:
systematic review and meta-analysis of randomised
controlled trials. BMJ 2014;348:g3174.
Formichella 2012
Formichella L, Romberg L, Bolz C, Vieth M, Geppert M,
Gottner G, et al. A novel line blot system to detect an
infection with pathogenic H. pylori. International Journal of
Medical Microbiology 2012;302:6.
Forne 2000
Forne M, Dominguez J, Fernandez-Banares F, Lite J, Esteve
M, Gali N, et al. Accuracy of an enzyme immunoassay
for the detection of Helicobacter pylori in stool specimens
in the diagnosis of infection and posttreatment check-up.
American Journal of Gastroenterology 2000;95(9):2200–5.
Fowora 2012
Fowora MA, Breithaupt U, Otegbayo JA, Akere
A, Onyekwere CA, Ndububa D, et al. Molecular
characterization of Helicobacter pylori infections in Nigeria.
Helicobacter 2012;17:88.
Fox 1989
Fox JG, Correa P, Taylor NS, Zavala D, Fontham E,
Janney F, et al. Campylobacter pylori-associated gastritis and
immune response in a population at increased risk of gastric
carcinoma. American Journal of Gastroenterology 1989;84
(7):775–81.
Fradkin 1997
Fradkin A, Yahav Y, DiverHaber A, Weisselberg B, Jonas
A. The value of anti-Helicobacter pylori IgG antibodies in
establishing eradication of infection in children. Israel
Journal of Medical Sciences 1997;33(2):87–92.
Franceschi 1999
Franceschi F, Armuzzi A, Maniccia E, Ojetti V, Torre
ES, Candelli M, et al. Delta(CO2)-C-13 excretion
and prevalence of gastrointestinal symptoms in subjects
evaluated for H-pylori infection through C-13-urea breath
test. Gastroenterology 1999;116(4 (suppl)):A164.
Franchini 2007
Franchini M, Cruciani M, Mengoli C, Pizzolo G, Veneri D.
Effect of Helicobacter pylori eradication on platelet count in
idiopathic thrombocytopenic purpura: a systematic review
and meta-analysis. Journal of Antimicrobial Chemotherapy
2007;60(2):237–46.
Fraser 1996a
Fraser AG, Moore L, Rafiq Ali M, Chua LE, Hollis B, Little
SV. An audit of low dose triple therapy for eradication of
Helicobacter pylori. New Zealand Medical Journal 1996;109
(1027):290–2.
Fraser 1996b
Fraser AG, Ali MR, McCullough S, Yeates NJ, Haystead A.
Diagnostic tests for Helicobacter pylori - can they help select
patients for endoscopy. New Zealand Medical Journal 1996;
109(1018):95–8.
Fraser 1997
Fraser AG, McIntosh C, Berry S, Moore L. The urea breath
test (UBT) for H-pylori (HP) in the initial assessment of
dyspepsia in primary care. Gut 1997;41(suppl):A77–A8.
Fraser 1998
Fraser AG, McIntosh C, Berry S, Moore L. Can the urea
breath test forH. pylori replace endoscopy for the assessment
of dyspepsia in primary care?. New Zealand Medical Journal
1998;111(1058):11–4.
Fraser 2003
Fraser A, Williamson S, Lane M, Hollis B. Nurse-led
dyspepsia clinic using the urea breath test for Helicobacter
pylori. New Zealand Medical Journal 2003;116(1176):
U479.
Frenck 2006
Frenck RW Jr, Fathy HM, Sherif M, Mohran Z, El
Mohammedy H, Francis W, et al. Sensitivity and specificity
of various tests for the diagnosis of Helicobacter pylori in
Egyptian children. Pediatrics 2006;118(4):e1195–e202.
Fruehauf 2003
Fruehauf H, Lindenmann N, Volkart K, Bauerfeind P, Ben-
Oren I, Fried M. The gastroscopic C-13-urea breath test: A
new rapid online test for Helicobacter pylori (HP) detection
during routine upper endoscopy. Gastroenterology 2003;124
(4 (suppl)):A176.
Fry 2005
Fry LC, Curioso WH, Rickes S, Horton G, Hirschowitz
BI, Monkemuller K. Comparison of 13C- urea blood test
to 13C-breath test and rapid urease test for the diagnosis
of Helicobacter pylori infection. Acta Gastroenterologica
Latinoamericana 2005;35(4):225–9.
Fujisawa 2001
Fujisawa T, Kaneko T, Kumagai T, Akamatsu T, Katsuyama
T, Kiyosawa K, et al. Evaluation of urinary rapid test for
Helicobacter pylori in general practice. Journal of Clinical
Laboratory Analysis 2001;15(3):154–9.
Fukuda 1996
Fukuda Y, Fukuda S, Munakata A, Yoshida Y, Shimoyama
T. Validity of various diagnostic tests to evaluate cure of
Helicobacter pylori infection. Journal of Gastroenterology
1996;31(2):171–4.
Fukuda 2002
Fukuda Y, Yoshida K, Ezaki H, Tomita T, Kosaka T, Hori
K, et al. Diagnosis of Helicobacter pylori infection. Nihon
Rinsho [Japanese Journal of Clinical Medicine] 2002;60(8):
1543–8.
60Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Fukuda 2003a
Fukuda Y, Tamura K, Tomita T, Hori K, Tanida N,
Shimoyama T. Validation of the accuracy of the H. pylori
stool antigen test (HPSA) in the Japanese population.
Digestive and Liver Disease 2003;35(1):62–3.
Fukuda 2003b
Fukuda Y, Hori K, Sakagami T, Shimoyama T. Suitable
diagnostic methods for H. pylori infection after eradication
therapy. Nihon Rinsho [Japanese Journal of Clinical Medicine]
2003;61(1):102–8.
Fukuda 2005
Fukuda S, Tanaka M, Shimoyama T, Sato M, Takahashi
R, Munakata A. Applicability of a Helicobacter pylori stool
antigen test to determine the results of eradication therapy.
Helicobacter 2005;10(5):524.
Fukuda 2006
Fukuda S, Shimoyama T, Nishiya D, Munakata A.
Applicability of a Helicobacter pylori stool antigen test to
determine the results of eradication therapy. Gastroenterology
2006;130(4 (suppl)):A571.
Fukuda 2007
Fukuda Y, Shimoyama T, Takahashi R, Nakabayashi N,
Koizuka H, Abe D, et al. Evaluation of a new monoclonal
antibody (HRII-51)-antigen capture ELISA with high
specificity for Helicobacter hepaticus using sera from mice
inoculated with Helicobacter species. Helicobacter 2007;12
(4):388–9.
Fukuda 2009
Fukuda Y, Shimoyama T, Ohmura T, Sano Y, Nakabayashi
N, Takahashi R, et al. Characterization and application
of a new monoclonal antibody with high specificity for
Helicobacter hepaticus. Helicobacter 2009;14(1):66–71.
Fusconi 1997
Fusconi M, Farinelli S, Menegatti M, Figura N, Landi
F, Quan S, et al. Western immunoblotting (WB) and
a recombinant immunoblotting assay (RIBA(TM)) for
detection of H-pylori (HP) anti Cag-A reactivity (anti-HP
Cag-A). Gut 1997;41(suppl):A73–A4.
Fusconi 1999
Fusconi M, Vaira D, Menegatti M, Farinelli S, Figura N,
Holton J, et al. Anti-caga reactivity in Helicobacter pylori-
negative subjects - a comparison of three different methods.
Digestive Diseases and Sciences 1999;44(8):1691–5.
Galleguillos 1998
Galleguillos C, Gonzalez P, Massardo T, Morales A,
Pimentel C, Gil C, et al. Low specificity of carbon-14-urea
breath test is the gold standard adequate for Helicobacter
pylori infection C. Journal of Nuclear Medicine 1998;39(5
Suppl):57P–8P.
Gallo 2001
Gallo N, Basso D, Zambon CF, Navaglia F, Di Mario F,
Rugge M, et al. Diagnosis of Helicobacter pylori infection:
Comparison of techniques. Recenti Progressi in Medicina
2001;92(5):332–5.
Ganga-Zandzou 2001
Ganga-Zandzou PS, Vincent P, Michaud L, Guimber D,
Turck D, Gottrand F. C-13-urea breath test in children with
Helicobacter pylori infection: Validity of the use of a mask
to collect exhaled breath samples. Acta Paediatrica 2001;90
(2):232–3.
Gangaidzo 1995
Gangaidzo I, Mason PR, Kiire CF, Bak-Jensen E,
Willen R, Lelwala-Guruge J, et al. Helicobacter pylori in
endoscopy patients in Zimbabwe: Value of enzyme-linked
immunosorbent assay and a rapid urease test. Transactions
of the Royal Society of Tropical Medicine & Hygiene 1995;89
(5):502–5.
Gao 2015
Gao F, Li W. Investigation on causes of false-negative 14-C-
urea breath test. Chinese Journal of Gastroenterology 2015;20
(3):151–4.
Garces 2012
Garces HRH, Gonzalez VVC, Fabian LG, Velazquez MI,
Pena K, Sierra YA. Chromoendoscopy with red phenol
in the diagnosis of Helicobacter pylori infection. Revista
Espanola De Enfermedades Digestivas 2012;104(1):4–9.
Garcia 1996
Garcia JIP, Garcia JMP, Alonso IJ. C13 urea breath test
for Helicobacter pylori. Validation of the method. Revista
Espanola De Enfermedades Digestivas 1996;88(3):202–8.
Garcia 2000
Garcia Valriberas R, Gisbert JP, Hermida C, Cabrera MM,
Diaz Blasco J, Pajares JM. Antibodies against Helicobacter
pylori in saliva. Study of their validity versus breath test and
its agreement with serology. Atencion Primaria / Sociedad
Espanola de Medicina de Familia y Comunitaria 2000;25(6):
390–4.
Garcia 2006
Garcia AJD, Gisbert JP. Is the string test a useful alternative
to gastroscopy with biopsy for h-pylori identification?.
Revista Espanola De Enfermedades Digestivas 2006;98(7):
542–6.
Garcia-Diaz 2002
Garcia-Diaz E, Castro-Fernandez M, Romero-Gomez
M, Vargas-Romero J. The effectiveness of (IgG-ELISA)
serology as an alternative diagnostic method for detecting
Helicobacter pylori infection in patients with gastro-
intestinal bleeding due to gastro-duodenal ulcer. Revista
Espanola De Enfermedades Digestivas 2002;94(12):725–36.
Garza-Gonzalez 2002
Garza-Gonzalez E, Perez-Perez GI, Tijerina-Menchaca R,
Maldonado-Garza HJ, Bosques-Padilla FJ. Helicobacter
pylori genotypes and their association with host’s immune
response. Revista de Gastroenterologia de Mexico 2002;67(3):
155–60.
Garza-Gonzalez 2003
Garza-Gonzalez E, Bosques-Padilla FJ, Tijerina-Menchaca
R, Flores-Gutierrez JP, Maldonado-Garza HJ, Perez-Perez
GI. Comparison of endoscopy-based and serum-based
61Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
methods for the diagnosis of Helicobacter pylori. Canadian
Journal of Gastroenterology 2003;17(2):101–6.
Gatta 2003a
Gatta L, Ricci C, Tampieri A. Noninvasive tests to diagnose
Helicobacter pylori infection. Current Gastroenterology
Reports 2003;5(5):351–2.
Gatta 2003b
Gatta L, Vakil N, Ricci C, Osborn JF, Tampieri A, Perna F,
et al. A rapid, low-dose, c-13-urea tablet for the detection
of Helicobacter pylori infection before and after treatment.
Alimentary Pharmacology & Therapeutics 2003;17(6):793–8.
Gatta 2003c
Gatta L, Vakil N, Tampieri A, Ricci C, Perna F, Miglioli M,
et al. Effects of proton pump inhibitor therapy (ppi) on
13C breath test (ubt) & stool antigen test (st) in h pylori
(hp): Effects of citric acid & orange juice. Gastroenterology
2003;124(4 (suppl)):A58.
Gatta 2003d
Gatta L, Ricci C, Stanghellini V, Ali A, Menegatti M, Labate
AMM, et al. Best cut-off values for c-14 -urea breath tests
for Helicobacter pylori detection. Scandinavian Journal of
Gastroenterology 2003;38(11):1144–8.
Gatta 2004a
Gatta L, Vakil N, Ricci C, Osborn JF, Tampieri A, Perna F,
et al. Effect of proton pump inhibitors and antacid therapy
on 13C urea breath tests and stool test for Helicobacter
pylori infection. American Journal of Gastroenterology 2004;
99(5):823–9.
Gatta 2004b
Gatta L, Perna F, Ricci C, Osborn JF, Tampieri A,
Bernabucci V, et al. A rapid immunochromatographic assay
for Helicobacter pylori in stool before and after treatment.
Alimentary Pharmacology & Therapeutics 2004;20(4):
469–74.
Gatta 2006
Gatta L, Ricci C, Tampieri A, Osborn J, Perna F, Bernabucci
V, et al. Accuracy of breath tests using low doses of 13C-urea
to diagnose Helicobacter pylori infection: A randomised
controlled trial. Gut 2006;55(4):457–62.
Gatta 2010a
Gatta L, Vaira D, Scarpignato C, Mario P, Cavestro G,
Cavallaro L, et al. Diagnostic accuracy of serum pepsinogens
and gastrin in the follow-up of Helicobacter pylori infection:
A pilot study. Digestive and Liver Disease 2010;42:S112.
Gatta 2010b
Gatta L, Di Mario F, Vaira D, Rugge M, Scarpignato
C, Malfertheiner P, et al. Diagnostic accuracy of serum
pepsinogens and gastrin to follow-up Helicobacter pylori
infection: A pilot study. Gastroenterology 2010;138(5 (suppl
1)):S340.
Gatta 2011
Gatta L, Di Mario F, Vaira D, Rugge M, Franze A, Plebani
M, et al. Quantification of serum levels of pepsinogens and
gastrin to assess eradication of Helicobacter pylori. Clinical
Gastroenterology & Hepatology 2011;9(5):440–2.
Geletneky 1996
Geletneky JV, Meineke I, Ludtke FE, Schauer A, Bauer FE.
Long-term investigation using the 13C-urea breath test
(13C-UBT) for the noninvasive semiquantitative assessment
of the extent of the mucosal lesion. Verdauungskrankheiten
1996;14(4):125–32.
Gemignani 2013
Gemignani L, Savarino E, Corbo M, Dulbecco P, Giacchino
M, Giambruno E, et al. The diagnostic value of narrow-
band imaging with magnifying endoscopy in the detection
of gastric intestinal metaplasia: A prospective study in an
unselected population. Digestive and Liver Disease 2013;45:
S206.
Gene 2000
Gene E, Calvet X, Azagra R. Diagnosis of Helicobacter
pylori after triple therapy in uncomplicated duodenal ulcers-
-a cost-effectiveness analysis. Alimentary Pharmacology &
Therapeutics 2000;14(4):433–42.
Gerards 1999
Gerards C, Leodolter A, Nilius M, Peitz U, Malfertheiner P.
Should we rely on serology or c-13-urea breath test (c-13-
ubt) for therapy decision in h. Pylori infection?. Gut 1999;
45(Suppl 3):A129.
Gerstenecker 1992
Gerstenecker B, Eschweiler B, Vogele H, Koch HK,
Hellerich U, Kist M. Serodiagnosis of Helicobacter
pylori infections with an enzyme immunoassay using
the chromatographically purified 120 kilodalton protein.
European Journal of Clinical Microbiology & Infectious
Diseases 1992;11(7):595–601.
Ghasemian 2005
Ghasemian Safaei H, Fazeli A, Tamizifar H, Rashidi N.
Comparison of salivary anti Helicobacter pylori IgG
with serum IgG and bacteriological tests in detecting
Helicobacter pylori infections. Journal of Research in Medical
Sciences 2005;10(1):1–5.
Ghosh 2014
Ghosh R, Uppal B, Aggarwal P, Chakravarti A, Jha AK,
Dubey AP. A comparative study of conventional and
molecular techniques in diagnosis of campylobacter
gastroenteritis in children. Annals of Clinical and Laboratory
Science 2014;44(1):42–8.
Ghoshal 2010
Ghoshal UC, Kumar S, Krishnani N, Chourasia D,
Tripathi S. Evaluation of utility of pepsinogen (pg)-i,
pg-ii and gastrin-17 serum levels in diagnosis of cancer-
associated gastric mucosal lesions like intestinal metaplasia
in patients with h. Pylori infection in india. Indian Journal
of Gastroenterology 2010;29(1 Suppl):A25–A6.
Gilger 2002
Gilger MA, Tolia V, Johnson A, Rabinowitz S, Jibaly R,
Elitsur Y, et al. The use of an oral fluid immunoglobulin g
ELISA for the detection of Helicobacter pylori infection in
children. Helicobacter 2002;7(2):105–10.
62Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gill 2007
Gill P, Amini M, Ghaemi A, Shokouhizadeh L, Abdul-
Tehrani H, Karami A, et al. Detection of Helicobacter pylori
by enzyme-linked immunosorbent assay of thermophilic
helicase-dependent isothermal DNA amplification.
Diagnostic Microbiology & Infectious Disease 2007;59(3):
243–9.
Girdalidze 2013
Girdalidze AM, Elisabedashvili GV, Sharvadze LG,
Dzhorbenadze TA. Comparative diagnostic value of
Helicobacter pylori infection testing methods. Georgian
Medical News 2013;225:53–60.
Gisbert 1996
Gisbert JP, Boixeda D, Redondo C, Alvarez Baleriola
I, Jimenez I, Perez Garcia JI, et al. Breath test in the
diagnosis of Helicobacter pylori infection: concordance
with histological methods and correlation with
anatomopathological lesions of the gastric mucosa. Revista
Espanola de Enfermedades Digestivas 1996;88(4):259–64.
Gisbert 1997
Gisbert JP, Boixeda D, deArgila CM, Barba M, Bermejo
F, Plaza AG, et al. Long-term follow-up after h-pylori
eradication: Reinfection incidence and evolution of urea
breath test. Gut 1997;41(suppl):A78.
Gisbert 1999a
Gisbert JP, Vazquez MA, Jimenez I, Carpio D, Cruzado AI,
Del Castillo E, et al. C-13-urea breath test for the diagnosis
of h-pylori infection: Is citric acid necessary?. Gut 1999;45
(Suppl 3):A129.
Gisbert 1999b
Gisbert JP, Vazquez MA, Jimenez I, Del Castillo E, Martin
MJ, Morales A, et al. C-13-urea breath test for the
diagnosis of h-pylori infection: Is citric acid necessary?.
Gastroenterology 1999;116(4 (suppl)):A171.
Gisbert 1999c
Gisbert JP, Boixeda D, Al-Mostafa A, Vila T, De Rafael
L, Baleriola IA, et al. Basal and stimulated gastrin and
pepsinogen levels after eradication of Helicobacter pylori: A
1-year follow-up study. European Journal of Gastroenterology
& Hepatology 1999;11(2):189–200.
Gisbert 2000a
Gisbert J, Gonzalez L, De Pedro A, Vaibuena M, Prieto
B, Llorca I, et al. C-13-urea breath test for the diagnosis
of h-pylori infection: Are basal samples necessary?.
Gastroenterology 2000;118(4):A1238.
Gisbert 2000b
Gisbert JP. Diagnosis of Helicobacter pylori infection.
Revista Clinica Espanola 2000;200(7):370–2.
Gisbert 2000c
Gisbert JP, Benito LM, Lara S, Vazquez A, Jimenez I, Pajares
JM. C-13-urea breath test for the diagnosis of Helicobacter
pylori infection: Are basal samples necessary?. European
Journal of Gastroenterology & Hepatology 2000;12(11):
1201–5.
Gisbert 2000d
Gisbert JP, Blanco M, Benito LM, Pajares JM. Value of
quantitative serology for confirmation of Helicobacter
pylori eradication: An 18-month follow-up study. Clinical
Infectious Diseases 2000;30(6):976–80.
Gisbert 2000e
Gisbert JP, Cruzado AI, Cabrera MM, Carpio D, Benito
LM, Perez Poveda JJ, et al. “Rapid” serology for the
diagnosis of Helicobacter pylori infection. Evaluation
of its accuracy compared with a gold-standard and its
concordance with “classic” serology. Gastroenterologia Y
Hepatologia 2000;23(4):159–64.
Gisbert 2000f
Gisbert JP, Vazquez MA, Jimenez I, Cruzado AI, Carpio D,
Del Castillo E, et al. 13C-urea breath test for the diagnosis
of Helicobacter pylori infection before treatment: Is citric
acid necessary?. Digestive & Liver Disease 2000;32(1):20–4.
Gisbert 2000g
Gisbert J, Cruzado A, Cabrera M, Carpio D, Benito
L, Perez-Poveda J, et al. Rapid whole blood test for
diagnosing H. pylori infection. Validation against a gold
standard and study of its concordance with ELISA serology.
Gastroenterology 2000;118(4):A1238.
Gisbert 2001
Gisbert JP, Pajares JM. Diagnosis of Helicobacter pylori
infection by stool antigen determination: A systematic
review. American Journal of Gastroenterology 2001;96(10):
2829–38.
Gisbert 2002a
Gisbert JP, Ducons J, Gomollon F, Dominguez-Muñoz E,
Borda F, Mino G, et al. Validation of c-13-urea breath test
for the initial diagnosis of Helicobacter pylori infection and
for the confirmation of its eradication after treatment. Gut
2002;51(Suppl):A109.
Gisbert 2002b
Gisbert JP, Gomollon F, Dominguez-Muñoz E, Borda
F, Jimenez I, Vazquez MA, et al. Isotope ratio mass
spectrometry (irms) versus nondispersive infrared
spectrometry (ndirs) c-13-urea breath test for the diagnosis
of Helicobacter pylori infection. Gut 2002;51(Suppl):
A111.
Gisbert 2002c
Gisbert JP, Vazquez MA, Cantero J, Pajares JM. Study of
the validity of «rapid» serology in diagnosing Helicobacter
pylori infection. Atencion Primaria 2002;30(8):501–6.
Gisbert 2002d
Gisbert JP, Cabrera Md Mdel M, Pajares JM. Stool antigen
test for initial Helicobacter pylori diagnosis and for
confirmation of eradication after therapy. Medicina Clinica
2002;118(11):401–4.
Gisbert 2003a
Gisbert JP, Gomollon F, Dominguez-Muñoz JE, Borda F,
Jimenez I, Vazquez MA, et al. Comparison between two
13C-urea breath tests for the diagnosis of Helicobacter
pylori infection: Isotope ratio mass spectrometer versus
63Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
infrared spectrometer. Gastroenterologia Y Hepatologia 2003;
26(3):141–6.
Gisbert 2003b
Gisbert JP, Ducons J, Gomollon F, Dominguez-Muñoz JE,
Borda F, Mino G, et al. Validation of the c-13-urea breath
test for the initial diagnosis of Helicobacter pylori infection
and to confirm eradication after treatment. Revista Espanola
De Enfermedades Digestivas 2003;95(2):121–6.
Gisbert 2004a
Gisbert JP, Pajares JM. Stool antigen test for the diagnosis
of Helicobacter pylori infection: A systematic review.
Helicobacter 2004;9(4):347–68.
Gisbert 2004b
Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E,
Dominguez-Muñoz E. Meta-analysis: Helicobacter pylori
eradication therapy vs. antisecretory non-eradication
therapy for the prevention of recurrent bleeding from peptic
ulcer. Alimentary Pharmacology and Therapeutics 2004;19
(6):617–29.
Gisbert 2005
Gisbert JP, Trapero M, Pajares JM. Evaluation of 3
different tests for the detection of stool antigens to confirm
Helicobacter pylori eradication after treatment. A pilot
study. Gastroenterologia Y Hepatologia 2005;28(10):615–8.
Gisbert 2006a
Gisbert JP, Abraira V. Accuracy of Helicobacter pylori
diagnostic tests in patients with bleeding peptic ulcer: A
systematic review and meta-analysis. American Journal of
Gastroenterology 2006;101(4):848–63.
Gisbert 2006b
Gisbert JP, De la Morena F, Abraira V. Accuracy of
monoclonal stool antigen test for the diagnosis of
Helicobacter pylori infection: A systematic review and
meta-analysis. Helicobacter 2006;11(4):380.
Gisbert 2006c
Gisbert JP, Esteban C, Jimenez I, Moreno-Otero R, Pajares
JM. C-13-urea breath test during hospitalization for the
diagnosis of Helicobacter pylori infection in peptic ulcer
bleeding. Helicobacter 2006;11(4):382.
Gisbert 2006d
Gisbert JP, Olivares D, Jimenez I, Pajares JM. Is there
any correlation between 13C-urea breath test values
and response to first-line and rescue Helicobacter pylori
eradication therapies?. Digestive & Liver Disease 2006;38
(4):254–9.
Gisbert 2006e
Gisbert JP, Olivares D, Jimenez I, Pajares JM. Is there
any correlation between c-13-urea breath test values
and response to first-line and rescue Helicobacter pylori
eradication therapies?. Helicobacter 2006;11(4):380–1.
Gisbert 2006f
Gisbert JP, Olivares D, Jimenez I, Pajares JM. Long-term
follow-up of 13C-urea breath test results after Helicobacter
pylori eradication: Frequency and significance of borderline
delta13Co2 values. Alimentary Pharmacology & Therapeutics
2006;23(2):275–80.
Gisbert 2006g
Gisbert JR, De la Morena F, Abraira V. Accuracy of
monoclonal stool antigen test for the diagnosis of h-pylori
infection: A systematic review and meta-analysis. American
Journal of Gastroenterology 2006;101(8):1921–30.
Gisbert 2006h
Gisbert JP. Breath test with c-13-urea for h. Pylori infection
diagnosis by means of mass spectrometry and infrared
spectrophotometry. Salud I Ciencia 2006;15(1):461–3.
Gisbert 2007
Gisbert JP, Esteban C, Jimenez I, Moreno-Otero R. 13C-
urea breath test during hospitalization for the diagnosis
of Helicobacter pylori infection in peptic ulcer bleeding.
Helicobacter 2007;12(3):231–7.
Glassman 1990
Glassman MS, Dallal S, Berezin SH, Bostwick HE,
Newman LJ, Perez-Perez GI, et al. Helicobacter pylori-
related gastroduodenal disease in children. Diagnostic
utility of enzyme-linked immunosorbent assay. Digestive
Diseases & Sciences 1990;35(8):993–7.
Glupczynski 1992
Glupczynski Y, Bourdeaux L, Verhas M, DePrez C, DeVos
D, Devreker T. Use of a urea breath test versus invasive
methods to determine the prevalence of Helicobacter pylori
in Zaire. European Journal of Clinical Microbiology &
Infectious Diseases 1992;11(4):322–7.
Gobert 1988
Gobert B, Bene MC, Faure G, Dekorwin JD, Conroy MC,
Mole C, et al. Detection of antibodies to campylobacter
pyloridis by immunoprint and by quantitative ELISA test.
Annales De Biologie Clinique 1988;46(7):523.
Gobert 1989
Gobert B, Bene MC, Faure G, Denis JJ, De Korwin
JD, Conroy MC, et al. IgG, IgA and IgM antibodies to
campylobacter pylori detected by dot-ELISA and ELISA.
Gastroduodenal pathology and Campylobacter pylori:
European Campylobacter Pylori Study Group ICS847.
1989:219–22.
Goel 2003
Goel N, Sherwal BL, Patwari AK, Bajaj P, Choudhury
M. Evaluation of invasive and non-invasive diagnostic
modalities for Helicobacter pylori infection in children.
Indian Pediatrics 2003;40(2):141–6.
Goettner 2012
Goettner G, Formicella L, Romberg L, Bolz C, Nolting C,
Soutschek E, et al. Novel immuno-line system to detect
infections with pathogenic h. Pylori. Helicobacter 2012;17:
70.
Goh 1995
Goh KL, Parasakthi N, Peh SC, Ong KK. 14c-urea
breath test: A useful non-invasive test in the diagnosis of
Helicobacter pylori infection. Medical Journal of Malaysia
1995;50(3):208–11.
64Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Goji 2015
Goji S, Tamura Y, Sasaki M, Nakamura M, Matsui H,
Yamagata Murayama S, et al. Helicobacter suis-infected
nodular gastritis and a review of diagnostic sensitivity for
Helicobacter heilmannii-like organisms. Case Reports in
Gastroenterology 2015;9:179–87.
Gold 2000
Gold BD, Colletti RB, Abbott M, Czinn SJ, Elitsur Y,
Hassall E, et al. Helicobacter pylori infection in children:
Recommendations for diagnosis and treatment. Journal of
Pediatric Gastroenterology and Nutrition 2000;31(5):490–7.
Gold 2014
Gold BD, Elfant AB. Helicobacter pylori detection and
eradication in pediatric and adult patients. Gastroenterology
and Hepatology 2014;10(7):447–50.
Gomes 2002
Gomes AT, Coelho LK, Secaf M, Modena JL, Troncon LE,
Oliveira RB. Accuracy of the 14c-urea breath test for the
diagnosis of Helicobacter pylori. Sao Paulo Medical Journal
[Revista Paulista de Medicina] 2002;120(3):68–71.
Gomes 2005
Gomes CAR Jr, Catapani WR, Mader AMAA, Locatelli
A, Silva CBP, Waisberg J. Antral exfoliative cytology for
the detection of Helicobacter pylori in the stomach. World
Journal of Gastroenterology 2005;11(18):2784–8.
Gomez 2000
Gomez MR, Vargas J, Grande L, Otero MA, Bernal S,
Fernandez MC. Usefulness of Helicobacter pylori antigens
detection in stools for infection diagnosis and confirming
eradication. Medicina Clinica 2000;114(15):571–3.
Gomez 2011
Gomez PP, Rodriguez CG, Meleiro JI, Rodriguez MM,
Sanchez FM. Helicobacter pylori infection in children
diagnosed via the urea breath test. Helicobacter 2011;16:
111.
Gomez-Camarasa 2014
Gomez-Camarasa C, Gutierrez-Fernandez J, Rodriguez-
Granger JM, Sampedro-Martinez A, Sorlozano-Puerto
A, Navarro-Mari JM. Evaluation of the rapid ridaquick
campylobacter test in a general hospital. Diagnostic
Microbiology and Infectious Disease 2014;78(2):101–4.
Gomollon 2003
Gomollon F, Ducons JA, Santolaria S, Omiste IL, Guirao
R, Ferrero A, et al. Breath test is very reliable for diagnosis
of Helicobacter pylori infection in real clinical practice.
Digestive and Liver Disease 2003;35(9):612–8.
Gong 2010
Gong YH, Sun LP, Jin SG, Yuan Y. Comparative study
of serology and histology based detection of Helicobacter
pylori infections: A large population-based study of 7,
241 subjects from China. European Journal of Clinical
Microbiology & Infectious Diseases 2010;29(7):907–11.
Gong 2014
Gong YH, Wei W, Yuan Y. Association between abnormal
gastric function risk and Helicobacter pylori infection
assessed by ELISA and C-14-urea breath test. Diagnostic
Microbiology and Infectious Disease 2014;80(4):316–20.
Gonzalez 2003
Gonzalez P, Galleguillos C, Massardo T, Rivera M, Morales
A, Smok G, et al. Could the [14c]urea breath test be
proposed as a ’gold standard’ for detection of Helicobacter
pylori infection ?. Medical Science Monitor 2003;9(8):
CR363–8.
Gonzalez 2004
Gonzalez P. 14c-urea breath test as a ’gold standard’ for
detection of Helicobacter pylori infection - in reply. Medical
Science Monitor 2004;10(9):LE17–LE8.
Gonzalez 2007
Gonzalez FCG, Serrano C, Harris PR. Diagnosis of
Helicobacter pylori infection in children based on stool
antigen test. Revista Medica De Chile 2007;135(2):182–8.
Gonzalez 2012
Gonzalez CA, Megraud F, Buissonniere A, Lujan Barroso
L, Agudo A, Duell EJ, et al. Helicobacter pylori infection
assessed by ELISA and by immunoblot and noncardia
gastric cancer risk in a prospective study: The eurgast-epic
project. Annals of Oncology 2012;23(5):1320–4.
Gonzalez 2013
Gonzalez L, Marrero K, Reyes O, Rodriguez E, Martinez
L, Rodriguez BL. Cloning and expression of a recombinant
caga -gene fragment of Helicobacter pylori and its
preliminary evaluation in serodiagnosis. Biomedica 2013;33
(4):546–53.
Gonzalez-Cuevas 2001
Gonzalez-Cuevas A, Juncosa T, Jene M, Varea V, Gene A,
Muñoz C, et al. Helicobacter pylori infections: Antigen
detection in stool samples. Enfermedades Infecciosas Y
Microbiologia Clinica 2001;19(2):49–52.
Good 1991
Good DJ, Dill S, Mossi S, Frey R, Beglinger C, Stalder GA,
et al. Sensitivity and specificity of a simplified, standardized
13C-urea breath test for the demonstration of Helicobacter
pylori. Schweizerische Medizinische Wochenschrift Journal
Suisse de Medecine 1991;121(20):764–6.
Goodwin 1987
Goodwin CS, Blincow E, Peterson G. Enzyme-linked
immunosorbent assay for campylobacter pyloridis:
Correlation with presence of c. Pyloridis in the gastric
mucosa. Journal of Infectious Diseases 1987;155(3):488–94.
Gosciniak 1993
Gosciniak G, Matysiak-Budnik T, Przondo-Mordarska
A. Evaluation of three serological tests for the detection
of Helicobacter pylori associated infection. Archivum
Immunologiae et Therapiae Experimentalis 1993;41(5-6):
315–9.
Gosciniak 1996
Gosciniak G, Poniewierka E, Iwanczak B, Grzeszek T.
Iga antibodies against Helicobacter pylori in serum and
saliva of patients with upper gastrointestinal tract diseases.
Gastroenterologia Polska 1996;3(2):119–24.
65Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gosciniak 2000
Gosciniak G, Przondo-Mordarska A, Iwanczak B,
Poniewierka E. Neutralisation of vacuolating activity of
cytotoxin by serum antibodies of Helicobacter pylori
infected patients. Acta Microbiologica Polonica 2000;49(2):
113–20.
Gosciniak 2002
Gosciniak G, Przondo-Mordarska A, Iwanczak B, Blitek A.
Detection of Helicobacter pylori antigen in stool specimens
taken from children with chronic gastritis. Polski Merkuriusz
Lekarski 2002;12(68):104–7.
Gosciniak 2003
Gosciniak G, Przondo-Mordarska A, Iwanczak B, Blitek A.
Helicobacter pylori antigens in stool specimens of gastritis
children before and after treatment. Journal of Pediatric
Gastroenterology & Nutrition 2003;36(3):376–80.
Goto 1995
Goto Y, Ogihara Y, Taniguchi Y, Satoh K, Kimura K,
Takatori K, et al. Simple rapid and inexpensive diagnosis
of Helicobacter-pylori infection in c-13-urea breath test
- ir spectrometric analysis. Gastroenterology 1995;108(4
(suppl)):A103.
Goto 1998
Goto A, Fujimori K, Kaneko T, Akamatsu T. Diagnosis of
Helicobacter infections by serodiagnosis, analysis of serum
pepsinogen, and urea breath tests. Nihon Naika Gakkai
Zasshi [Journal of the Japanese Society of Internal Medicine]
1998;87(5):863–7.
Gotoh 1997
Gotoh T, Nishizono A, Mifune K, Fujioka T, Nasu
M, Azumi J. Validity of the new ELISA system of
serodiagnosis for eradication of Helicobacter pylori
infection. Gastroenterology 1997;112(4 (suppl)):A131.
Gottrand 2001
Gottrand F. Diagnostic tests and treatment of helicopter
pylori gastritis in children. Archives De Pediatrie 2001;8:
396S–8S.
Graham 1986
Graham DY, Klein PD, Evans DG, Opekun AR, Evans
DG, Alpert LC, et al. Rapid noninvasive diagnosis of gastric
campylobacter by a c-13 urea breath test. Gastroenterology
1986;90(5):1435.
Graham 1987
Graham DY, Evans DJ, Alpert LC, Klein PD, Evans
DG, Opekun AR, et al. Campylobacter-pylori detected
noninvasively by the c-13 urea breath test. Lancet 1987;1
(8543):1174–7.
Graham 1991
Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein
PD, Adam E. Epidemiology of Helicobacter pylori in an
asymptomatic population in the United States. Effect of
age, race, and socioeconomic status. Gastroenterology 1991;
100(6):1495–501.
Graham 1996b
Graham DY, Malaty HM, ElZimaity HM, Genta RM,
Yousfi MM, Klein PD. 20 minute fasting version of the us
c-13-urea breath test for the diagnosis of h-pylori infection.
Gastroenterology 1996;110(4 (suppl)):A122.
Graham 2000
Graham DY, Klein PD. Accurate diagnosis of Helicobacter
pylori - c-13-urea breath test. Gastroenterology Clinics of
North America 2000;29(4):885.
Graham 2001a
Graham DY, Malaty HM, Cole RA, Martin RF, Klein PD.
Simplified 13C-urea breath test for detection of Helicobacter
pylori infection. American Journal of Gastroenterology 2001;
96(6):1741–5.
Graham 2001b
Graham DY, Reddy S. Rapid detection of anti-Helicobacter
pylori igg in urine using immunochromatography.
Alimentary Pharmacology & Therapeutics 2001;15(5):
699–702.
Graham 2001c
Graham DY. An alternate explanation of the effect of citric
acid on proton pump inhibitor-associated false negative
urea breath tests. American Journal of Gastroenterology 2001;
96(10):3037–9.
Graham 2010
Graham DY. Monoclonal stool antigen testing for
diagnosing Helicobacter pylori in young children: Revisited.
Journal of Pediatric Gastroenterology and Nutrition 2010;51
(3):373.
Granberg 1993
Granberg C, Mansikka A, Lehtonen OP, Kujari H, Gronfors
R, Nurmi H, et al. Diagnosis of Helicobacter pylori
infection by using Pyloriset EIA-G and EIA-A for detection
of serum immunoglobulin G (IgG) and IgA antibodies.
Journal of Clinical Microbiology 1993;31(6):1450–3.
Grino 2001
Grino P, Pascual S, Such J, Casellas JA, Niveiro M,
Andreu M, et al. Comparison of diagnostic methods
for Helicobacter pylori infection in patients with upper
gastrointestinal bleeding. Scandinavian Journal of
Gastroenterology 2001;36(12):1254–8.
Grino 2003
Grino P, Pascual S, Such J, Casellas JA, Niveiro M, Andreu
M, et al. Comparison of stool immunoassay with standard
methods for detection of Helicobacter pylori infection in
patients with upper-gastrointestinal bleeding of peptic
origin. European Journal of Gastroenterology & Hepatology
2003;15(5):525–9.
Grossi 2000
Grossi C, Mombelli B, Capurso G, Martino G, Gismondo
M, Lahner E, et al. Low sensitivity of c-13-urea breath test
(ubt) in the diagnosis of h-pylori infection in atrophic body
gastritis patients (abg). Gut 2000;47(Suppl 1):A117.
Grossi 2012
Grossi L, Di Tullio AM, Pagliaro M, Tavani R, Cocciolillo
S, Ciccaglione AF, et al. Relationship between Helicobacter
pylori infection and gerd symptoms. Digestive and Liver
Disease 2012;44:S152.
66Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Grotowski 1998
Grotowski M, Winnicki L, Trawinski J, Gancarz
A, Domaniecki J. Prevalence of Helicobacter pylori
infection after surgery of gastric or duodenal peptic ulcer.
Gastroenterologia Polska 1998;5(6):525–30.
Groves 1997
Groves FD, Zhang L, Li JY, You WC, Chang YS, Zhao L,
et al. Comparison of two enzyme-linked immunosorbent
assay tests for diagnosis of Helicobacter pylori infection in
China. Cancer Epidemiology, Biomarkers & Prevention 1997;
6(7):551–2.
Groves 2002
Groves FD, Perez-Perez G, Zhang L, You WC, Lipsitz SR,
Gail MH, et al. Serum antibodies to Helicobacter pylori
and the caga antigen do not explain differences in the
prevalence of precancerous gastric lesions in two Chinese
populations with contrasting gastric cancer rates. Cancer
Epidemiology Biomarkers and Prevention 2002;11(10 I):
1091–4.
Guducuoglu 2010
Guducuoglu H, Berktas M, Bozkurt H, Toka Ozer T, Bulut
G, Ozturk O, et al. Evaluation of western blot method for
the detection of antibodies to Helicobacter pylori antigens
in patients with gastric carcinoma and cases with epigastric
complaints. Mikrobiyoloji Bulteni 2010;44(1):21–8.
Guell 2006
Guell M, Artigau E, Esteve V, Sanchez-Delgado J, Junquera
F, Calvet X. Usefulness of a delayed test for the diagnosis
of Helicobacter pylori infection in bleeding peptic ulcer.
Alimentary Pharmacology & Therapeutics 2006;23(1):53–9.
Guja 1999
Guja M, Lombardo L, Andrini L, Della Monica P, Vicari
S, Sallio F, et al. Is Helicobacter pylori stool antigen assay
comparable to urea breath test in the diagnosis of h-pylori
infection?. Gastroenterology 1999;116(4 (suppl)):A178.
Gulcan 2005
Gulcan EM, Varol A, Kutlu T, Cullu F, Erkan T, Adal E, et
al. Helicobacter pylori stool antigen test. Indian Journal of
Pediatrics 2005;72(8):675–8.
Gunay 2009
Gunay EC, Yengel E, Ucblek E, Altintas E, Sezgin O. C-
14 urea breath test values do not correlate with the degree
of colonization by Helicobacter pylori in adults. European
Journal of Nuclear Medicine and Molecular Imaging 2009;
36:S442.
Guo 2005
Guo YY, Zhang ST, Peng XX, Zhan SY. A systematic review
of diagnosis of Helicobacter pylori infection by Helicobacter
pylori stool antigen test.. National Medical Journal of China
2005;85(22):1564–7.
Gupta 2003
Gupta P, Pandey LB, Behra RN, Rai MK, Chandra R. Role
of ELISA in H. pylori detection and its correlation with
urease test. Indian Journal of Pathology & Microbiology
2003;46(3):511–4.
Gurbuz 2009
Gurbuz ED, Soyturk M, Yilmaz O, Bekmen N, Guvenir
M, Ellidokuz H, et al. The importance of stool antigen
test for the diagnosis of Helicobacter pylori infection and
eradication follow-up. Clinical Microbiology and Infection
2009;15:S316.
Guslandi 2000
Guslandi M. Stool immunoassay for Helicobacter pylori is
not specific enough. BMJ 2000;320(7248):1541.
Gutierrez 1999
Gutierrez A, Celdran MT, Bonilla F, Vazquez N, Royo G,
Sillero C. Use of Helicobacter pylori (hp) antigen test in
stool samples to detect hp infection. Gastroenterologia y
Hepatologia 1999;22(10):533.
Gutierrez 2005
Gutierrez S, Chacon-Petrola M, Flores M, Pinto A, Pacheco
M. Evaluation of infection by Helicobacter pylori in hiv
positive patients trough enzyme immunoassay and specific
amplification of DNA. Investigacion Clinica 2005;46(1):
43–52.
Guven 2011
Guven MA, Ertas IE, Coskun A, Ciragil P. Serologic and
stool antigen assay of Helicobacter pylori infection in
hyperemesis gravidarum: Which test is useful during early
pregnancy?. Taiwanese Journal of Obstetrics & Gynecology
2011;50(1):37–41.
Hackelsberger 1998
Hackelsberger A, Schultze V, Peitz U, Gunther T, Nilius M,
Diete U, et al. Performance of a rapid whole blood test for
Helicobacter pylori in primary care: A German multicenter
study. Helicobacter 1998;3(3):179–83.
Haggerty 2005
Haggerty TD, Perry S, Sanchez L, Perez-Perez G, Parsonnet
J. Significance of transiently positive enzyme-linked
immunosorbent assay results in detection of Helicobacter
pylori in stool samples from children. Journal of Clinical
Microbiology 2005;43(5):2220–3.
Hahn 2000
Hahn M, Fennerty MB, Corless CL, Magaret N, Lieberman
DA, Faigel DO. Noninvasive tests as a substitute for
histology in the diagnosis of Helicobacter pylori infection.
Gastrointestinal Endoscopy 2000;52(1):20–6.
Hamlet 1995
Hamlet AK, Erlandsson KIM, Olbe L, Svennerholm AM,
Backman VEM, Pettersson AB. A simple, rapid, and highly
reliable capsule-based 14C urea breath test for diagnosis
of Helicobacter pylori infection. Scandinavian Journal of
Gastroenterology 1995;30(11):1058–63.
Hamlet 1999
Hamlet A, Stage L, Lonroth H, Cahlin C, Nystrom
C, Pettersson A. A novel tablet-based c-13 urea breath
test for Helicobacter pylori with enhanced performance
during acid suppression therapy. Scandinavian Journal of
Gastroenterology 1999;34(4):367–74.
67Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Han 2006
Han FC, Li XJ, Jiang H, Qin LP, Li D, Guo YH, et al.
Detection of h. Pylori antibody profile in serum by protein
array. World Journal of Gastroenterology 2006;12(25):
4044–8.
Hanvivatvong 2004
Hanvivatvong O, Pongpanich A, Thong-Ngam D,
Thammacharoenrach N, Kullavanijaya P. Evaluation of
commercial immunoassays for detection of antibody against
Helicobacter pylori in thai dyspeptic patients. Clinical and
Diagnostic Laboratory Immunology 2004;11(3):618–20.
Hanvivatvong 2006
Hanvivatvong O, Thong-Ngam D, Kuakarn S, Mahachai V.
Evaluation of Helicobacter pylori stool antigen test in Thai
patients with upper gastrointestinal bleeding. Journal of the
Medical Association of Thailand 2006;89 Suppl 3:S98–103.
Harde 2008
Harde H, Dressler M, Helmrich G, Wolff M, Groninga H.
New optical analyzer for c-13-breath test. Biophotonics:
photonic solutions for better health care. Progress
in biomedical optics and imaging; 2008 April 8-10;
Strasbourg. Bellingham (DC): SPIE, 2008; Vol. 6691:
69910T. [DOI: 10.1117/12.781271; 69910T
Harde 2010
Harde H, Helmrich G, Wolff M. Optoacoustic c-13-breath
test analyzer. Photons plus ultrasound: imaging and sensing
2010. International Society for Optical Engineering; 2010
Jan 24-26; San Francisco (CA). Bellingham (WA): SPIE,
2010; Vol. 7564:75641E. [DOI: 10.1117/12.841660
Harries 1992
Harries AD, Stewart M, Deegan KM, Mughogho GK,
Wirima JJ, Hommel M, et al. Helicobacter pyrlori in
Malawi, central africa. Journal of Infection 1992;24(3):
269–76.
Harris 1995
Harris AW. Helicobacter pylori testing at home. European
Journal of Gastroenterology & Hepatology 1995;7(7):595–6.
Harris 1998
Harris AW. Helicobacter pylori and urea breath testing.
Can the breath test result predict the outcome of treatment?
. Italian Journal of Gastroenterology & Hepatology 1998;30
(2):151–2.
Harrison 1998
Harrison JR, Bevan J, Furth EE, Metz DC. Accustat
whole blood fingerstick test for Helicobacter pylori
infection - a reliable screening method. Journal of Clinical
Gastroenterology 1998;27(1):50–3.
Hart 1999
Hart GC, Avison MP. 13C-urea versus 14c-urea breath
test: Is there still a need for 14c-urea?. Nuclear Medicine
Communications 1999;20(5):495–6.
Hartman 1992
Hartman NG, Jay M, Hill DB, Bera RK, Nickl NJ, Ryo UY.
Noninvasive detection of Helicobacter pylori colonization
in stomach using 11C-urea. Digestive Diseases and Sciences
1992;37(4):618–21.
Hartmann 2003
Hartmann D, Schilling D, Riemann JF. New nondispersive
infrared spectrometry in c-13-urea breath tests. Deutsche
Medizinische Wochenschrift 2003;128(31-32):1645–8.
Hashemi 2008
Hashemi MR, Rahnavardi M, Bikdeli B, Zahedani MD,
Iranmanesh F. Touch cytology in diagnosing Helicobacter
pylori: Comparison of four staining methods. Cytopathology
2008;19(3):179–84.
Hassan 2013
Hassan K, Haq M. To study the frequency of h pylori in
patients presenting with functional dyspepsia using stool
antigen test and its comparison with serology. Journal of
Gastroenterology and Hepatology 2013;28:547.
Hauser 2006
Hauser B, Wybo I, Tshibuabua G, Pierard D, Vandenplas
Y. Multiple-step polyclonal versus one-step monoclonal
enzyme immunoassay in the detection of Helicobacter
pylori antigen in the stools of children. Acta Paediatrica
2006;95(3):297–301.
Havlasova 1998
Havlasova J, Bures J, Rejchrt S, Voxova B, Krejsek J.
Helicobacter pylori caga antigen antibodies. Casopis Lekaru
Ceskych 1998;137(13):404–9.
Hawthorne 1999
Hawthorne Barney A, Morgan S, Westmoreland D, Stenson
R, Thomas GAO, Newcombe RG. A comparison of two
rapid whole-blood tests and laboratory serology, in the
diagnosis of Helicobacter pylori infection. European Journal
of Gastroenterology & Hepatology 1999;11(8):863–5.
Hawtin 1999
Hawtin PR. Serology and urea breath test in the diagnosis
of h-pylori infection. Molecular Biotechnology 1999;11(1):
85–92.
Hayashi 2003
Hayashi T, Karasawa T, Nagase H, Kinami S, Fujimura T,
Miwa K, et al. Timing of sampling in endoscopic 13C-urea
breath test for H. pylori infection. Japanese Pharmacology
and Therapeutics 2003;31(8):667–70.
He 1997
He YN, Chen HY, Zheng JJ, Zhang GY, Chen
ZL. Differential pulse voltammetric enzyme-linked
immunoassay for the determination of Helicobacter pylori
specific immunoglobulin g (igg) antibody. Talanta 1997;44
(5):823–30.
Heaney 1998
Heaney A, Collins JS, Watson RG, McFarland RJ, Bamford
KB. Rapid serological diagnosis of Helicobacter pylori: A
need for caution and re-evaluation. Irish Journal of Medical
Science 1998;167(3):152–4.
Heanhean 2013
Heanhean Ng T, Rosaida R. Evaluation of serology and urea
breath test as reliable diagnostic test for h.Pylori infection.
Journal of Gastroenterology and Hepatology 2013;28:97.
68Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Heenan 1989
Heenan A. Breath tester. Nursing Times 1989;85(36):23.
Hegedus 2001a
Hegedus O, Rehnberg AS, Bengtsson C, Befrits R,
GranstromM, Hellstrom PM. Refinement and development
of a “dry” novel 14c-urea breath test (heliprobe (tm)) for
detection of Helicobacter pylori. Gastroenterology 2001;120
(5 (suppl)):A653.
Hegedus 2001b
Hegedus O, Mjornell U, Prior C, Ryden J, Hellstrom
PM. Rapid urea breath test (heliprobe) for detection of
Helicobacter pylori by use of encapsulated acidified solid c-
14-urea: Validation of test accuracy. Gut 2001;49(Suppl):
A101.
Hegedus 2002
Hegedus O, Ryden J, Rehnberg AS, Nilsson S, Hellstrom
PM. Validated accuracy of a novel urea breath test for
rapid Helicobacter pylori detection and in-office analysis.
European Journal of Gastroenterology & Hepatology 2002;14
(5):513–20.
Helvaci 1993
Helvaci S, Akdis C, Gulten M, Yerci O. Evaluation of the
ELISA method for the diagnosis of Helicobacter pylori.
Mikrobiyoloji Bulteni 1993;27(4):294–8.
Henze 1988
Henze E, Malfertheiner P, Burkhardt H, Clausen M, Adam
WE. The c-14 urea breath test for detecting colonization of
campylobacter pylori invivo. European Journal of Nuclear
Medicine 1988;14(5-6):245.
Henze 1989
Henze E, Malfertheiner P, Clausen M, Lietzenmaier R,
Burkhardt H, AdamWE. Diagnostic accuracy of a 14C-urea
breath test for detecting campylobacter pylori infection.
Gastroduodenal pathology and Campylobacter pylori:
European Campylobacter Pylori Study Group ICS847.
1989:85–8.
Henze 1990
Henze E, Malfertheiner P, Clausen M, Burkhardt H, Adam
WE. Validation of a simplified carbon-14-urea breath
test for routine use for detecting Helicobacter [correction
of heliobacter] pylori noninvasively. Journal of Nuclear
Medicine 1990;31(12):1940–4.
Herbrink 1988
Herbrink P, Vandenmunckhof HAM, Bumkens M,
Lindeman J, Vandijk WC. Human-serum antibody-
response in campylobacter-jejuni enteritis as measured by
enzyme-linked immunosorbent-assay. European Journal
of Clinical Microbiology & Infectious Diseases 1988;7(3):
388–93.
Herold 2002
Herold R, Becker M. 13C-urea breath test threshold
calculation and evaluation for the detection of Helicobacter
pylori infection in children. BMC Gastroenterology 2002;2:
12.
Hidaka 2010
Hidaka N, Nakayama Y, Horiuchi A, Kato S, Sano K.
Endoscopic identification of Helicobacter pylori gastritis in
children. Digestive Endoscopy 2010;22(2):90–4.
Higazy 2000
Higazy E, Al-Saeedi F, Loutfi I, Heiba S, Kalaoui M, Al-
Nakib B, et al. The impact of brushing teeth on carbon-
14 urea breath test results. Journal of Nuclear Medicine
Technology 2000;28(3):162–4.
Hildebrand 1997
Hildebrand P, Beglinger C. Nondispersive infrared
spectrometry: A new method for the detection of
Helicobacter pylori infection with the c-13-urea breath test.
Clinical Infectious Diseases 1997;25(5):1003–5.
Hilker 1994
Hilker E, Stoll R, Domschke W. Quantitative assessment of
Helicobacter-pylori (hp) colonization of the gastric-mucosa
by c-13-urea breath test. Gastroenterology 1994;106(4
(suppl)):A93.
Hilker 1996
Hilker E, Domschke W, Stoll R. C-13-urea breath test for
detection of Helicobacter pylori and its correlation with
endoscopic and histologic findings. Journal of Physiology
and Pharmacology 1996;47(1):79–90.
Hino 2004
Hino B, Eliakim T, Levine A, Sprecher H, Berkowitz D,
Hartman C, et al. Comparison of invasive and non-invasive
tests diagnosis and monitoring of Helicobacter pylori
infection in children. Journal of Pediatric Gastroenterology
and Nutrition 2004;39(5):519–23.
Hirschl 1990
Hirschl AM, Rathbone BJ, Wyatt JI, Berger J, Rotter
ML. Comparison of ELISA antigen preparations alone
or in combination for serodiagnosing Helicobacter pylori
infections. Journal of Clinical Pathology 1990;43(6):511–3.
Hirschl 1991
Hirschl AM, Hirschl MM, Berger J, Rotter ML. Evaluation
of a commercial latex test for serological diagnosis of
Helicobacter pylori infection in treated and untreated
patients. European Journal of Clinical Microbiology &
Infectious Diseases 1991;10(11):971–4.
Hirschl 1993
Hirschl AM, Brandstatter G, Dragosics B, Hentschel
E, Kundi M, Rotter ML, et al. Kinetics of specific igg
antibodies for monitoring the effect of anti-Helicobacter
pylori chemotherapy. Journal of Infectious Diseases 1993;168
(3):763–6.
Hirschl 1996
Hirschl AM, Rotter ML. Serological tests for monitoring
Helicobacter pylori eradication treatment. Journal of
Gastroenterology 1996;31 Suppl 9:33–6.
Hirschl 2005
Hirschl AM, Makristathis A. Non-invasive Helicobacter
pylori diagnosis: Stool or breath tests?. Digestive & Liver
Disease 2005;37(10):732–4.
69Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ho 1996
Ho AS, Young TH, Shyu RY, Yeh C, Tseng HH, Lee SC,
et al. The accuracy of the rapid urease test and 13C-urea
breath test in the diagnosis of Helicobacter pylori infection.
Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]
1996;58(6):400–6.
Ho 2000
Ho B, Marshall BJ. Accurate diagnosis of Helicobacter
pylori - serologic testing. Gastroenterology Clinics of North
America 2000;29(4):853.
Ho 2004
Ho CY, Chen TS, Chang FY, Lee SD. Rapid urease test
from non-ulcer part of stomach is superior to histology
from ulcer in detection of Helicobacter pylori infection in
patients with gastric ulcer. Hepato-Gastroenterology 2004;51
(60):1877–80.
Hoang 2006
Hoang TT, Rehnberg AS, Wheeldon TU, Bengtsson C,
Phung DC, Befrits R, et al. Comparison of the performance
of serological kits for Helicobacter pylori infection with
european and asian study populations. Clinical Microbiology
& Infection 2006;12(11):1112–7.
Hoek 1992
Hoek FJ, Noach LA, Rauws EAJ, Tytgat GNJ. Evaluation
of the performance of commercial test kits for detection of
Helicobacter pylori antibodies in serum. Journal of Clinical
Microbiology 1992;30(6):1525–8.
Hollenz 1999
Hollenz M, Stolte M, Labenz J. Helicobacter pylori
screening in a general practice. Deutsche Medizinische
Wochenschrift 1999;124(7):171–5.
Hong 2008
Hong WD, Zhu QH, Chen XR. Study on the value of
helieobacter pylori (h. Pylori) stool antigen immunocard
stat in the diagnosis of h. Pylori infection: A meta-analysis..
Zhonghua Liu Xing Bing Xue Za Zhi 2008;29(1):71–4.
Hooton 2006
Hooton C, Keohane J, Clair J, Azam M, O’Mahony S,
Crosbie O, et al. Comparison of three stool antigen assays
with the c-13-urea breath test for the primary diagnosis of
Helicobacter pylori infection and monitoring treatment
outcome. European Journal of Gastroenterology & Hepatology
2006;18(6):595–9.
Hoshiya 2001
Hoshiya S, Tokunaga K, Tanaka A, Takahashi S. Serological
diagnosis of Helicobacter pylori infection. Nihon Rinsho
[Japanese Journal of Clinical Medicine] 2001;59(2):259–64.
Houben 1998
Houben M, Hensen EF, Stam P, Van’t Hoff BWM, Van
der Hulst RWM, Van der Ende A, et al. Post-eradication
evaluation of h-pylori (hp) status: The c-13 urea laser
assisted ratio analyzer (lara) breath test. Gastroenterology
1998;114(4 (suppl)):A153.
Houben 1999
Houben M, Vaira D, Lam K, Hensen EF, Stam P, Van ’t
Hoff BWM, et al. Usefulness of the c-13 lara (tm) urea
breath test in confirming eradication of Helicobacter pylori
(hp). Gastroenterology 1999;116(4 (suppl)):A190.
Hsu 2010
Hsu PI. Application of serology in the diagnosis of
Helicobacter pylori infection in patients with atrophic
gastritis. Journal of the Chinese Medical Association 2010;73
(11):561–2.
Hu 1995
Hu P, Cui Y, Chen M. Application of serology and 14c-urea
breath test to monitoring of the effect of anti-Helicobacter
pylori chemotheraphy.. Zhonghua Nei Ke Za Zhi [Chinese
journal of internal medicine] 1995;34(12):819–22.
Hu 2000
Hu F, Cheng H, Li J. Evaluation and comparison of
the Helicobacter pylori stool antigen test and the gastric
mucosal antigen test.. Zhonghua Yi Xue Za Zhi 2000;80
(11):820–2.
Hu 2007
Hu HM, Kuo CH, Lo YC, Wu MT, Wu IC, Lu CY, et al.
Evaluation of the two immunochromatographic methods
for detecting urine and serum igg antibodies to Helicobacter
pylori and comparison of accuracy and clinical utility.
Hepato-Gastroenterology 2007;54(73):119–23.
Hu 2011
Hu FL. Performance of current infection marker test for
the diagnosis of Helicobacter pylori current infection: A
multicenter clinical trial. National Medical Journal of China
2011;91(27):1891–4.
Huang 1993
Huang CK, Chen GH, Kao CH, Wang SJ, Leu JF, Shir
JM, et al. A 10-minute carbon-14 urea breath test for
the detection of Helicobacter pylori. Chinese Journal of
Gastroenterology 1993;10(3):212–20.
Huang 1996
Huang MS, Wang WM, Wu DC, Chen LT, Jan CM, Chen
CY, et al. Utility of brushing cytology in the diagnosis of
Helicobacter pylori infection. Acta Cytologica 1996;40(4):
714–8.
Huang 1998
Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of
the relationship between Helicobacter pylori seropositivity
and gastric cancer. Gastroenterology 1998;114(6):1169–79.
Huang 2000
Huang JJ, Huang CJ, Ruaan MK, Chen KW, Yen TS,
Sheu BS. Diagnostic efficacy of (13)c-urea breath test for
Helicobacter pylori infection in hemodialysis patients.
American Journal of Kidney Diseases 2000;36(1):124–9.
Huang 2002
Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter
pylori infection and non-steroidal anti-inflammatory drugs
in peptic-ulcer disease: a meta-analysis. Lancet 2002;359
(9300):14–22.
Huang 2003
Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt
RH. Meta-analysis of the relationship between cagA
70Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
seropositivity and gastric cancer. Gastroenterology 2003;125
(6):1636–44.
Huelin 1996
Huelin J, Sanchez-Galdon S, Cardenas A, Ibanez J, Espana
P, De la Cruz J, et al. Comparative study of Helisal™ rapid
blood and ELISA, Jatrox and pathologic anatomy in the
diagnosis of Helicobacter pylori infection [Spanish]. Revista
Espanola de Enfermedades Digestivas 1996;88(12):825–7.
Huijsdens 2004
Huijsdens XW, Linskens RK, Koppes J, Tang YL,
Meuwissen SGM, Vandenbroucke-Grauls CMJE, et al.
Detection of Helicobacter species DNA by quantitative
PCR in the gastrointestinal tract of healthy individuals
and of patients with inflammatory bowel disease. FEMS
Immunology and Medical Microbiology 2004;41(1):79–84.
Hung 2002
Hung CT, Leung WK, Chan FKL, Sung JJY. Comparison
of two new rapid serology tests for diagnosis of Helicobacter
pylori infection in Chinese patients. Digestive and Liver
Disease 2002;34(2):111–5.
Hung 2010
Hung HH, Chen TS, Lin HC. Immunoglobulin g antibody
against Helicobacter pylori is an accurate test for atrophic
gastritis. Journal of the Chinese Medical Association 2010;73
(7):355–9.
Husson 2000
Husson MO, Rolland C, Gottrand F, Guimber D, Kalach
N, Spyckerelle C, et al. Evaluation of a Helicobacter
pylori stool antigen test for the diagnosis and follow-up
of infections in children. European Journal of Clinical
Microbiology & Infectious Diseases 2000;19(10):787–9.
Hynes 1998
Hynes SO, Moran AP. Comparison of enzyme-linked
immunosorbent assay, immunodot and western blot
techniques for detecting lewis antigen expression on
Helicobacter pylori clinical isolates. Gut 1998;43(Suppl 2):
A20.
Hynes 2000
Hynes SO, Moran AP. Comparison of three serological
methods for detection of lewis antigens on the surface of
Helicobacter pylori. FEMS Microbiology Letters 2000;190
(1):67–72.
Ibrahim 2012
Ibrahim NH, Gomaa AA, Abu-Sief MA, Hifnawy TM,
Tohamy MAE. The use of different laboratory methods in
diagnosis of Helicobacter pylori infection; a comparative
study. Life Science Journal-Acta Zhengzhou University
Overseas Edition 2012;9(4):249–59.
Ichinose 1998
Ichinose Y, Kanai E, Yamasawa F, Nishi I, Toyama K.
Simultaneous continuous 13C, 12c analysis of expired gas
in the 13C breath test. Respirology 1998;3(1):21–4.
Ierardi 2002
Ierardi E, Margiotta M, Monno R, De Francesco V,
Minenna MF, Burattini O, et al. A new semiquantitative
method of quantifying Helicobacter pylori in antigen stools.
Journal of Clinical Gastroenterology 2002;35(5):375–8.
Ierfone 2003
Ierfone N, Di Fulvio A, Standoli M, Pontone S, Tonda M,
Pontone P. Breath test as non-invasive assessment for the
initial screening of non-ulcerous dyspepsia. Giornale di
Chirurgia 2003;24(10):357–63.
Ignys 2006
Ignys I, Klincewicz B, Malewski W, Cichy W. The non-
invasive diagnostic test for detection of Helicobacter pylori
infection in children - the value of Helicobacter pylori stool
antigen test. Pediatria Wspolczesna 2006;8(4):234–6.
Iijima 1998
Iijima K, Ohara S, Sekine H, Moriyama S, Kato K, Koike
T, et al. Correlation between 13C-urea breath test and
gastric histological findings in Helicobacter pylori positive
patients. Nippon Shokakibyo Gakkai Zasshi [Japanese Journal
of Gastroenterology] 1998;95(1):18–25.
Ilan 1998
Ilan Y, Israelit YY, Bar Meir S, Yudchack S, Goldin E. A
novel method & device for Helicobacter pylori detection:
Continuous, fast c-13-urea breath test. Gastroenterology
1998;114(4):A157.
Ilga 2008
Ilga U, Ozyurt M, Yildirim S, Ergunay K, Ardic N,
Demirturk L, et al. Helicobacter pylori isolation, serology
and caga, cage and virb11 detection in patients with
non-ulcer dyspepsia from Turkey: Correlation with
histopathologic findings. Central European Journal of
Medicine 2008;3(1):41–6.
Imperiale 1996
Imperiale TF, McCullough AJ. C-13 urea breath test
for Helicobacter pylori infection. American Journal of
Gastroenterology 1996;91(1):175–6.
Imrie 2001
Imrie C, Rowland M, Bourke B, Drumm B. Limitations
to carbon 13-labeled urea breath testing for Helicobacter
pylori in infants. Journal of Pediatrics 2001;139(5):734–7.
Inaba 2002
Inaba T, Mizuno M, Kawai K, Takaguchi K, Yoshida Y,
Kita K, et al. Effect of antiulcer agents on the urea breath
test - comparison between rebamipide and ecabet sodium.
Japanese Journal of Gastroenterology 2002;99(1):27–33.
Iranikhah 2013
Iranikhah A, Ghadir MR, Sarkeshikian S, Saneian H,
Heidari A, Mahvari M. Stool antigen tests for the detection
of Helicobacter pylori in children. Iranian Journal of
Pediatrics 2013;23(2):138–42.
Ishihara 2000
Ishihara S, Kaji T, Kawamura A, Rumi MAK, Sato H,
Okuyama T, et al. Diagnostic accuracy of a new non-
invasive enzyme immunoassay for detecting Helicobacter
pylori in stools after eradication therapy. Alimentary
Pharmacology and Therapeutics 2000;14(5):611–4.
71Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ishizuka 1999
Ishizuka J. Clinical evaluation of Helicobacter pylori stool
antigen (HPSA) assay for assessment of diagnosis and
eradication. Japanese Journal of Gastroenterology 1999;96
(10):1196.
Islami 2008
Islami F, Kamangar F. Helicobacter pylori and esophageal
cancer risk: a meta-analysis. Cancer Prevention Research
2008;1(5):329–38.
Ismail 2016
Ismail H, Morgan C, Griffiths P, Williams J, Jenkins G.
A newly developed nested PCR assay for the detection of
Helicobacter pylori in the oral cavity. Journal of Clinical
Gastroenterology 2016;50(1):17–22.
Isomoto 2002
Isomoto H, Inoue K, Shikuwa S, Furusu H, Nishiyama T,
Omagari K, et al. Five minute endoscopic urea breath test
with 25 mg of c-13-urea in the management of Helicobacter
pylori infection. European Journal of Gastroenterology &
Hepatology 2002;14(10):1093–100.
Isomoto 2003
Isomoto H, Inoue KI, Mizuta Y, Nakazato M, Kanazawa
Y, Nishiyama H, et al. Validation of endoscopic 13C-
urea breath test with nondispersive infrared spectrometric
analysis in the management of Helicobacter pylori infection.
Hepato-Gastroenterology 2003;50(50):422–5.
Isomoto 2006
Isomoto H, Kawazoe K, Inoue K, Kohno S. Usefulness
of the immunological rapid urease test for detection of
Helicobacter pylori in patients who are reluctant to undergo
endoscopic biopsies. Digestive Diseases & Sciences 2006;51
(12):2302–5.
Israeli 2003
Israeli E, Ilan Y, Meir SB, Buenavida C, Goldin E. A novel
13C-urea breath test device for the diagnosis of Helicobacter
pylori infection: Continuous online measurements allow
for faster test results with high accuracy. Journal of Clinical
Gastroenterology 2003;37(2):139–41.
Ito 2002
Ito M, Haruma K, Kaya S, Kamada T, Kim S, Sasaki A, et
al. Role of anti-parietal cell antibody in Helicobacter pylori-
associated atrophic gastritis: Evaluation in a country of high
prevalence of atrophic gastritis. Scandinavian Journal of
Gastroenterology 2002;37(3):287–93.
Ito 2005
Ito M, Tanaka S, Kim SJ, Tahara K, Kawamura Y, Sumii M,
et al. A combination of the Helicobacter pylori stool antigen
test and urea breath test is useful for clinical evaluation
of eradication therapy: A multicenter study. Journal of
Gastroenterology and Hepatology 2005;20(8):1241–5.
Iwanczak 2005
Iwanczak F, Pytrus T, Iwanczak B, Gosciniak G,Witkowska-
Vogtt E, Dzierzanowska D, et al. Assessment of selected
tests in diagnostics of Helicobacter pylori infections. Polski
Merkuriusz Lekarski 2005;19(109):52–6.
Jaakkimainen 1999
Jaakkimainen RL, Boyle E, Tudiver F. Is Helicobacter pylori
associated with non-ulcer dyspepsia and will eradication
improve symptoms? A meta-analysis. BMJ 1999;319
(7216):1040–4.
Jabbari 2009
Jabbari Moghaddam Y, Rafeey M, Radfar R. Comparative
assessment of Helicobacter pylori colonization in children
tonsillar tissues. International Journal of Pediatric
Otorhinolaryngology 2009;73(9):1199–201.
Jadresin 2000
Jadresin O, Kolacek S, Percl M, Tambic A, Dasovic I,
Grguric J. Detection of Helicobacter pylori antigen in stools
- an alternative method of verifying hp infection in children.
Paediatria Croatica 2000;44(4):141–4.
Jaff 2011
Jaff MS. Relation between ABO blood groups and
Helicobacter pylori infection in symptomatic patients.
Clinical and Experimental Gastroenterology 2011;4(1):
221–6.
Jafri 2010
Jafri W, Yakoob J, Abid S, Siddiqui S, Awan S, Nizami
SQ. Helicobacter pylori infection in children: Population-
based age-specific prevalence and risk factors in a developing
country. Acta Paediatrica 2010;99(2):279–82.
Jaime 2013
Jaime F, Villagran A, Serrano C, Cerda J, Harris PR.
Frequency of Helicobacter pylori infection in 144 school
age Chilean children. Revista Medica de Chile 2013;141
(10):1249–54.
Jain 1999
Jain A, Buddhiraja S, Khurana B, Singhal R, Nair D, Arora
P, et al. Risk factors for duodenal ulcer in north India.
Tropical Gastroenterology 1999;20(1):36–9.
Jalali 1988
Jalali S, Hollingsworth J, Vanzanten SV, Tytgat K, Goldie J,
Bowen B, et al. C-14 urea breath test for the detection of C
pylori (cp) infections. Gastroenterology 1988;94(5):A205.
Jane 1999
Jane Santamaria M, Varea Calderon V, Camacho E.
Concordance between breath test and histologic damage in
Helicobacter pylori associated infections in infancy. Revista
Espanola De Enfermedades Digestivas 1999;91(10):703–10.
Janjetic 2010
Janjetic MA, Goldman CG, Balcarce NE, Rua EC, Gonzalez
AB, Fuda JA, et al. Iron, zinc, and copper nutritional status
in children infected with Helicobacter pylori. Journal of
Pediatric Gastroenterology & Nutrition 2010;51(1):85–9.
Janjetic 2011
Janjetic MA, Goldman CG, Barrado DA, Rua EC, Balcarce
N, Mantero P, et al. Decreasing trend of Helicobacter pylori
infection in children with gastrointestinal symptoms from
Buenos Aires, Argentina. Helicobacter 2011;16(4):316–9.
72Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Janjetic 2015
Janjetic MA, Mantero P, Rua EC, Balcarce N, De Palma
GZ, Catalano M, et al. Dietary and anthropometric
indicators of nutritional status in relation to Helicobacter
pylori infection in a paediatric population. British Journal of
Nutrition 2015;113(7):1113–9.
Janssen 2001
Janssen K. Diagnostic series. Helicobacter pylori infections
rapidly recognized. MMW Fortschritte der Medizin 2001;
143(13):41–2.
Janulaityte 1998
Janulaityte D, Kupcinskas L, Pavilonis A, Wadstrom T,
Andersen L. Western blot analysis of Helicobacter pylori
infection in patients with and without gastric cancer. Gut
1998;43(Suppl 2):A69.
Janus 1991
Janus G, Hammermeister I, Prignet JM, Saccharin C, Kist
M, Koch HK. Helicobacter pylori: A serological study
of young soldiers with endoscopic. Microbiologic and
histologic study of ten cases with positive serology. Medecine
et Maladies Infectieuses 1991;21(5):308–12.
Jarbol 2006
Jarbol DE, Kragstrup J, Stovring H, Havelund T,
Schaffalitzky de Muckadell OB. Proton pump inhibitor or
testing for Helicobacter pylori as the first step for patients
presenting with dyspepsia? A cluster-randomized trial.
American Journal of Gastroenterology 2006;101(6):1200–8.
Jensen 1993
Jensen AKV, Andersen LP, Wachmann CH. Evaluation of
eight commercial kits for Helicobacter pylori IgG antibody
detection. APMIS 1993;101(10):795–801.
Ji 1993
Ji J, Li XM, Jiang GH. Diagnosis of Helicobacter pylori
infection by 13C-urea breath test. Zhonghua Nei Ke za Zhi
[Chinese Journal of Internal Medicine] 1993;32(3):170–2.
Jiang 2004
Jiang Z, Huang AL, Tao XH, Wang PL. Diagnosis of
Helicobacter pylori infection and diseases associated with
Helicobacter pylori by Helicobacter pylori outer membrane
proteins. World Journal of Gastroenterology 2004;10(23):
3464–9.
Jo 2008
Jo Y, Chung M, Lim C, Son B, Jun D, Kim S, et al. Urea
breath test is the most reliable h. Pylori diagnostic test in
patients with upper gastrointestinal bleeding in high h.
Pylori prevalent population. Helicobacter 2008;13(5):451.
Jo 2014
Jo Y, Lee J, Kim J, Kim T. Urea breath test and serological
test have equivalent accuracy to detect Helicobacter pylori
in patients with gastroduodenal ulcer bleeding. Helicobacter
2014;19:124.
Johansen 2004
Johansen JK, Sehested A, Myrhoj T, Ladefoged K, Krogfelt
KA. Helicobacter pylori infection in Greenlandic patients
with dyspepsia. International Journal of Circumpolar Health
2004;63 Suppl 2:219–20.
Johnston 1998
Johnston BJ, Gruer N, Johnson P. Effect of patient position
on the performance of the c-13-urea breath test for the
detection of Helicobacter pylori. Gut 1998;43(Suppl 2):
A57.
Jolley 2007
Jolley CD, Wagner DA. Comparison of the c-13-urea blood
test to histology and rapid urease testing in the diagnosis
of Helicobacter pylori infection in children. Journal of
Pediatric Gastroenterology and Nutrition 2007;44(1):68–70.
Jonaitis 2007
Jonaitis LV, Kiudelis G, Kupcinskas L. Evaluation of a
novel c-14-urea breath test “heliprobe” in diagnosis of
Helicobacter pylori infection. Medicina-Lithuania 2007;43
(1):32–5.
Jones 1997a
Jones R, Phillips I, Felix G, Tait C. An evaluation of near-
patient testing for Helicobacter pylori in general practice.
Alimentary Pharmacology & Therapeutics 1997;11(1):101–5.
Jones 1997b
Jones NL, Bourke B, Sherman PM. Breath testing for
Helicobacter pylori infection in children: A breath of fresh
air?. Journal of Pediatrics 1997;131(6):791–3.
Jones 2007
Jones RT, Darboe MK, Doherty CP, MacKay WG, Weaver
LT, Campbell DI, et al. Evaluation of c-13-urea breath
test and fecal antigen immunoassay to detect Helicobacter
pylori infection in Gambian infants. Journal of Pediatric
Gastroenterology and Nutrition 2007;44(5):650–2.
Juhasz 2000
Juhasz M, Pronai L, Zagoni T, Nemeth A, Herszenyi L,
Schandl L, et al. Comparison of various methods in the
detection of Helicobacter pylori infection. Orvosi Hetilap
2000;141(17):911–4.
Juncal 1998
Juncal AR, Garea MT, Cid A, Penalver MD, Vazquez R,
Montero E, et al. Evaluation of four commercial enzyme
immunoassays for the serologic diagnosis of infection by
Helicobacter pylori. Enfermedades Infecciosas y Microbiologia
Clinica 1998;16(4):185–9.
Jung 2002
Jung A, Wasilewska-Radwanska M, Kopanski Z.
Semiempirical model for diagnostication Helicobacter
pylori infection by use of c-14 labelled urea. Nukleonika
2002;47(3):95–9.
Jung 2013
Jung H, Moon J, Park K, Kwon M, Jeong S, Park Y, et al.
Detection rates of clarithromycin resistance and eradication
rates of Helicobacter pylori infection: efficacy of Panplex™
Clar-H. pylori detection. Helicobacter 2013;18:132.
Kabir 2001
Kabir S. Detection of Helicobacter pylori in faeces by
culture, PCR and enzyme immunoassay. Journal of Medical
Microbiology 2001;50(12):1021–9.
73Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kajiwara 1997
Kajiwara M, Iida K, Takatori K, Taniguchi Y, Kimura K.
Validity of the c-13-urea breath test for the diagnosis of
Helicobacter pylori infection. Chemical & Pharmaceutical
Bulletin 1997;45(4):741–3.
Kajiwara 1998
Kajiwara M, Iida K, Takatori K, Taniguchi Y, Kimura K.
Validity of the c-13-urea breath test for the diagnosis of
Helicobacter pylori infection. In: Heys JR, Melillo DG
editor(s). Synthesis and Applications of Isotopically Labelled
Compounds 1997. 1st Edition. Chichester: John Wiley &
Sons, 1998:627–31.
Kakinoki 2001
Kakinoki K, Takemori Y, Noda Y. Efficacy of the urine
antibody test for detection of Helicobacter pylori:
Comparison with serum antibody tests. Japanese Journal of
Gastroenterology 2001;98(8):935–41.
Kaklikkaya 2006
Kaklikkaya N, Akdogan RA, Ozgur O, Uzun DY,
Cobanoglu U, Dinc U, et al. Evaluation of a new rapid
lateral flow chromatography test for the diagnosis of
Helicobacter pylori. Saudi Medical Journal 2006;27(6):
799–803.
Kalach 1996
Kalach N, Briet F, Raymond J, Benhamou P, Senouci L,
Bergert M, et al. Time course analysis and simplification
of the c-13-urea breath test (c-13-ubt) in the detection
of Helicobacter pylori infection (h-pylori) in children.
Gastroenterology 1996;110(4 (suppl)):A148.
Kalach 1998b
Kalach N, Benhamou PH, Briet F, Raymond J, Dupont
C. The urea-c-13 breath test in the course of Helicobacter
pylori gastric infection in children. Archives De Pediatrie
1998;5(12):1359–65.
Kalach 2005
Kalach N, Nguyen V, Bergeret M, Boutros N, Dupont C,
Raymond J. Usefulness and influence of age of a novel
rapid monoclonal enzyme immunoassay stool antigen for
the diagnosis of Helicobacter pylori infection in children.
Diagnostic Microbiology and Infectious Disease 2005;52(2):
157–60.
Kalach 2009
Kalach N, Dehecq E, Gosset P, Decoster A, Bergeret
M, Dupont C, et al. Usefulness and influence of age of
a novel rapid Hpstar™ stool antigen for the diagnosis
of Helicobacter pylori infection in children. Diagnostic
Microbiology and Infectious Disease 2009;65(4):450–3.
Kalem 2010
Kalem F, Ozdemir M, Baysal B. Investigation of the
presence of Helicobacter pylori by different methods in
patients with dyspeptic complaints. Mikrobiyoloji Bulteni
2010;44(1):29–34.
Kang 1999
Kang G, Rajan DP, Patra S, Chacko A, Mathan MM.
Use of serology, the urease test & histology in diagnosis
of Helicobacter pylori infection in symptomatic &
asymptomatic Indians. Indian Journal of Medical Research
1999;110:86–90.
Kannath 2007
Kannath A, Rutt HN. Development of low cost
instrumentation for non-invasive detection of Helicobacter
pylori - art. No. 64300l. Advanced Biomedical and Clinical
Diagnostic Systems 2007;6430:L4300.
Kao 1993
Kao CH, Huang CK, Wang SJ, Hsu CY, Lin WY, Chen
GH. Accuracy of a rapid 10-minute carbon-14 urea breath
test for the diagnosis of Helicobacter pylori-associated
peptic ulcer disease. European Journal of Nuclear Medicine
1993;20(8):708–11.
Kaore 2012
Kaore NM, Nagdeo NV, Thombare VR. Comparative
evaluation of the diagnostic tests for Helicobacter pylori and
dietary influence for its acquisition in dyspeptic patients:
a rural hospital based study in central India. Journal of
Clinical and Diagnostic Research 2012;6(4 SUPPL 2):
636–41.
Kaptan 2009
Kaptan ZK, Emir H, Uzunkulaoglu H, Yucel M, Karakoc
E, Koca G, et al. Determination of Helicobacter pylori in
patients with chronic nonspecific pharyngitis. Laryngoscope
2009;119(8):1479–83.
Karakus 2013
Karakus C, Salih BA. Comparison of the lateral flow
immunoassays (LFIA) for the diagnosis of Helicobacter
pylori infection. Journal of Immunological Methods 2013;
396(1-2):8–14.
Karsligil 2010
Karsligil T, Mehli M, Koruk M, Eksi F. Urea breath test and
specific IgA in Helicobacter pylori infection. Nobel Medicus
2010;6(3):46–50.
Kasho 1996
Kasho VN, Cheng S, Jensen DM, Ajie H, Lee WNP,
Faller LD. Feasibility of analysing c-13 urea breath tests
for Helicobacter pylori by gas chromatography-mass
spectrometry in the selected ion monitoring mode.
Alimentary Pharmacology & Therapeutics 1996;10(6):
985–95.
Kassa 1996
Kassa E, Tsega E, Gebre W. Comparison of diagnostic
methods for detection of Helicobacter pylori. East African
Medical Journal 1996;73(4):239–41.
Katelaris 1997
Katelaris PH, Jones DB. Testing for Helicobacter pylori
infection after antibiotic treatment. American Journal of
Gastroenterology 1997;92(8):1245–7.
Katelaris 1998
Katelaris PH, Connor SJ, Seow F, Huntley S, Ngu MC.
The effect of short term omeprazole use on the accuracy of
the c-13-urea breath test in Helicobacter pylori infected
subjects. Gut 1998;43(Suppl 2):A53.
74Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kato 1997
Kato M, Ohara S, Asaka M, Toyota T. New, on-the-spot
infrared analyzer for c-13-urea breath test: A simple, easy-
to-use method for detecting Helicobacter pylori in the
physician’s office. Gastroenterology 1997;112(4 (suppl)):
A169.
Kato 1998
Kato M, Kobayashi T, Ishizuka J, Kudo T, Katagiri M,
Komatsu Y, et al. Detection of h-pylori infections by urine-
based enzyme-linked immunosorbent assay. Gastroenterology
1998;114(4):A169.
Kato 1999
Kato M, Asaka M, Saito M, Ohara S, Toyota T, Akamatsu
T, et al. Clinical usefulness of a urine-based ELISA
for detection of anti-Helicobacter pylori antibody.
Gastroenterology 1999;116(4 (suppl)):A206–A7.
Kato 2000a
Kato M, Hokari K, Ishizuka J, Mizushima T, Sukegawa
M, Komatsu Y, et al. Assessment of Helicobacter pylori
eradication using a urine-based ELISA of anti-Helicobacter
pylori antibody. Gastroenterology 2000;118(4 Part 1):A505.
Kato 2000b
Kato S, Tachikawa T, Ozawa K, Konno M, Oyake Y,
Nakazato Y, et al. Usefulness of urine-based ELISA for
detection of IgG antibodies to Helicobacter pylori in
children. Gastroenterology 2000;118(4):A506.
Kato 2000c
Kato M, Asaka M, Saito M, Sekine H, Ohara S, Toyota
T, et al. Clinical usefulness of urine-based enzyme-
linked immunosorbent assay for detection of antibody to
Helicobacter pylori: A collaborative study in nine medical
institutions in Japan. Helicobacter 2000;5(2):109–19.
Kato 2001a
Kato M. Evaluation of a new 13co2 infrared analyzer
(ubit-ir300) for 13C-urea breath test. Japanese Journal of
Gastroenterology 2001;98(7):853.
Kato 2001b
Kato S, Tachikawa T, Ozawa K, Konno M, Okuda
M, Fujisawa T, et al. Urine-based enzyme-linked
immunosorbent assay for the detection of Helicobacter
pylori infection in children. Pediatrics 2001;107(6):E87.
Kato 2001c
Kato C, Yamaguchi T, Yusa K, Sasaki H, Suzuki K, Sato K,
et al. 13C-urea breath test. Nippon Rinsho [Japanese Journal
of Clinical Medicine] 2001;59(2):267–71.
Kato 2002a
Kato M, Iwasaki T, Miyazaki H, Ohira K, Oizumi S,
Kawarazaki M, et al. Urea breath test for diagnosis of
Helicobacter pylori infection. Nippon Rinsho [Japanese
Journal of Clinical Medicine] 2002;60(Suppl 2):332–8.
Kato 2002b
Kato S, Ozawa K, Konno M, Kagimoto S, Okuda M,
Fujisawa T, et al. Usefulness of the stool antigen test
(HPSA) for diagnosis of Helicobacter pylori infection in
Japanese children: A multicenter study. Gastroenterology
2002;122(4 (suppl)):A202–A3.
Kato 2002c
Kato S, Ozawa K, Konno M, Tajiri H, Yoshimura N,
Shimizu T, et al. Diagnostic accuracy of the c-13-urea
breath test for childhood Helicobacter pylori infection:
A multicenter Japanese study. American Journal of
Gastroenterology 2002;97(7):1668–73.
Kato 2002d
Kato S, Ozawa K, Minoura T, Iinuma K. A simplified c-
13-urea breath test for diagnosis of Helicobacter pylori
infection in children. Gastroenterology 2002;122(4 (Suppl)):
A206.
Kato 2002e
Kato C, Kasugai S, Fukuda Y, Yusa K, Kudara N, Iwasaki
M, et al. Diagnosis of Helicobacter pylori infection by the
antigen analysis of stools. Nippon Rinsho [Japanese Journal
of Clinical Medicine] 2002;60(Suppl 2):347–9.
Kato 2003a
Kato C, Sugiyama T, Sato K, Saito S, Kudara N, Abiko
Y, et al. Appropriate cut-off value of 13C-urea breath test
after eradication of Helicobacter pylori infection in Japan.
Journal of Gastroenterology & Hepatology 2003;18(12):
1379–83.
Kato 2003b
Kato S, Ozawa K, Okuda M, Fujisawa T, Kagimoto S,
Konno M, et al. Accuracy of the stool antigen test for
the diagnosis of childhood Helicobacter pylori infection:
A multicenter Japanese study. American Journal of
Gastroenterology 2003;98(2):296–300.
Kato 2004a
Kato S, Nakayama K, Minoura T, Konno M, Tajiri
H, Matsuhisa T, et al. Comparison between the 13C-
urea breath test and stool antigen test for the diagnosis
of childhood Helicobacter pylori infection. Journal of
Gastroenterology 2004;39(11):1045–50.
Kato 2004b
Kato S, Ozawa K, Okuda M, Nakayama Y, Yoshimura N,
Konno M, et al. Multicenter comparison of rapid lateral
flow stool antigen immunoassay and stool antigen enzyme
immunoassay for the diagnosis of Helicobacter pylori
infection in children. Helicobacter 2004;9(6):669–73.
Kato 2004c
Kato M, Saito M, Fukuda S, Kato C, Ohara S, Hamada
S, et al. C-13-urea breath test, using a new compact
nondispersive isotope-selective infrared spectrophotometer:
Comparison with mass spectrometry. Journal of
Gastroenterology 2004;39(7):629–34.
Kato 2005a
Kato M, Shimizu Y, Nakagawa S, Nakagawa M, Ono Y,
Ono S, et al. Prevention of false-positive result of 13C-urea
breath test after eradication of h. Pylori using film-coated
13C-urea tablet. Gastroenterology 2005;128(4 (suppl)):
A561.
75Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kato 2005b
Kato M, Shimizu Y, Shouji E, Takeda H, Asaka M. Problem
of 13C-urea breath test in the diagnosis of h. Pylori after
eradication. Nippon Rinsho [Japanese Journal of Clinical
Medicine] 2005;63(Suppl 11):221–5.
Kato 2005c
Kato M, Asaka M. Helicobacter pylori igg antibody, urea
breath test, Helicobacter pylori antigen in the stool. Nippon
Rinsho [Japanese Journal of Clinical Medicine] 2005;63
(Suppl 7):175–9.
Kato 2007
Kato C, Sugiyama T, Horie A, Igarashi M, Takayanagi N,
Tsuchida Y. Diagnostic accuracy of a novel Helicobacter
pylori stool antigen test using monoclonal antibody after
eradication therapy in Japanese population. Helicobacter
2007;12(4):442–3.
Kato 2010
Kato M, Asaka M. Helicobacter pylori (igg antibody test,
urea breath test, stool antigen test). Nippon Rinsho [Japanese
Journal of Clinical Medicine] 2010;68(Suppl 6):183–8.
Katsuragi 1998
Katsuragi K, Noda A, Tachikawa T, Azuma A, Mukai F,
Murakami K, et al. Highly sensitive urine-based enzyme-
linked immunosorbent assay for detection of antibody to
Helicobacter pylori. Helicobacter 1998;3(4):289–95.
Kaul 1998
Kaul A, Bhasin DK, Pathak CM, Ray P, Vaiphei K, Sharma
BC, et al. Normal limits of 14c-urea breath test. Tropical
Gastroenterology 1998;19(3):110–3.
Kawai 2008
Kawai T, Kawakami K, Kataoka M, Itoi T, Takei K,
Moriyasu F, et al. A study of the relationship between
Helicobacter pylori microbial susceptibility, 13C-urea
breath test values. Hepato-Gastroenterology 2008;55(82-83):
786–90.
Kawakami 2002
Kawakami E, Machado RS, Reber M, Patricio FR. 13 c-
urea breath test with infrared spectroscopy for diagnosing
Helicobacter pylori infection in children and adolescents.
Journal of Pediatric Gastroenterology & Nutrition 2002;35
(1):39–43.
Kazemi 2011
Kazemi S, Tavakkoli H, Habizadeh MR, Emami MH.
Diagnostic values of Helicobacter pylori diagnostic tests:
Stool antigen test, urea breath test, rapid urease test, serology
and histology. Journal of Research in Medical Sciences 2011;
16(9):1097–104.
Kearney 1999
Kearney DJ, Boes L, Peacock JS. Use of a dried plasma
collection card for simplified diagnosis of Helicobacter
pylori infection. Alimentary Pharmacology & Therapeutics
1999;13(11):1531–4.
Kearney 2002
Kearney DJ, Hubbard T, Putnam D. Breath ammonia
measurement in Helicobacter pylori infection. Digestive
Diseases & Sciences 2002;47(11):2523–30.
Ken 2013
Ken Dror S, Barak M. Evaluation of the diasorin liaison
automatic stool antigen test for the diagnosis of Helicobacter
pylori infection. Biochimica Clinica 2013;37:S659.
Kesli 2010
Kesli R, Gokturk HS, Erbayrak M, Karabagli P, Terzi Y.
Comparison of the diagnostic values of the 3 different stool
antigen tests for the noninvasive diagnosis of Helicobacter
pylori infection. Journal of Investigative Medicine 2010;58
(8):982–6.
Kessenich 2012
Kessenich CR, Erigo-Backsman RC. Gastritis and
noninvasive testing for Helicobacter pylori. Nurse
Practitioner 2012;37(4):7–9.
Khafri 2005
Khafri A, Van yousefi J, Madani R, Pourdian M, Khaki
P. Designing an ELISA technique for h.Pylori antibody
detection using water extracted antigens. Iranian Journal of
Public Health 2005;34(2):14–9.
Khalifehgholi 2013
Khalifehgholi M, Shamsipour F, Ajhdarkosh H, Daryani
NE, Reza Pourmand M, Hosseini M, et al. Comparison of
five diagnostic methods for Helicobacter pylori. Iranian
Journal of Microbiology 2013;5(4):396–401.
Kharchenko 2012
Kharchenko N, Lopukh I, Janelidze D. Helicobacter pylori
immediate detection with helic breath test: Diagnostic value
comparison with c-13 breath test and PCR DNA in feces.
Journal of Gastroenterology and Hepatology 2012;27:297–8.
Khorovskaya 2003
Khorovskaya LA, Kornienko EA, Dmitrienko MA,
Nazhiganov ON. Experience of a modified non-isotopic,
non-invasive breath test for Helicobacter pylori in pediatric
practice. Clinical Chemistry 2003;49(6 (suppl)):A52.
Kias 2011
Kias F, Taleb F, Mouffok F, Matougui N, Boudjella M,
Lamri A, et al. Helicobacter pylori: diagnosis of infection in
adults in Algeria. Helicobacter 2011;16:116.
Kikuchi 1999
Kikuchi H, Ichinose Y, Ishii H, Mori M, Yamaguchi K, Igari
K. Influence on diagnosis of Helicobacter pylori infection in
13C urea breath test of existence of dead space gas. Journal
of Occupational Health 1999;41(6):183–9.
Kim 1996
Kim J, Bank S, Bailey B. Comparison of C14 breath
test with clo test in detecting Helicobacter pylori.
Gastroenterology 1996;110(4 (suppl)):A155.
Kim 1997
Kim MJ, Michener R, Triadafilopoulos G. Serum c-13-
bicarbonate assay for the diagnosis of gastric Helicobacter
pylori infection and response to treatment. Gastroenterology
1997;113(1):31–7.
76Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kim 1999
Kim PS, Lee JW, Pai SH, Choe YH, Shin YW, Kim YS.
Detection of H. pylori antigen in stool by ELISA. Gut 1999;
45(Suppl 3):A133.
Kim 2001
Kim I, Kim P, Kwon K, Lee D, Kim H, Shin Y, et al.
Comparison of urine-based enzyme-linked immunosorbent
assay and c-14 ubt test for detection of Helicobacter pylori.
Gut 2001;49(suppl):A102–A3.
Kim 2002
Kim PS, Lee J, Pai SH, Kim YB, Cho JK, Lee JW, et al.
Detection of Helicobacter pylori antigen in stool by enzyme
immunoassay. Yonsei Medical Journal 2002;43(1):7–13.
Kim 2009
Kim D. The detection of Helicobacter pylori in the terminal
ileum and rectum from urea breath test positive healthy
adults with culture and PCR during colonoscopy. American
Journal of Gastroenterology 2009;104:S514.
Kim 2012
Kim WJ, Kim HD. The efficacy of monoclonal antibody-
based test as addictive tool to detect h. Pylori. Journal of
Gastroenterology and Hepatology 2012;27:65.
Kim 2013
Kim HD, Kim DH, Park H, Kim WJ, Ahn YS, Lee YJ,
et al. Detection of Helicobacter pylori in gastric aspirates
using a monoclonal antibody-based test. Gut and Liver
2013;7(1):30–4.
Kim 2014
Kim H, Choi S, Beom J. New monoclonal antibody-based
test for Helicobacter pylori urease in gastric tissue. Journal of
Gastroenterology and Hepatology (Australia) 2014;29:228–9.
Kindermann 2000
Kindermann A, Demmelmair H, Koletzko B, Krauss-
Etschmann S, Wiebecke B, Koletzko S. Influence of age on
c-13-urea breath test results in children. Journal of Pediatric
Gastroenterology and Nutrition 2000;30(1):85–91.
Kindermann 2001a
Kindermann A, Konstantopoulos N, Lehn N, Demmelmair
H, Koletzko S. Evaluation of two commercial enzyme
immunoassays, testing immunoglobulin g (igg) and iga
responses, for diagnosis of Helicobacter priori infection in
children. Journal of Clinical Microbiology 2001;39(10):
3591–6.
Kindermann 2001b
Kindermann A, Faus-Kessler T, Ballauff A, Findeisen A,
Laske G, Demmelmair H, et al. Evaluation of a rapid
whole blood test to detect Helicobacter pylori infection in
children. Scandinavian Journal of Gastroenterology 2001;36
(6):572–6.
Kishkun 2002
Kishkun AA, Sadokov VM, Arsenin SL, Budzinskii AA,
Klimkova MA, Kuchin GA, et al. Significance of the
operational test parameters in selection of a diagnostic
test for Helicobacter infection. Eksperimental’naia i
Klinicheskaia Gastroenterologiia [Experimental & Clinical
Gastroenterology] 2002;4:103-8, 34-35.
Kist 1999
Kist M, Strobel S, Kirchner T, Dammann HG. Impact of
ELISA and immunoblot as diagnostic tools one year after
eradication of Helicobacter pylori in a multicentre treatment
study. FEMS Immunology & Medical Microbiology 1999;24
(2):239–42.
Klein 1996
Klein PD,Malaty HM,Martin RF, Graham KS, Genta RM,
Graham DY. Noninvasive detection of Helicobacter pylori
infection in clinical practice: The c-13 urea breath test.
American Journal of Gastroenterology 1996;91(4):690–4.
Klein 1999
Klein PD, Malaty HM, Czinn SJ, Emmons SC, Martin RF,
Graham DY. Normalizing results of 13C-urea breath testing
for co2 production rates in children. Journal of Pediatric
Gastroenterology & Nutrition 1999;29(3):297–301.
Klyucharova 2013
Klyucharova A, Garipova E, Skorohodkina O. Comparison
of the urea breath test with bacteriological investigation in
detecting of Helicobacter pylori in patients with chronic
urticaria. Allergy: European Journal of Allergy and Clinical
Immunology 2013;68:604–5.
Kobayashi 2002
Kobayashi D, Eishi Y, Ohkusa T, Ishige I, Suzuki T, Minami
J, et al. Gastric mucosal density of Helicobacter pylori
estimated by real-time PCR compared with results of urea
breath test and histological grading. Journal of Medical
Microbiology 2002;51(4):305–11.
Koca 2005
Koca G, Ozdemir E, Cakal E, Culha C, Turkolmez S,
Korkmaz M, et al. Comparison of c-14 urea-breath test,
Helicobacter pylori igg and cytotoxin associated gene a
findings in diabetic patients with dyspeptic complaints.
European Journal of Nuclear Medicine and Molecular Imaging
2005;32:S218.
Kodama 2004
Kodama M, Fujioka T, Okimoto T, Kagawa J, Murakami
K, Sato R, et al. Evaluation of the Helicobacter pylori
stool antigen (HPSA) assay for diagnosing infection
and confirming eradication after treatment. Journal of
Gastroenterology 2004;39(12):1219–20.
Kodama 2012
Kodama M, Murakami K, Okimoto T, Fukuda Y,
Shimoyama T, Okuda M, et al. Infuence of proton pump
inhibitor treatment on Helicobacter pylori stool antigen
test. World Journal of Gastroenterology 2012;18(1):44–8.
Koizumi 2003
Koizumi W, Tanabe S, Imaizumi H, Hibi KI, Kida M,
Ohida M, et al. Effect of anti-Helicobacter pylori igg
antibody titer following eradication of Helicobacter pylori
infection. Hepato-Gastroenterology 2003;50(49):293–6.
77Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kokkola 1998
Kokkola A, Puolakkainen P, Rautelin H, Sipponen P,
Farkkila M, Haapiainen R, et al. Positive serology indicates
an active h-pylori infection in patients with atrophic gastritis
in spite of negative histology and c-13-urea breath test.
Gastroenterology 1998;114(4):A183.
Kokkola 2000
Kokkola A, Rautelin H, Puolakkainen P, Sipponen P,
Farkkila M, Haapiainen R, et al. Diagnosis of Helicobacter
pylori infection in patients with atrophic gastritis:
Comparison of histology, c-13-urea breath test, and
serology. Scandinavian Journal of Gastroenterology 2000;35
(2):138–41.
Koletzko 1995
Koletzko S, Haisch M, Seeboth I, Braden B, Hengels K,
Koletzko B, et al. Isotope-selective non-dispersive infrared
spectrometry for detection of Helicobacter pylori infection
with 13C-urea breath test. Lancet 1995;345(8955):961–2.
Koletzko 2003
Koletzko S, Konstantopoulos N, Bosman D, Feydt-Schmidt
A, Van der Ende A, Kalach N, et al. Evaluation of a
novel monoclonal enzyme immunoassay for detection of
Helicobacter pylori antigen in stool from children. Gut
2003;52(6):804–6.
Kolho 2002
Kolho KL, Korhonen J, Verkasalo M, Lindahl H, Savilahti
E, Rautelin H. Helicobacter pylori serology at diagnosis
and follow-up of biopsy-verified infection in children.
Scandinavian Journal of Infectious Diseases 2002;34(3):
177–82.
Kolho 2006
Kolho KL, Klemola T, Koivusalo A, Rautelin H. Stool
antigen tests for the detection of Helicobacter pylori in
children. Diagnostic Microbiology and Infectious Disease
2006;55(4):269–73.
Kolt 1997
Kolt SD, Dow C, Elliott SL, Yeomans ND. Effect of
omeprazole on the accuracy of the i mu ci c-14-urea breath
test for h-pylori. Gastroenterology 1997;112(4 (suppl)):
A180.
Kolts 1993
Kolts BE, Joseph B, Achem SR, Bianchi T, Monteiro C.
Helicobacter-pylori detection - a quality and cost-analysis.
American Journal of Gastroenterology 1993;88(5):650–5.
Kondo 2000
Kondo T, Mitsui T, Kitagawa M, Nakae Y. Association
of fasting breath nitrous oxide concentration with gastric
juice nitrate and nitrite concentrations and Helicobacter
pylori infection. Digestive Diseases & Sciences 2000;45(10):
2054–7.
Konorev 2013
Konorev MR, Matveenko ME, Komleva EN. Comparative
evaluation of efficiency of helic ammonia breath test
for diagnostics of h. Pylori infection in gastric mucous.
Helicobacter 2013;18:122.
Konorev 2014
Konorev MR, Komleva EN, Matveenko ME. Evaluation of
efficiency of helic ammonia breath test for diagnostics of h.
Pylori infection in stomach in rheumatoid arthritis patients
taking nsaids. Helicobacter 2014;19:123.
Konstantopoulos 2001
Konstantopoulos N, Russmann H, Tasch C, Sauerwald
T, Demmelmair H, Autenrieth I, et al. Evaluation of the
Helicobacter pylori stool antigen test (HPSA) for detection
of Helicobacter pylori infection in children. American
Journal of Gastroenterology 2001;96(3):677–83.
Konturek 1999
Konturek SJ, Bielanski W, Bobrzynski A, Rembiarz K,
Winiarski M, Karczewska E, et al. Upper gastrointestinal
bleeding does not interfere with the effectiveness of urea
breath test in detecting of Helicobacter pylori in humans.
Gastroenterology 1999;116(4 (suppl)):A220.
Kopacova 1999
Kopacova M, Bures J, Vorisek V, Konstacky M, Rejchrt S,
Zivny P, et al. Detection of Helicobacter pylori by means
of 13C-urea breath test: Clinical reproducibility of the test.
Klinicka Biochemie a Metabolismus 1999;7(4):213–6.
Kopacova 2005
Kopacova M, Bures J, Vorisek V, Konstacky M, Rejchrt S,
Zivny P, et al. Comparison of different protocols for c-
13-urea breath test for the diagnosis of Helicobacter pylori
infection in healthy volunteers. Scandinavian Journal of
Clinical & Laboratory Investigation 2005;65(6):491–8.
Kopanski 1993a
Kopanski Z, Cienciata A. Serologic detection of
Helicobacter pylori antibodies after surgery for stomach and
duodenal ulcer. Wiener Klinische Wochenschrift 1993;105
(14):408–11.
Kopanski 1993b
Kopanski Z, Cienciala A, Slowakiewicz E, Witkowska
B, Ulatowski Z. Serological diagnosis of infection by
Helicobacter pylori in chronic ulcer disease. Materia Medica
Polona 1993;25(2):81–2.
Kopanski 1996
Kopanski Z, Schlegel-Zawadzka M, Witkowska B, Cienciala
A, Szczerba J. Role of the enterotest in the diagnosis of the
Helicobacter pylori infections. European Journal of Medical
Research 1996;1(11):520–2.
Kopanski 1997
Kopanski Z, Niziol J, Micherdzinski J, Wasilewska-
Radwanska H, Schlegel-Zawadzka M, Lasa J, et al.
Significance of the 14c-urea breath test in the determination
of the location infected by Helicobacter pylori in the
alimentary canal. European Journal of Medical Research
1997;2(3):136–8.
Kopanski 2002
Kopanski Z, Jung A, Wasilewska-Radwanska M, Kuc
T, Schlegel-Zawadzka M, Witkowska B. Comparative
diagnostic value of the breath test and the urine test
with 14C-urea in the detection of the Helicobacter pylori
infection. Nuclear Medicine Review 2002;5(1):21–4.
78Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Korkmaz 2013
Korkmaz H, Kesli R, Karabagli P, Terzi Y. Comparison
of the diagnostic accuracy of five different stool antigen
tests for the diagnosis of Helicobacter pylori infection.
Helicobacter 2013;18(5):384–91.
Korkmaz 2015
Korkmaz H, Findik D, Ugurluoglu C, Terzi Y. Reliability
of stool antigen tests: Investigation of the diagnostic value
of a new immunochromatographic Helicobacter pylori
approach in dyspeptic patients. Asian Pacific Journal of
Cancer Prevention: Apjcp 2015;16(2):657–60.
Korzonek 1997
Korzonek M. Diagnostic value of different methods applied
for detecting Helicobacter pylori infection in gastric mucosa.
Annales Academiae Medicae Stetinensis 1997;43:143–59.
Koumi 2011
Koumi A, Filippidis T, Leontara V, Makri L, Panos MZ.
Detection of Helicobacter pylori: A faster urease test can
save resources. World Journal of Gastroenterology 2011;17
(3):349–53.
Kountouras 1996
Kountouras J, Boura P, Iliadis M, Giannouli P, Tsapas G.
Saliva urease test and serological surveillance of Helicobacter
pylori infection during treatment of peptic ulcer disease.
Hellenic Journal of Gastroenterology 1996;9(1):67–71.
Kowalski 1990
Kowalski AJ, Cuan J, Chiang CS, Grove T, Perezperez G,
Blaser M. Detection of antibodies to Helicobacter-pylori by
ELISA. Clinical Chemistry 1990;36(6):1092.
Kozaiwa 1997
Kozaiwa K, Tajiri H, Sawada A, Miyoshi Y, Tada K, Etani
Y, et al. Usefulness of c-13 urea breath test in diagnosis
and monitoring of Helicobacter pylori infection in children
with recurrent abdominal pain. Gastroenterology 1997;112
(4 (suppl)):A184.
Kozlov 2006
Kozlov AV, Evstratova Iu S, Novikova VP, Tkachenko EI,
Khochinskaia O. Gas analyzer “helicosense” as a new device
for diagnosis of the Helicobacter infection. Meditsinskaia
Tekhnika 2006;3:44–6.
Krausse 2008
Krausse R, Muller G, Doniec M. Evaluation of a rapid
new stool antigen test for diagnosis of Helicobacter pylori
infection in adult patients. Journal of Clinical Microbiology
2008;46(6):2062–5.
Kroser 1998
Kroser JA, Faigel DO, Furth EE, Metz DC. Comparison
of rapid office-based serology with formal laboratory-based
ELISA testing for diagnosis of Helicobacter pylori gastritis.
Digestive Diseases & Sciences 1998;43(1):103–8.
Krumbiegel 2000a
Krumbiegel P, Muller DM. Helicobacter pylori in vivo
diagnosis after food intake: Results of simultaneous n-
15 urea urine and c-13 acetate breath tests. Isotopes in
Environmental and Health Studies 2000;36(2):99–110.
Krumbiegel 2000b
Krumbiegel P, Herbarth O, Kiess W, Muller DM, Richter
T. Diagnosis of Helicobacter pylori infection in children: Is
the n-15 urine test more reliable than the c-13 breath test?.
Scandinavian Journal of Gastroenterology 2000;35(4):353–8.
Kryvy 2012
Kryvy V, Klyaryts’ka I. Modified 13C-urea breath test in
the diagnosis of infection h. Pylori in crimean population
patients with gastritis. Helicobacter 2012;17:94.
Kuang 1998
Kuang A, Liang Z, Tan T, Chen D, Ma H, Si K, et al. Rapid
microdose 14c-urea breath test for detection of Helicobacter
pylori infection.. Hua Xi Yi Ke Da Xue Xue Bao [Journal
of West China University of Medical Sciences] 1998;29(4):
435–8.
Kubo 2001
Kubo Y, Matsui H, Ninomiya T, Mizukami Y, Onji M.
Non-invasive approach for diagnosing atrophic gastritis
using the c-13-bicarbonate breath test. International Journal
of Molecular Medicine 2001;7(4):381–4.
Kubota 2002
Kubota K, Shimoyama S, Shimizu N, Noguchi C, Mafune
K, Kaminishi M, et al. Studies of c-13-urea breath test for
diagnosis of Helicobacter pylori infection in patients after
partial gastrectomy. Digestion 2002;65(2):82–6.
Kubota 2003
Kubota K, Hiki N, Shimizu N, Shimoyama S, Noguchi
C, Tange T, et al. Utility of [13C] urea breath test
for Helicobacter pylori detection in partial gastrectomy
patients. Digestive Diseases & Sciences 2003;48(11):2135–8.
Kumbhari 2012
Kumbhari V, Rahme N, Meredith CG. Evaluation of a
novel office-based c-14 urea breath test ’heliprobe (r)’
for the rapid detection of Helicobacter pylori. Journal of
Gastroenterology and Hepatology 2012;27:58.
Kumbhari 2013
Kumbhari V, Rahme N, Meredith C. Evaluation of a novel
office based 14c urea breath test, heliprobe, in patients
undergoing endoscopy. Gastroenterology 2013;1:S334.
Kuo 2002
Kuo CH, Wu DC, Lu CY, Su YC, Yu FJ, Lee YC, et al.
The media of rapid urease test influence the diagnosis of
Helicobacter pylori. Hepato-Gastroenterology 2002;49(47):
1191–4.
Kuo 2005
Kuo FC, Wang SW, Wu IC, Yu FJ, Yang YC, Wu JY, et al.
Evaluation of urine ELISA test for detecting Helicobacter
pylori infection in Taiwan: a prospective study. World
Journal of Gastroenterology 2005;11(35):5545–8.
Kushch 2009
Kushch I, Korenev N, Kamarchuk L, Pospelov A,
Alexandrov J, Kamarchuk G. Non-urease recognition
of Helicobacter pylori infection using novel sensor
technique for breath gas analysis. Scandinavian Journal of
Gastroenterology 2009;44:25.
79Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kwon 2004
Kwon KT, Lee DS, Chung IK, Park MJ, Park CK, Cho
CM, et al. The diagnostic validity of Helicobacter pylori
stool antigen test in the pre- and post-eradication. Taehan
Sohwagi Hakhoe C [Korean Journal of Gastroenterology]
2004;44(4):199–205.
Kwon 2015
Kwon YH, Kim N, Lee JY, Choi YJ, Yoon K, Hwang JJ, et
al. The diagnostic validity of citric acid-free, high dose c-
13-urea breath test after Helicobacter pylori eradication in
Korea. Helicobacter 2015;20(3):159–68.
Kyrlagkitsis 2007
Kyrlagkitsis I, Ladas SD, Mallass EG, Raptis S, Mentis
A, Delliou E, et al. Evaluation of a conventional ELISA
(Novitec) and a near patient immunochromatographic test
(Stick H. pyl) for Helicobacter pylori antigen detection in
stool. Hepato-Gastroenterology 2007;54(75):799–802.
Labenz 1996
Labenz J, Barsch G, Peitz U, Aygen S, Hennemann O,
Tillenburg B, et al. Validity of a novel biopsy urease test
(hut) and a simplified 13C-urea breath test for diagnosis of
Helicobacter pylori infection and estimation of the severity
of gastritis. Digestion 1996;57(6):391–7.
Labenz 1997
Labenz J, Peitz U, Aygen S, Hennemann O, Stolte M.
Accuracy of rapid urease test and urea breath test for
diagnosis of Helicobacter pylori infection after treatment
- an investigator blind multicenter study. Gastroenterology
1997;112(4 (suppl)):A188.
Ladas 2000
Ladas SD, Malamou H, Giota G, Varzakakos I, Kitsanta P,
Georgopoulos S, et al. Prospective evaluation of a whole-
blood antibody test (flexpack hp) for in-office diagnosis
of Helicobacter pylori infection in untreated patients.
European Journal of Gastroenterology & Hepatology 2000;12
(7):727–31.
Ladas 2002b
Ladas SD, Varzakakos I, Malamou H, Georgopoulos S,
Giota G, Triantafyllou K, et al. Evaluation of a single-step
serological assay for laboratory diagnosis of Helicobacter
pylori infection. European Journal of Clinical Microbiology
& Infectious Diseases 2002;21(1):56–9.
Lahaie 1995
Lahaie RG, Desroches J, Picard M, Lemoyne M, Poitras P,
GagnonM, et al. Value of one-step, 20 min c-14 urea breath
test in diagnosis and proof of eradication of Helicobacter-
pylori infection. Gastroenterology 1995;108(4):A141.
Laheij 2006
Laheij RJ. Assessment of a new rapid urease test (gut test) to
diagnose Helicobacter pylori infection. Netherlands Journal
of Medicine 2006;64(9):317–8.
Lai 1997
Lai KC, Chu KM, Hui WM, Wong BCY, Lam SK. Non-
invasive tests before endoscopy in area with high prevalence
of gastric carcinoma - Helicobacter pylori serology or urea
breath test?. Gastroenterology 1997;112(4 (Suppl)):A599.
Laine 1997
Laine L, Lewin DN, Naritoku W, Cohen H. Prospective
comparison of H&E, Giemsa, and Genta stains for the
diagnosis of Helicobacter pylori. Gastrointestinal Endoscopy
1997;45(6):463–7.
Laine 1999
Laine L, Knigge K, Faigel D, Margaret N, Marquis SP,
Vartan G, et al. Fingerstick Helicobacter pylori antibody
test: Better than laboratory serological testing?. American
Journal of Gastroenterology 1999;94(12):3464–7.
Lamarque 1996
Lamarque D, Tankovic J, Benamouzig R, Mahe S,
Chaumette MT, Auroux J, et al. Quantification of
Helicobacter pylori (hp) infection in antrum: Comparison
of culture, histological examination and c-13-urea breath
test. Gastroenterology 1996;110(4 (suppl)):A169.
Langhorst 2002
Langhorst J, Heuer S, Drouven FU, Schwobel HD,
Reichenberger S, Neuhaus H. Evaluation of a new
immunochromatographic based whole blood near patient
test for the diagnosis of Helicobacter pylori infection.
Zeitschrift Fur Gastroenterologie 2002;40(6):389–93.
Larras 2009
Larras R, Moubri M, Berrah H, Mouffok F, Bouhadef A,
Bouzid K, et al. Evaluation of a monoclonal stool antigen
test for the diagnosis of H. pylori infection in preschool
Algerian children. Helicobacter 2009;14(4):347.
Lassnig 1988
Lassnig C, Umlauft F, Schaber E, Stoffler G, Aigner F. The
value of indirect immunofluorescence, ELISA and western
blots for diagnosis and epidemiology of campylobacter pylori
infections. Biological Chemistry Hoppe-Seyler 1988;369(9):
862.
Laszewicz 2014
Laszewicz W, Iwanczak F, Iwanczak B, Task Force of the
Polish Society of Gastroenterology. Seroprevalence of
Helicobacter pylori infection in Polish children and adults
depending on socioeconomic status and living conditions.
Advances in Medical Sciences 2014;59(1):147–50.
Lee 1999
Lee CL, Lee SC, Wu CH, Chen TK. Diagnosis of h. Pylori
infection by urea breath test: Comparison of 50 mg vs 100
mg of c-13 urea. Gut 1999;45(Suppl 3):A131.
Lee 2000a
Lee SC, Sheu BS, Huang JJ, Yang HB, Lin XZ. Diagnostic
efficacy of c-13-urea breath test for Helicobacter pylori
infection in hemodialysis patients. Gut 2000;47(Suppl 1):
A120.
Lee 2000b
Lee JM, Breslin NP, Fallon C, O’Morain CA. Rapid urease
tests lack sensitivity in Helicobacter pylori diagnosis when
peptic ulcer disease presents with bleeding. American
Journal of Gastroenterology 2000;95(5):1166–70.
Lee 2003
Lee YH, Lee SY, Kim YT, Park CK, Jo CM, Tak WY, et
al. Diagnosis of Helicobacter pylori infection with urine
80Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
and stool. Taehan Sohwagi Hakhoe Chi [Korean Journal of
Gastroenterology] 2003;42(2):115–20.
Lee 2013
Lee YC, Chiu HM, Chiang TH, Yen AMF, Chiu SYH,
Chen SLS, et al. Accuracy of faecal occult blood test and
Helicobacter pylori stool antigen test for detection of upper
gastrointestinal lesions. BMJ Open 2013; Vol. 3, issue 10:
e003989. [DOI: 10.1136/bmjopen-2013-003989
Lee 2014
Lee YC, Tseng PH, Liou JM, Chen MJ, Chen CC, Tu CH,
et al. Performance of a one-step fecal sample-based test for
diagnosis of Helicobacter pylori infection in primary care
and mass screening settings. Journal of the Formosan Medical
Association 2014;113(12):899–907.
Lee 2015a
Lee SY, Moon HW, Hur M, Yun YM. Validation of western
Helicobacter pylori igg antibody assays in Korean adults.
Journal of Medical Microbiology 2015;64(Pt 5):513–8.
Lee 2015b
Lee JY, Kim N. Diagnosis of Helicobacter pylori by invasive
test: histology. Annals of Translational Medicine 2015;3(1):
10.
Leja 2009
Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L,
Ivanauskas A, et al. The validity of a biomarker method
for indirect detection of gastric mucosal atrophy versus
standard histopathology. Digestive Diseases & Sciences 2009;
54(11):2377–84.
Lelwala 1990
Lelwala Guruge J, Schalen C, Nilsson I, Ljungh A,
Tyskiewicz T, Wikander M, et al. Detection of antibodies
to Helicobacter pylori cell surface antigens. Scandinavian
Journal of Infectious Diseases 1990;22(4):457–65.
Lemus 2004
Lemus SMV, Acar MR, Ponce MC, Torres J, Rodriguez
OO. Detection of antibodies against Helicobacter pylori
and positivity to the 13 carbon urea breath test in patients
with rosacea. Dermatologia Revista Mexicana 2004;48(4):
189–96.
Leodolter 1997
Leodolter A, DominguezMunoz JE, Nilius M, VonArnim
U, Malfertheiner P. Non-invasive primary diagnosis of
h-pylori infection: 13C-urea breath test or serology?.
Gastroenterology 1997;112(4 (suppl)):A197.
Leodolter 1998a
Leodolter A, Dominguez-Muñoz JE, Von Arnim U, Manes
G, Malfertheiner P. 13C-urea breath test for the diagnosis of
Helicobacter pylori infection. A further simplification for
clinical practice. Scandinavian Journal of Gastroenterology
1998;33(3):267–70.
Leodolter 1998b
Leodolter A, Dominguez-Muñoz JE, Gerards C, Von Arnim
U, Malfertheiner P. Validity of a modified c-13-urea breath
test (c-13-ubt) for pre- and post-treatment diagnosis of
Helicobacter pylori infection in clinical routine. Gut 1998;
43(Suppl 2):A52.
Leodolter 1999a
Leodolter A, Dominguez-Muñoz JE, Von Arnim U,
Malfertheiner P. Citric acid or orange juice for the c-13-
urea breath test: The impact of ph and gastric emptying.
Alimentary Pharmacology & Therapeutics 1999;13(8):
1057–62.
Leodolter 1999b
Leodolter A, Dominguez-Muñoz JE, Von Arnim U, Kahl
S, Peitz U, Malfertheiner P. Validity of a modified c-13-
urea breath test for pre- and posttreatment diagnosis of
Helicobacter pylori infection in the routine clinical setting.
American Journal of Gastroenterology 1999;94(8):2100–4.
Leodolter 2000
Leodolter A, Von Arnim U, Gerards C, Kahl S,
Malfertheiner P. Pre- and post-treatment diagnosis of h-
pylori infection by the c-13-urea breath test (13C-ubt):
Validation of a new isotope-selective infrared spectrometer
(isis). Gastroenterology 2000;118(4 Part 1):A506.
Leodolter 2001a
Leodolter A, Vaira D, Bazzoli F, Hirschl A, Megraud F,
Malfertheiner P. European multicentre validation trial
of two new non-invasive tests for detection of antibody
to H. pylori: urine-based ELISA and rapid urine test.
Gastroenterology 2001;120(5):A491.
Leodolter 2001b
Leodolter A, Ziegler K, Lehn N, Malfertheiner P. The h-
pylori antigen stool test for determination of h-pylori status
in general practice: Is unfrozen delivery of stool specimens
sufficient using a regular postal service?. Gut 2001;49
(suppl):A97.
Leodolter 2001c
Leodolter A, Agha-Amiri K, Peitz U, Gerards C, Ebert
MP, Malfertheiner P. Validity of a Helicobacter pylori stool
antigen assay for the assessment of h-pylori status following
eradication therapy. European Journal of Gastroenterology &
Hepatology 2001;13(6):673–6.
Leodolter 2002
Leodolter A, Peitz U, Ebert MP, Agha-Amiri K,
Malfertheiner P. Comparison of two enzyme immunoassays
for the assessment of Helicobacter pylori status in stool
specimens after eradication therapy. American Journal of
Gastroenterology 2002;97(7):1682–6.
Leodolter 2003a
Leodolter A, Wolle K, Wex T, Peitz U, Malfertheiner P.
Evaluation of a novel rapid H. pylori stool antigen test:
Is a reliable diagnosis now possible in the doctor’s office?.
Gastroenterology 2003;124(4):A58.
Leodolter 2003b
Leodolter A, Vaira D, Bazzoli F, Schutze K, Hirschl A,
Megraud F, et al. European multicentre validation trial of
two new non-invasive tests for the detection of Helicobacter
pylori antibodies: urine-based ELISA and rapid urine
test. Alimentary Pharmacology & Therapeutics 2003;18(9):
927–31.
81Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Leodolter 2004
Leodolter A, Wolle K, Peitz U, Schaffranke A, Wex T,
Malfertheiner P. Evaluation of a near-patient fecal antigen
test for the assessment of Helicobacter pylori status.
Diagnostic Microbiology & Infectious Disease 2004;48(2):
145–7.
Leodolter 2005
Leodolter A, Wolle K, Von Arnim U, Kahl S, Treiber
G, Ebert MP, et al. Breath and string test: A diagnostic
package for the identification of treatment failure and
antibiotic resistance of Helicobacter pylori without the
necessity of upper gastrointestinal endoscopy. World Journal
of Gastroenterology 2005;11(4):584–6.
Lepper 2004
Lepper PM, Moricke A, Vogt K, Bode G, Trautmann
M. Comparison of different criteria for interpretation of
immunoglobulin g immunoblotting results for diagnosis
of Helicobacter pylori infection. Clinical & Diagnostic
Laboratory Immunology 2004;11(3):569–76.
Lerang 1998a
Lerang F, Moum B, Mowinckel P, Haug JB, Ragnhildstveit
E, Berge T, et al. Accuracy of seven different tests for the
diagnosis of Helicobacter pylori infection and the impact
of H2 receptor antagonists on test results. Scandinavian
Journal of Gastroenterology 1998;33(4):364–9.
Lerang 1998b
Lerang F, Haug JB, Moum B, Mowinckel P, Berge T,
Ragnhildstveit E, et al. Accuracy of IgG serology and
other tests in confirming Helicobacter pylori eradication.
Scandinavian Journal of Gastroenterology 1998;33(7):710–5.
Leszczynska 2009
Leszczynska K, Namiot DB, Namiot Z, Leszczynska JK,
Jakoniuk P, Kemona A. Application of immunoassay for
detection of Helicobacter pylori antigens in the dental
plaque. Advances in Medical Sciences 2009;54(2):194–8.
Leung 1998a
Leung WK, Ng EKW, Sung JY. Performance of
commercially available serological ELISA test for H.
pylori infection: discrepancy between east and west.
Gastroenterology 1998;114(4 (suppl)):A201.
Leung 1998b
Leung WK, Chan FKL, Falk MS, Suen R, Sung JJY.
Comparison of two rapid whole-blood tests for Helicobacter
pylori infection in Chinese patients. Journal of Clinical
Microbiology 1998;36(11):3441–2.
Leung 1999
Leung WK, Ng EKW, Chan FKL, Chung SCS, Sung
JJY. Evaluation of three commercial enzyme-linked
immunosorbent assay kits for diagnosis of Helicobacter
pylori in Chinese patients. Diagnostic Microbiology and
Infectious Disease 1999;34(1):13–7.
Leung 2001
Leung WK, Chow TP, Ng EKW, Chan FKL, Chung SCS,
Sung JJY. Validation of a new immunoblot assay for the
diagnosis of Helicobacter pylori in the asian population.
Alimentary Pharmacology and Therapeutics 2001;15(3):
423–8.
Leunk 1990
Leunk RD, Ferguson MA, Morgan DR, Low DE, Simor
AE. Antibody to cytotoxin in infection by Helicobacter
pylori. Journal of Clinical Microbiology 1990;28(6):1181–4.
Levine 2004a
Levine A, Shevah O, Shabat-Sehayek V, Aeed H, Boaz M,
Moss SF, et al. Masking of c-13 urea breath test by proton
pump inhibitors is dependent on type of medication:
Comparison between omeprazole, pantoprazole,
lansoprazole and esomeprazole. Alimentary Pharmacology &
Therapeutics 2004;20(1):117–22.
Levine 2004b
Levine A, Shevah O, Miloh T, Wine F, Niv Y, Bujanover Y,
et al. Validation of a novel real time c-13 urea breath test
for rapid evaluation of Helicobacter pylori in children and
adolescents. Journal of Pediatrics 2004;145(1):112–4.
Lew 1999
Lew EA, Pisegna JR, Ohning GV, Faller LD, David S,
Walsh JH, et al. Intragastric ph titration affects the accuracy
of uc urea breath test in the diagnosis of Helicobacter pylori.
Gastroenterology 1999;116(4 (suppl)):A235.
Lewin-van 1999
Lewin-van den Broek NT, Numans ME, Buskens E, De Wit
NJ, Smout AJPM, Verheij TJM. Validation and value of an
enzyme-linked immunosorbent assay for Helicobacter pylori
in primary care. Scandinavian Journal of Gastroenterology
1999;34(4):391–5.
Lewis 1997
Lewis JD, Kroser J, Bevan J, Furth EE, Metz DC. Urease-
based tests for Helicobacter pylori gastritis - accurate for
diagnosis but poor correlation with disease severity. Journal
of Clinical Gastroenterology 1997;25(2):415–20.
Li 1995
Li C, Ha T, Ferguson DA, Zhao RG, Chi DS, Patel NR, et
al. Comparison of PCR detection of Helicobacter-pylori
infection using gastric biopsy, saliva and stool specimens
with other established techniques (ELISA, culture and
histology). Gastroenterology 1995;108(4):A147.
Li 1996
Li C, Ha T, Ferguson DA, Jr, Chi DS, Zhao R, et al. A
newly developed PCR assay of h. Pylori in gastric biopsy,
saliva, and feces. Evidence of high prevalence of h. Pylori
in saliva supports oral transmission. Digestive Diseases &
Sciences 1996;41(11):2142–9.
Li 2004
Li YH, Guo H, Zhang PB, Zhao XY, Da SP. Clinical value
of Helicobacter pylori stool antigen test, immunocard stat
HPSA, for detecting h pylori infection. World Journal of
Gastroenterology 2004;10(6):913–4.
Liao 2002
Liao CC, Lee CL, Chiang TC, Lee SC, Huang SH, Tu TC,
et al. The c-13-urea breath test to detect Helicobacter pylori
injection: A validated simple methodology with 50 mg c-
82Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
13-urea. Alimentary Pharmacology & Therapeutics 2002;16
(4):787–92.
Liao 2003
Liao CC, Lee CL, Lai YC, Huang SH, Lee SC, Wu CH,
et al. Accuracy of three diagnostic tests used alone and in
combination for detecting Helicobacter pylori infection
in patients with bleeding gastric ulcers. Chinese Medical
Journal 2003;116(12):1821–6.
Lie 2012
Lie MR, Ganesh S, Haringsma J, Francke J, Kuipers EJ.
Analytical equivalence study of ndirs versus irms in breath
test analysis. Gastroenterology 2012;142(5 (Suppl 1)):S487.
Lim 2005
Lim LG, Yeoh KG, Ho B, Lim SG. Validation of four
Helicobacter pylori rapid blood tests in a multi-ethnic asian
population. World Journal of Gastroenterology 2005;11(42):
6681–3.
Lin 1992
Lin SK, Lambert JR, Schembri M, Nicholson L, Finlay
M, Wong C, et al. A comparison of diagnostic tests
to determine Helicobacter pylori infection. Journal of
Gastroenterology & Hepatology 1992;7(2):203–9.
Lin 2004a
Lin HJ, Lo WC, Perng CL, Li AF, Tseng GY, Sun IC, et
al. Helicobacter pylori stool antigen test in patients with
bleeding peptic ulcers. Helicobacter 2004;9(6):663–8.
Lin 2004b
Lin HJ, Sun IC, Lo WC. Helicobacter pylori stool antigen
test is not reliable in patients with bleeding peptic ulcers.
Gastroenterology 2004;126(4 (Suppl)):A184.
Lin 2004c
Lin FY, Sabri M, Erickson D, Alirezaie J, Li D, Sherman
PM. Development of a novel microfluidic immunoassay
for the detection of Helicobacter pylori infection. Analyst
2004;129(9):823–8.
Lin 2015
Lin Z, Cheng SL, Yan Q, Liu XF, Zheng W, Hu XM, et
al. Development of an immunochromatographic lateral
flow device for rapid detection of Helicobacter pylori stool
antigen. Clinical Biochemistry 2015;48(18):1298–303.
Lindsetmo 2008
Lindsetmo RO, Johnsen R, Eide TJ, Gutteberg T, Husum
HH, Revhaug A. Accuracy of Helicobacter pylori serology
in two peptic ulcer populations and in healthy controls.
World Journal of Gastroenterology 2008;14(32):5039–45.
Ling 2013
Ling D. Carbon-13 urea breath test for Helicobacter
pylori infection in patients with uninvestigated ulcer-like
dyspepsia: An evidence-based analysis. Ontario Health
Technology Assessment Series 2013;13(19):1–30.
Liquornik 1998
Liquornik KN, Liacouras CA, Ruchelli ED, Metz DC. The
c13-urea breath test: An excellent noninvasive method
for detection of h-pylori infection in pediatric patients.
Gastroenterology 1998;114(4 (suppl)):A205.
Liston 1996
Liston R, Pitt MA, Banerjee AK. IgG ELISA antibodies and
detection of Helicobacter pylori in elderly patients. Lancet
1996;347(8996):269.
Liu 2002
Liu W, Xiao S, Wang J, Zhao Z, Qian J, Hu F, et al.
Evaluation of Helicobacter pylori stool antigen test for
detection of Helicobacter pylori: A multicenter study.
Chinese Journal of Gastroenterology 2002;7(3):136–9.
Llor 2014
Llor C, Bjerrum L. Antimicrobial resistance: risk associated
with antibiotic overuse and initiatives to reduce the problem.
Therapeutic Advances in Drug Safety 2014;5(6):229–41.
Lo 2005
Lo CC, Lai KH, Peng NJ, Lo GH, Tseng HH, Lin CK,
et al. Polymerase chain reaction: A sensitive method for
detecting Helicobacter pylori infection in bleeding peptic
ulcers. World Journal of Gastroenterology 2005;11(25):
3909–14.
Locatelli 2004
Locatelli A, Catapani WR, Gomes CR Jr, Silva CBP,
Waisberg J. Detection of anti-Helicobacter pylori antibodies
in serum and duodenal fluid in peptic gastroduodenal
disease. World Journal of Gastroenterology 2004;10(20):
2997–3000.
Loeb 1997
Loeb MB, Riddell RH, James C, Hunt R, Smaill FM.
Evaluation of salivary antibodies to detect infection with
Helicobacter pylori. Canadian Journal of Gastroenterology
1997;11(5):437–40.
Loffeld 1989
Loffeld RJ, Stobberingh E, Flendrig JA, Van Spreeuwel JP,
Arends JW. Diagnostic value of an immunoassay to detect
anti campylobacter pylori antibodies in non-ulcer dyspepsia.
Lancet 1989;1(8648):1182–5.
Loffeld 1993
Loffeld RJLF, Vriese WTJ, Stobberingh EE. Usefulness
of several commercial enzyme-linked; immunoassays
for detection of Helicobacter pylori infection in clinical
medicine. European Journal of Gastroenterology & Hepatology
1993;5(5):333–7.
Logan 1990
Logan RPH, Dill S, Walker MM, Bauer FE, Rathbone BP,
Johnson P, et al. Evaluation of European standard c-13 urea
breath test for the detection of Helicobacter-pylori. Gut
1990;31(10):A1177.
Logan 1991b
Logan RPH, Dill S, Bauer FE, Walker MM, Hirschl AM,
Gummett PA, et al. The European c-13-urea breath test for
the detection of Helicobacter-pylori. European Journal of
Gastroenterology & Hepatology 1991;3(12):915–21.
Lombardo 1999
Lombardo L, Masoero G, Della Monica P, Taraglio S, Motta
M, Ravarino N, et al. Six-time points c-13-urea breath test
is a suitable method for Helicobacter pylori diagnosis in
postgastrectomy patients. Gut 1999;45(Suppl 3):A131.
83Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lopez 2001
Lopez Penas D, Naranjo Rodriguez A, Munoz Molinero J,
Rodriguez Lopez F, Galvez Calderon C, Chicano Gallardo
M, et al. Efficacy of fecal detection of Helicobacter pylori
with the HPSA technique in patients with upper digestive
hemorrhage. Gastroenterologia y Hepatologia 2001;24(1):
5–8.
Lopez 2004
Lopez T, Quesada M, Almirall J, Sanfeliu I, Segura F,
Calvet X. Usefulness of non-invasive tests for diagnosing
Helicobacter pylori infection in patients undergoing dialysis
for chronic renal failure. Helicobacter 2004;9(6):674–80.
Lopez-Brea 1998
Lopez-Brea M, Alarcon T, Domingo D, Sanchez I, Martinez
MJ, Sanz JC. Evaluation of a western-blot technique
(helicoblot 2.0) for the detection of antibodies versus
specific antigens of Helicobacter in children. Enfermedades
Infecciosas Y Microbiologia Clinica 1998;16(6):275–9.
Lotterer 1991
Lotterer E, Ramaker J, Ludtke FE, Tegeler R, Geletneky
JV, Bauer FE. The simplified 13C-urea breath test--one
point analysis for detection of Helicobacter pylori infection.
Zeitschrift Fur Gastroenterologie 1991;29(11):590–4.
Lotterer 1993a
Lotterer E, Ludtke FE, Tegeler R, Lepsien G, Bauer FE.
The 13C-urea breath test--detection of Helicobacter pylori
infection in patients with partial gastrectomy. Zeitschrift Fur
Gastroenterologie 1993;31(2):115–9.
Lotterer 1993b
Lotterer E, Ludtke FE, Tegeler R, Bauer FE. The c-13-urea
breath test, Helicobacter-pylori infection, and the operated
stomach. Journal of Clinical Gastroenterology 1993;16(1):
82–3.
Loy 1996
Loy CT, Irwig LM, Katelaris PH, Talley NJ. Do commercial
serological kits for Helicobacter pylori infection differ
in accuracy? A meta-analysis. American Journal of
Gastroenterology 1996;91(6):1138–44.
Lozniewski 1996
Lozniewski A, DeKorwin JD, Conroy MC, Plenat F, Weber
M. Evaluation of Pyloriset dry, a new rapid agglutination
test for Helicobacter pylori antibody detection. Journal of
Clinical Microbiology 1996;34(7):1773–5.
Lu 2005
Lu CY, Kuo CH, Lo YC, Chuang HY, Yang YC, Wu IC, et
al. The best method of detecting prior Helicobacter pylori
infection. World Journal of Gastroenterology 2005;11(36):
5672–6.
Lu 2006
Lu CY, Kuo FC, Wang SW, Lo YC, Wu IC, Chang LL, et
al. The clinical applications and accuracy of 2 rapid near-
patient tests in detecting Helicobacter pylori infection.
Diagnostic Microbiology & Infectious Disease 2006;56(3):
241–6.
Lucio 1999
Lucio L, Masoero G, Della Monica P, Taraglio S, Motta M,
Ravarino N, et al. Six-time points c-13-urea breath test is a
suitable method for Helicobacter pilory diagnosis in post-
gastrectomy patients. Gastroenterology 1999;116(4 (suppl)):
A240.
Luzza 1995
Luzza F, Maletta M, Imeneo M, Doldo P, Marasco R,
Biancone L, et al. Salivary specific igg is a sensitive indicator
of the humoral immune response to Helicobacter pylori.
FEMS Immunology & Medical Microbiology 1995;10(3-4):
281–3.
Luzza 1997
Luzza F, Oderda G, Maletta M, Imeneo M, Mesuraca L,
Chioboli E, et al. Salivary immunoglobulin g assay to
diagnose Helicobacter pylori infection in children. Journal
of Clinical Microbiology 1997;35(12):3358–60.
Luzza 2000
Luzza F, ImeneoM,Marasco A, Crotta S, Ierardi E, Usai P, et
al. Evaluation of a commercial serological kit for detection
of salivary immunoglobulin g to Helicobacter pylori: A
multicentre study. European Journal of Gastroenterology &
Hepatology 2000;12(10):1117–20.
Ma 2006
Ma YJ, Liu GQ, Zhang HD, FangQB, ZhaoHG. Feasibility
of ammonia breath test in diagnosis of Helicobacter pylori
infection.. World Chinese Journal of Digestology 2006;14
(36):3504–8.
Maaroos 2004
Maaroos HI, Andreson H, Loivukene K, Hutt P, Kolk
H, Kull I, et al. The diagnostic value of endoscopy and
Helicobacter pylori tests for peptic ulcer patients in late
post-treatment setting. BMC Gastroenterology 2004;4:27.
Macaskill 2013
Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi
Y, editor(s). Chapter 10: Analysing and Presenting Results.
In: Deeks JJ, Bossuyt PM, Gatsonis C, editor(s). Cochrane
Handbook for Systematic Reviews of Diagnostic Test
Accuracy Version 1.0.0. The Cochrane Collaboration,
2013. Available from srdta.cochrane.org.
Machado 2004
Machado RS, Patricio FRD, Kawakami E. C-13-urea breath
test to diagnose Helicobacter pylori infection in children
aged up to 6 years. Helicobacter 2004;9(1):39–45.
Machado 2006
Machado RS, Kawakami E, Patricio FRD, Reber M.
Urease activity does not reflect the degree of colonization
by Helicobacter pylori in children. Pediatrics International
2006;48(4):398–402.
MacKay 2003
MacKay WG, Williams CL, McMillan M, Ndip RN,
Shepherd AJ, Weaver LT. Evaluation of protocol using gene
capture and PCR for detection of Helicobacter pylori DNA
in feces. Journal of Clinical Microbiology 2003;41(10):
4589–93.
84Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Madico 1995
Madico G, Verastegui M. Serodiagnosis of Helicobacter
pylori infection by enzyme-linked immunoelectrotransfer
blot. Gastrointestinal physiology working group of
Cayetano Heredia University. Journal of Diarrhoeal Diseases
Research 1995;13(2):122–6.
Mahmood 2010
Mahmood S, Hamid A. Comparison between invasive
and noninvasive tests in diagnosis of Helicobacter pylori
infection. Pakistan Journal of Biological Sciences 2010;13
(10):509–12.
Mahony 1988
Mahony MJ, Littlewood JM. Diagnosis of campylobacter
pylori gastritis by IgG ELISA. Pediatric Research 1988;24
(3):416.
Maity 2014
Maity A, Banik GD, Ghosh C, Som S, Chaudhuri S,
Daschakraborty SB, et al. Residual gas analyzer mass
spectrometry for human breath analysis: A new tool for
the non-invasive diagnosis of Helicobacter pylori infection.
Journal of Breath Research 2014;8(1):016005.
Makristathis 1998
Makristathis A, Pasching E, Schutze K, Wimmer M, Rotter
ML, Hirschl AM. Detection of Helicobacter pylori in stool
specimens by PCR and antigen enzyme immunoassay.
Journal of Clinical Microbiology 1998;36(9):2772–4.
Makristathis 2000
Makristathis A, BarouschW, Pasching E, Binder C, Kuderna
C, Apfalter P, et al. Two enzyme immunoassays and PCR
for detection of Helicobacter pylori in stool specimens from
pediatric patients before and after eradication therapy.
Journal of Clinical Microbiology 2000;38(10):3710–4.
Malaty 1996
Malaty HM, El-Zimaity HM, Genta RM, Klein PD,
Graham DY. Twenty-minute fasting version of the us 13C-
urea breath test for the diagnosis of h. Pylori infection.
Helicobacter 1996;1(3):165–7.
Malaty 2000
Malaty HM, Logan ND, Graham DY, Ramchatesingh JE,
Reddy SG. Helicobacter pylori infection in asymptomatic
children: Comparison of diagnostic tests. Helicobacter
2000;5(3):155–9.
Malaty 2002
Malaty HM, Haveman T, Graham DY, Fraley JK.
Helicobacter pylori infection in asymptomatic children:
Impact of epidemiologic factors on accuracy of diagnostic
tests. Journal of Pediatric Gastroenterology & Nutrition 2002;
35(1):59–63.
Malfertheiner 1988
Malfertheiner P, Henze E, Stanescu A, Glasbrenner B,
Schoetensack C, Ditschuneit H. C-14-breath-test to
identify campylobacter-pylori colonization of the mucous-
membrane of the stomach. Zeitschrift fur Gastroenterologie
1988;26(9):528.
Malfertheiner 2002
Malfertheiner P, Axon A, O’Morain C, Pajares-Garcia
JM, Ekstrom P, Schutze K, et al. Evaluation of a new
Helicobacter pylori catalase based stool antigen test
(femtolab h. Pylori cnx): A European multicenter study.
Gastroenterology 2002;122(4 (Suppl)):A205.
Malfertheiner 2005
Malfertheiner P. 13C-urea breath test: Further modification
towards an unrestricted use. Digestion 2005;71(4):206–7.
Malfertheiner 2012
Malfertheiner P, Megraud F, O’Morain CA, Atherton J,
Axon AT, Bazzoli F, et al. Management of Helicobacter
pylori infection - the Maastricht IV/ Florence Consensus
Report. Gut 2012;61(5):646–64.
Mana 2000a
Mana F, Lacor P, Urbain D. 13C urea breath test for the
diagnosis of Helicobacter pylori infection: Contribution of
an infrared spectrometer. Tijdschrift voor Geneeskunde 2000;
56(17):1240–6.
Mana 2000b
Mana F, Franken PR, Ham HR, Reynaert H, Urbain D.
C-13 urea breath test with nondispersive isotope-selective
infrared spectrometry: Reproducibility and importance of
the fasting status. Helicobacter 2000;5(2):104–8.
Mana 2001b
Mana F, Ham HR, Reynaert H, Franken P, Urbain D.
Urea breath test for the diagnosis of Helicobacter pylori.
Gastrointestinal Endoscopy 2001;53(6):700–1.
Mana 2005
Mana F, Van Laer W, Bossuyt A, Urbain D. The early effect
of proton pump inhibitor therapy on the accuracy of the
13C-urea breath test [erratum appears in Digestive & Liver
Disease 2009;41(8):613 note: Van laere, w [corrected to
van laer, w]]. Digestive & Liver Disease 2005;37(1):28–32.
Manes 2000
Manes G, Balzano A, Iaquinto G, Ricci C, Giardullo N,
Lioniello M, et al. Accuracy of the h-pylori stool antigen test
in the pre- and post-eradication assessment and in patients
on omeprazole treatment. Gut 2000;47(Suppl 1):A113.
Manes 2001
Manes G, Balzano A, Iaquinto G, Ricci C, Piccirillo MM,
Giardullo N, et al. Accuracy of the stool antigen test in the
diagnosis of Helicobacter pylori infection before treatment
and in patients on omeprazole therapy. Alimentary
Pharmacology & Therapeutics 2001;15(1):73–9.
Manes 2005
Manes G, Zanetti MV, Piccirillo MM, Lombardi G, Balzano
A, Pieramico O. Accuracy of a new monoclonal stool
antigen test in post-eradication assessment of Helicobacter
pylori infection: Comparison with the polyclonal stool
antigen test and urea breath test. Digestive & Liver Disease
2005;37(10):751–5.
Mansour-Ghanaei 2013
Mansour-Ghanaei F, Joukar F, Sheykhian MR, Soati F,
Rafatzand AM. Effect of gastric acidification on the c-14-
85Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
ubt heliprobe (r) accuracy during pantoprazole treatment in
Helicobacter pylori positive patients. International Journal
of Clinical and Experimental Medicine 2013;6(3):185–91.
Marchildon 1996
Marchildon PA, Ciota LM, Zamaniyan FZ, Peacock JS,
Graham DY. Evaluation of three commercial enzyme
immunoassays compared with the c-13 urea breath test
for detection of Helicobacter pylori infection. Journal of
Clinical Microbiology 1996;34(5):1147–52.
Marchildon 1999
Marchildon P, Balaban DH, Sue M, Charles C, Doobay R,
Passaretti N, et al. Usefulness of serological igg antibody
determinations for confirming eradication of Helicobacter
pylori infection. American Journal of Gastroenterology 1999;
94(8):2105–8.
Marchildon 2003
Marchildon PA, Sugiyama T, Fukuda Y, Peacock JS, Asaka
M, Shimoyama T, et al. Evaluation of the effects of strain-
specific antigen variation on the accuracy of serologic
diagnosis of Helicobacter pylori infection [erratum appears
in Journal of Clinical Microbiology 2003;41(7):3462 note:
Fukada, y [corrected to fukuda, y]]. Journal of Clinical
Microbiology 2003;41(4):1480–5.
Marshall 1988a
Marshall BJ, Surveyor I. Carbon-14 urea breath test for
the diagnosis of campylobacter pylori associated gastritis.
Journal of Nuclear Medicine 1988;29(1):11–6.
Marshall 1988b
Marshall BJ, Guerrant RL, Plankey MW, Dye KR, Barrett
L, Frierson HF, et al. Comparison of c-14-urea breath
test, microbiology and histology for the diagnosis of
campylobacter pylori. Gastroenterology 1988;94(5):A284.
Marshall 1988c
Marshall BJ, Plankey MW, Dye KR, Frierson H, Hoffman
SR, Barrett L, et al. A rapid c-14 urea breath test for the
diagnosis of c-pylori associated gastritis. Clinical Research
1988;36(1):A14.
Marshall 1991
Marshall BJ, Plankey MW, Hoffman SR, Boyd CL, Dye
KR, Frierson HF Jr, et al. A 20-minute breath test for
Helicobacter pylori. American Journal of Gastroenterology
1991;86(4):438–45.
Marshall 1999
Marshall JK, O’Brien BJ, Armstrong D. C-13-urea breath
test or h-pylori serology for the initial evaluation of young
patients with ulcer-like dyspepsia: A decision analysis.
Gastroenterology 1999;116(4 (suppl)):A78.
Marusic 2006
Marusic M, Presecki V, Katicic M, Dominis M, Kalenic
S. The place and role of serologic methods in detecting
Helicobacter pylori infection. Collegium Antropologicum
2006;30(3):529–33.
Masoero 2000
Masoero G, Lombardo L, Della Monica P, Vicari S, Crocilla
C, Duglio A, et al. Discrepancy between Helicobacter pylori
stool antigen assay and urea breath test in the detection
of Helicobacter pylori infection. Digestive & Liver Disease
2000;32(4):285–90.
Massarrat 2012
Massarrat S, Sheykholeslami A. Serum pepsinogen ii as a
good marker for mass screening and eradication of h. Pylori
infection in populations at risk for gastric cancer. Archives of
Iranian Medicine 2012;15(4):265–6.
Matougui 2007
Matougui N, Boudjella MA, Oumnia N, Lahcene M,
Tebaibia A, Mouffok F, et al. Evaluation of pronto-dry test
versus c-13 urea breath test in determining Helicobacter
pylori status after treatment. Helicobacter 2007;12(4):445.
Matsuda 2003a
Matsuda M, Noda Y, Takemori Y. Utility and limitations of
a method for detecting Helicobacter pylori-specific antigens
in the stool. Journal of Gastroenterology 2003;38(3):222–8.
Matsuda 2003b
Matsuda M, Noda Y, Takemori Y. Novel diagnostic method
of testing for Helicobacter pylori infection using the rapid
leukocyte strip test, leukostix. Journal of Gastroenterology
and Hepatology 2003;18(10):1196–201.
Matsukura 1995
Matsukura N, Onda M, Tokunaga A, Kato S, Yamashita K,
Ohbayashi M. Detection of Helicobacter pylori DNA in
gastric juice by the polymerase chain reaction: Comparison
with findings in bacterial culture and the detection of tissue
iga and serum igg antibodies against Helicobacter pylori.
Journal of Gastroenterology 1995;30(6):689–95.
Matsukura 2004
Matsukura N, Tajiri T, Kato S, Togashi A, Masuda G,
Tokunaga A, et al. Diagnostic value of culture, histology
and PCR for Helicobacter pylori in the remnant stomach
after surgery. Alimentary Pharmacology & Therapeutics
2004;20 Suppl 1:33–8.
Matsuo 2000
Matsuo K, Hamajima N, Tominaga S, Suzuki T, Nakamura
T, Matsuura A, et al. Helicobacter pylori igg antibody test
established in the United States showed a substantially lower
sensitivity for Japanese population. American Journal of
Gastroenterology 2000;95(6):1597–8.
Mattar 1999
Mattar R, Silva FM, Alexandrino AM, Laudanna AA.
Validation of 14c-urea breath test for diagnosis of
Helicobacter pylori. Revista do Instituto de Medicina Tropical
de Sao Paulo 1999;41(1):3–8.
Mattar 2014
Mattar R, Villares CA, Marostegam PF, Chaves CE, Pinto
VB, Carrilho FJ. Low dose capsule based 13C-urea breath
test compared with the conventional 13C-urea breath test
and invasive tests. Arquivos de Gastroenterologia 2014;51(2):
133–8.
Matthews 2000
Matthews GM, Butler RN, Cummins AG, Lawrence
A, Johnson B, Campbell F. The c-13-urea breath test
86Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
reflects the severity of Helicobacter pylori associated antral
inflammation. Gastroenterology 2000;118(4 (Part 2)):
A1272.
Matthews 2005
Matthews GM, Cummins AG, Lawrence A, Johnson
B, Campbell F, Butler RN. 13C-urea breath test:
Reproducibility and association with the severity of
Helicobacter pylori-associated antral gastritis. Journal of
Gastroenterology and Hepatology 2005;20(2):270–4.
Mauro 2006a
Mauro M, Radovic V, Zhou P, Wolfe M, Kamath M,
Bercik P, et al. 13C urea breath test for Helicobacter
pylori: determination of the optimal cut-off point in a
Canadian community population. Canadian Journal of
Gastroenterology 2006;20(12):770–4.
Mauro 2006b
Mauro M, Radovic V, Wolfe M, Kamath M, Bercik P,
Armstrong D. C-13 urea breath test for Helicobacter pylori:
Evaluation of 10-minute breath collection. Canadian
Journal of Gastroenterology 2006;20(12):775–8.
McColl 1997
McColl KE, El-Nujumi A, Murray L, El-Omar E, Gillen
D, Dickson A, et al. The Helicobacter pylori breath test:
A surrogate marker for peptic ulcer disease in dyspeptic
patients. Gut 1997;40(3):302–6.
McColl 2003
McColl KE, Murray LS, Gillen D, Delaney B. Noninvasive
Helicobacter pylori testing was as effective as endoscopy for
managing dyspepsia. Evidence-Based Medicine 2003;8(1):
20–1.
McNamara 1999
McNamara D, Whelan H, Hamilton H, Beattie S,
O’Morain C. Hpsa: Assessment of a new non-invasive
diagnostic assay for Helicobacter pylori infection in an Irish
population. Irish Journal of Medical Science 1999;168(2):
111–3.
McNulty 1999
McNulty CA, Nair P, Watson BE, Uff JS, Valori RM. A
comparison of six commercial kits for Helicobacter pylori
detection. Communicable Disease & Public Health 1999;2
(1):59–63.
McNulty 2005
McNulty C, Teare L, Owen R, Tompkins D, Hawtin P,
McColl K. Test and treat for dyspepsia - but which test?.
BMJ 2005;330(7483):105–6.
Mediero 2007
Mediero GG, Ramos JM, Garcia JI, Varela IO, Del Blanco
T, Conde JAS. Evaluation of Helicobacter pylori stool
antigen test for the detection of h-pylori infection in
paediatric patients. International Journal of Antimicrobial
Agents 2007;29:S641.
Megraud 1988
Megraud F. Comparison of different tests for campylobacter
pylori. Scandinavian Journal of Gastroenterology - Supplement
1988;142:64–8.
Megraud 2000
Megraud F, Burette A, Glupczynski Y, Fiocca R, Logan R,
Quina M, et al. Comparison of tests for assessment of
Helicobacter pylori eradication: Results of a multi-centre
study using centralized facility testing. European Journal of
Gastroenterology & Hepatology 2000;12(6):629–33.
Megraud 2005
Megraud F, European PTFonHp. Comparison of non-
invasive tests to detect Helicobacter pylori infection in
children and adolescents: Results of a multicenter European
study. Journal of Pediatrics 2005;146(2):198–203.
Mehrazma 2014
Mehrazma M, Nakhaii S, Talachian E, Harahdashti AL.
Diagnostic accuracy of Helicobacter pylori stool antigen test
in iranian children. Infectious Diseases in Clinical Practice
2014;22(3):154–6.
Meijer 1997
Meijer BC, Thijs JC, Kleibeuker JH, Van Zwet AA,
Berrelkamp RJP. Evaluation of eight enzyme immunoassays
for detection of immunoglobulin g against Helicobacter
pylori. Journal of Clinical Microbiology 1997;35(1):292–4.
Meltzer 2013
Meltzer AC, Pierce R, Cummings DAT, Pines JM, May L,
Smith MA, et al. Rapid 13C urea breath test to identify
Helicobacter pylori infection in emergency department
patients with upper abdominal pain. Western Journal of
Emergency Medicine 2013;14(3):278–82.
Mendall 1992
Mendall MA, Goggin PM, Marrero JM, Molineaux N,
Levy J, Badve S, et al. Role of Helicobacter pylori serology
in screening prior to endoscopy. European Journal of
Gastroenterology & Hepatology 1992;4(9):713–7.
Mendoza 2006
Mendoza RB, Sio-Aguilar JO. The validity of Helicobacter
pylori immunochromatographic stool antigen test and
campylobacter urease test in the diagnosis of Helicobacter
pylori infection among pediatric patients. Journal of
Gastroenterology and Hepatology 2006;21:A392.
Menegatti 1997a
Menegatti M, Vaira D, Stanghellini V, Ali A, Landi F, Ricci
C, et al. Comparison of c-13- vs c-14-urea breath test (ubt)
for Helicobacter pylori (hp). Gastroenterology 1997;112(4
(suppl)):A218.
Menegatti 1997b
Menegatti M, Stanghellini V, Landi F, Farinelli S, Mucci
F, Ali A, et al. C-13 with and without test meal vs c-14
urea breath test (ubt) to detect h-pylori before and after
treatment. Gut 1997;41(Suppl):A162–A3.
Metz 1998
Metz DC, Furth EE, Faigel DO, Kroser JA, Alavi A,
Barrett DM, et al. Realities of diagnosing Helicobacter
pylori infection in clinical practice: A case for non-invasive
indirect methodologies. Yale Journal of Biology & Medicine
1998;71(2):81–90.
87Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Metz 2000
Metz DC. Stool testing for Helicobacter pylori infection:
Yet another noninvasive alternative. American Journal of
Gastroenterology 2000;95(2):546–8.
Midolo 1995
Midolo PD, Lambert JR, Russell EG, Lin SK. A practical
single sample dry latex agglutination test for Helicobacter
pylori antibody detection. Journal of Clinical Pathology
1995;48(10):969–71.
Miehlke 1996
Miehlke S, Figura N, Kim JG, Small SM, Graham DY, Do
MF. Western blotting for detection of Helicobacter pylori
anti-caga antibodies strongly correlates with presence of the
caga gene. Gastroenterology 1996;110(4 (suppl)):A197.
Miftahussurur 2016
Miftahussurur M, Yamaoka Y. Diagnostic methods of
Helicobacter pylori infection for epidemiological studies:
Critical importance of indirect test validation. BioMed
Research International 2016; Vol. 2016:4819423. [DOI:
10.1155/2016/4819423
Minoli 1998
Minoli G, Prada A, Schuman R, Murnick D, Rigas B. A
simplified urea breath test for the diagnosis of Helicobacter
pylori infection using the lara system. Journal of Clinical
Gastroenterology 1998;26(4):264–6.
Mion 1996
Mion F, Rousseau M. Diagnostic tests to document
Helicobacter pylori eradication. Gastroenterology 1996;110
(1 (suppl)):324–5.
Mion 1997a
Mion F, Rosner G, Rousseau M, Minaire Y. 13C-urea breath
test for Helicobacter pylori: Cut-off point determination by
cluster analysis. Clinical Science 1997;93(1):3–6.
Mion 1997b
Mion F, Rosner G, Rousseau M, Brazier JL. C-13-urea
breath test for Helicobacter pylori: Optimal cutoff point
determination by roc curve and cluster analysis. Clinical
Chemistry 1997;43(6 (Suppl 2)):17.
Mion 2001
Mion F, Ecochard R, Guitton J, Ponchon T. (co2)-
c-13 breath tests: Comparison of isotope ratio mass
spectrometry and non-dispersive infrared spectrometry
results. Gastroenterologie Clinique Et Biologique 2001;25(4):
375–9.
Mirbagheri 2005
Mirbagheri SA, Sohrabpour AA, Hasibi M, Moghimi
B, Mohamadnejad M. 14c-urea breath test in patients
undergoing anti-tuberculosis therapy. World Journal of
Gastroenterology 2005;11(11):1712–4.
Mitchell 1988
Mitchell HM, Lee A, Berkowicz J, Borody T. The use of
serology to diagnose active campylobacter pylori infection.
Medical Journal of Australia 1988;149(11-12):604–9.
Miwa 1997
Miwa H, Murai T, Ohkura R, Kawabe M, Tanaka H,
Ogihara T, et al. Effect of fasting subjects’ posture on c-
13-urea breath test for detection of Helicobacter pylori
infection. Helicobacter 1997;2(2):82–5.
Miwa 1998a
Miwa H, Ohkura R, Nagahara A, Murai T, Ogihara T,
Watanabe S, et al. C-13 -urea breath test for assessment
of cure of Helicobacter pylori infection at 1 month after
treatment. Journal of Clinical Gastroenterology 1998;27:
S150–S3.
Miwa 1998b
Miwa H, Murai T, Ohkura R, Nagahara A, Watanabe
H, Terai T, et al. Usefulness of the c-13 -urea breath test
for detection of Helicobacter pylori infection in fasting
patients. Journal of Gastroenterology and Hepatology 1998;
13(10):1039–43.
Miwa 1999
Miwa H, Hirose M, Kikuchi S, Terai T, Iwazaki R,
Kobayashi O, et al. How useful is the detection kit for
antibody to Helicobacter pylori in urine (urinelisa) in
clinical practice?. American Journal of Gastroenterology 1999;
94(12):3460–3.
Miwa 2000
Miwa H, Kikuchi S, Ohtaka K, Kobayashi O, Ogihara A,
Hojo M, et al. Insufficient diagnostic accuracy of imported
serological kits for Helicobacter pylori infection in Japanese
population. Diagnostic Microbiology & Infectious Disease
2000;36(2):95–9.
Miwa 2001
Miwa H, Akamatsu S, Tachikawa T, Sogabe T, Ohtaka K,
Nagahara A, et al. On-site diagnosis of h-pylori infection by
urine. Diagnostic Microbiology and Infectious Disease 2001;
39(2):95–7.
Mizukami 1994
Mizukami T, Osawa T, Niwa M, Oya A, Masubuchi N,
Takahashi S. An enzyme-linked immunosorbent assay for
the detection of igg antibodies against urease of Helicobacter
pylori. Rinsho Byori [Japanese Journal of Clinical Pathology]
1994;42(11):1188–93.
Moayyedi 1997
Moayyedi P, Braunholtz D, Heminbrough E, Clough M,
Tompkins DS, Mapstone NP, et al. Do patients need
to fast for a c-13-urea breath test?. European Journal of
Gastroenterology & Hepatology 1997;9(3):275–7.
Mock 1999
Mock T, Yatscoff R, Foster R, Hyun JH, Chung IS, Shim
CS, et al. Clinical validation of the helikit™: A c-13 urea
breath test used for the diagnosis of Helicobacter pylori
infection. Clinical Biochemistry 1999;32(1):59–63.
Mohammadi 2008
Mohammadi M, Talebkhan Y, Khalili G, Mahboudi F,
Massarrat S, Zamaninia L, et al. Advantage of using a
home-made ELISA kit for detection of Helicobacter pylori
infection over commercially imported kits. Indian Journal
of Medical Microbiology 2008;26(2):127–31.
88Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Moncayo 2006
Moncayo JI, Santacruz JJ, Alvarez AL, Franco B, Lopez MA,
Angel A, et al. Comparison of methods in the diagnosis
of Helicobacter pylori infection in Quindio, Colombia.
Colombia Medica 2006;37(3):203–12.
Monteiro 2001b
Monteiro L, Gras N, Megraud F. Magnetic immuno-
PCR assay with inhibitor removal for direct detection of
Helicobacter pylori in human feces. Journal of Clinical
Microbiology 2001;39(10):3778–80.
Morales 2002
Morales A, Hurtado C, Madrid AM, Pimentel C, Espinosa
MN. An ELISA stool test to detect Helicobacter pylori
infection. Revista Medica de Chile 2002;130(1):61–5.
Moshkowitz 1993
Moshkowitz M, Peled Y, Baratz M, Halpern Z, Tiomny E,
Gilat T. 14c-urea breath test--a simple, noninvasive method
for the detection of Helicobacter pylori infection. Israel
Journal of Medical Sciences 1993;29(2-3):94–7.
Motta 2009
Motta O, De Caro F, Quarto F, Proto A. New FTIR
methodology for the evaluation of (13)C/(12)C isotope
ratio in Helicobacter pylori infection diagnosis. Journal of
Infection 2009;59(2):90–4.
Moulton-Barrett 1993
Moulton-Barrett R, Triadafilopoulos G, Michener R,
Gologorsky D. Serum 13C-bicarbonate in the assessment of
gastric Helicobacter pylori urease activity. American Journal
of Gastroenterology 1993;88(3):369–74.
Mowat 1997
Mowat C, Murray L, Hilditch TE, Kelman A, Oien K,
McColl KEI. Comparison of helisal test kit and c-14-urea
breath test in determining h-pylori status and predicting
ulcer disease in dyspeptic patients. Gastroenterology 1997;
112(4 (suppl)):A226.
Mowat 1998
Mowat C, Murray L, Hilditch TE, Kelman A, Oien K,
McColl KE. Comparison of helisal rapid blood test and
14c-urea breath test in determining Helicobacter pylori
status and predicting ulcer disease in dyspeptic patients.
American Journal of Gastroenterology 1998;93(1):20–5.
Mrevlje 2012
Mrevlje Z, Plut S, Jeverica S, Osredkar J, Stabuc B.
Comparison of success rates of noninvasive and invasive
methods in diagnosis of Helicobacter pylori infection.
Helicobacter 2012;17:94.
Muhsen 2006
Muhsen K, Athamna A, Athamna M, Spungin-Bialik A,
Cohen D. Evaluation of a urine-based enzyme-linked
immunosorbent assay test for the detection of Helicobacter
pylori infection among 3- to 5-year-old Israeli Arab healthy
children. Journal of Pediatric Gastroenterology & Nutrition
2006;43(3):398–401.
Muhsen 2012
Muhsen K, Jurban M, Goren S, Cohen D. Incidence, age of
acquisition and risk factors of Helicobacter pylori infection
among Israeli Arab infants. Journal of Tropical Pediatrics
2012;58(3):208–13.
Munster 1993
Munster DJ, Chapman BA, Burt MJ, Dobbs BR, Allardyce
RA, Bagshaw PF, et al. The fate of ingested 14c-urea in
the urea breath test for Helicobacter pylori infection.
Scandinavian Journal of Gastroenterology 1993;28(8):661–6.
Murakami 2003
Murakami K, Sato R, Okimoto T, Watanabe K, Nasu M,
Fujioka T, et al. Influence of anti-ulcer drugs used in Japan
on the result of c-13-urea breath test for the diagnosis of
Helicobacter pylori infection. Journal of Gastroenterology
2003;38(10):937–41.
Murakami 2011
Murakami K, Kamada T, Ishikawa H, Imamura H,
Matsumoto H, Fujita M, et al. An evaluation of the
performance of a novel stick-type kit for rapid detection of
Helicobacter pylori antibodies in urine. Clinical Laboratory
2011;57(7-8):481–7.
Murata 2002
Murata Y, Kojyo A, Ikeda A, Yamanaka K. Study on the
detection methods of Helicobacter pylori from clinical
specimens. Rinsho Biseibutsu Jinsoku Shindan Kenkyukai Shi
[JARMAM : Journal of the Association for Rapid Method and
Automation in Microbiology] 2002;12(2):105–19.
Murphy 2015
Murphy C, Yamaguchi D, Rainey PM. Helicobacter pylori
c-13-urea breath test: The unique challenges of validating
a clia-waived test. American Journal of Clinical Pathology
2015;143:A11.
Murugesan 2011
Murugesan SV, Steele I, Tiszlavicz L, Farragher T, Moore
AR, Varro A, et al. Factors that determine the sensitivity of
rapid urease tests for the detection of Helicobacter pylori
infection. Gastroenterology 2011;140(5 (suppl)):S879.
Muñoz 1998
Muñoz E, Corcuera M, Roldán M, Gómez F, Picazo A,
Baquero M, et al. Comparative study of microbiological
and histopathological techniques used for the detection of
Helicobacter pylori. European Journal of Histochemistry
1998;42(4):297–302.
Muñoz 1999
Muñoz C, Jane M, Gonzalez-Cuevas A, Juncosa T, Gene
A, Varea V, et al. Evaluation of a simple, rapid polymerase
chain reaction (PCR) technique for the diagnosis of
Helicobacter pylori infection in infancy. Enfermedades
Infecciosas Y Microbiologia Clinica 1999;17(3):119–25.
Myllyniemi 2007
Myllyniemi M, Linnala A, Paloheimo LI, Hendolin P,
Engstrand L, Perez GP, et al. Improved specificity of
Helicobacter pylori IgA/IgG ELISA over other H. pylori
tests. Helicobacter 2007;12(4):447.
Myllyniemi 2008
Myllyniemi M, Hendolin P, Telaranta-Keerie A, Nikulin M,
Paloheimo LI, Engstrand L, et al. New specific H. pylori
IgG ELISA test. Helicobacter 2008;13(5):472–3.
89Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Nagahara 2003
Nagahara Y, Mizuno M, Maga T, Ishiki K, Okuno T,
Yoshida T, et al. Outcome of patients with inconsistent
results from c-13-urea breath test and bacterial culture at
the time of assessment of heliclobacter pylori eradication
therapy in Japan. Hepato-Gastroenterology 2003;50(53):
1700–3.
Nair 1995
Nair P, Stephens JC, Mackay EH, West K, Mayberry JF,
Wicks ACB, et al. A simple 3-minute latex agglutination-test
for rapid Helicobacter-pylori serodiagnosis. Gastroenterology
1995;108(4):A174.
Nakagawa 1995
Nakagawa T, Ohara H, Yamamoto M, Yoneshima M, Suzuki
T, Murai S, et al. 13C-urea breath test for the detection
of Helicobacter pylori infection and the assessment of
therapeutic effect. Nippon Shokakibyo Gakkai Zasshi
[Japanese Journal of Gastroenterology] 1995;92(3):264.
Nakata 1995
Nakata H, Itoh H, Yokoya Y, Kawai J, Nishioka S,
Miyamoto K, et al. Serum antibody against Helicobacter
pylori assayed by a new capture ELISA. Journal of
Gastroenterology 1995;30(3):295–300.
Nakata 2004
Nakata H, Itoh H, Ishiguchi T, Iwata T, Sato H,
Higashimoto Y, et al. Immunological rapid urease test using
monoclonal antibody for Helicobacter pylori. Journal of
Gastroenterology and Hepatology 2004;19(9):970–4.
Nakayama 2004
Nakayama K, Konno M, Tajiri H, Matsuhisa T, Kato S,
Minoura T, et al. Comparison between the 13C-urea breath
test and stool antigen test for the diagnosis of childhood
Helicobacter pylori infection. Journal of Gastroenterology
2004;39(11):1045–50.
Naruki 1996
Naruki Y, Koyama H, Kurita T, Nishino M, Higashi Y,
Otsuka S, et al. Evaluation of c-13 urea breath test in
a diagnosis of Helicobacter pylori. Journal of Nuclear
Medicine 1996;37(5 (suppl)):246 (abstract 1103).
Navarro 1992
Navarro F, Coll P, Sainz S, Mirelis B, Cardenosa N, Alonso
C, et al. Evaluation of two different commercial kits
for Helicobacter pylori specific antibodies detection in
patients undergoing gastrointestinal endoscopic procedures.
A seroprevalence study in asymptomatic population.
Enfermedades Infecciosas Y Microbiologia Clinica 1992;10(4):
190–4.
NCBI 2014
NCBI. MeSH. NLM Controlled Vocabulary. Helicobacter
pylori. www.ncbi.nlm.nih.gov/mesh/68016480 (accessed 3
August 2014).
Negayama 1992
Negayama K, Terada S, Kawanishi K. Clinical significance
of anti-Helicobacter pylori antibody in the diagnosis
of Helicobacter pylori infection in chronic gastritis.
Kansenshogaku Zasshi [Journal of the Japanese Association for
Infectious Diseases] 1992;66(11):1597–8.
Negrini 1992
Negrini R, Zanella I, Savio A, Poiesi C, Verardi R, Ghielmi
S, et al. Serodiagnosis of Helicobacter pylori-associated
gastritis with a monoclonal antibody competitive enzyme-
linked immunosorbent assay. Scandinavian Journal of
Gastroenterology 1992;27(7):599–605.
Neri 1999
Neri M, Angelucci D, Laterza F, Ricciuti M, Del Duca L,
Di Matteo S, et al. False negativity of c-13 urea breath test
in the presence of coccoid forms of h.Pylori: Effects on the
sensitivity of the test. Gastroenterology 1999;116(4 (suppl)):
A265.
Neumann 2010
Neumann H, Foertsch S, Vieth M, Mudter J, Kuth R,
Neurath MF. Immediate detection of Helicobacter infection
with a novel electrochemical system: Feasibility and
comparison of diagnostic yield with immunohistochemistry,
13C urea breath test and Helicobacter urease test.
Gastroenterology 2010;138(5 (suppl 1)):S114.
Neumann 2011
Neumann H, Foertsch S, Vieth M, Kuth R, Roll S, Neurath
MF. A newly developed electrochemical device enables
accurate and immediate detection of h. Pylori infection
within 10 seconds. Gastroenterology 2011;140(5 (suppl)):
S58.
Neumann 2012
Neumann H, Foertsch S, Ritter B, Vieth M, Kuth R,
Neurath MF. Final data of a new electrochemical device that
enables rapid and accurate detection of Helicobacter pylori
infection. Gastroenterology 2012;142(5 (Suppl 1)):S484.
Newell 1988
Newell DG, Johnston BJ, Ali MH, Reed PI. An enzyme-
linked immunosorbent assay for the serodiagnosis of
campylobacter pylori-associated gastritis. Scandinavian
Journal of Gastroenterology - Supplement 1988;142:53–7.
Newell 1989a
Newell DG, Rathbone BJ. The serodiagnosis of
campylobacter pylori infection. Serodiagnosis and
Immunotherapy in Infectious Disease 1989;3(1):1–6.
Newell 1989b
Newell DG, Stacey A. Antigens for the serodiagnosis of
campylobacter pylori infections. Gastroenterologie Clinique
et Biologique 1989;13(1 Pt 1):37B–41B.
Newell 1991
Newell DG, Hawtin PR, Stacey AR, MacDougall MH,
Ruddle AC. Estimation of prevalence of Helicobacter pylori
infection in an asymptomatic elderly population comparing
[14c] urea breath test and serology. Journal of Clinical
Pathology 1991;44(5):385–7.
Ng 2002
Ng FH, Lai KC, Wong BC, Wong WM, Wong SY,
Chow KC, et al. [13C]-urea breath test without prior
fasting and without test meal is accurate for the detection
90Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
of Helicobacter pylori infection in Chinese. Journal of
Gastroenterology and Hepatology 2002;17(8):834–8.
Ng 2013
Ng TH, Rosaida R. Evaluation of serology and urea breath
test as reliable diagnostic test for h.Pylori infection. Journal
of Gastroenterology and Hepatology 2013;28:97.
Nguyen 2008a
Nguyen TV, Bengtsson C, Nguyen GK, Granstrom M.
Evaluation of a novel monoclonal-based antigen-in-stool
enzyme immunoassay (premier platinum HPSA plus) for
diagnosis of Helicobacter pylori infection in Vietnamese
children. Helicobacter 2008;13(4):269–73.
Nguyen 2008b
Nguyen TVH, Bengtsson C, Nguyen GK, Granstrom M.
Evaluation of a novel monoclonal-based antigen-in-stool
enzyme immunoassay (premier platinum HPSA plus) for
diagnosis of Helicobacter pylori infection in Vietnamese
children. Helicobacter 2008;13(4):269–73.
Nguyen 2010
Nguyen LT, Uchida T, Tsukamoto Y, Trinh TD, Ta L,
Ho DQD, et al. Evaluation of rapid urine test for the
detection of Helicobacter pylori infection in the Vietnamese
population. Digestive Diseases and Sciences 2010;55(1):
89–93.
Nguyen 2012
Nguyen VB, Nguyen GK, Ha Nguyen TV, Ha Hoang
TT, Anh Le TL, Xuan Nguyen TA, et al. Helicobacter
pylori (hp) infection in Vietnam: Epidemiology,
symptomatology, diagnosis and treatment in children.
Journal of Gastroenterology and Hepatology 2012;27:46.
Nguyen 2013
Nguyen B, Anhthi Nguyen V, Nguyen K, Anhthi Le L,
Hathi Nguyen V, Hathi Hoang T, et al. Helicobacter
pylori (hp) infection in Vietnam: Epidemiology,
symptomatology, diagnosis and treatment in children.
Journal of Gastroenterology and Hepatology 2013;28:550–1.
Ni 2000
Ni YH, Lin JT, Huang SF, Yang JC, Chang MH. Accurate
diagnosis of Helicobacter pylori infection by stool antigen
test and six other currently available tests in children.
Gastroenterology 2000;118(4):A1283.
Nightingale 1996
Nightingale SL. Breath test for Helicobacter pylori
collection kit approved. Journal of the American Medical
Association 1996;276(21):1710.
Nijevitch 2001
Nijevitch AA, Sataev VU. The reliability of urease tests
for Helicobacter pylori in childhood. Journal of Clinical
Gastroenterology 2001;32(3):277–9.
Nilius 2001
Nilius M, Wex T, Muller-Dietz G, Leodolter A, Schilling
D, Malfertheiner P. Comparative evaluation of two
hemagglutination tests for the detection of anti-Helicobacter
pylori antibodies. Diagnostic Microbiology & Infectious
Disease 2001;41(4):221–3.
Nishi 1998
Nishi I, Irie H, Watanabe N, Futami J, Suzuki H, Ichinose
Y, et al. Urea breath test “breath by breath measurement”
of (v)over-dot(13)co(2) and (v)over-dot(12)co(2): An
approach to the quantitative evaluation for the therapeutic
elimination of h-pylori. Gastroenterology 1998;114(4
(suppl)):A243.
Nishikawa 1996
Nishikawa K, Katagiri M, Kagaya H, Kudo M, Kato
M, Takeda H, et al. Evaluation of rapid urease tests for
Helicobacter pylori in biopsy specimens, compared with
culture and c-13-urea breath test. Gastroenterology 1996;
110(4 (suppl)):A212.
Nishikawa 1999
Nishikawa K, Kato M, Sugiyama T, Asaka M. Helicobacter
pylori, serum igg antibody, urea breath test. Nippon Rinsho
1999;57(Suppl):154–6.
Nishikawa 2000
Nishikawa K, Sugiyama T, Kato M, Ishizuka J, Kagaya H,
Hokari K, et al. A prospective evaluation of new rapid urease
tests before and after eradication treatment of Helicobacter
pylori, in comparison with histology, culture and c-13-urea
breath test. Gastrointestinal Endoscopy 2000;51(2):164–8.
Nishizono 1998
Nishizono A, Gotoh T, Fujioka T, Murakami K, Kubota T,
Nasu M, et al. Serological assessment of the early response
to eradication therapy using an immunodominant outer
membrane protein of Helicobacter pylori. Clinical &
Diagnostic Laboratory Immunology 1998;5(6):856–61.
Niv 1998
Niv Y, Sperber AD, Scapa E, Maoz E, Fraser G, Druzd T,
et al. A comparison of new rapid urease tests for detection
of Helicobacter pylori: Test characteristics and factors
affecting positivity and time to positivity. Journal of Clinical
Gastroenterology 1998;27(4):327–30.
Niv 2000
Niv Y, Abuksis G, Ben-Gur S, Koren K. 13C-urea breath test
(13C-ubt) for validation of successful Helicobacter pylori
eradication. Evaluation of 1371 patients. Gastroenterology
2000;118(4 (part 2)):A1284.
Niv 2003
Niv Y, Abuksis G, Koren R. 13C urea breath test (13C
ubt) for Helicobacter pylori (hp) diagnosis in geriatrics.
Gastroenterology 2003;124(4 (suppl)):A625.
Noguchi 2007
Noguchi N, Rimbara E, Kato A, Tanaka A, Tokunaga K,
Kawai T, et al. Detection of mixed clarithromycin-resistant
and -susceptible Helicobacter pylori using nested PCR and
direct sequencing of DNA extracted from faeces. Journal of
Medical Microbiology 2007;56(9):1174–80.
Notarnicola 1996
Notarnicola M, Russo F, Cavallini A, Bianco M, Jirillo
E, Pece S, et al. PCR identification of Helicobacter
pylori DNA in faeces from patients with gastroduodenal
pathology. Medical Science Research 1996;24(11):785–7.
91Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Nugalieva 2006
Nugalieva ZZ, Opekun AR, Graham DY. Problem of
distinguishing false-positive tests from acute or transient
Helicobacter pylori infections. Helicobacter 2006;11(2):
69–74.
Nurgalieva 2003
Nurgalieva Z, Goodman KJ, Wang C, Day RS, Campos A,
de la Rosa J. Detection of Helicobacter pylori infection in
children followed from birth: Correspondence of serology
and the urea breath test. American Journal of Epidemiology
2003;157(11):S85–S.
Nurgalieva 2008
Nurgalieva Z, Goodman KJ, Phillips CV, Fischbach L, de la
Rosa JM, Gold BD. Correspondence between Helicobacter
pylori antibodies and urea breath test results in a US-Mexico
birth cohort. Paediatric and Perinatal Epidemiology 2008;22
(3):302–12.
Nysaeter 1992
Nysaeter G, Berstad K, Weberg R, Berstad A, Hardardottir
H. Diagnosis of Helicobacter pylori infection. Rapid urease
test, microscopy of smears and culture from ventricular
biopsy compared with the 14c-urea breath test. Tidsskrift
for Den Norske Laegeforening 1992;112(18):2356–8.
O’Connor 2010
O’Connor A, O’Morain NR, Dobson M, Qasim A, Ryan
BM, Breslin N, et al. Helicobacter pylori eradication
treatment is more successful when diagnosis is made after
urea breath test than after rapid urease testing at endoscopy
in patients with dyspepsia. Gastroenterology 2010;138(5
(suppl 1)):S340.
Oak 2011
Oak JH, Chung WC, Jung SH, Choi KH, Kim EJ, Kang
BK, et al. Effect of acid pump antagonist (revaprazan,
revanex(r)) on result of 13C urea breath test in patients with
Helicobacter pylori associated peptic ulcer disease. Taehan
Sohwagi Hakhoe Chi Korean Journal of Gastroenterology]
2011;57(1):8–13.
Obata 2003
Obata Y, Kikuchi S, Miwa H, Yagyu K, Lin YS, Ogihara
A. Diagnostic accuracy of serological kits for Helicobacter
pylori infection with the same assay system but different
antigens in a Japanese patient population. Journal of Medical
Microbiology 2003;52(10):889–92.
Obradovic 2001
Obradovic V, Artiko V, Petrovic M, Petrovic N, Davidovic
B, Bosnjakovic V, et al. Detection of Helicobacter pylori
infection using 14-c urea breath test. European Journal of
Nuclear Medicine 2001;28(8):1188.
Odaka 2002
Odaka T, Yamaguchi T, Koyama H, Saisho H, Nomura
F. Evaluation of the Helicobacter pylori stool antigen test
for monitoring eradication therapy. American Journal of
Gastroenterology 2002;97(3):594–9.
Oderda 1989
Oderda G, Vaira D, Holton J, Dowsett JF, Ansaldi N.
Serum pepsinogen i and igg antibody to campylobacter
pylori in non-specific abdominal pain in childhood. Gut
1989;30(7):912–6.
Oderda 1998a
Oderda G, Garisio P, Harding M, Thomas JE. Use of the c-
13 urea breath test for the diagnosis of Helicobacter pylori
infection in childhood. Gut 1998;43:S11–S2.
Oderda 1998b
Oderda G, Harding M, Thomas JE, Coward WA, Bazzoli
F, Zagari M, et al. The c-13 urea breath test to assess
Helicobacter pylori eradication in childhood h pylori
gastritis. Gut 1998;43(Suppl 3):S9–S10.
Oderda 1999
Oderda G, Rapa A, Ronchi B, Lerro P, Pastore M, Staiano
A, et al. Evaluation of the Helicobacter pylori stool antigen
test (HPSA) for detection of h-pylori infection in children.
A multicentre Italian study. Gut 1999;45(Suppl 3):A93–A4.
Oderda 2000
Oderda G, Rapa A, Ronchi B, Lerro P, Pastore M, Staiano
A, et al. Detection of Helicobacter pylori in stool specimens
by non-invasive antigen enzyme immunoassay in children:
Multicentre Italian study. BMJ 2000;320(7231):347–8.
Oderda 2004
Oderda G, Rapa A, Bona G. Diagnostic tests for childhood
Helicobacter pylori infection: Invasive, noninvasive or
both?. Journal of Pediatric Gastroenterology and Nutrition
2004;39(5):482–4.
Ogunc 2003
Ogunc D, Artan R, Ongut G, Gelen T, Colak D, Donmez
L, et al. Evaluation of a western blot technique (helicoblot
2.1) for the diagnosis of Helicobacter pylori infection in
children. Pathology 2003;35(2):157–60.
Ohara 1995
Ohara H, Suzuki T, Nakagawa T, Yoneshima M, Yamamoto
M, Tsujino D, et al. 13C-ubt using an infrared spectrometer
for detection of Helicobacter pylori and for monitoring the
effects of lansoprazole. Journal of Clinical Gastroenterology
1995;20 Suppl 2:S115–7.
Ohara 1996
Ohara S, Sekine H, Moriyama S, Sugiyama K, Arikawa T,
Iijima K, et al. Methodological study of 13C urea breath
test for detection of Helicobacter pylori infection. Japanese
Journal of Gastroenterology 1996;93(8):530–6.
Ohara 1997
Ohara S, Kato M, Asaka M, Toyota T. Cut-off vague and
clinical utility of c-13-urea breath test for diagnosis of
Helicobacter pylori infection. Gastroenterology 1997;112(4
(suppl)):A241.
Ohara 1998a
Ohara S, Kato M, Asaka M, Toyota T. Studies of 13C-urea
breath test for diagnosis of Helicobacter pylori infection in
Japan. Journal of Gastroenterology 1998;33(1):6–13.
Ohara 1998b
Ohara S, Kato M, Asaka M, Toyota T. The ubit-100
13Co2 infrared analyzer: Comparison between infrared
92Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
spectrometric analysis and mass spectrometric analysis.
Helicobacter 1998;3(1):49–53.
Ohara 2004
Ohara S, Kato M, Saito M, Fukuda S, Kato C, Hamada S,
et al. Comparison between a new c-13-urea breath test,
using a film-coated tablet, and the conventional c-13-urea
breath test for the detection of Helicobacter pylori infection.
Journal of Gastroenterology 2004;39(7):621–8.
Ohkura 1998
Ohkura R. Usefulness of Helicobacter pylori stool antigen
(HPSA) assay for detection of Helicobacter pylori infection.
Japanese Journal of Gastroenterology 1998;95(12):1397.
Ohkura 2000
Ohkura R, Miwa H, Murai T, Nagahara A, Ohta K, Sato
K, et al. Usefulness of a novel enzyme immunoassay for
the detection of Helicobacter pylori in feces. Scandinavian
Journal of Gastroenterology 2000;35(1):49–53.
Oksanen 1997
Oksanen A, Bergstrom M, Sjostedt S, Gad A, Hammarlund
B, Seensalu R. Accurate detection of Helicobacter
pylori infection with a simplified c-13 urea breath test.
Scandinavian Journal of Clinical & Laboratory Investigation
1997;57(8):689–94.
Oksanen 1998
Oksanen A, Veijola L, Sipponen P, Schauman KO, Rautelin
H. Evaluation of Pyloriset screen, a rapid whole-blood
diagnostic test for Helicobacter pylori infection. Journal of
Clinical Microbiology 1998;36(4):955–7.
Oksanen 2001
Oksanen A, Sipponen P, Sarna S, Rautelin H. Serologic
diagnosis of Helicobacter pylori infection in outpatients
aged 45 years or less. European Journal of Clinical
Microbiology & Infectious Diseases 2001;20(8):554–7.
Okuda 2002
Okuda M, Miyashiro E, Koike M, Tanaka T, Bouoka
M, Okuda S, et al. Serodiagnosis of Helicobacter pylori
infection is not accurate for children aged below 10.
Pediatrics International 2002;44(4):387–90.
Okuda 2004
Okuda M, Nakazawa T, Booka M, Miyashiro E, Yosikawa
N. Evaluation of a urine antibody test for Helicobacter
pylori in Japanese children. Journal of Pediatrics 2004;144
(2):196–9.
Okuda 2005
Okuda M, Sugiyama T, Fukunaga K, Kondou M, Miyashiro
E, Nakazawa T. A strain-specific antigen in Japanese
Helicobacter pylori recognized in sera of Japanese children.
Clinical & Diagnostic Laboratory Immunology 2005;12(11):
1280–4.
Okuda 2010
Okuda M, Oomatsu H, Kotake J, Fukuda N, Yamamoto
N, Sakaedani N, et al. Evaluation of urine antibody test for
h. pylori in Japanese children. Helicobacter 2010;15(4):361.
Okuda 2013
Okuda M, Kamiya S, Booka M, Kikuchi S, Osaki T,
Hiwatani T, et al. Diagnostic accuracy of urine-based kits
for detection of Helicobacter pylori antibody in children.
Pediatrics International 2013;55(3):337–41.
Okuda 2014
Okuda M, Osaki T, Kikuchi S, Ueda J, Lin YS, Yonezawa
H, et al. Evaluation of a stool antigen test using a mab for
native catalase for diagnosis of Helicobacter pylori infection
in children and adults. Journal of Medical Microbiology
2014;63:1621–5.
Olafsson 2012
Olafsson S, Patel B, Jackson C, Cai J. Helicobacter pylori
breath testing in an open access system has a high rate of
potentially false negative results due to protocol violations.
Helicobacter 2012;17(5):391–5.
Oleastro 2000
Oleastro M, Monteiro L, Matos R, Lopes AI, Cabral J,
Cabrita J. Evaluation of a western blot test, helico blot
2.1, in the diagnosis of Helicobacter pylori infection in a
Portuguese paediatric population. Gut 2000;47(Suppl 1):
A98.
Oleastro 2002
Oleastro M, Matos R, Cabral J, Barros R, Lopes AI,
Ramalho P, et al. Evaluation of a western blot test, helico
blot 2.1, in the diagnosis of Helicobacter pylori infection in
a pediatric population. Helicobacter 2002;7(3):210–5.
Oliaro 2000
Oliaro J, Johnson RD, Chen WX, Chadwick VS, Murray
A. Identification of an immunogenic 18-kda protein of
Helicobacter pylori by alkaline phosphatase gene fusions.
Journal of Medical Microbiology 2000;49(7):643–50.
Olsson 1993
Olsson K, Wadstrom T, Tyskiewicz T. PCR identification of
Helicobacter pylori in gastritis patients. Lancet 1993;341
(8853):1155.
Omorogbe 2015
Omorogbe JA, Brennan D, Alsaffar M, Smith S, McNamara
D, Trinity Acad Gastroenterology G. Comparison of non-
invasive tests; stool HpSA ELISA and c13urea breath test
in the diagnosis of Helicobacter pylori infection in a low
prevalence cohort. Helicobacter 2015;20:89.
Ong 1993
Ong KK, Goh KL, Parasakthi N. C-14 urea breath test -
a useful noninvasive test in the diagnosis of Helicobacter-
pylori infection. Gastroenterology 1993;104(4 suppl):A165.
Opekun 2002
Opekun AR, Abdalla N, Sutton FM, Hammoud F, Kuo
GM, Torres E, et al. Urea breath testing and analysis in the
primary care office. Journal of Family Practice 2002;51(12):
1030–2.
Opekun 2006
Opekun AR, Luu P, Gotschall AB, Abdalla N, Torres E,
Rudd SB, et al. Point-of-care Helicobacter pylori urine
antibody detection in a multi-ethnic adult population in
93Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
the United States. Translational Research: The Journal Of
Laboratory & Clinical Medicine 2006;148(1):13–8.
Ormand 1990
Ormand JE, Talley NJ, Carpenter HA, Shorter RG, Conley
CR, Wilson WR, et al. [14c]urea breath test for diagnosis
of Helicobacter pylori. Digestive Diseases & Sciences 1990;
35(7):879–84.
Ortiz-Olvera 2007
Ortiz-Olvera Nayeli NX, Moran Villota S, Gallardo Wong
I, Blancas Valencia JM, Cabrera Muñoz L. Validation of a
simplified method of the 13C urea breath test for diagnosis
of Helicobacter pylori. Revista Espanola de Enfermedades
Digestivas 2007;99(7):392–7.
Osaki 2008
Osaki T, Mabe K, Hanawa T, Kamiya S. Urease-positive
bacteria in the stomach induce a false-positive reaction
in a urea breath test for diagnosis of Helicobacter pylori
infection. Journal of Medical Microbiology 2008;57(Pt 7):
814–9.
Osman 2014
Osman HA, Hasan H, Suppian R, Bahar N, Hussin NSC,
Rahim AA, et al. Evaluation of the atlas Helicobacter pylori
stool antigen test for diagnosis of infection in adult patients.
Asian Pacific Journal of Cancer Prevention 2014;15(13):
5245–7.
Osoba 2004
Osoba AO, Ibrahim MB, Al-Shareef BA, Yassen AA,
Hussein BA. Comparison of Helicobacter pylori stool
antigen test with clo test in the diagnosis of Helicobacter
pylori associated dyspepsia in a Saudi population. Saudi
Medical Journal 2004;25(12):1906–8.
Ou 2013
Ou ZY, Xiong LY, Li DY, Geng LL, Li LX, Chen PY, et al.
Evaluation of a new fluorescence quantitative PCR test for
diagnosing Helicobacter pylori infection in children. BMC
Gastroenterology 2013 Jan 14; Vol. 13:7. [DOI: 10.1186/
1471-230X-13-7
Ozdemir 2008
Ozdemir E, Karabacak NI, Degertekin B, Cirak M, Dursun
A, Engin D, et al. Could the simplified 14C urea breath test
be a new standard in noninvasive diagnosis of Helicobacter
pylori infection?. Annals of Nuclear Medicine 2008;22(7):
611–6.
Ozturk 2009
Ozturk E, Yesilova Z, Ilgan S, Ozguven M, Dagalp K.
Performance of acidified c-14-urea capsule breath test
during pantoprazole and ranitidine treatment. Journal of
Gastroenterology and Hepatology 2009;24(7):1248–51.
Pacheco 2001
Pacheco N, Mago V, Gomez I, Gueneau P, Guelrud M,
Reyes N, et al. Comparison of PCR and common clinical
tests for the diagnosis of h-pylori in dyspeptic patients.
Diagnostic Microbiology and Infectious Disease 2001;39(4):
207–10.
Pacheco 2013
Pacheco SLM, Ogata SK, Machado RS, Patricio FRDS,
Pardo MLE, Kawakami E. Diagnosis of Helicobacter pylori
infection by means of reduced-dose 13C-urea breath test
and early sampling of exhaled breath. Journal of Pediatric
Gastroenterology and Nutrition 2013;57(5):607–11.
Paimela 2006
Paimela HM, Oksala NK, Kaariainen IP, Carlson PJ,
Kostiala AA, Sipponen PI. Faecal antigen tests in the
confirmation of the effect of Helicobacter eradication
therapy. Annals of Medicine 2006;38(5):352–6.
Palka 2010
Palka M, Tomasik T, Windak A, Margas G, Mach T,
Bohonos A. The reliability of ELISA in predicting H. pylori
infection in dyspeptic populations under age 45. Medical
Science Monitor 2010;16(1):PH24–8.
Pandya 2014
Pandya HB, Patel JS, Agravat HH, Singh NKR. Non-
invasive diagnosis of Helicobacter pylori: Evaluation of two
enzyme immunoassays, testing serum igg and iga response
in the Anand district of central Gujarat, india. Journal of
Clinical and Diagnostic Research 2014;8(6):D12–D5.
Pantoflickova 1999
Pantoflickova D, Blum AL, Blackmon K, Dorta G.
Optimization of c-13 urea breath test (ubt) for diagnosis
of h-pylori (hp) infection. Gastroenterology 1999;116(4
(suppl)):A276.
Pantoflickova 2000
Pantoflickova D, Lew EA, Dorta G, Pisegna JR, Ohning
GV, Faller LV, et al. Intragastric ph affects the results of the
c-13-urea breath test (ubt) in the diagnosis of h-pylori (hp).
Gastroenterology 2000;118(4 (part 1)):A507.
Pantoflickova 2003
Pantoflickova D, Scott DR, Sachs G, Dorta G, Blum AL.
13C urea breath test (ubt) in the diagnosis of Helicobacter
pylori: Why does it work better with acid test meals?. Gut
2003;52(7):933–7.
Paoluzi 2001
Paoluzi OA, Rossi P, Montesano C, Bernardi S, Carnieri
E, Marchione OP, et al. Discrepancy between polymerase
chain reaction assay and western blot analysis in the
assessment of caga status in dyspeptic patients. Helicobacter
2001;6(2):130–5.
Parejo 1998
Parejo Carranza R, Olivares Miguel F, Escobar Castro
H, Jimenez Alonso I, De Rafael Nerpell L, Camarero
Salces C. Comparative analysis of diagnostic methods for
Helicobacter pylori infection in children. Anales Espanoles
de Pediatria 1998;49(3):257–63.
Parente 2000a
Parente F, Maconi G, Sainaghi M, Imbesi V, Vago L, Porro
GB. Pretreatment c-13-urea breath test values but not h-
pylori antigen levels in stool correlate well with bacterial
density and gastritis activity in the gastric body. Gut 2000;
47(Suppl 1):A114.
94Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Parente 2000b
Parente F, Sainaghi M, Maconi G, Imbesi V, Cucino C,
Porro GB. Not all short-term proton pump inhibitors (ppi)
impair the accuracy of c-13-urea breath test and h.Pylori
stool antigen assay. Gut 2000;46(Suppl 2):A86.
Parente 2001
Parente F, Bianchi Porro G. The (13)c-urea breath test for
non-invasive diagnosis of Helicobacter pylori infection:
Which procedure and which measuring equipment?.
European Journal of Gastroenterology & Hepatology 2001;13
(7):803–6.
Parente 2002a
Parente F, Maconi G, Porro GB, Caselli M. Stool test with
polyclonal antibodies for monitoring Helicobacter pylori
eradication in adults: A critical reappraisal. Scandinavian
Journal of Gastroenterology 2002;37(7):747–9.
Parente 2002b
Parente F, Sainaghi M, Sangaletti O, Imbesi V, Maconi
G, Anderloni A, et al. Different effects of short-term
omeprazole, lansoprazole or pantoprazole on the accuracy
of the c-13-urea breath test. Alimentary Pharmacology &
Therapeutics 2002;16(3):553–7.
Park 2001
Park D, Kang D, Jung M, Park H, Kim J. Patients factors,
dob value of c-13-urea breath test and clinical diagnosis
do not affect eradication of Helicobacter pylori with
omeprazole based triple therapy. Gut 2001;49(suppl):A95.
Park 2006
Park YB. Diagnostic value of rapid urine test (Rapirun)
compared with biopsy, C-13-UBT, and serum IgG-ELISA
in Helicobacter pylori. Helicobacter 2006;11:40.
Park 2009
Park S, Park J, Kim Y, Seol S, Moon J, Jee S, et al. The
clinical usefulness of the noninvasive rapid urine test to h.
Pylori: Rapirun. Helicobacter 2009;14 (4):342–3.
Park 2015
Park YH, Kim N, Shim YK, Lee CM, Kyuahn B, Jaepark
S, et al. The effect of pre-intake of citric acid on the delta
value of the 13C-urea breath test. Journal of Gastroenterology
and Hepatology 2015;30:120.
Parolova 2012
Parolova N, Dmitrienko M. The effectiveness of non-
invasive tests in diagnosis of Helicobacter pylori infection in
children. Helicobacter 2012;17:94.
Patel 1994
Patel P, Mendall MA, Khulusi S, Molineaux N, Levy J,
Maxwell JD, et al. Salivary antibodies to Helicobacter
pylori: Screening dyspeptic patients before endoscopy.
Lancet 1994;344(8921):511–2.
Pathak 1992
Pathak CM, Panigrahi D, Bhasin DK, Rana SV, Malik AK,
Mehta SK. Advantage of use of dpm for 14C -urea breath
test for the detection of Helicobacter pylori. American
Journal of Gastroenterology 1992;87(12):1887–8.
Pathak 1994
Pathak CM, Bhasin DK, Panigrahi D, Goel RC. Evaluation
of 14c-urinary excretion and its comparison with 14co2 in
breath after 14c-urea administration in Helicobacter pylori
infection. American Journal of Gastroenterology 1994;89(5):
734–8.
Pathak 2008
Pathak CM, Avti PK, Bunger D, Khanduja KL. Kinetics
of 14carbon dioxide excretion from 14c-urea by oral
commensal flora. Journal of Gastroenterology and Hepatology
2008;23(10):1603–7.
Pathak 2011
Pathak CM, Kaur B, Bhasin DK, Mittal BR, Sharma S,
Khanduja KL. Comparative performance of capsulated vs
noncapsulated 14c-urea breath test for the detection of
Helicobacter pylori infection. Indian Journal of Nuclear
Medicine 2011;26(Suppl 1):S20.
Pathak 2012
Pathak CM, Kaur B, Bhasin DK, Mittal BR, Sharma S,
Khanduja KL, et al. Superiority of non-capsulated 14c-
urea breath test over capsule based method for detection
of Helicobacter pylori infection - a preliminary report.
Tropical Gastroenterology 2012;33(2):123–8.
Pathak 2013
Pathak CM, Kaur B, Bhasin DK, Mittal BR, Sharma S,
Khanduja KL, et al. Comparison of capsulated versus
non-capsulated 14c-urea breath test for the detection of
Helicobacter pylori infection: A scintigraphy study. Indian
Journal of Gastroenterology 2013;32(1 SUPPL):A18–A9.
Pathak 2014
Pathak CM, Kaur B, Bhasin DK, Mittal BR, Sharma S,
Khanduja KL, et al. Comparison of encapsulated versus
nonencapsulated (14) c-urea breath test for the detection
of Helicobacter pylori infection: A scintigraphy study.
Helicobacter 2014;19(2):116–23.
Pattison 1996
Pattison CP, Marshall L. C-13-urea breath test for
Helicobacter pylori: A second look analysis. American
Journal of Gastroenterology 1996;91(11):2447.
Pattison 1997
Pattison CP, Kaczmarski DR, Bruggen JT, Oconnor MC.
Comparison of c-14-urea breath test (c-14-ubt) and serology
for detection of Helicobacter pylori in hiv positive patients.
Gastroenterology 1997;112(4 (suppl)):A1060.
Pavlitou 1998
Pavlitou K, Pastore F,Moldovanidou K, Gioula G, Routsinas
C, Polidorou F, et al. Rapid immunochromatographic
assay for detection of Helicobacter pylori antibodies. Acta
Microbiologica Hellenica 1998;43(3):267–70.
Pavlitou 2000
Pavlitou K, Pastore F, Konias A, Chrisohoidou S, Tsintarakis
E, Polydorou F, et al. Evaluation of a rapid serological test
for the detection of igg antibodies to Helicobacter pylori.
[greek]. Acta Microbiologica Hellenica 2000;45(3):293–7.
95Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pawar 2014
Pawar S, Reddy SR, Chelluri LK, Prasad CE. Detection of
Helicobacter pylori infection in patients with obstructive
airway diseases with sero techniques using highly specific
igg antibodies for Helicobacter pylori antigen. Asian Pacific
Journal of Tropical Disease 2014;4:S366–S72.
Payne 2006
Payne I, Mold JW. What is the most sensitive non-invasive
test for initial diagnosis of h. Pylori infection in adults?
. Journal Oklahoma State Medical Association 2006;99(6):
368–9.
Peitz 2000
Peitz U, Agha-Amiri K, Glasbrenner B, Leodolter A, Kahl S,
Maertens D, et al. High specificity, but reduced sensitivity
of h-pylori stool test in upper gastrointestinal bleeding. Gut
2000;47(Suppl 1):A121–A2.
Peitz 2003
Peitz U, Leodolter A, Kahl S, Agha-Amiri K, Wex T, Wolle
K, et al. Antigen stool test for assessment of Helicobacter
pylori infection in patients with upper gastrointestinal
bleeding. Alimentary Pharmacology & Therapeutics 2003;17
(8):1075–84.
Peitz 2004
Peitz U, Leodolter A, Wex T, Schutze D, Wolle K, Welte T,
et al. Diagnostics of Helicobacter pylori infection in patients
with peptic ulcer bleeding. Zeitschrift fur Gastroenterologie
2004;42(2):141–6.
Peleteiro 2014
Peleteiro B, Bastos A, Ferro A, Lunet N. Prevalence of
Helicobacter pylori Infection worldwide: a systematic
review of studies with national coverage. Digestive Diseases
and Sciences 2014;59(8):1698–709.
Pena 1989
Pena AS, Endtz HP, Offerhaus GJ, Hoogenboom-
Verdegaal A, Van Duijn W, De Vargas N, et al. Value of
serology (ELISA and immunoblotting) for the diagnosis
of campylobacter pylori infection. Digestion 1989;44(3):
131–41.
Peng 2000a
Peng NJ, Hsu PI, Lee SC, Tseng HH, Huang WK, Tsay
DG, et al. A 15-minute c-13 -urea breath test for the
diagnosis of Helicobacter pylori infection in patients
with non-ulcer dyspepsia. Journal of Gastroenterology and
Hepatology 2000;15(3):284–9.
Peng 2000b
Peng NJ, Hsu PI, Lee SC, Tsay DW, Lai KH, Lin LC,
et al. Ultrarapid endoscopic c-13-urea breath test for
the diagnosis of Helicobacter pylori infection. Journal of
Nuclear Medicine 2000;41(5):317P.
Peng 2001a
Peng NJ, Lai KH, Liu RS, Lee SC, Tsay DG, Lo CC,
et al. Clinical significance of oral urease in diagnosis of
Helicobacter pylori infection by c-13 urea breath test.
Digestive Diseases and Sciences 2001;46(8):1772–8.
Peng 2001b
Peng NJ, Hsu PI, Lee SC, Tsay DG, Lai KH, Liu RS.
Ultrarapid capsule-based c-13-urea breath test for the
diagnosis of Helicobacter pylori infection. Journal of
Nuclear Medicine 2001;42(5):329P.
Peng 2002
Peng NJ, Hsu PI, Lee SC, Tsay DG, Lai KH, Liu RS.
Comparison of 100 mg and 50 mg endoscopic c-13-urea
breath test for the diagnosis of Helicobacter pylori infection.
Journal of Nuclear Medicine 2002;43(5):333P.
Peng 2003
Peng NJ, Lai KH, Liu RS, Lee SC, Tsay DG, Lo CC, et
al. Endoscopic c-13-urea breath test for the diagnosis of
Helicobacter pylori infection. Digestive and Liver Disease
2003;35(2):73–7.
Peng 2005
Peng NJ, Lai KH, Liu RS, Lee SC, Tsay DG, Lo CC,
et al. Capsule 13C-urea breath test for the diagnosis
of Helicobacter pylori infection. World Journal of
Gastroenterology 2005;11(9):1361–4.
Peng 2009
Peng NJ, Lai KH, Lo GH, Hsu PI. Comparison of
noninvasive diagnostic tests for Helicobacter pylori
infection. Medical Principles & Practice 2009;18(1):57–61.
Perets 2014
Perets TT, Shporn E, Hamouda D, Niv Y, Dickman R. Can
we achieve the same results from repetitive testing of 13Co2
breath samples for the diagnosis of Helicobacter pylori?.
Gastroenterology 2014;146(5 (suppl)):S397–S8.
Perets 2015
Perets TT, Shporn E, Dickman R, Niv Y. Stability of
13Co2 breath tests samples over time in the diagnosis
of Helicobacter pylori. Clinical Chemistry and Laboratory
Medicine 2015;53:S1268.
Perez 1996
Perez Paramo M, Albillos Martinez A, Calleja Panero JL,
Marin Rojas MC, Marcos Moreno ML, Freile Garcia I,
et al. Effectiveness of the breath test with 14C-urea in the
diagnosis of Helicobacter pylori infection. Revista Espanola
de Medicina Nuclear 1996;15(1):15–20.
Perez 1998
Perez Paramo M, Albillos Martinez A, Ortiz Berrocal J. The
breath test with labled urea for the diagnosis of Helicobacter
pylori infection. Revista Espanola de Medicina Nuclear 1998;
17(6):455–67.
Perez-Perez 1997
Perez-Perez GI, Cutler AF, Blaser MJ. Value of serology as a
noninvasive method for evaluating the efficacy of treatment
of Helicobacter pylori infection. Clinical Infectious Diseases
1997;25(5):1038–43.
Perezperez 1994
Perezperez GI, Brown WR, Cover TL, Dunn BE, Cao P,
Blaser MJ. Correlation between serological and mucosal
inflammatory responses to Helicobacter-pylori. Clinical and
Diagnostic Laboratory Immunology 1994;1(3):325–9.
96Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Perna 2002
Perna F, Tampieri A, Ricci C, Gatta L, Miglioli M, Vaira
D. Evaluation of a new rapid one step stool antigen test for
Helicobacter pylori (hp) infection diagnosis. Gut 2002;51
(Suppl):A106.
Perna 2005
Perna F, Ricci C, Gatta L, Bernabucci V, Cavina M, Miglioli
M, et al. Diagnostic accuracy of a new rapid urease test
(pronto dry) before and after treatment of Helicobacter
pylori infection. Minerva Gastroenterologica e Dietologica
2005;51(3):247–54.
Perri 1994
Perri F, Ghoos Y, Maes B, Annese V, Geypens B, Hiele M, et
al. Urea breath test in Helicobacter-pylori infected subjects
is influenced by gastric-emptying rate. Gastroenterology
1994;106(4 (suppl)):A160.
Perri 1995
Perri F, Ghoos Y, Hiele M, Andriulli A, Rutgeerts P.
The urea breath test: A non-invasive clinical tool for
detecting Helicobacter pylori infection. Italian Journal of
Gastroenterology 1995;27(2):55–63.
Perri 1997a
Perri F, Clemente R, Bisceglia M, Annese V, Niro G, Ghoos
Y, et al. The c-13-urea breath test (ubt) predicts intragastric
bacterial load and correlates with the depth of inflammation
in h-pylori related gastritis. Gastroenterology 1997;112(4
(suppl)):A256.
Perri 1997b
Perri F, Clemente R, Bisceglia M, Quitadamo M, Festa V,
Niro G, et al. The c-13-urea breath test (ubt) correlates
with the bacterial load ansi the severity of inflammation in
h-pylori (hp) gastritis. Gut 1997;41(Suppl):A80–A1.
Perri 1998a
Perri F, Clemente R, Pastore M, Quitadamo M, Festa V,
Bisceglia M, et al. The c-13-urea breath test as a predictor of
intragastric bacterial load and severity of Helicobacter pylori
gastritis. Scandinavian Journal of Clinical & Laboratory
Investigation 1998;58(1):19–27.
Perri 1998b
Perri F, Clemente R, Festa V, Quitadamo M, Conoscitore
P, Niro G, et al. Relationship between the results of pre-
treatment urea breath test and efficacy of eradication
of Helicobacter pylori infection. Italian Journal of
Gastroenterology & Hepatology 1998;30(2):146–50.
Perri 1998c
Perri F, Clemente R, Quitadamo M, Annese V, Andriulli A.
C-13 urea breath test is a very accurate clinical tool in the
diagnosis of intragastric Helicobacter pylori infection. Gut
1998;43(Suppl 3):S8–9.
Perri 2000
Perri F. Diagnosis of Helicobacter pylori infection: Which is
the best test? The urea breath test. Digestive & Liver Disease
2000;32 Suppl 3:S196–8.
Perri 2002a
Perri F, Manes G, Neri M, Vaira D, Nardone G.
Helicobacter pylori antigen stool test and 13C-urea breath
test in patients after eradication treatments. American
Journal of Gastroenterology 2002;97(11):2756–62.
Perri 2002b
Perri F, Manes G, Nardone G, Neri M, Vaira D.
Helicobacter pylori antigen stool test (HPSA) and 13C-urea
breath test (ubt) in patients after eradicating treatments.
Gastroenterology 2002;122(4 (suppl)):A206.
Perri 2002c
Perri F, Ricciardi R, Merla A, Piepoli A, Gasperi V,
Quitadamo M, et al. Appropriateness of urea breath test: A
prospective observational study based on maastricht 2000
guidelines. Alimentary Pharmacology & Therapeutics 2002;
16(8):1443–7.
Perri 2005
Perri F, Quitadamo M, Ricciardi R, Piepoli A, Cotugno
R, Gentile A, et al. Comparison of a monoclonal antigen
stool test (hp star) with the c-13-urea breath test (ubt) in
monitoring Helicobacter pylori eradication therapy. World
Journal of Gastroenterology 2005;11(37):5878–81.
Perrone 2005
Perrone M, Muñoz L, Camorlinga M, Correnti M,
Cavazza ME, Lecuna V, et al. Importance of IgG anti-caga
antibodies of Helicobacter pylori in Venezuelan patients with
gastric diseases. Investigacion Clinica 2005;46(4):357–67.
Petrovic 2011
Petrovic M, Artiko V, Novosel S, Ille T, Sobic-Saranovic D,
Pavlovic S, et al. Relationship between Helicobacter pylori
infection estimated by c-14-urea breath test and gender,
blood groups and rhesus factor. Hellenic Journal of Nuclear
Medicine 2011;14(1):21–4.
Pettersson 2001
Pettersson A, Rasmusson M, Kyronpalo S, Sipponen P,
Rautilin H, Farkkila M, et al. A 10 minutes tablet based
13C-urea breath test for the diagnosis of Helicobacter
pylori. Gastroenterology 2001;120(5 (suppl)):A579.
Pianko 1999
Pianko S, Petterson A, Lundqvist T, Stringer C, Sievert W,
Korman M. Evaluation of a novel tablet based carbon 13
urea breath test for the rapid diagnosis of Helicobacter
pylori infection. Gastroenterology 1999;116(4 (Suppl)):
A282.
Pilotto 1999
Pilotto A, Franceschi M, Leandro G, Rassu M, Zagari RM,
Bazzoli F, et al. The non-invasive diagnosis of h-pylori
infection in older subjects: Comparison of c-13-urea breath
test with serology. Gastroenterology 1999;116(4 (suppl)):
A283.
Pilotto 2000a
Pilotto A, Franceschi M, Leandro G, Rassu M, Zagari RM,
Bozzola L, et al. Noninvasive diagnosis of Helicobacter
pylori infection in older subjects: Comparison of the c-
13-urea breath test with serology. Journals of Gerontology
97Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Series A-Biological Sciences and Medical Sciences 2000;55(3):
M163–M7.
Pilotto 2000b
Pilotto A, Franceschi M, Rassu M, Novello R, Brusarosco
G, Bozzola L, et al. Stool antigen test (HPSA) for detection
of h-pylori infection in elderly subjects: Comparison with
serology and influence of concomitant treatments on
diagnostic accuracy. Gut 2000;47(Suppl 1):A117–A8.
Pilotto 2002
Pilotto A, Franceschi M, Furlan F, Bozzola L, Fucito L,
Rassu M, et al. The noninvasive diagnosis of h-pylori
infection in geriatric subjects by the c-13-urea breath test
(c-13-ubt) and the stool antigen test (HPSA): The role of
disability and cognitive status. Gut 2002;51(Suppl):A108.
Plebani 1999
Plebani M, Basso D. Diagnosis of Helicobacter pylori
infection by HPSA test. Lancet 1999;354(9185):1210.
Ploier 1995
Ploier R, Rezanka E, Emhofer J, Dorninger L, Feichtinger J,
Haidinger R, et al. Predictive value of latex agglutination on
Helicobacter pylori in children with recurrent abdominal
pain. Klinische Padiatrie 1995;207(1):8–11.
Ploier 1996
Ploier R, Dorninger L, Emhofer J, Franz V, Feichtinger
J. Predictive value of an ELISA for Helicobacter pylori
infection in children. Monatsschrift fur Kinderheilkunde
1996;144(12):1326–9.
Ploier 1997
Ploier R, Doringer I, Emhofer J, Franz V, Feichtinger
J. Predictive value of an ELISA for the detection
of Helicobacter pylori infection in children - reply.
Monatsschrift fur Kinderheilkunde 1997;145(10):1094.
Polat 2010
Polat TB, Urganci N, Selcukcan F, Yenici FN. Efficacy
of non-invasive tests in the diagnosis and post-treatment
follow-up of Helicobacter pylori infection in pediatric
patients. Gazi Medical Journal 2010;21(1):17–22.
Pons 2014
Pons C, Maisterra S, Salord S, Pla A, Asensio D, Fernandez
FJ, et al. Almagate interference in breath test results for the
diagnosis of Helicobacter pylori infection. Revista Espanola
De Enfermedades Digestivas 2014;106(7):448–51.
Porter 2009a
Porter V, Macdonald JC, Zahid MA, Mackie B, McNamara
D. Validation of a low dose tablet formulation 13C urea
and citric acid breath test employing an automated non
dispersive isotope selective infrared spectroscopy analyser
(helifan/fan as) for the diagnosis of Helicobacter pylori
infection in a Scottish population. Gastroenterology 2009;
136(5 (suppl )):A346.
Porter 2009b
Porter V, Zahid A, Mackie B, McNamara DA. Results of
a prospective comparison pilot validation study of a low-
dose tablet formulation c-13 urea and citric acid breath
test employing a novel automated nondispersive isotope
selective infrared spectroscopy analyser for the diagnosis
of Helicobacter pylori infection. European Journal of
Gastroenterology & Hepatology 2009;21(11):1321–2.
Portorreal 2002
Portorreal A, Kawakami E. Evaluation of enzyme-linked
immunosorbent assay for the diagnosis of Helicobacter
pylori infection in children and adolescents. Arquivos de
Gastroenterologia 2002;39(3):198–203.
Posteraro 2006
Posteraro P, Branca G, Sanguinetti M, Ranno S, Cammarota
G, Rahimi S, et al. Rapid detection of clarithromycin
resistance in Helicobacter pylori using a PCR-based
denaturing hplc assay. Journal of AntimicrobialChemotherapy
2006;57(1):71–8.
Potashov 1996
Potashov LV, Morozov VP, Kudrevatykh IP, Savranskii
VM, Aurtiunian AA, Did-Zurabova ES, et al. The
diagnosis of Helicobacter infections in patients with
gastric and duodenal peptic ulcers. Zhurnal Mikrobiologii,
Epidemiologii, i Immunobiologii 1996;6:11–3.
Pourakbari 2011a
Pourakbari B, Mirsalehian A, Maleknejad P, Mamishi S,
Azhdarkosh H, Daryani NE, et al. Evaluation of a new
antigen for diagnosis of Helicobacter pylori infection in
stool of adult and children. Helicobacter 2011;16(1):42–6.
Pourakbari 2011b
Pourakbari B, Mirsalehian A, Mamishi S, Najafi M, Kazemi
B, Paknejad M, et al. Diagnosis of Helicobacter pylori
infection by invasive and noninvasive methods. Tropical
Medicine and International Health 2011;16:264–5.
Pourakbari 2013
Pourakbari B, Ghazi M, Mahmoudi S, Mamishi S,
Azhdarkosh H, Najafi M, et al. Diagnosis of Helicobacter
pylori infection by invasive and noninvasive tests. Brazilian
Journal of Microbiology 2013;44(3):795–8.
Prabakaran 1997
Prabakaran K, Fernandes V, McDonald J, Jones RC.
Single sample c-14 urea breath test for the diagnosis of
Helicobacter pylori infection. Journal of Nuclear Medicine
1997;38(5 Suppl):Abstract 261.
Prell 2009
Prell C, Osterrieder S, Schwarzer A, Lottspeich C, Rusmann
H, Ossiander G, et al. Improved performance of a novel
rapid one-step monoclonal chromatographic immunoassay
for detection of Helicobacter pylori antigen in stool in
children. Journal of Pediatric Gastroenterology and Nutrition
2009;48(Suppl 3):E47–E8.
Presecki 1997
Presecki V, Katicic M, Kalenic S, Marusic M, Ticak M,
Prskalo M, et al. Evaluation of commercial cf and ELISA
tests for diagnosis of H-pylori infection in gastric carcinoma
and non Hodgkin lymphoma patients. Gut 1997;41:A164.
98Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Prieto 1994
Prieto Bozano G. Clinical diagnosis of Helicobacter
pylori infection in the child. Enfermedades Infecciosas Y
Microbiologia Clinica 1994;12 Suppl 1:18–22.
Pronovost 1994
Pronovost AD, Rose SL, Pawlak JW, Robin H, Schneider
R. Evaluation of a new immunodiagnostic assay for
Helicobacter pylori antibody detection: Correlation with
histopathological and microbiological results. Journal of
Clinical Microbiology 1994;32(1):46–50.
Przyklenk 1990
Przyklenk B, Bauernfeind A, Bornschein W, Gabor M.
Evaluation of an IgG-ELISA-kit for diagnosing Helicobacter
pylori associated gastroduodenal disease. Serodiagnosis and
Immunotherapy in Infectious Disease 1990;4(4):263–9.
Pu 2005
Pu XH, Guo XQ, Shi YL, An T, Qiu M, Qiu XX. Values
of Helicobacter pylori stool antigen test in the etiological
diagnosis of recurrent abdominal pain in children. Chinese
Journal of Contemporary Pediatrics 2005;7(5):426–8.
Puolakkainen 1997
Puolakkainen P, Rautelin H, Sipponen P, Farkkila M,
Kosunen T, Haapiainen R, et al. Comparison of histology,
c-13 urea breath test (ubt) and serology for detecting
h-pylori infection in patients with atrophic gastritis.
Gastroenterology 1997;112(4 (suppl)):A262.
Puz 2006
Puz S, Kovach Z, Hirschl AM, Hafner M, Innerhofer
A, Rotter M, et al. Evaluation of the novel Helicobacter
pylori clarires real-time PCR assay for detection and
clarithromycin susceptibility testing of h-pylori in stool
specimens and gastric biopsies; comparison with the stool
antigen test drug resistance. Helicobacter 2006;11(4):396.
Puz 2008
Puz S, Innerhofer A, Ramharter M, Haefner M, Hirschl
AM, Kovach Z, et al. A novel noninvasive genotyping
method of Helicobacter pylori using stool specimens.
Gastroenterology 2008;135(5):1543–51.
Qibi 2008
Qibi EM, Abdulla ZA. Detection of Helicobacter
pylori infection in dyspeptic patients by different sero-
bacteriological methods. Qatar Medical Journal 2008;17(2):
17–21.
Quach 2014
Quach DT, Hiyama T, Shimamoto F, Le QD, Ho LX, Vu
NH, et al. Value of a new stick-type rapid urine test for the
diagnosis of Helicobacter pylori infection in the Vietnamese
population. World Journal of Gastroenterology 2014;20(17):
5087–91.
Queiroz 1999
Queiroz DMM, Mendes EN, Rocha GA, Oliveira AMR,
Oliveira CA, Cabral MMDA, et al. Serological and direct
diagnosis of Helicobacter pylori in gastric carcinoma: A
case-control study. Journal of Medical Microbiology 1999;48
(5):501–6.
Queiroz 2000
Queiroz DMM, Rocha AMC, Rocha GA, Mendes EN,
Carvalho AST, Nogueira AMF, et al. Validation of a
commercial ELIS to detect anti-caga antibodies in children
with H. pylori (hp) infection. Gut 2000;47(Suppl 1):A96.
Queiroz 2013
Queiroz DM, Saito M, Rocha GA, Rocha AM, Melo FF,
Checkley W, et al. Helicobacter pylori infection in infants
and toddlers in South America: concordance between
[13C]urea breath test and monoclonal H. pylori stool
antigen test. Journal of Clinical Microbiology 2013;51(11):
3735–40.
Queralt 2005
Queralt N, Bartolome R, Araujo R. Detection of
Helicobacter pylori DNA in human faeces and water with
different levels of faecal pollution in the north-east of Spain.
Journal of Applied Microbiology 2005;98(4):889–95.
Quesada 2006a
Quesada M, Calvet X, Dosal A, Calvet V, Sanfeliu I,
Ribera L, et al. Evaluation of four different fecal tests for
determination of cure after Helicobacter pylori treatment.
Journal of Clinical Gastroenterology 2006;40(9):790–4.
Quesada 2006b
Quesada M, Calvet X, Calvet V, Choat T, Fallowfield
B, Sanfeliu I, et al. Usefulness of rapid hp star, a new
immumochromatographic, monoclonal antigen-based
faecal test, for diagnosing Helicobacter pylori infection in
dyspeptic patients. Gastroenterology 2006;130(4 (suppl)):
A458.
Rabbe 1988
Rabbe MP, Megraud F. Anti-campylobacter-pylori antibody
titer by ELISA. Gastroenterologie Clinique et Biologique
1988;12(6-7):587–8.
Radke 1997
Radke M. Predictive value of an ELISA for the detection of
Helicobacter pylori infection in children. Monatsschrift fur
Kinderheilkunde 1997;145(10):1093.
Rae 1995
Rae AJ, Belzberg A, Cleator IGM, Caglar M. Use of the
c-14 breath test in the treatment of Helicobacter-pylori.
Canadian Journal of Gastroenterology 1995;9(4):191–4.
Raedsch 1992
Raedsch R. Serological screening for Helicobacter pylori.
Deutsche Medizinische Wochenschrift 1992;117(21):844–5.
Raguza 2005
Raguza D, Granato CFH, Kawakami E. Evaluation of the
stool antigen test for Helicobacter pylori in children and
adolescents. Digestive Diseases and Sciences 2005;50(3):
453–7.
Raguza 2010
Raguza D, MacHado RS, Ogata SK, Granato CFH, Patricio
FRS, Kawakami E. Validation of a monoclonal stool antigen
test for diagnosing Helicobacter pylori infection in young
children. Journal of Pediatric Gastroenterology and Nutrition
2010;50(4):400–3.
99Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Rahman 2008
Rahman SHZ, Azam MG, Rahman MA, Arfin MS, Alam
MM, Bhuiyan TM, et al. Non-invasive diagnosis of h
pylori infection: Evaluation of serological tests with and
without current infection marker cim. World Journal of
Gastroenterology 2008;14(8):1231–6.
Raju 1994
Raju GS, Smith MJ, Morton D, Bardhan KD. Mini-
dose (1-microci) 14c-urea breath test for the detection of
Helicobacter pylori. American Journal of Gastroenterology
1994;89(7):1027–31.
Ramírez-Lázaro 2011
Ramírez-Lázaro MJ, Lario S, Casalots A, Sanfeliu E,
Boix L, García-Iglesias P, et al. Real-time PCR improves
Helicobacter pylori detection in patients with peptic ulcer
bleeding. PLoS ONE 2011; Vol. 6, issue 5:e20009. [DOI:
10.1371/journal.pone.002000
Ramírez-Lázaro 2015
Ramírez-Lázaro MJ, Lario S, Calvet X, Sánchez-Delgado J,
Montserrat A, Quilez EM, et al. Occult h-pylori infection
partially explains “false-positive’ results of c-13-urea breath
test. United European Gastroenterology Journal 2015;3(5):
437–42.
Rao 2001
Rao P, Sarkar A, Shivananda PG, Pai G. Comparison of
ELISA for antibody detection and biopsy urease test against
h. Pylori in cases of gastroduodenal disorders. Indian
Journal of Medical Sciences 2001;55(7):366–70.
Rapoport 2014
Rapoport SI, Shubina NA. 13-year period of application of
the 13C-urease breath test for determining Helicobacter
pylori in Russian clinical practice. Klinicheskaia Meditsina
2014;92(11):59–64.
Rasheed 2014
Rasheed F, Khalid A, Saadia A, Habib S, Khan SM, Saeed
F, et al. Correlation of c-13 urea breath test values with
Helicobacter pylori load among positive patients. Hepato-
Gastroenterology 2014;61(129):125–8.
Ratnaraj 2015
Ratnaraj F, Hamdeh S, Salih M, Ayan M, Mansour
G, Reddymasu S. Urea breath test (ubt) versus stool
antigen test in post-treatment eradication of Helicobacter
pylori infection: A meta-analysis. American Journal of
Gastroenterology 2015;110:S1038.
Rauws 1987
Rauws EAJ, Langenberg W, Houthoff HJ, Tytgat
GN. Histology, culture, breath test and therapeutic
attempts in campylobacter pylori gastritis. Zeitschrift fur
Gastroenterologie 1987;25(SUPPl. 4):24–8.
Rauws 1989a
Rauws EAJ. Detecting campylobacter-pylori with the c-
13 urea and c-14-urea breath test. Scandinavian Journal of
Gastroenterology 1989;24:25–6.
Rauws 1989b
Rauws EA, Van Royen EA, Tytgat GN. 14c-urea breath test
as a method to detect campylobacter pylori colonization.
Gastroenterologie Clinique et Biologique 1989;13(1 Pt 1):
42B–3B.
Rauws 1989c
Rauws EAJ, Royen EAV, Langenberg W, Woensel JV, Vrij
AA, Tytgat GN. 14C-urea breath test in C pylori gastritis.
Gut 1989;30(6):798–803.
Raymond 1999
Raymond J, Sauvestre C, Kalach N, De Korwin JD,
Valverde V. Evaluation of a new serologic test for diagnosis
of Helicobacter pylori infection in children. European
Journal of Clinical Microbiology & Infectious Diseases 1999;
18(3):192–8.
Raymond 2000
Raymond J, Sauvestre C, Kalach N, Bergeret M, Dupont C.
Immunoblotting and serology for diagnosis of Helicobacter
pylori infection in children. Pediatric Infectious Disease
Journal 2000;19(2):118–21.
Razaghi 2010
Razaghi M, Boutorabi SM, Mirjalili A, Norolahi S,
Hashemi M, Jalalian M. Diagnosis of Helicobacter pylori
infection by ELISA stool antigen and comparison with the
other diagnostic methods. Healthmed 2010;4(3):545–51.
Rechcinski 1997
Rechcinski T, Chmiela M, Malecka-Panas E, Planeta-
Malecka I, Rudnicka W. Serological indicators of
Helicobacter pylori infection in adult dyspeptic patients and
healthy blood donors. Microbiology & Immunology 1997;41
(5):387–93.
Redéen 2011
Redéen S, Petersson F, Törnkrantz E, Levander H, Mårdh
E, Borch K. Reliability of diagnostic tests for Helicobacter
pylori infection. Gastroenterology Research and Practice
2011; Vol. 2011:940650. [DOI: 10.1155/2011/940650
Rehnberg 2001
Rehnberg AS, Bengtsson C, Befrits R, Granstrom M,
Hellstrom PM. Refinement of the c-14-urea breath test for
detection of Helicobacter pylori. Scandinavian Journal of
Gastroenterology 2001;36(8):822–6.
Reilly 1997
Reilly TG, Poxon V, Sanders DSA, Elliott TSJ, Walt RP.
Comparison of serum, salivary, and rapid whole blood
diagnostic tests for Helicobacter pylori and their validation
against endoscopy based tests. Gut 1997;40(4):454–8.
Rejchrt 2004
Rejchrt S, Havlasova J, Bures J, Siroky M, Kopacova M,
Voxova B, et al. Evaluation of serum anti-Helicobacter
pylori IgG antibodies against p120 antigen (caga)
and investigation of specific antibody response against
Helicobacter pylori by means of western blotting. Klinicka
Biochemie a Metabolismus 2004;12(1):19–23.
Ren 2005
Ren Z, Borody T, Pang G, Dunkley M, Clancy R, Xia
HHX, et al. Evaluation of anti-Helicobacter pylori igg2
antibody for the diagnosis of Helicobacter pylori infection in
western and Chinese populations. Alimentary Pharmacology
and Therapeutics 2005;21(1):83–9.
100Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ren 2010
Ren HT, Xu XW, Li AH. Diagnostic value of gene chip test
for detection of h.Pylori infection and relationship between
H.pylori virulence factors and the severity of gastroduodenal
lesions. World Chinese Journal of Digestology 2010;18(26):
2826–30.
Reshetnikov 2007
Reshetnikov OV, Kurilovich SA, Krotov SA, Krotova VA.
Comparison of two ELISA kits for Helicobacter pylori
detection in Siberian populations. Helicobacter 2007;12(4):
441.
Reynders 2012
Reynders MBML, Deyi VYM, Dahma H, Scheper T,
Hanke M, Decolvenaer M, et al. Performance of individual
Helicobacter pylori antigens in the immunoblot-based
detection of h. Pylori infection. FEMS Immunology and
Medical Microbiology 2012;64(3):352–63.
Riaz 2011
Riaz S, Munir I, Nawaz MK, Bashir H, Muzahir S,
Saadullah M, et al. C-14 - urea breath test in the diagnosis
of Helicobacter pylori infection in Pakistani population.
European Journal of Nuclear Medicine and Molecular Imaging
2011;38:S403.
Ricci 2007
Ricci C, Holton J, Vaira D. Diagnosis of Helicobacter
pylori: invasive and non-invasive tests. Best Practice &
Research: Clinical Gastroenterology 2007;21(2):299–313.
Richter 2002
Richter J, Stiborova I, Kral V, Jilek D. Direct evidence of
the Helicobacter pylori antigen in faeces. Prakticky Lekar
2002;82(4):205–7.
Riepl 2000
Riepl RL, Folwaczny C, Otto B, Klauser A, Blendinger C,
Wiebecke B, et al. Accuracy of c-13-urea breath test in
clinical use for diagnosis of Helicobacter pylori infection.
Zeitschrift fur Gastroenterologie 2000;38(1):13–9.
Ritchie 2009
Ritchie B, Brewster D, Tran CD, McNeil Y, Zacharakis
B, Davidson GP, et al. Lack of diagnostic accuracy of the
monoclonal stool antigen test for detection of Helicobacter
pylori infection in young Australian aboriginal children.
Pediatric Infectious Disease Journal 2009;28(4):287–9.
Rocha 1998
Rocha GA, Oliveira AM, Queiroz DM, Mendes EN, Moura
SB, Oliveira CA, et al. Serodiagnosis of Helicobacter pylori
infection by cobas core ELISA in adults from Minas Gerais,
Brazil. Brazilian Journal of Medical & Biological Research
1998;31(10):1263–8.
Rocha 2002
Rocha GA, Cardinali LCC, Queiroz DMM, Rocha AMC,
Moura SB, Soares TF, et al. The performance of the c-13-
urea breath test for the diagnosis of Helicobacter pylori
infection in children from a developing country. Gut 2002;
51(Suppl):A82.
Rocha 2004
Rocha AM, Rocha GA, Leite JL, Lisboa RL, Silva PV,
Queiroz DM. Immunoblotting for the serodiagnosis of
Helicobacter pylori infection in Brazilian patients with and
without gastric carcinoma. Memorias do Instituto Oswaldo
Cruz 2004;99(2):189–93.
Rogge 1995
Rogge JD, Wagner DR, Carrico RJ, Glowinski EA,
Mahoney SJ, Boguslaski RC, et al. Evaluation of a
new urease reagent strip for detection of Helicobacter-
pylori in gastric biopsy specimens. American Journal of
Gastroenterology 1995;90(11):1965–8.
Roggero 2002
Roggero P, Bonfiglio A, Luzzani S, Valade A, Cataliotti
E, Corno G, et al. Helicobacter pylori stool antigen test:
A method to confirm eradication in children. Journal of
Pediatrics 2002;140(6):775–7.
Rollan 1997
Rollan A, Giancaspero R, Arrese M, Figueroa C, Vollrath V,
Schultz M, et al. Accuracy of invasive and noninvasive tests
to diagnose Helicobacter pylori infection after antibiotic
treatment. American Journal of Gastroenterology 1997;92(8):
1268–74.
Roma-Giannikou 2010
Roma-Giannikou E, Roubani A, Sgouras DN, Panayiotou
J, Van-Vliet C, Polyzos A, et al. Endoscopic tests for the
diagnosis of Helicobacter pylori infection in children:
Validation of rapid urease test. Helicobacter 2010;15(3):
227–32.
Romaozinho 2011
Romaozinho JGM, Donato MRSR, Ferreira J, Sofia
C. Detection of Helicobacter pylori infection: clinical
validation of 14C (37 kbq) urea breath test. Helicobacter
2011;16:115.
Roth 2001
Roth DE, Taylor DN, Gilman RH, Meza R, Katz U,
Bautista C, et al. Posttreatment follow-up of Helicobacter
pylori infection using a stool antigen immunoassay. Clinical
& Diagnostic Laboratory Immunology 2001;8(4):718–23.
Rothenbacher 2000a
Rothenbacher D, Marchildon P, Peacock J, Bode G, Brenner
H. Diagnosis of h-pylori infection in children: Comparison
of a salivary igg antibody test with c-13-urea breath test.
Gut 2000;47(Suppl 1):A116.
Rothenbacher 2000b
Rothenbacher D, Bode G, Brenner H. Diagnosis of
Helicobacter pylori infection with a novel stool antigen-
based assay in children. Pediatric Infectious Disease Journal
2000;19(4):364–6.
Rowland 1997a
Rowland M, Lambert I, Gormally S, Thomas JE, Daly LE,
Durnin M, et al. C-13-urea breath test for the diagnosis of
Helicobacter pylori in children. Gastroenterology 1997;112
(4 (suppl)):A272.
101Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Rowland 1997b
Rowland M, Lambert I, Gormally S, Daly LE, Thomas JE,
Hetherington C, et al. Carbon 13-labeled urea breath test
for the diagnosis Helicobacter pylori infection in children.
Journal of Pediatrics 1997;131(6):815–20.
Rutter 2001
Rutter CM, Gatsonis CA. A hierarchical regression approach
to meta-analysis of diagnostic test accuracy evaluations.
Statistics in Medicine 2001;20(19):2865–84.
Sabbi 2005
Sabbi T, De Angelis P, Colistro F, Dall’Oglio L, Di Abriola
GF, Castro M. Efficacy of noninvasive tests in the diagnosis
of Helicobacter pylori infection in pediatric patients.
Archives of Pediatrics & Adolescent Medicine 2005;159(3):
238–41.
Sadowski 1998
Sadowski D, Cohen H, Laine L, Greenberg P, Goldstein J,
Mihalov M, et al. Evaluation of the flexsure hp whole blood
antibody test for diagnosis of Helicobacter pylori infection.
American Journal of Gastroenterology 1998;93(11):2119–23.
Saez 2012
Saez J, Belda S, Santibanez M, Rodriguez JC, Sola-Vera J,
Galiana A, et al. Real-time PCR for diagnosing Helicobacter
pylori infection in patients with upper gastrointestinal
bleeding: Comparison with other classical diagnostic
methods. Journal of Clinical Microbiology 2012;50(10):
3233–7.
Saffari 2003
Saffari M, Motavalii MA, Fazeli A. Immunoblot assay in
determination of serum antibody profile of Helicobacter
pylori infection. Iranian Journal of Medical Sciences 2003;
28(2):90–2.
Salama 1993
Salama SM, Wefuan JN, Shiro-Koulla S, Mbakop A, Tagni-
Sartre M, Ndam EC, et al. Value of whole-cell antigen
extracts for serologic detection of Helicobacter pylori.
Journal of Clinical Microbiology 1993;31(12):3331–2.
Salih 2013
Salih BA, Karakus C, Ulupinar Z, Akbas F. A novel lateral
flow test strip (lfts) for the detection of Helicobacter pylori
infection. Helicobacter 2013;18:124.
Salles-Montaudon 2001
Salles-Montaudon N, Dertheil S, Broutet N, Monteiro L,
Gras N, Pereira E, et al. How should Helicobacter pylori
infection be diagnosed in the elderly?. Revue de Medecine
Interne 2001;22(4):339–47.
Salomaa-Rasanen 2004
Salomaa-Rasanen A, Kosunen TU, Mattila J, Sarna S,
Rautelin H. Age-dependent accuracy of Helicobacter pylori
antibody assays for adults, with special emphasis on atrophic
gastritis. Clinical and Diagnostic Laboratory Immunology
2004;11(6):1185–8.
Saltik 2001
Saltik IN, Ercis S, Kocak N, Hascelik G, Ozen H, Yuce
A, et al. Helicobacter pylori stool antigen (HpSA) test in
children with recurrent abdominal pain. American Journal
of Gastroenterology 2001;96(8):2514–5.
Saltik 2003
Saltik IN, Demir H, Kocak N, Ozen H, Gurakan F, Yuce
A. Diagnostic accuracy of c-13-urea breath test for Turkish
children with Helicobacter pylori infection. American
Journal of Gastroenterology 2003;98(1):222–3.
Sampson 2008
Sampson M, Shojania KG, McGowan J, Daniel R, Rader
T, Iansavichene AE, et al. Surveillance search techniques
identified the need to update systematic reviews. Journal of
Clinical Epidemiology 2008;61(8):755–62.
Sanches 2013
Sanches BSF, Martins GM, Pinto HAF, Meira ACD, Alves
EJ, Trindade OR, et al. Evaluation of stool antigen test
on initial diagnosis and control test of Helicobacter pylori
eradication. Helicobacter 2013;18:122.
Saneian 2013
Saneian H, Rahimi H, Mahmoodi NS. Comparison of
the sensitivity and specificity of available methods in
Helicobacter pylori infection detection in children. Journal
of Isfahan Medical School 2013; Vol. 30, issue 212.
Sano 2004
Sano N, Ohara S, Koike T, Sekine H, Imatani A, Kitagawa
Y, et al. Influence of urease activity of the oral cavity and
oropharynx on 13C-urea breath test. Japanese Journal of
Gastroenterology 2004;101(12):1302–8.
Santogade 1990
Santogade PJ, Bokkenheuser VD, Faisal MA, Kotler
DP, Scholes JV, Holt PR. Evaluation of methods for
identification of campylobacter pyloris infection. New York
State Journal of Medicine 1990;90(1):4–7.
Sarker 2003
Sarker SA, Bardhan PK, Rahaman M, Beglinger C, Gyr
N. Usefulness of the Helicobacter pylori stool antigen test
for detection of Helicobacter pylori infection in young
Bangladeshi children. Gastroenterology 2003;124(4 suppl):
A178.
SAS [Computer program]
SAS Institute Inc. SAS. Version 9.4. Cary, NC, USA: SAS
Institute Inc, 2013.
Sastry 1997
Sastry A, Flynn K, Mehra M. Development of an ELISA
method for the measurement of H. pylori in human serum
using a single reagent tmb system. Clinical Chemistry 1997;
43(6 (Suppl 2)):628.
Sato 2012
Sato M, Shimoyama T, Takahashi R, Kajiyama H, Sano Y,
Sakaedani N, et al. Characterization and usefulness of stool
antigen tests using a monoclonal antibody to Helicobacter
pylori catalase. Journal of Gastroenterology and Hepatology
(Australia) 2012;27(SUPPL.3):23–8.
Satoh 1993
Satoh K, Yoshida Y, Taniguchi Y, Kimura K. Elisa tests for
detection of Helicobacter pylori antibodies. Nihon Rinsho
[Japanese Journal of Clinical Medicine] 1993;51(12):3201–4.
102Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Savarino 1999
Savarino V, Mela GS, Zentilin P, Bisso G, Pivari M, Mansi
C, et al. Comparison of isotope ratio mass spectrometry
and nondispersive isotope-selective infrared spectroscopy for
c-13-urea breath test. American Journal of Gastroenterology
1999;94(5):1203–8.
Savarino 2000a
Savarino V, Bisso G, Pivari M, Zentilin P, Bilardi C,
Dulbecco P, et al. Effect of gastric acid suppression on c-13-
urea breath test: Comparison of ranitidine with omeprazole.
Alimentary Pharmacology & Therapeutics 2000;14(3):291–7.
Savarino 2000b
Savarino V, Landi F, Dulbecco P, Ricci C, Tessieri L, Biagini
R, et al. Isotope ratio mass spectrometry (irms) versus laser-
assisted ratio analyzer (lara) - a comparative study using
two doses of c-13 urea and two test meals for pre- and
posttreatment diagnosis of Helicobacter pylori infection.
Digestive Diseases and Sciences 2000;45(11):2168–74.
Savarino 2001
Savarino V, Tracci D, Dulbecco P, Mele MR, Zentilin P,
Mansi C, et al. Negative effect of ranitidine on the results
of urea breath test for the diagnosis of Helicobacter pylori.
American Journal of Gastroenterology 2001;96(2):348–52.
Savio 1999
Savio A, Buffoli F, Landi F, Ricci C, Acciardi C, Gatta L,
et al. The value of a new capture ELISA system for the
diagnosis and the follow-up of Helicobacter pylori (hp)
infection. Gut 1999;45(Suppl 3):A128.
Sawada 2001
Sawada A, Tajiri H, Yoshimura N, Kozaiwa K, Ida S,
Fujisawa T, et al. A simplified C-13-urea breath test in
children with Helicobacter pylori infection: Assessment
of eradication therapy and follow-up after treatment.
Gastroenterology 2001;120(5 suppl):A579.
Sayed 2011
Sayed MM, Ibrahim WA, Abdel-Bary SA, Abdelhakam
SM, El-Masry SA, Ghoraba D. Salivary PCR detection
of Helicobacter pylori DNA in Egyptian patients with
dyspepsia. Egyptian Journal of Medical Human Genetics
2011;12(2):211–6.
Schaefer 1999
Schaefer R, Bugno M, Auer P, Ramp U, Gabbert HE,
Erckenbrecht JF. Does quantitative c-13-urea breath test
reflect intensity of gastric Helicobacter pylori colonization
or mucosal inflammation?. Gastroenterology 1999;116(4
(suppl)):A304.
Scherbakov 2001
Scherbakov PL, Belousov B, Govorun VM, Filin VA, Isakov
VA, Kaganov BS, et al. Diagnosis of Helicobacter pylori
infection in children by PCR in stool: comparative study
with antigen stool test. Gut 2001;49(suppl):A81.
Schilling 2003
Schilling D, Demel A, Adamek HE, Nusse T, Weidmann
E, Riemann JF. A negative rapid urease test is unreliable
for exclusion of Helicobacter pylori infection during acute
phase of ulcer bleeding - a prospective case control study.
Digestive and Liver Disease 2003;35(4):217–21.
Schmitt 1996
Schmitt B, Bartel J. Comparison of a new rapid blood assay
for detection of antibodies to Helicobacter pylori (bm-test
Helicobacter pylori rapid assay, boehringer mannheim)
with an enzyme-linked immunosorbent assay (enzygnost,
behringwerke marburg). Klinisches Labor 1996;42(7-8):
601–6.
Schuman 1995
Schuman R, Rigas B, Prada A, Minoli G. Diagnosis of
Helicobacter-pylori infection by the Lara™ system -
towards a simplified breath test. Gastroenterology 1995;108
(4 suppl):A215.
Schumann 2006
Schumann C, Triantafilou K, Rasche FM, Moricke A,
Vogt K, Triantafilou M, et al. Serum antibody positivity
for distinct Helicobacter pylori antigens in benign and
malignant gastroduodenal disease. Ijmm International
Journal of Medical Microbiology 2006;296(4-5):223–8.
Schwarzer 2007
Schwarzer A, Lottspeich C, Russmann H, Ossiander
G, Koletzko S. Evaluation of a novel rapid one-step
monoclonal chromatographic immunoassay for detection
of Helicobacter pylori in stool from children. European
Journal of Clinical Microbiology & Infectious Diseases 2007;
26(7):475–80.
Sedlackova 1992
Sedlackova M, Soucek A, Mucksova J. Serologic detection of
antibodies to Helicobacter pylori in children and adolescents
using ELISA. Ceskoslovenska Pediatrie 1992;47(10):577–80.
Sen 2005
Sen N, Yilmaz O, Simsek I, Kupelioglu AA, Ellidokuz H.
Detection of Helicobacter pylori DNA by a simple stool
PCR method in adult dyspeptic patients. Helicobacter 2005;
10(4):353–9.
Sen 2011
Sen N, Demiray-Gurbuz E, Yilmaz O, Kupeliotlu A,
Simsek I. Comparing the accuracy of stool antigen tests
for the detection of Helicobacter pylori infection in Turkish
dyspeptic patients. Helicobacter 2011;16:114–5.
Seo 2004
Seo JK. Diagnostic validity of the Helicobacter pylori stool
antigen test before and after eradication treatment. Taehan
Sohwagi Hakhoe Chi [Korean Journal of Gastroenterology]
2004;44(4):229–35.
Seo 2013
Seo JH, Jun JS, Youn HS, Yeom JS, Park JS, Park CH, et
al. Development of an ELISA for quantitative detection of
immunoglobulin g (IgG) and IgA antibodies to Helicobacter
pylori for use in Korean patients with H. pylori-associated
diseases. Gut and Liver 2013;7(4):437–42.
Serrano 2008
Serrano CA, Gonzalez CG, Rollan AR, Duarte I, Torres
J, Pena AJ, et al. Lack of diagnostic utility of specific
103Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
immunoglobulin m in Helicobacter pylori infection in
children. Journal of Pediatric Gastroenterology and Nutrition
2008;47(5):612–7.
Sfarti 2009
Sfarti C, Stanciu C, Cojocariu C, Trifan A. 13C-urea breath
test for the diagnosis of Helicobacter pylori infection in
bleeding duodenal ulcer. Revista Medico-Chirurgicala a
Societatii de Medici si Naturalisti Din Lasi 2009;113(3):
704–9.
Shaikh 2005
Shaikh S, Khaled MA, Islam A, Kurpad AV, Mahalanabis
D. Evaluation of stool antigen test for Helicobacter pylori
infection in asymptomatic children from a developing
country using 13C-urea breath test as a standard. Journal of
Pediatric Gastroenterology & Nutrition 2005;40(5):552–4.
Sharma 1995
Sharma TK, Cutler AF. Relationship between the magnitude
of c-13 urea breath test-results and endoscopic diagnoses in
Helicobacter-pylori infected individuals. Gastroenterology
1995;108(4 (suppl)):A217.
Sharma 1997
Sharma TK, Young EL, Miller S, Cutler AF. Evaluation of
a rapid, new method for detecting serum igg antibodies to
Helicobacter pylori. Clinical Chemistry 1997;43(5):832–6.
Sharma 1999
Sharma BC, Bhasin DK, Pathak CM, Sinha SK,
Ray P, Vaiphei K, et al. C-14 -urea breath test to
confirm eradication of Helicobacter pylori. Journal of
Gastroenterology and Hepatology 1999;14(4):309–12.
Sharma 2015
Sharma U, Rehmani B, Shirazi N, Mittal G. A study of
Helicobacter pylori infection in perforated peptic ulcer
disease. International Journal of Surgery 2015;23:S119–S20.
She 2009
She RC,Wilson AR, Litwin CM. Evaluation of Helicobacter
pylori immunoglobulin g (igg), iga, and igm serologic
testing compared to stool antigen testing. Clinical and
Vaccine Immunology 2009;16(8):1253–5.
Sheikhian 2007
Sheikhian A, Hassan Zuhair M, Mostafaie A. Detection
of Helicobacter pylori diagnostic antigens in the stool of
infected patients. Iranian Journal of Medical Sciences 2007;
32(4):198–204.
Shepherd 2000
Shepherd AJ, Williams CL, Doherty CP, Hossack M,
Preston T, McColl KEL, et al. Comparison of an enzyme
immunoassay for the detection of Helicobacter pylori
antigens in the faeces with the urea breath test. Archives of
Disease in Childhood 2000;83(3):268–70.
Sheu 1997
Sheu BS, Lee SC, Lin XZ. Quantitative result of c-13 urea
breath test can predict the bacterial density of h-pylori. Gut
1997;41:A84.
Sheu 1999a
Sheu BS, Lee SC, Yang HB, Lin XZ. Quantitative result
of c-13 urea breath test at 15 minutes may correlate with
the bacterial density of h-pylori in the stomach. Hepato-
Gastroenterology 1999;46(27):2057–62.
Sheu 1999b
Sheu BS, Lee SC, Wang YL, Shiesh SC, Yang HB, Lin
XZ. A lower cut-off point of c-13 urea breath test is more
suitable to monitor the success of h-pylori eradication. Gut
1999;45(Suppl 3):A125.
Sheu 2000a
Sheu BS, Lee SC, Yang HB, Kuo AW, Wang YL, Shiesh SC,
et al. Selection of lower cutoff point of c-13 urea breath
test is helpful to monitor h-pylori eradication after proton
pump inhibitor-based triple therapy. Digestive Diseases and
Sciences 2000;45(7):1330–6.
Sheu 2000b
Sheu BS, Lee SC, Yang HB, Wu HW, Wu CS, Lin XZ, et
al. Lower-dose c-13-urea breath test to detect Helicobacter
pylori infection - comparison between infrared spectrometer
and mass spectrometry analysis. Alimentary Pharmacology &
Therapeutics 2000;14(10):1359–63.
Sheu 2000c
Sheu BS, Lee SC, Lin PW, Wang ST, Chang YC, Yang
HB, et al. (13)carbon urea breath test is not as accurate as
endoscopy to detect Helicobacter pylori after gastrectomy.
Gastrointestinal Endoscopy 2000;51(6):670–5.
Sheu 2002
Sheu BS, Yang HB, Wang YL, Kao AW, Chuang CH, Lin
PW, et al. Stool antigen assay to screen h-pylori infection
and to assess the success of 3-day and 7-day eradication
therapy in the patients with partial gastrectomy. Helicobacter
2002;7(3):199–204.
Shiba 1998
Shiba K. The rapid method in microbiology using chemical
method and immunochemical method. Rinsho Biseibutsu
Jinsoku Shindan Kenkyukai Shi [Journal of the Association for
Rapid Method and Automation in Microbiology] 1998;9(2):
73–81.
Shimada 1994
Shimada T, Ogura K, Ota S, Terano A, Takahashi M,
Hamada E, et al. Identification of Helicobacter pylori in
gastric specimens, gastric juice, saliva, and faeces of Japanese
patients. Lancet 1994;343(8913):1636–7.
Shimizu 2003a
Shimizu T, Yarita Y, Haruna H, Kaneko K, Yamashiro Y,
Gupta R, et al. Urine-based enzyme-linked immunosorbent
assay for the detection of Helicobacter pylori antibodies in
children. Journal of Paediatrics & Child Health 2003;39(8):
606–10.
Shimizu 2003b
Shimizu T, Fujii T, Haruna H, Shoji H, Kudo T, Yamashiro
Y. Effects of stool dilution on the faecal Helicobacter pylori
antigen test. Journal of Paediatrics and Child Health 2003;
39(4):286–8.
104Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Shimoyama 1996
Shimoyama T, Fukuda Y, Fukuda S, Munakata A, Yoshida
Y, Shimoyama T. Validity of various diagnostic tests to
evaluate cure of Helicobacter pylori infection. Journal of
Gastroenterology 1996;31(2):171–4.
Shimoyama 2009a
Shimoyama T, Oyama T, Matsuzaka M, Danjo K, Nakaji S,
Fukuda S. Comparison of a stool antigen test and serology
for the diagnosis of Helicobacter pylori infection in mass
survey. Helicobacter 2009;14(2):87–90.
Shimoyama 2009b
Shimoyama T, Kato C, Kodama M, Kobayashi I, Fukuda Y.
Applicability of a monoclonal antibody-based stool antigen
test to evaluate the results of Helicobacter pylori eradication
therapy. Japanese Journal of Infectious Diseases 2009;62(3):
225–7.
Shimoyama 2010
Shimoyama T, Kobayashi I, Kato C, Kodama M, Fukuda Y.
Comparison of monoclonal antibody-based stool antigen
tests to determine the results of Helicobacter pylori
eradication therapy. Scandinavian Journal of Gastroenterology
2010;45(12):1431–4.
Shimoyama 2011
Shimoyama T, Sawaya M, Ishiguro A, Hanabata N,
Yoshimura T, Fukuda S. Applicability of a rapid stool
antigen test, using monoclonal antibody to catalase, for the
management of Helicobacter pylori infection. Journal of
Gastroenterology 2011;46(4):487–91.
Shimoyama 2014
Shimoyama T, Chinda D, Ebina T, Iwamura H, Fukuda
S. Screening of Helicobacter pylori infection using stool
antigen test for young adults in a Japanese population with
high incidence of gastric cancer. Helicobacter 2014;19:121.
Shimoyama 2015
Shimoyama T, Sawada Y, Fukuda S. Accuracy of a stick-
type kit and enzyme-linked immunosorbent assay for
the detection of Helicobacter pylori antibodies in urine.
American Journal of Gastroenterology 2015;110:S1020.
Shirin 2001
Shirin H, Kenet G, Shevah O, Wardi Y, Birkenfeld S,
Shahmurov M, et al. Evaluation of a novel continuous
real time c-13 urea breath analyser for Helicobacter pylori.
Alimentary Pharmacology & Therapeutics 2001;15(3):
389–94.
Shirin 2003
Shirin H, Frenkel D, Shevah O, Levine A, Bruck R,
Moss SF, et al. Effect of proton pump inhibitors on the
continuous real time c-13-urea breath test. American Journal
of Gastroenterology 2003;98(1):46–50.
Shirin 2005
Shirin H, Levine A, Shevah O, Shabat-Sehayek V, Aeed H,
Wardi J, et al. Eradication of Helicobacter pylori can be
accurately confirmed 14 days after termination of triple
therapy using a high-dose citric acid-based c-13 urea breath
test. Digestion 2005;71(4):208–12.
Shmuely 2007
Shmuely H, Yahav J, Samra Z, Chodick G, Ofek I.
Elevated c-13 urea breath test values females infected with
Helicobacter pylori. Digestive Diseases and Sciences 2007;52
(2):402–4.
Shuber 2002
Shuber AP, Ascaño JJ, Boynton KA, Mitchell A, Frierson
HF Jr, El-Rifai W, et al. Accurate, noninvasive detection
of Helicobacter pylori DNA from stool samples: Potential
usefulness for monitoring treatment. Journal of Clinical
Microbiology 2002;40(1):262–4.
Shukla 2012
Shukla S, Pujani M, Agarwal A, Pujani M, Rohtagi A.
Correlation of serology with morphological changes
in gastric biopsy in Helicobacter pylori infection and
evaluation of immunohistochemistry for h. Pylori
identification. Saudi Journal of Gastroenterology 2012;18(6):
369–74.
Sicinschi 2003a
Sicinschi LA, Correa P, Schneider BG. Comparison of
genotyping of Helicobacter pylori caga and vaca virulence
genes from gastric biopsies and stool specimens. Helicobacter
2003;8(6):601–7.
Sicinschi 2003b
Sicinschi LA, Correa P, Bravo LE, Schneider BG. Detection
and typing of Helicobacter pylori caga/vaca genes by
radioactive, one-step polymerase chain reaction in stool
samples from children. Journal of Microbiological Methods
2003;52(2):197–207.
Siddiqui 2010
Siddiqui AA, Ansari MA, Rahman RU, Jabeen R, Qureshi
NR, Kashoob MB. Comparison between Helicobacter
pylori fecal antigen detection and endoscopic gastric biopsy
in diagnosis of h. Pylori infection in 50 adult cases. Journal
of the Liaquat University of Medical and Health Sciences
2010;9(1):23–6.
Silva 2009
Silva DG, Stevens RH, Macedo JMB, Hirata R, Pinto AC,
Alves LM, et al. Higher levels of salivary muc5b and muc7
in individuals with gastric diseases who harbor Helicobacter
pylori. Archives of Oral Biology 2009;54(1):86–90.
Sito 1994
Sito E, Karczewska E, Szczeba J, Kaminski K, Oleksy
J, Nowak-Sadzikowska J, et al. Comparative evaluation
of culture techniques and ELISA test in detection of
Helicobacter pylori infection. Medycyna Doswiadczalna i
Mikrobiologia 1994;46(4):301–4.
Slade 1999
Slade PE, Davidson AR, Steel A, Cox RA, Blackburn
PA. Reducing the endoscopic workload: Does serological
testing for Helicobacter pylori help?. European Journal of
Gastroenterology & Hepatology 1999;11(8):857–62.
Slater 2004
Slater C, Preston T, Weaver LT. Is there an advantage in
normalising the results of the Helicobacter pylori c-13 urea
105Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
breath test for co2 production rate in children?. Isotopes in
Environmental and Health Studies 2004;40(1):89–98.
Slomianski 1994
Slomianski A, Schubert T, Cutler AF. C-13 urea breath
test to confirm eradication of Helicobacter-pylori.
Gastroenterology 1994;106(4 (suppl)):A183.
Slomianski 1995
Slomianski A, Schubert T, Cutler AF. [13C]urea breath test
to confirm eradication of Helicobacter pylori. American
Journal of Gastroenterology 1995;90(2):224–6.
Smith 2006
Smith SI, Oyedeji KS, Odeniyi OAM, Arigbabu AO, Coker
AO. Diagnosis of Helicobacter pylori infection among
patients with dental caries by stool antigen test. British
Journal of Biomedical Science 2006;63(3):144–5.
Smith 2009
Smith SI, Omonigbehin EA, Goodluck HA, Abdulkareem
FB, Onyekwere CA, Agomo C, et al. The use of histology
as a gold standard for diagnosis of h. Pylori in Nigeria.
Helicobacter 2009;14(4):342.
Smith 2010
Smith SI, Fowora MA, Lesi OA, Agbebaku E, Abdulkareem
FB, Contreras M, et al. Application of stool-PCR test for
the diagnosis of h. Pylori in Nigeria. Helicobacter 2010;15
(4):363.
Smith 2011
Smith SI, Oyedeji KS, Goodluck HA, Fowora MA,
Anomneze E, Lesi OA. The use of Helicobacter pylori
stool antigen test for the diagnosis of Helicobacter pylori
in Lagos, Nigeria. West Indian Medical Journal 2011;60(1):
33–5.
Smith 2012
Smith SI, Fowora MA, Lesi OA, Agbebaku E, Odeigah P,
Abdulkareem FB, et al. Application of stool-PRC for the
diagnosis of Helicobacter pylori from stool in Nigeria- a
pilot study. Springerplus 2012;1(1):78. [DOI: 10.1186/
2193-1801-1-78
Snyder 1999
Snyder JD, Veldhuyzen Van Zanten S. Novel diagnostic
tests to detect Helicobacter pylori infection: A pediatric
perspective. Canadian Journal of Gastroenterology 1999;13
(7):585–9.
Sobala 1991
Sobala GM, Crabtree JE, Pentith JA, Rathbone BJ,
Shallcross TM, Wyatt JI, et al. Screening dyspepsia by
serology to Helicobacter pylori. Lancet 1991;338(8759):
94–6.
Sokucu 2002
Sokucu S, Suoglu OD, Turkkan E, Elkabes B, Ozden T,
Saner G. Helicobacter pylori infection in turkish children
with gastrointestinal symptoms and evaluation of serology.
Turkish Journal of Pediatrics 2002;44(2):102–8.
Song 2000
Song Q, Lange T, Spahr A, Adler G, Bode G. Characteristic
distribution pattern of Helicobacter pylori in dental plaque
and saliva detected with nested PCR. Journal of Medical
Microbiology 2000;49(4):349–53.
Song 2014
Song Y, Jiang K, Jin H, Wang BM. The application of
methane and hydrogen breath test in the diagnosis and
treatment of Helicobacter pylori. Journal of Digestive
Diseases 2014;15:116.
Sonmezoglu 2005
Sonmezoglu M, Baysal B, Ergen A, Barut SG. Detection
and evaluation of salivary antibodies to Helicobacter pylori
in dyspeptic patients. International Journal of Clinical
Practice 2005;59(4):433–6.
Sorberg 1997
Sorberg M, Engstrand L, Strom M, Jonsson KA, Jorbeck
H, Granstrom M. The diagnostic value of enzyme
immunoassay and immunoblot in monitoring eradication
of Helicobacter pylori. Scandinavian Journal of Infectious
Diseases 1997;29(2):147–51.
Steen 1995
Steen T, Berstad K, Meling T, Berstad A. Reproducibility
of the 14c urea breath test repeated after 1 week. American
Journal of Gastroenterology 1995;90(12):2103–5.
Stege 2010
Stege PW, Raba J, Messina GA. Online immunoaffinity
assay-ce using magnetic nanobeads for the determination
of anti-Helicobacter pylori IgG in human serum.
Electrophoresis 2010;31(20):3475–81.
Stermer 1997
Stermer E, Levy N, Tabak M, Neeman I. Lanzoprazole
and ranitidine affect the accuracy of the 14c-urea breath
test by a ph-dependent mechanism. American Journal of
Gastroenterology 1997;92(9):1575–6.
Sternberg 1997
Sternberg A, Coscas D, Wagner Y, Auslander L, Kaufshtein
M, Fireman Z. Comparison of various Helicobacter pylori
detection methods: Serology, histology and bacteriology.
Israel Journal of Medical Sciences 1997;33(3):160–3.
Stirling 1995
Stirling N, McCallion W. Helicobacter pylori gastritis:
Non-invasive diagnosis. Paediatric Nursing 1995;7(2):17–9.
Stojkovic 2011
Stojkovic M, Durutovic DR, Petrovic MN, Stojkovic MV,
Petrovic NS, Antic AA, et al. Helicobacter pylori infection
in various groups of patients studied, estimated by 14c-urea
breath test. Acta Chirurgica Iugoslavica 2011;58(1):95–8.
Stone 1997
Stone MA, Mayberry JF, Wicks ACB, Livsey SA, Stevens
M, Swann RA, et al. Near patient testing for Helicobacter
pylori: A detailed evaluation of the cortecs helisal rapid
blood test. European Journal of Gastroenterology &
Hepatology 1997;9(3):257–60.
Storskrubb 2005
Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M,
Wreiber K, et al. A negative Helicobacter pylori serology
test is more reliable for exclusion of premalignant gastric
106Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
conditions than a negative test for current h. Pylori
infection: A report on histology and h. Pylori detection
in the general adult population. Scandinavian Journal of
Gastroenterology 2005;40(3):302–11.
Stray-Pedersen 2007
Stray-Pedersen A, Gaustad P, Stray-Pedersen B, Rognum
TO. Detection rate of Helicobacter pylori stool antigen in
newborn infants and small children. Journal of Perinatal
Medicine 2007;35(2):155–8.
Stuppy 2010
Stuppy W, Everitt M. Correlation of salivary antibody
(HPSAigg) and stool antigen (hpstag) in Helicobacter pylori
infection. American Journal of Gastroenterology 2010;105:
S46.
Stuppy 2011
Stuppy W, El Khoury M. Pre- and post-treatment
correlation of salivary antibody with stool antigen in
Helicobacter pylori infection. American Journal of
Gastroenterology 2011;106:S49.
Sudraba 2010
Sudraba A, Funka K, Tolmanis I, Vanags A, Daugule I,
Janciauskas D, et al. Gastric biomarkers in h. Pylori positive
and negative patients. Helicobacter 2010;15(4):353.
Sudraba 2011
Sudraba A, Daugule I, Rudzite D, Funka K, Tolmanis I,
Engstrand L, et al. Performance of routine Helicobacter
pylori tests in patients with atrophic gastritis. Journal of
Gastrointestinal & Liver Diseases 2011;20(4):349–54.
Sue 1996
Sue M, Peura D, Charles C, Doobay R, Reid H, Morris
E, et al. Comparison of two treatment strategies for the
eradication of h-pylori utilizing a screening antibody serum
blot test and confirmatory c 14 breath test. Gastroenterology
1996;110(4 (suppl)):A266.
Sugiyama 1991
Sugiyama T, Imai K, Yoshida H, Takayama Y, Yabana
T, Yokota K, et al. A novel enzyme immunoassay
for serodiagnosis of Helicobacter pylori infection.
Gastroenterology 1991;101(1):77–83.
Sujatha 2013
Sujatha R, Arunagiri D, Singh DN, Hariomsharan.
Diagnosis of Helicobacter pylori associated acid peptic
disease by serology and rapid urease test. Journal of Pure and
Applied Microbiology 2013;7(1):691–5.
Sukhanov 2011
Sukhanov AV, Pikerskii IE, Saifutdinov RG, Makarov AA,
Frolov SV. Comparison of various diagnostic methods of
Helicobacter infection. Eksperimental’naia i Klinicheskaia
Gastroenterologiia [Experimental & Clinical Gastroenterology]
2011;5:8–15.
Sumona 2009
Sumona AA, Hossain MA, Musa AK, Shamsuzzaman
AK, Mahmud MC, Khan MS, et al. Anti h.Pylori igm in
symptomatic and asymptomatic population. Mymensingh
Medical Journal: MMJ 2009;18(1):18–20.
Sunnerstam 1999
Sunnerstam B, Kjerstadius T, Jansson L, Giesecke J,
Bergstrom M, Ejderhamn J. Detection of Helicobacter
pylori antibodies in a pediatric population: Comparison
of three commercially available serological tests and
one in-house enzyme immunoassay. Journal of Clinical
Microbiology 1999;37(10):3328–31.
Surveyor 1988
Surveyor I, Goodwin CS, Warren JR, Geelhoed E, Murray
RN, Waters TE. Further experience of the c-14 urea breath
test for the detection of c-pylori infection. Australian and
New Zealand Journal of Medicine 1988;18(3):505.
Suto 1997a
Suto H, Azuma T, Ito S, Ito Y, Miyaji H, Yamazaki Y, et al.
Evaluation of the endoscopic c-13-urea breath test: A new
accurate diagnostic test of Helicobacter pylori infection.
Gastroenterology 1997;112(4 (suppl)):A301.
Suto 1997b
Suto H, Azuma T, Ito S, Ito Y, Miyaji H, Yamazaki Y,
et al. A trial of 13C-urea breath test combined with
endoscopic phenol red test for detection of Helicobacter
pylori infection. Digestive Endoscopy 1997;9(4):283–9.
Suto 1999
Suto H, Azuma T, Ito S, Ito Y, Miyaji H, Yamazaki Y,
et al. Evaluation of endoscopic c-13-urea breath test for
assessment of Helicobacter pylori eradication. Journal of
Gastroenterology 1999;34(Suppl 11):67–71.
Suto 2000a
Suto H, Azuma T, Ito S, Ito Y, Miyaji H, Yamazaki Y, et
al. Endoscopic13C-urea breath test for quantification of
Helicobacter pylori infection. Journal of Gastroenterology
and Hepatology (Australia) 2000;15(2):161–7.
Suto 2000b
Suto G, Vincze A, Pakodi F, Hunyady B, Karadi O,
Garamszegi M, et al. C-13-urea breath test is superior in
sensitivity to detect Helicobacter pylori infection than either
antral histology or rapid urease test. Journal of Physiology-
Paris 2000;94(2):153–6.
Suzuki 2010
Suzuki K, Shimoyama T, Kobayashi I, Kato C, Kodama
M, Fukuda Y. Comparison of monoclonal antibody-based
stool antigen tests to determine the results of h. Pylori
eradication therapy. Helicobacter 2010;15 (4):358.
Syam 2005
Syam AF, Rani AA, Abdullah M, Manan C, Makmun D,
Simadibrata M, et al. Accuracy of Helicobacter pylori stool
antigen for the detection of Helicobacter pylori infection in
dyspeptic patients. World Journal of Gastroenterology 2005;
11(3):386–8.
Sykora 2002
Sykora J, Valeckova K, Hejda V, Varvarovska J, Stozicky
F. Accurate noninvasive diagnosis of Helicobacter pylori
infection using antigen determination in the feces in the
pediatric population. Casopis Lekaru Ceskych 2002;141(13):
425–7.
107Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Sykora 2003
Sykora J, Valeckova K, Stozicky F, Schwarz J, Varvarovska J.
Revealing of the Helicobacter pylori infection in children by
detection of stool antigen by a novel enzyme immunoassay
using monoclonal antibodies (hpstar). Casopis Lekaru
Ceskych 2003;142(11):687–90.
Taha 1992
Taha AS, Boothman P, Nakshabendi I, Reid J, Morran
C, Gemmell CG, et al. Diagnostic tests for Helicobacter
pylori: Comparison and influence of non-steroidal anti-
inflammatory drugs. Journal of Clinical Pathology 1992;45
(8):709–12.
Taha 1993
Taha AS, Reid J, Boothmann P, Gemmell CG, Lee FD,
Sturrock RD, et al. Serological diagnosis of Helicobacter
pylori--evaluation of four tests in the presence or absence
of non-steroidal anti-inflammatory drugs. Gut 1993;34(4):
461–5.
Takagi 1993
Takagi A, Suyama T, Kida M, Matsuda M, Matsumoto
H, Kojima K, et al. Comparison between ELISA and
culture method for detection of Helicobacter pylori. Rinsho
Byori [Japanese Journal of Clinical Pathology] 1993;41(12):
1333–7.
Takagi 2002
Takagi A, Mine T. Serodiagnosis of Helicobacter pylori
infection. Nihon Rinsho [Japanese Journal of Clinical
Medicine] 2002;60(Suppl 2):324–7.
Takagi 2003
Takagi A. Detection of h. Pylori by serum and urine-based
ELISA. Nihon Rinsho [Japanese Journal of Clinical Medicine]
2003;61(1):88–91.
Takahashi 2010
Takahashi R, Shimoyama T, Abe D, Nakabayashi N, Okuda
M, Fukuda Y. Determining cut-off values for serodiagnosis
of Helicobacter hepaticus infection by hrii-51-hh-15
capture enzyme-linked immunosorbent assay. Helicobacter
2010;15(4):362.
Takwoingi 2013
Takwoingi Y, Leeflang MM, Deeks JJ. Empirical evidence
of the importance of comparative studies of diagnostic test
accuracy. Annals of internal medicine 2013;158(7):544–54.
[PUBMED: 23546566]
Takwoingi 2017
Takwoingi Y, Guo B, Riley RD, Deeks JJ. Performance of
methods for meta-analysis of diagnostic test accuracy with
few studies or sparse data. Statistical Methods in Medical
Research 2017; Vol. 26, issue 4:1896–911.
Talebkhan 2009
Talebkhan Y, Ebrahimzadeh F, Esmaeili M, Oghalaie A,
Sadeghi M, Mohammadi M. H. Pylori immunoreactive
antigens and their screening applications. Helicobacter
2009;14 (4):338.
Talebkhan 2010
Talebkhan Y, Esmaili M, Hassanpour P, Morakabati A,
Rakhshani N, Mohagheghi M, et al. Comparison of
routinely used invasive and non invasive approaches in
diagnosis of h. Pylori infection. Helicobacter 2010;15(4):
358–9.
Talley 1991
Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson
WR, Zinsmeister AR, et al. Serodiagnosis of Helicobacter
pylori: Comparison of enzyme-linked immunosorbent
assays. Journal of Clinical Microbiology 1991;29(8):1635–9.
Talley 1992
Talley NJ, Kost L, Haddad A, Zinsmeister AR. Comparison
of commercial serological tests for detection of Helicobacter
pylori antibodies. Journal of Clinical Microbiology 1992;30
(12):3146–50.
Talley 1998
Talley NJ, Lambert JR, Howell S, Xia HH, Lin SK, Agreus
L. An evaluation of whole blood testing for Helicobacter
pylori in general practice. Alimentary Pharmacology &
Therapeutics 1998;12(7):641–5.
Talley 2008
Talley NJ, Fock KM,Moayyedi P. Gastric Cancer Consensus
conference recommends Helicobacter pylori screening
and treatment in asymptomatic persons from high-risk
populations to prevent gastric cancer. American Journal of
Gastroenterology 2008;103(3):510–4.
Tamura 2001
Tamura S, Yokoyama Y, Morita T, Tadokoro T, Higashidani
Y, Onishi S. Stool test for Helicobacter pylori. American
Journal of Gastroenterology 2001;96(6):1936–8.
Tanahashi 1998
Tanahashi T, Kodama T, Yamaoka Y, Sawai N, Tatsumi
Y, Kashima K, et al. Analysis of the c-13-urea breath test
for detection of Helicobacter pylori infection based on the
kinetics of delta-(co2)-c-13 using laser spectroscopy. Journal
of Gastroenterology and Hepatology 1998;13(7):732–7.
Tanaka 2001
Tanaka A, Watanabe K, Tokunaga K, Hoshiya S, Imase K,
Sugano H, et al. Evaluation of Helicobacter pylori stool
antigen test before and after eradication therapy. Gut 2001;
49(suppl):A101.
Tanaka 2003
Tanaka A, Watanabe K, Tokunaga K, Hoshiya S, Imase K,
Sugano H, et al. Evaluation of Helicobacter pylori stool
antigen test before and after eradication therapy. Journal of
Gastroenterology & Hepatology 2003;18(6):732–8.
Tanaka 2004
Tanaka A, Takahashi S. Helicobacter pylori stool antigen
test. Nihon Rinsho [Japanese Journal of Clinical Medicine]
2004;62(3):464–9.
Tanaka 2005
Tanaka A, Tokunaga K, Imase K, Sugano H, Ishida H,
Takahashi S. Evaluation of rapid h-pylori stool antigen test
before and after eradication therapy. American Journal of
Gastroenterology 2005;100(9):S69–70.
108Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Tanigawa 1996
Tanigawa T, Mizo-oku Y, Moriguchi K, Suzuki T, Osumi
T, Odomi M. Simple and rapid quantitative assay of 13C-
labelled urea in human serum using liquid chromatography-
atmospheric pressure chemical ionization mass spectrometry.
Journal of Chromatography B: Biomedical Applications 1996;
683(2):135–42.
Taniguchi 1995
Taniguchi Y, Kimura K, Satoh K, Kawada H, Sohara
H, Yamamoto H, et al. Substitute, inexpensive
diagnosis of Helicobacter-pylori infection by infrared (ir)
spectrophotometer in c-13-urea breath test. Gastroenterology
1995;108(4 (Suppl)):A235.
Taylor 1987
Taylor DE, Chang N. Immunoblot and enzyme-linked
immunosorbent assays of campylobacter major outer-
membrane protein and application to the differentiation of
campylobacter species. Molecular & Cellular Probes 1987;1
(3):261–74.
Taylor 2014
Taylor J, Hafner M, Yerushalmi E, Smith R, Bellasio
J, Vardavas R, et al. Estimating the economic costs of
antimicrobial resistance. Model and Results. www.rand.org/
pubs/research reports/RR911.html 2014 (accessed 15
December 2016).
Teich 1997
Teich M, Bohn I, Niessen KH. Validation of a children’s c-
13-urea breath test for diagnosis of Helicobacter pylori.
Monatsschrift Kinderheilkunde 1997;145(3):242–8.
Temelli 2011
Temelli B, Velipasaoglu Z, Akdemir E, Bozkurt MF.
Efficacy of carbon-14 urea breath test in the diagnosis
of Helicobacter pylori infection in children: Comparison
among different tests to find out the best. European Journal
of Nuclear Medicine and Molecular Imaging 2011;38:
S190–S1.
Teo 1997
Teo EK, Fock KM, Ng TM, Khor CJL, Lee YM, Sim
CS. 13 carbon-urea breath test for detection of h-pylori
infection. Gastroenterology 1997;112(4 suppl):A311.
Tepes 2015
Tepes B, Malfertheiner P, Labenz J, Aygen S. The
accuracy of a new c-13 urea breath test meal (refex (r))
for Helicobacter pylori in patients taking proton pump
inhibitors. Helicobacter 2015;20:81.
Tereshchenko 2014
Tereshchenko S, Gorbacheva N, Anisimova E, Babushkin
V. The diagnostic accuracy of Helicobacter pylori antigen
detection in duodenal juice. Helicobacter 2014;19:125–6.
Tewari 2001
Tewari V, Nath G, Gupta H, Dixit VK, Jain AK. 14c-
urea breath test for assessment of gastric Helicobacter
pylori colonization and eradication. Indian Journal of
Gastroenterology 2001;20(4):140–3.
Tham 1993
Tham TCK, McLaughlin N, Hughes DF, Ferguson M,
Crosbie JJ, Madden M, et al. Evaluation of a commercial
ELISA for the serodiagnosis of Helicobacter-pylori
infection. Gastroenterology 1993;104(4 suppl):A210.
Tham 1994
Tham TCK, McLaughlin M, Hughes DF, Ferguson M,
Crosbie JJ, Madden M, et al. Possible role of Helicobacter
pylori serology in reducing endoscopy workload.
Postgraduate Medical Journal 1994;70(829):809–12.
Thijs 1994
Thijs JC, Van Zwet AA, Meyer BC, Berrelkamp RJP.
Serology to monitor the efficacy of anti-Helicobacter
pylori treatment. European Journal of Gastroenterology &
Hepatology 1994;6(7):579–83.
Thijs 1995a
Thijs WJ, Thijs JC, Kleibeuker JH, Elzinga H, Stellaard F.
Evaluation of clinical and home performance of the 13C-
urea breath test for the detection of Helicobacter pylori.
European Journal of Gastroenterology & Hepatology 1995;7
(7):603–7.
Thijs 1995b
Thijs WJ, Thijs JC, Kleibeuker JH, Elzinga H, Stellaard F.
The c-13-urea breath test for the detection of Helicobacter-
pylori - an analysis of the test performed clinically and at
home. Gastroenterology 1995;108(4 (suppl)):A241.
Thijs 1996
Thijs JC, Van Zwei AA, Thijs WJ, Oey HB, Karrenbeld A,
Stellaard F, et al. Diagnostic tests for Helicobacter pylori: A
prospective evaluation of their accuracy, without selecting
a single test as the gold standard. American Journal of
Gastroenterology 1996;91(10):2125–9.
Thillainayagam 1991
Thillainayagam AV, Arvind AS, Cook RS, Harrison IG,
Tabaqchali S, Farthing MJG. Diagnostic efficiency of an
ultrarapid endoscopy room test for Helicobacter-pylori.
Gut 1991;32(5):467–9.
Thomas 1990
Thomas JE, Whatmore AM, Barer MR, Eastham EJ, Kehoe
MA. Serodiagnosis of Helicobacter pylori infection in
childhood. Journal of Clinical Microbiology 1990;28(12):
2641–6.
Thomas 1999
Thomas JE, Dale A, Harding M, Coward WA, Cole TJ,
Sullivan PB, et al. Interpreting the c-13-urea breath
test among a large population of young children from a
developing country. Pediatric Research 1999;46(2):147–51.
Thongbai 2007
Thongbai T, Thong-Ngam D, Mahachai V, Kullavanijaya
P. Effect of antiulcer drugs used on the detection of
Helicobacter pylori using urea breath test. Helicobacter
2007;12(4):443.
Tindberg 2001
Tindberg Y, Bengtsson C, Bergstrom M, Granstrom M.
Phe accuracy of serologic diagnosis of Helicobacter pylori
109Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
infection in school-aged children of mixed ethnicity.
Helicobacter 2001;6(1):24–30.
Tinnert 1998
Tinnert A, Hamlet A, Svennerholm AM. Antibodies against
Helicobacter pylori in feces and saliva before and after
eradication therapy. Clinical Microbiology and Infection
1998;4(11):634–43.
Tiryaki 2010
Tiryaki Z, Yilmaz-Ciftdogan D, Kasirga E. Diagnostic value
of stool antigen and antibody tests for Helicobacter pylori
infection in Turkish children with upper gastrointestinal
complaints before and after eradication. Turkish Journal of
Pediatrics 2010;52(5):505–11.
Togashi 2006
Togashi A, Matsukura N, Kato S, Masuda G, Ohkawa K,
Tokunaga A, et al. Simple and accurate c-13-urea breath
test for detection of Helicobacter pylori in the remnant
stomach after surgery. Journal of Gastroenterology 2006;41
(2):127–32.
Tokunaga 1998
Tokunaga Y, Shirahase H, Yamamoto E, Gouda Y, Kanaji
K, Ohsumi K. Semiquantitative evaluation for diagnosis
of Helicobacter pylori infection in relation to histological
changes. American Journal of Gastroenterology 1998;93(1):
26–9.
Tokunaga 2000
Tokunaga Y, Shirahase H, Yamamoto E, Inao R, Hamaguchi
S, Kanaji K, et al. Modified rapid urease test for Helicobacter
pylori detection in relation to an immunohistochemical
stain. Journal of Gastroenterology and Hepatology 2000;15
(6):617–21.
Tokunaga 2005
Tokunaga K, Watanabe K, Tanaka A, Sugano H, Imase
K, Ishida H, et al. Evaluation of 13C-urea breath test to
confirm eradication of Helicobacter pylori. Japanese Journal
of Gastroenterology 2005;102(2):176–82.
Toporowska-Kowalska 2005
Toporowska-Kowalska E, Wasowska-Krolikowska K,
Kurnatowski M, Gebora-Kowalska B. Clinical applicability
of non-invasive testing of Helicobacter pylori infection
in children - stool antygen (HPSA) and urea breath test.
Pediatria Wspolczesna 2005;7(3):177–9.
Tormo 2013
Tormo R. Urea c-13 test is not enough to diagnose
a Helicobacter pylori infection. Journal of Pediatric
Gastroenterology and Nutrition 2013;56(6):e53.
Torres 2001
Torres J, Camorlinga M, Perez-Perez G, Gonzalez G,
Muñoz O. Validation of the string test for the recovery of
Helicobacter pylori from gastric secretions and correlation
of its results with urea breath test results, serology, and
gastric ph levels. Journal of Clinical Microbiology 2001;39
(4):1650–1.
Toyama 1999
Toyama J, Kato C, Sato K, Sato S. The 13C-urea breath
test efficacy in determining Helicobacter pylori eradication.
Nihon Rinsho [Japanese Journal of Clinical Medicine] 1999;
57(1):93–6.
Trautmann 1994
Trautmann M, Moldrzyk M, Vogt K, Korber J, Held T,
Marre R. Use of a receiver operating characteristic in the
evaluation of two commercial enzyme immunoassays for
detection of Helicobacter pylori infection. European Journal
of Clinical Microbiology & Infectious Diseases 1994;13(10):
812–9.
Treiber 2000
Treiber G, Malfertheiner P. Usefulness of serology for
diagnosis and follow-up of h.pylori infection - comparison
of third vs. second generation ELISA. Gastroenterology
2000;118(4 Part 2):A1316.
Trevisani 1998
Trevisani L, Sartori S, Galvani F, Rossi MR, Ruina M,
Caselli M. Detection of Helicobacter pylori in faeces with
a new enzyme immunoassay method: Preliminary results.
Scandinavian Journal of Gastroenterology 1998;33(8):893–4.
Trevisani 1999a
Trevisani L, Sartori S, Ruina M, Caselli M, Rossi MR, Costa
F, et al. Helicobacter pylori stool antigen test - clinical
evaluation and cost analysis of a new enzyme immunoassay.
Digestive Diseases and Sciences 1999;44(11):2303–6.
Trevisani 1999b
Trevisani L, Sartori S, Galvani F, Rossi MR, Ruina
M, Chiamenti C, et al. Evaluation of a new enzyme
immunoassay for detecting Helicobacter pylori in feces: A
prospective pilot study. American Journal of Gastroenterology
1999;94(7):1830–3.
Trevisani 2002
Trevisani L, Sartori S. The accuracy of the Helicobacter
pylori stool antigen test in diagnosing h-pylori in treated
patients. European Journal of Gastroenterology & Hepatology
2002;14(1):89.
Tseng 2005
Tseng CA, Wang WM, Wu DC. Comparison of the clinical
feasibility of three rapid urease tests in the diagnosis of
Helicobacter pylori infection. Digestive Diseases and Sciences
2005;50(3):449–52.
Tu 1999
Tu TC, Lee CL, Wu CH, Chen TK, Chan CC, Huang
SH, et al. Comparison of invasive and noninvasive tests for
detecting Helicobacter pylori infection in bleeding peptic
ulcers. Gastrointestinal Endoscopy 1999;49(3 I):302–6.
Tucci 1996
Tucci A, Poli L, Donati M, Mazzoni C, Cevenini R,
Sambri V, et al. Value of serology (ELISA) for the diagnosis
of Helicobacter pylori infection: evaluation in patients
attending endoscopy and in those with fundic atrophic
gastritis. Italian Journal of Gastroenterology 1996;28(7):
371–6.
Tummala 2007
Tummala S, Sheth SG, Goldsmith JD, Goldar-Najafi A,
Murphy CK, Osburne MS, et al. Quantifying gastric
110Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Helicobacter pylori infection: A comparison of quantitative
culture, urease breath testing, and histology. Digestive
Diseases & Sciences 2007;52(2):396–401.
Uchida 2011
Uchida T, Vilaichone R, Ratanachu-Ek T, Mahachai V,
Tshering L, Fujioka T, et al. Evaluation of diagnostic
tests for h. Pylori infection in the Bhutanese population.
Helicobacter 2011;16:114.
Ueda 2014
Ueda J, Okuda M, Nishiyama T, Lin YS, Fukuda Y, Kikuchi
S. Diagnostic accuracy of the e-plate serum antibody test kit
in detecting Helicobacter pylori infection among Japanese
children. Journal of Epidemiology 2014;24(1):47–51.
Uematsu 2002
Uematsu T, Matsuno H, Tanba M, Kozawa O, Ikei N,
Kawasaki J, et al. Clinical pharmacology study of c-13
ubt tablet for the in vivo diagnosis of Helicobacter pylori
infection. Japanese Journal of Clinical Pharmacology and
Therapeutics 2002;33(3):81–4.
Urita 2000
Urita Y, Miki K. Endoscopic 13C-urea breath test. Digestive
Endoscopy 2000;12(1):29–32.
Urita 2002
Urita Y, Torii N, Hike K, Kikuchi Y, Kanda E, Sasajima M,
et al. Proteinuria reduces the diagnostic accuracy of urine-
based enzyme-linked immunosorbent assay for detection
of antibody to Helicobacter pylori. American Journal of
Gastroenterology 2002;97(9):S49.
Urita 2004a
Urita Y, Hike K, Torii N, Kikuchi Y, Kurakata H, Kanda
E, et al. Comparison of serum iga and igg antibodies for
detecting Helicobacter pylori infection. Internal Medicine
2004;43(7):548–52.
Urita 2004b
Urita Y, Kikuchi Y, Hike K, Torii N, Kanda E, Kurakata
H, et al. Endoscopic 13C-urea breath test for detection
of Helicobacter pylori infection after partial gastrectomy.
Gastrointestinal Endoscopy 2004;59(5):AB153.
Urita 2004c
Urita Y, Hike K, Torii N, Kikuchi Y, Kanda E, Kurakata
H, et al. Breath sample collection through the nostril
reduces false-positive results of c-13-urea breath test for the
diagnosis of Helicobacter pylori infection. Digestive and
Liver Disease 2004;36(10):661–5.
Urita 2006
Urita Y, Hike K, Torii N, Kikuchi Y, Kanda E, Kurakata H,
et al. Influence of urease activity in the intestinal tract on the
results of c-13-urea breath test. Journal of Gastroenterology
and Hepatology 2006;21(4):744–7.
Urita 2007a
Urita Y, Maeda T, Ishihara S, Sugimoto M, Watanabe
T, Domon K, et al. Endoscopic c-13-urea breath test for
detection of Helicobacter pylori infection after partial
gastrectomy. Hepato-Gastroenterology 2007;54(78):1891–4.
Urita 2007b
Urita Y, Hike K, Torii N, Kikuchi Y, Watanabe T, Kurakata
H, et al. Ten-second endoscopic breath test using a 20-mg
dose of c-13-urea to detect Helicobacter pylori infection.
Hepato-Gastroenterology 2007;54(75):951–4.
Us 2002
Us D, Engin D, Hascelik G. Evaluation of western blot
methods for serologic diagnosis of Helicobacter pylori
infections. Mikrobiyoloji Bulteni 2002;36(2):153–60.
Uyub 1994
Uyub AM, Anuar AK, Aiyar S. Reliability of two
commercial serological kits for serodiagnosing Helicobacter
pylori infection. Southeast Asian Journal of Tropical Medicine
& Public Health 1994;25(2):316–20.
Vafaeimanesh 2014
Vafaeimanesh J, Bagherzadeh M. Noninvasive stool antigen
assay for screening of Helicobacter pylori infection and
assessing success of eradication therapy in patients on
hemodialysis. Journal of Gastroenterology and Hepatology
(Australia) 2014;29:236.
Vaira 1989
Vaira D, Holton J. Serum immunoglobulin g antibody
levels for campylobacter pylori diagnosis. Gastroenterology
1989;97(4):1069–70.
Vaira 1996
Vaira D, Stanghellini V, Miglioli M, Corinaldesi R. IgG
ELISA antibodies and detection of Helicobacter pylori in
elderly patients. Italian Helicobacter pylori Study Group.
Lancet 1996;347(8996):269–70.
Vaira 1999a
Vaira D, Malfertheiner P, Megraud F, Axon AT. Diagnosis
of Helicobacter pylori infection by HPSA test. European
Helicobacter pylori HPSA study group. Lancet 1999;354
(9191):1732.
Vaira 1999b
Vaira D, Malfertheiner P, Megraud F, Axon AT, Deltenre
M, Hirschl AM, et al. Diagnosis of Helicobacter pylori
infection with a new non-invasive antigen-based assay. Hpsa
European Study Group. Lancet 1999;354(9172):30–3.
Vaira 1999c
Vaira D, Malferteiner P, Megraud F, Moayyedi P, Axon
ATR, Deltenre M, et al. Accuracy of a new antigen based
stool test for Helicobacter pylori (hp) in 117 endoscoped
patients before and after treatment. European Multicentre
Study. Gut 1999;44(Suppl 3):A96.
Vaira 2000a
Vaira D, Menegatti M, Ricci C, Gatta L, Berardi S, Miglioli
M. Accurate diagnosis of Helicobacter pylori stool tests.
Gastroenterology Clinics of North America 2000;29(4):
917–23.
Vaira 2000b
Vaira D, Ricci C, Menegatti M, Gatta L, Geminiani A,
Miglioli M. Clinical role of fecal antigen determination
in the diagnosis of Helicobacter pylori infection. Clinical
Laboratory 2000;46(9-10):487–91.
111Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Vaira 2000c
Vaira D, Malfertheiner P, Megraud F, Axon AT, Deltenre
M, Gasbarrini G, et al. Noninvasive antigen-based assay
for assessing Helicobacter pylori eradication: A European
multicenter study. The European Helicobacter pylori HPSA
Study Group. American Journal of Gastroenterology 2000;95
(4):925–9.
Vaira 2002
Vaira D, Vakil N, Menegatti M, Van’t Hoff B, Ricci C,
Gatta L, et al. The stool antigen test for detection of
Helicobacter pylori after eradication therapy [summary for
patients in Annals of Internal Medicine. feb 19 2002;136
(4):I36; pmid: 11848739]. Annals of Internal Medicine
2002;136(4):280–7.
Vaira 2009
Vaira D, Gatta L, Ricci C, Di Mario F, Lanzini A. Accuracy
of urea breath tests tablets after 10 minutes compared
with standard 30 minutes to diagnose and monitoring
Helicobacter pylori infection: A randomized controlled
trial. Journal of Clinical Gastroenterology 2009;43(7):693–4.
Vaira 2010a
Vaira D, Vakil N, Gatta L, Ricci C, Perna F, Saracino I, et
al. Accuracy of a new ultrafast rapid urease test to diagnose
Helicobacter pylori infection in 1000 consecutive dyspeptic
patients. Alimentary Pharmacology & Therapeutics 2010;31
(2):331–8.
Vaira 2010b
Vaira D, Gatta L, Ricci C, Perna F, Saracino I, Fiorini G,
et al. A comparison amongst three rapid urease tests to
diagnose Helicobacter pylori infection in 375 consecutive
dyspeptic. Internal & Emergency Medicine 2010;5(1):41–7.
Vakil 1999
Vakil N, Affi A, Sundaram M, Robinson J, Dunn B,
Phadnis S. Prospective, blinded evaluation of the accuracy
of a stool test for the detection of h-pylori. Gastroenterology
1999;116(4 (suppl)):A342.
Vakil 2000a
Vakil N, Affi A, Robinson J, Sundaram M, Phadnis S.
Prospective blinded trial of a fecal antigen test for the
detection of Helicobacter pylori infection. American Journal
of Gastroenterology 2000;95(7):1699–701.
Vakil 2000b
Vakil N. Is the stool test out of breath?. Digestive & Liver
Disease 2000;32(4):291–3.
Valdeperez 2003
Valdeperez J, Vicente R, Novella MP, Valle L, Sicilia B, Yus
C, et al. Is the breath test reliable in primary care diagnosis
of Helicobacter pylori infection?. Atencion Primaria 2003;
31(2):93–7.
Valentine 1991
Valentine JL, Arthur RR, Mobley HLT, Dick JD. Detection
of Helicobacter-pylori by using the polymerase chain-
reaction. Journal of Clinical Microbiology 1991;29(4):
689–95.
Valle 1997
Valle J, Vazquez MA, Zomeno M, FernandezSalazar
L, JimenezAlonso I, Lara S, et al. Direct correlation
between the c-13-urea breath test values and the density of
Helicobacter pylori in antrum biopsies. Gut 1997;41:A87.
Valle 2013
Valle PC, Breckan RK, Mortensen L, Amin A, Kildahl-
Andersen O, Paulssen EJ. Managing dyspepsia in the young
adult patient: Effects of different tests for Helicobacter
pylori in a ”test-and-scope“ approach. Scandinavian Journal
of Gastroenterology 2013;48(8):913–20.
Van Bohemen 1988
Van Bohemen CG, Langenberg ML, Rauws EAJ, Weterings
E, Zanen HC. Assay-igg to campylobacter pylori in
histological chronic and biopsy campylobacter positive
gastritis. FEMS Microbiology Letters 1988;55(3):321–6.
Van Bohemen 1989
Van Bohemen CG, Langenberg ML, Rauws EAJ, Oudbier
J, Weterings E, Zanen HC. Rapidly decreased serum
igg to campylobacter pylori following elimination of
campylobacter in histological chronic biopsy campylobacter-
positive gastritis. Immunology Letters 1989;20(1):59–61.
Van de Wouw 1995
Van de Wouw BA, De Boer WA, Jansz AR, Staals AP,
Roymans RT. Serodiagnosis of Helicobacter pylori infection:
an evaluation of a commercially available ELISA-IgG.
Netherlands Journal of Medicine 1995;47(6):272–7.
Van de Wouw 1996
Van de Wouw BA, De Boer WA, Jansz AR, Roymans RT,
Staals AP. Comparison of three commercially available
enzyme-linked immunosorbent assays and biopsy-
dependent diagnosis for detecting Helicobacter pylori
infection. Journal of Clinical Microbiology 1996;34(1):94–7.
Van de Wouw 1997
Van de Wouw BA, De Boer WA, Hermsen HW, Valkenburg
JG, Geuskens LM, Tytgat GN. Usefulness of the 14c urea
breath test as a semi-quantitative monitoring instrument
after therapy for Helicobacter pylori infection. Scandinavian
Journal of Gastroenterology 1997;32(2):112–7.
Van Den 1991
Van Den Oever HLA, Loffeld RJLF, Stobberingh EE.
Usefulness of a new serological test (bio-rad) to diagnose
Helicobacter pylori-associated gastritis. Journal of Clinical
Microbiology 1991;29(2):283–6.
Van Der Ende 1999
Van Der Ende A, Van Der Hulst RWM, Roorda P, Tytgat
GNJ, Dankert J. Evaluation of three commercial serological
tests with different methodologies to assess Helicobacter
pylori infection. Journal of Clinical Microbiology 1999;37
(12):4150–2.
Van der Est 1990
Van der Est MMC, Veenendaal RA, Pena AS, Van Duijn
W, Kuiper I, Lamers CBHW. ELISA analysis of IgA
subclass antibodies to Helicobacter pylori. Elevated serum
IgA1 antibodies in Helicobacter pylori infected patients.
112Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Journal of Clinical Nutrition and Gastroenterology 1990;5(1):
185–90.
Van Der Hulst 1999
Van Der Hulst RWM, Lamouliatte H, Megraud F, Pounder
RE, Stolte M, Vaira D, et al. Laser assisted ratio analyser
13C-urea breath testing, for the detection of H. pylori:
A prospective diagnostic European multicentre study.
Alimentary Pharmacology & Therapeutics 1999;13(9):
1171–7.
Van der Hulst 1999
Van der Hulst RW, Hensen EF, Van der Ende A, Kruizinga
SP, Homan A, Tytgat GN. Laser-assisted 13C-urea breath
test; a new noninvasive detection method for Helicobacter
pylori infection. Nederlands Tijdschrift voor Geneeskunde
1999;143(8):400–4.
Van der Voort 1998
Van der Voort PHJ, Van der Hulst RWM, Zandstra DF,
Geraedts AAM, Tytgat GNJ. Detection of h-pylori in
mechanically ventilated intensive care patients using the
lara-c-13-urea breath test. Gastroenterology 1998;114(4
(suppl)):A319.
Van der Voort 1999
Van der Voort PHJ, Van der Hulst RWM, Zandstra DF,
Van der Ende A, Geraedts AAM, Tytgat GNJ. Detection of
Helicobacter pylori in mechanically ventilated patients: The
lara-13C-urea breath test and serology. Clinical Intensive
Care 1999;10(3):91–5.
Van der Wouden 1999
Van der Wouden ET, Thijs JC, Van Zwet AA, Oey HB,
Kleibeuker JH. Reliability of biopsy-based diagnostic
tests for Helicobacter pylori after treatment aimed at
its eradication. European Journal of Gastroenterology &
Hepatology 1999;11(11):1255–8.
Van Doorn 2000
Van Doorn LJ, Henskens Y, Nouhan N, Verschuuren A,
Vreede R, Herbink P, et al. The efficacy of laboratory
diagnosis of Helicobacter pylori infections in gastric biopsy
specimens is related to bacterial density and vacA, cagA, and
iceA genotypes. Journal of Clinical Microbiology 2000;38
(1):13–7.
Van Doorn 2001
Van Doorn OJ, Bosman DK, Van THBW, Taminiau JA,
Ten Kate FJ, Van der Ende A. Helicobacter pylori stool
antigen test: A reliable non-invasive test for the diagnosis of
Helicobacter pylori infection in children. European Journal
of Gastroenterology & Hepatology 2001;13(9):1061–5.
Van Leerdam 2002
Van Leerdam ME, Van der Ende A, Ten Kate F, Rauws
EAJ, Tytgat GNJ. Lack of accuracy of the non-invasive
Helicobacter pylori stool antigen test in patients with
gastroduodenal ulcer bleeding. Gastroenterology 2002;122(4
(suppl)):A46.
Van Leerdam 2003
Van Leerdam ME, Van der Ende A, Ten Kate FJW, Rauws
EAJ, Tytgat GNJ. Lack of accuracy of the noninvasive
Helicobacter pylori stool antigen test in patients with
gastroduodenal ulcer bleeding. American Journal of
Gastroenterology 2003;98(4):798–801.
Van Zanten 1998
Van Zanten SV, Bleau BL, Best L, Hutchison D, Blevins J,
Thee D. Use of the Helicobacter pylori stool antigen test
(HPSAt) for detection of h-pylori (hp) infection. Gut 1998;
43(Suppl 2):A49.
Van Zanten 1999
Van Zanten S, Bleau BL, Best LM, Hutchison DM,
Blevins J, Thee D. Helicobacter pylori stool antigen test
(HPSA): Use for detection of infection and eradication.
Gastroenterology 1999;116(4 (suppl)):A837.
Van Zwet 1992
Van Zwet AA, Meyer BC, Berrelkamp RJ, Thijs JC.
Serological tests to monitor treatment of Helicobacter
pylori. Lancet 1992;340(8810):51.
Van Zwet 1994
Van Zwet AA, Thijs JC, Kooistra-Smid AMD, Schirm
J, Snijder JAM. Use of PCR with feces for detection of
Helicobacter pylori infections in patients. Journal of Clinical
Microbiology 1994;32(5):1346–8.
Van’t Hoff 2000
Van’t Hoff BW, Vaira D, Vakil NB, Gasbarrini G,
Quina M, Garcia JMP, et al. Early diagnosis of failed
Helicobacter pylori (hp) eradication using a stool antigen
test. Gastroenterology 2000;118(4):A697.
Vannella 2009
Vannella L, Gianni D, Lahner E, Amato A, Grossi E, Delle
Fave G, et al. Pre-endoscopic screening for Helicobacter
pylori and celiac disease in young anemic women. World
Journal of Gastroenterology 2009;15(22):2748–53.
Vargas 2013
Vargas J, Lopez-Sanchez M, Pabon M, Lamas E, Parra M,
CastroFernandez M. Evaluation of a novel chemiluminiscent
inmunoassay for the detection of Helicobacter pylori
antigen and their correlation with immunochromatographic
rapid test in stools samples from adults patients. Helicobacter
2013;18:121.
Vaz Coelho 2005
Vaz Coelho LG, De Castro Boechat L, Rocha Z, Almeida
Aguiar RO, Andrade Aragao AL, Silva Dias EE, et al. 13C-
urea breath test for the detection of h. pylori infection
in children: determination of the cut-off point by a
graphic method not depending on the gold standard.
Gastroenterologia Endoscopia Digestiva 2005;24(1):15–20.
Vecsei 2010
Vecsei A, Innerhofer A, Binder C, Gizci H, Hammer K,
Bruckdorfer A, et al. Stool polymerase chain reaction
for Helicobacter pylori detection and clarithromycin
susceptibility testing in children. Clinical Gastroenterology
& Hepatology 2010;8(3):309–12.
Veenendaal 1995
Veenendaal RA, Gotz JM, Schroijen V, Kurban F, Bernards
AT, Veselic M, et al. Diagnosis of Helicobacter pylori
infection by specific gastric mucosal iga and igg pylori
113Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
antibodies. Journal of Clinical Pathology 1995;48(11):
990–3.
Veijola 2005a
Veijola L, Myllyluoma E, Korpela R, Rautelin H. Stool
antigen tests in the diagnosis of Helicobacter pylori infection
before and after eradication therapy. World Journal of
Gastroenterology 2005;11(46):7340–4.
Veijola 2005b
Veijola L, Oksanen A, Lofgren T, Sipponen P, Karvonen
AL, Rautelin H. Comparison of three stool antigen tests
in confirming Helicobacter pylori eradication in adults.
Scandinavian Journal of Gastroenterology 2005;40(4):
395–401.
Veijola 2008
Veijola L, Oksanen A, Sipponen P, Rautelin H. Evaluation
of a commercial immunoblot, helicoblot 2.1, for diagnosis
of Helicobacter pylori infection. Clinical & Vaccine
Immunology: CVI 2008;15(11):1705–10.
Velayos 2012
Velayos B, Fernandez-Salazar L, Pons-Renedo F, Muñoz
MF, Almaraz A, Aller R, et al. Accuracy of urea breath
test performed immediately after emergency endoscopy in
peptic ulcer bleeding. Digestive Diseases & Sciences 2012;57
(7):1880–6.
Veldhuyzen 1990
Veldhuyzen van Zanten SJO, Tytgat KMAJ, Hollingsworth
J, Jalali S, Rashid FA, Bowen BM, et al. 14C-urea breath test
for the detection of Helicobacter pylori. American Journal of
Gastroenterology 1990;85(4):399–403.
Veldhuyzen 1991
Veldhuyzen van Zanten SJO, Tytgat DeGara KMAJCJ,
Goldie J, Rashid FA, Bowen BM, Cook RJ, et al. A
prospective comparison of symptoms and five diagnostic
tests in patients with Helicobacter pylori positive and
negative dyspepsia. European Journal of Gastroenterology &
Hepatology 1991;3(6):463–8.
Vesna 2005
Vesna Vukadinovic M, Prohaska Potocnik C. Specific
igg decline after successful treatment of Helicobacter
pylori infection according to treatment protocol with
azithromycin. Infektoloski Glasnik 2005;25(4):137–42.
Vincent 1999
Vincent P, Michaud L, Martin de Lasalle E, Benon B,
Turck D, Gottrand F. 13C-urea breath test and gastric
mucosal colonization by Helicobacter pylori in children:
Quantitative relation and usefulness for diagnosis of
infection. Helicobacter 1999;4(4):233–7.
Vinette 2004
Vinette KMB, Gibney KM, Proujansky R, Fawcett PT.
Comparison of PCR and clinical laboratory tests for
diagnosing h-pylori infection in pediatric patients. BMC
Microbiology 2004;4:5.
Vivas 1993
Vivas J, Contreras M, Mathew C, Peraza S, Maury de Tami
I, Oliver W, et al. The use of urea carbon 14 in breath tests
as diagnostic method for Helicobacter pylori infections.
GEN 1993;47(3):150–6.
Von Wulffen 1988a
Von Wulffen H, Grote HJ, Laufs R. Serodiagnosis of
campylobacter pylori-related antrum gastritis by ELISA
and immunoblot methods. Zentralblatt fur Bakteriologie,
Mikrobiologie, und Hygiene. Series A, Medical Microbiology,
Infectious Diseases, Virology, Parasitology 1988;268(4):499.
Von Wulffen 1988b
Von Wulffen H, Grote HJ. Enzyme-linked immunosorbent
assay for detection of immunoglobulin a and g antibodies
to campylobacter pylori. European Journal of Clinical
Microbiology & Infectious Diseases 1988;7(4):559–65.
Von Wulffen 1989
Von Wulffen H, Grote HJ. Serodiagnosis of campylobacter
pylori infection using an enzyme-linked immunosorbent
assay. Gastroduodenal pathology and Campylobacter
pylori: European Campylobacter Pylori Study Group
ICS847. 1989:231–6.
Von Wulffen 1993
Von Wulffen H, Gatermann S, Windler E, Gabbe E,
Heinrich HC. Performance of Helicobacter pylori acid
extract and urease enzyme-linked immunosorbent assays in
relation to 14c-urea breath test. Zentralblatt fur Bakteriologie
1993;280(1-2):203–13.
Vorobjova 1991
Vorobjova T, Maaroos HI, Uibo R, Wadstrom T, Wood
WG, Sipponen P. Helicobacter pylori: Histological and
serological study on gastric and duodenal ulcer patients
in Estonia. Scandinavian Journal of Gastroenterology -
Supplement 1991;186:84–9.
Vyas 1994
Vyas SK, Sharpstone D, Treasure J, Fine D, Hawtin PR. Pre-
endoscopy screening using serodiagnosis of Helicobacter
pylori infection. European Journal of Gastroenterology &
Hepatology 1994;6(9):783–5.
Wadstrom 1994
Wadstrom T, Bolin I, Fandriks L, Gad A, Carling L.
Diagnosis of Helicobacter pylori infection. Lakartidningen
1994;91(19):1926–7.
Wallace 2006
Wallace RA, Schluter P, Webb P. Stool antigen testing for the
diagnosis and confirmation of eradication of Helicobacter
pylori infection. Internal Medicine Journal 2006;36(2):
139–41.
Wang 1998
Wang WM, Lee SC, Ding HJ, Jan CM, Chen LT, Wu
DC, et al. Quantification of Helicobacter pylori infection:
Simple and rapid c-13-urea breath test in Taiwan. Journal of
Gastroenterology 1998;33(3):330–5.
Wang 2000
Wang WM, Lee SC, Wu DC, Chen LT, Liu CS, Peng CF,
et al. Simplified 13C-urea breath test for the diagnosis of
Helicobacter pylori infection--the availability of without
fasting and without test meal. Kaohsiung Journal of Medical
Sciences 2000;16(12):607–13.
114Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Wang 2001
Wang YL, Sheu BS, Huang JJ, Yang HB. Noninvasive
stool antigen assay can effectively screen Helicobacter
pylori infection and assess success of eradication therapy in
hemodialysis patients. American Journal of Kidney Diseases
2001;38(1):98–103.
Wang 2002
Wang L, Zhou L, Tian R. Helicobacter pylori antigen and
its igg, iga-type specific immunocomplexes in sera from
patients with Helicobacter pylori infection. Chinese Medical
Journal 2002;115(3):381–3.
Wang 2003
Wang SW, Yu FJ, Lo YC, Yang YC, Wu MT, Wu IC, et
al. The clinical utility of string-PCR test in diagnosing
Helicobacter pylori infection. Hepato-Gastroenterology
2003;50(53):1208–13.
Wang 2015a
Wang H, Zou WJ. Comparison of different methods for
detecting Helicobacter pylori.. World Chinese Journal of
Digestology 2015;23(3):525–9.
Wang 2015b
Wang Z, Xie L, Liu C, Zhao H. Reliability of stool antigen
test for clinical diagnosis of Helicobacter pylori infection..
Chinese Journal of Gastroenterology 2015;20(2):78–80.
Watanabe 2001
Watanabe K, Joh T, Seno K, Sasaki M, Todoroki I,
Miyashita M, et al. Development and clinical application of
an immunoassay using intact Helicobacter pylori attached
to a solid phase as an antigen. Clinical Biochemistry 2001;
34(4):291–5.
Watanabe 2013
Watanabe K, Nagata N, Shimbo T, Nakashima R, Furuhata
E, Sakurai T, et al. Accuracy of endoscopic diagnosis
of Helicobacter pylori infection according to level of
endoscopic experience and the effect of training. BMC
Gastroenterology 2013;13:128.
Weijnen 2001a
Weijnen CF, De Wit NJ, Numans ME, Kuipers EJ, Hoes
AW, Verheij TJM. Helicobacter pylori testing in the
primary care setting: Which diagnostic test should be used?
. Alimentary Pharmacology and Therapeutics 2001;15(8):
1205–10.
Weijnen 2001b
Weijnen CF, Hendriks HA, Hoes AW, Verweij WM, Verheij
TJM, De Wit NJ. New immunoassay for the detection of
Helicobacter pylori infection compared with urease test,
c-13 breath test and histology: Validation in the primary
care setting. Journal of Microbiological Methods 2001;46(3):
235–40.
Weingart 2003
Weingart V, Ruessmann H, Koletzko S, Weingart J,
Hoechter W, Sackmann M. A novel monoclonal stool
antigen test for the detection of h. Pylori before and after
eradication therapy: A prospective study in outpatients.
Gastroenterology 2003;124(4 (suppl)):A177.
Weingart 2004
Weingart V, Russmann H, Koletzko S, Weingart J, Hochter
W, Sackmann M. Sensitivity of a novel stool antigen test
for detection of Helicobacter pylori in adult outpatients
before and after eradication therapy. Journal of Clinical
Microbiology 2004;42(3):1319–21.
Werdmuller 1998
Werdmuller BFM, Van der Putten A, Veenendaal RA,
Lamers C, Loffeld R. Can screening for igg antibodies
against Helicobacter pylori be used in clinical practice?
Omit endoscopy in seropositive or seronegative patients?.
Digestive Diseases and Sciences 1998;43(10):2296–300.
Westblom 1992
Westblom TU, Madan E, Gudipati S, Midkiff BR, Czinn
SJ. Diagnosis of Helicobacter pylori infection in adult
and pediatric patients by using Pyloriset, a rapid latex
agglutination test. Journal of Clinical Microbiology 1992;30
(1):96–8.
Westblom 1999
Westblom TU, Bhatt BD. Diagnosis of Helicobacter pylori
infection. Current Topics in Microbiology & Immunology
1999;241:215–35.
Whiting 2006
Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt
PN, Kleijnen J. Evaluation of QUADAS, a tool for the
quality assessment of diagnostic accuracy studies. BMC
Medical Research Methodology 2006;6:9.
Whiting 2011
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks
JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the
quality assessment of diagnostic accuracy studies. Annals of
Internal Medicine 2011;155(8):529–36.
Wilcox 1996
Wilcox MH, Dent THS, Hunter JO, Gray JJ, Brown DFJ,
Wight DGD, et al. Accuracy of serology for the diagnosis
of Helicobacter pylori infection - a comparison of eight kits.
Journal of Clinical Pathology 1996;49(5):373–6.
Wildgrube 1995
Wildgrube HJ. C-12 urea breath test in Helicobacter-pylori
infection of the gastric-mucosa. Deutsche Medizinische
Wochenschrift 1995;120(25-26):940–1.
Wildner-Christensen 2002
Wildner-Christensen M, Lassen AT, Lindebjerg J,
Schaffalitzky De Muckadell OB. Diagnosis of Helicobacter
pylori in bleeding peptic ulcer patients, evaluation of urea-
based tests. Digestion 2002;66(1):9–13.
Wilson 2008
Wilson RB, Lam VWT, Trinh LK. Clo test in Helicobacter
gastritis. ANZ Journal of Surgery 2008;78(8):722.
Winiarski 2003a
Winiarski M, Bielanski W, Plonka M, Dobrzanska
M, Kaminska A, Bobrzynski A, et al. The usefulness
of capsulated 13C-urea breath test in diagnosis of
Helicobacter pylori infection in patients with upper
gastrointestinal bleeding.[erratum appears in Journal of
115Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Clinical Gastroenterology 2003;37(2):198]. Journal of
Clinical Gastroenterology 2003;37(1):34–8.
Winiarski 2003b
Winiarski M, Bielanski W, Plonka M, Dobrzanska
M, Kaminska A, Bobrzynski A, et al. Erratum:
The usefulness of capsulated 13C-urea breath test in
diagnosis of Helicobacter pylori infection in patients
with upper gastrointestinal bleeding (Journal of Clinical
Gastroenterology (2003) 37 (34-38)). Journal of Clinical
Gastroenterology 2003;37(2):198.
Wirtheim 2001
Wirtheim E, Yahav J, Maoz E, Dickman R, Braun M, Fraser
GM, et al. Evaluation of novel enzyme immunoassay for
detection of Helicobacter pylori antigen in stool. European
Journal of Clinical Microbiology and Infectious Diseases 2001;
20(4):293–4.
Wisniewska 2002a
Wisniewska M, Bak-Romaniszyn L, Planeta-Malecka I,
Rechcinski T, Plonka M, Bielanski W, et al. The detection
of Helicobacter pylori antigens in stool with premier
platinum HPSA test. Pediatria Wspolczesna 2002;4(3):
373–6.
Wisniewska 2002b
Wisniewska M, Nilsson HO, Bak-Romaniszyn L,
Rechcinski T, Bielanski W, Planeta-Malecka I, et al.
Detection of specific Helicobacter pylori DNA and antigens
in stool samples in dyspeptic patients and healthy subjects.
Microbiology & Immunology 2002;46(10):657–65.
Wisniewska 2006
Wisniewska M, Grebowska A, Rechcinski T, Bak-
Romaniszyn L, Czkwianianc E, Planeta-Malecka I, et al.
Usefulness of selected noninvasive tests in detection of
Helicobacter pylori infections. Gastroenterologia Polska
2006;13(4):265–8.
Witt 1990
Witt CS, Anderson J, McShane LA, Montgomery JM, Stiel
D, Clancy RL, et al. False positive with campylobacter-
pylori antibody ELISA. Advances in mucosal immunology.
Fifth international congress of mucosal immunology; July
1989; London. Dordrecht: Kluwer Academic, 1990:793–4.
[250]
Wong 1999
Wong CY, Wong KW, Lam SK, Lai KC, Hu WHC, Lau
GKK, et al. A simplified c13-urea breath test for detection
of Helicobacter pylori (hp) infection. Gastroenterology 1999;
116(4 (suppl)):A356–A7.
Wong 2000a
Wong WM, Wong BC, Wong KW, Fung FM, Lai KC,
Hu WH, et al. (13)c-urea breath test without a test
meal is highly accurate for the detection of Helicobacter
pylori infection in Chinese. Alimentary Pharmacology &
Therapeutics 2000;14(10):1353–8.
Wong 2000b
Wong BC, Wong W, Tang VS, Lai K, Yuen S, Hu WH, et
al. An evaluation of whole blood testing for Helicobacter
pylori infection in the Chinese population. Alimentary
Pharmacology & Therapeutics 2000;14(3):331–5.
Wong 2000c
Wong WM, Wong BCY, Wong KW, Fung FMY, Lai KC,
Hu WHC, et al. C-13-urea breath test without a test
meal is highly accurate for the detection of Helicobacter
pylori infection in Chinese. Alimentary Pharmacology &
Therapeutics 2000;14(10):1353–8.
Wong 2001a
Wong BC, Wong WM, Wang WH, Tang VS, Young J,
Lai KC, et al. An evaluation of invasive and non-invasive
tests for the diagnosis of Helicobacter pylori infection in
Chinese. Alimentary Pharmacology & Therapeutics 2001;15
(4):505–11.
Wong 2001b
Wong WM, Wong BCY, Li TM, Wong KW, Cheung KL,
Fung FMY, et al. Twenty-minute 50 mg c-13-urea breath
test without test meal for the diagnosis of Helicobacter
pylori infection in Chinese. Alimentary Pharmacology &
Therapeutics 2001;15(9):1499–504.
Wong 2003a
Wong WM, Lam SK, Lai KC, Chu KM, Xia HHX, Wong
KW, et al. A rapid-release 50-mg tablet-based c-13-urea
breath test for the diagnosis of Helicobacter pylori infection.
Alimentary Pharmacology & Therapeutics 2003;17(2):253–7.
Wong 2003b
Wong BCY, Xia HHX, Cheung HKL, Ng FH, Wong SY,
Chow KC, et al. Evaluation of two stool antigen tests for
the detection of Helicobacter pylori infection in the Chinese
population. Journal of Gastroenterology and Hepatology
(Australia) 2003;18(1):26–31.
Wong 2003c
Wong WM, Lam SK, Tong TSM, Cheung KL, Tang VSY,
Xia HHX, et al. Evaluation of a rapid stool antigen test for
the diagnosis of Helicobacter pylori infection in Chinese
patients. Chinese Journal of Digestive Diseases 2003;4(3):
132–5.
Wu 1992
Wu JC, Liu GL, Zhang ZH, Mou YL, Chen Q, Wu JC, et
al. (nh4+)-n-15 excretion test - a new method for detection
of Helicobacter-pylori infection. Journal of Clinical
Microbiology 1992;30(1):181–4.
Wu 2001a
Wu DC, Kuo CH, Lu CY, Su YC, Yu FJ, Lee YC, et
al. Evaluation of an office-based urine test for detecting
Helicobacter pylori: A prospective pilot study. Hepato-
Gastroenterology 2001;48(39):614–7.
Wu 2001b
Wu S, Gao Q, Zhang D, Xiao S. 13C-urea breath test
with infrared heterodyne ratiometry in the diagnosis
of Helicobacter pylori infection. Chinese Journal of
Gastroenterology 2001;6(4):206–8.
Wu 2003
Wu IC, Ke HL, Lo YC, Yang YC, Chuang CH, Yu FJ, et
al. Evaluation of a newly developed office-based stool test
116Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
for detecting Helicobacter pylori: An extensive pilot study.
Hepato-Gastroenterology 2003;50(54):1761–5.
Wu 2004
Wu IC, Wu DC, Lu CY, Kuo CH, Su YC, Yu FJ, et al.
Comparison of serum and urine ELISA methods for the
diagnosis of Helicobacter pylori - a prospective pilot study.
Hepato-Gastroenterology 2004;51(60):1736–41.
Wu 2006a
Wu DC, Wu IC, Wang SW, Lu CY, Ke HL, Yuan
SSF, et al. Comparison of stool enzyme immunoassay
and immunochromatographic method for detecting
Helicobacter pylori antigens before and after eradication.
Diagnostic Microbiology and Infectious Disease 2006;56(4):
373–8.
Wu 2006b
Wu IC, Wang SW, Yang YC, Yu FJ, Kuo CH, Chuang CH,
et al. Comparison of a new office-based stool immunoassay
and c-13-ubt in the diagnosis of current Helicobacter pylori
infection. Journal of Laboratory and Clinical Medicine 2006;
147(3):145–9.
Wu 2013
Wu Q, Yang ZP, Xu P, Gao LC, Fan DM. Association
between Helicobacter pylori infection and the risk of
colorectal neoplasia: a systematic review and meta-analysis.
Colorectal Disease 2013;15(7):e352–64.
Xia 2000a
Xia HH, Kalantar JS, Wyatt JM, Adams S, Cheung K,
Eslick GD, et al. High sensitivity and specificity of a
laboratory-based serological test, pylori dtect ELISA, for
detection of Helicobacter pylori infection. Diagnostic
Microbiology & Infectious Disease 2000;36(2):69–74.
Xia 2000b
Xia HHX, Kalantar JS, Mitchell HM, Talley NJ. Can
Helicobacter pylori serology still be applied as a surrogate
marker to identify peptic ulcer disease in dyspepsia?.
Alimentary Pharmacology and Therapeutics 2000;14(5):
615–24.
Xia 2002
Xia HHX, Wong BCY, Wong WM, Tang VSY, Cheung
HKL, Sham FNF, et al. Optimal serological tests for the
detection of Helicobacter pylori infection in the Chinese
population. Alimentary Pharmacology and Therapeutics
2002;16(3):521–6.
Xiao 1991
Xiao SD, Pan ZJ, Zhang ZH, Jiang SJ. Enzyme-linked
immunosorbent assay for detection of immunoglobulin
g antibody against Helicobacter pylori. Chinese Medical
Journal 1991;104(11):904–8.
Xiao 2013
Xiao M, Wang Y, Gao Y. Association between Helicobacter
pylori infection and pancreatic cancer development: a meta-
analysis. PloS One 2013;8(9):e75559.
Xie 2008a
Xie F, Luo N, Blackhouse G, Goeree R, Lee HP. Cost-
effectiveness analysis of Helicobacter pylori screening in
prevention of gastric cancer in Chinese. International
Journal of Technology Assessment in Health Care 2008;24(1):
87–95.
Xie 2008b
Xie F, Luo N, Lee HP. Cost effectiveness analysis of
population-based serology screening and 13C-urea breath
test of Helicobacter pylori to prevent gastric cancer: A
Markov model. World Journal of Gastroenterology 2008;14
(19):3021–7.
Xue 2001
Xue FB, Xu YY, Wan Y, Pan BR, Ren J, Fan DM.
Association of H. pylori infection with gastric carcinoma: a
meta analysis. World Journal of Gastroenterology 2001;7(6):
801–4.
Yachi 1991
Yachi A, Yabana T, Imai K, Sugiyama T, Takayama Y,
Yoshida H, et al. Novel ELISA for serodiagnosis of
Helicobacter-pylori (campylobacter-pylori) infection-
associated gastritis. Frontiers of Mucosal Immunology 1991;
939:697–700.
Yakoob 2008
Yakoob J, Jafri W, Abbas Z, Abid S, Islam M, Ahmed Z.
The diagnostic yield of various tests for Helicobacter pylori
infection in patients on acid-reducing drugs. Digestive
Diseases and Sciences 2008;53(1):95–100.
Yakoob 2014
Yakoob J, Abbas Z. Agreement between serology and
histology for detection of Helicobacter pylori infection.
Journal of the College of Physicians & Surgeons - Pakistan
2014;24(10):779–80.
Yamakawa 1993
Yamakawa O, Takemori Y, Noda Y, Ohta G. Availability
of determination of serum anti-Helicobacter pylori igg
antibody in diagnosis of Helicobacter pylori infection.
Japanese Journal of Gastroenterology 1993;90(9):2090–6.
Yamamoto 1995
Yamamoto Y, Kouda M, Abe K, Sakurabayashi S, Sezai
S, Hirano M, et al. Detection of Helicobacter pylori by
culture and the 13C-urea breath test using an automated
breath 13C analyzer. Japanese Journal of Gastroenterology
1995;92(11):1839–45.
Yamamoto 1996
Yamamoto Y, Koda M, Abe K, Sakurabayashi M, Sezai H,
Hirano M, et al. The detection of Helicobacter pylori by
the 13C-urea breath test (13C-ubt) using automated breath
13C analyser. Nippon Shokakibyo Gakkai Zasshi [Japanese
Journal of Gastroenterology] 1996;93(1):68.
Yamamoto 2000
Yamamoto S, Uemura N, Okamoto S, Yamaguchi S,
Mashiba H, Tachikawa T. A new rapid test for detecting
anti-Helicobacter pylori antibody excreted into urine.
Helicobacter 2000;5(3):160–4.
Yamamoto 2003
Yamamoto T, Tamura M, Ishii T, Anjiki H, Hattori K,
Saitoh M, et al. Urinary antibody titers to Helicobacter
117Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
pylori and an impact of clinical characteristics. Journal of
Clinical Gastroenterology 2003;36(4):329–31.
Yamamoto 2005
Yamamoto T, Ishii T, Kawakami T, Sase Y, Horikawa C,
Aoki N, et al. Reliability of urinary tests for antibody to
Helicobacter pylori in patients with pulmonary tuberculosis.
World Journal of Gastroenterology 2005;11(3):412–4.
Yamamoto 2008
Yamamoto T, Ishii T, Sanaka M, Kuyama Y. Diagnosis
of Helicobacter pylori infection using rapirun h. Pylori
antibody detection kit. Expert Review of Molecular
Diagnostics 2008;8(5):565–9.
Yamaoka 1998
Yamaoka Y, Kodama T, Graham DY, Kashima K.
Comparison of four serological tests to determine the caga
or vaca status of Helicobacter pylori strains. Journal of
Clinical Microbiology 1998;36(11):3433–4.
Yamasaki 2004
Yamasaki T, Kume K, Yamasaki M, Yoshikawa I, Otsuki M.
Light meal decreased false-positive in the 13C-urea breath
test for the diagnosis of Helicobacter pylori infection.
Gastroenterology 2004;126(4 (suppl)):A187.
Yamashiro 1995
Yamashiro Y, Oguchi S, Otsuka Y, Nagata S, Shioya T,
Shimizu T. Helicobacter pylori colonization in children
with peptic ulcer disease iii. Diagnostic value of the 13C-
urea breath test to detect gastric h. Pylori colonization. Acta
Paediatrica Japonica (Overseas Edition) 1995;37(1):12–6.
Yan 2010
Yan J, Yamaguchi T, Odaka T, Suzuki T, Ohyama N,
Hara T, et al. Stool antigen test is a reliable method to
detect Helicobacter pylori in the gastric remnant after
distal gastrectomy for gastric cancer. Journal of Clinical
Gastroenterology 2010;44(1):73–4.
Yanez 2000
Yanez P, Madrazo-de la Graz A, Perez-Perez G, Cabrera L,
Muñoz O, Torres J. Comparison of invasive and noninvasive
methods for the diagnosis and evaluation of eradication
of Helicobacter pylori infection in children. Archives of
Medical Research 2000;31(4):415–21.
Yang 2005
Yang HR, Seo JK. Diagnostic accuracy of the c-13-urea
breath test in children: Adjustment of the cut-off value
according to age. Journal of Gastroenterology and Hepatology
2005;20(2):264–9.
Yang 2007
Yang YJ, Sheu BS, Lee SC, Wu JJ. More economic 25
mg c-13-urea breath test can be effective in detecting
primary Helicobacter pylori infection in children. Journal of
Gastroenterology and Hepatology 2007;22(3):335–9.
Yang 2008a
Yang HR, Seo JK. Helicobacter pylori stool antigen (HpSA)
tests in children before and after eradication therapy:
comparison of rapid immunochromatographic assay and
HpSA ELISA. Digestive Diseases & Sciences 2008;53(8):
2053–8.
Yang 2008b
Yang HR, Ko JS, Seo JK. Does the diagnostic accuracy
of the 13C-urea breath test vary with age even after the
application of urea hydrolysis rate?. Helicobacter 2008;13
(4):239–44.
Yang 2015
Yang BL, Yeh C, Kwong WG, Lee SD. A novel one-step
Helicobacter pylori saliva antigen test. Journal of the Chinese
Medical Association 2015;78(2):96–100.
Yasuda 2009
Yasuda A, Uchida T, Nguyen LT, Kawazato H, Tanigawa M,
Murakami K, et al. A novel diagnostic monoclonal antibody
specific for Helicobacter pylori caga of east Asian type.
APMIS; Acta Pathologica, Microbiologica, et Immunologica
Scandinavica 2009;117(12):893–9.
Ye 2005
Ye WM, Held M, Enroth H, Kraaz W, Engstrand L,
Nyren O. Histology and culture results among subjects
with antibodies to caga but no evidence of Helicobacter
pylori infection with IgG ELISA. Scandinavian Journal of
Gastroenterology 2005;40(3):312–8.
Ye 2014
Ye CL, Liao GP, He S, Pan YN, Kang YB, Zhang ZY.
Levofloxacin and proton pump inhibitor-based triple
therapy versus standard triple first-line therapy for
Helicobacter pylori eradication. Pharmacoepidemiology and
Drug Safety 2014;23(5):443–55.
Yee 2002
Yee YK, Yip KT, Que TL, Chang KK, Li KF, Lee CK, et
al. Efficacy of enzyme immunoassay for the detection of
Helicobacter pylori antigens in frozen stool specimens:
Local validation. Alimentary Pharmacology and Therapeutics
2002;16(10):1739–42.
Yilmaz 2006
Yilmaz O, Sen N, Kupelioglu AA, Simsel I. Detection of
h pylori infection by ELISA and western blot techniques
and evaluation of anti caga seropositivity in adult Turkish
dyspeptic patients. World Journal of Gastroenterology 2006;
12(33):5375–8.
Yin 2015
Yin SM, Zhang F, Shi DM, Xiang P, Xiao L, Huang YQ,
et al. Effect of posture on c-13-urea breath test in partial
gastrectomy patients. World Journal of Gastroenterology
2015;21(45):12888–95.
Yokota 1990
Yokota K, Oguma K, Yoshida H, Takayama Y, Sugiyama T,
Yabana T, et al. Comparison of three methods for detecting
campylobacter pylori and measurement of human antibody
titers against the whole organisms. Kansenshogaku Zasshi
[Journal of the Japanese Association for Infectious Diseases]
1990;64(5):597–603.
Yong 2006
Yong CS, Kim YI, Park SM, Kwon R, Han HH, Park JG,
et al. Trials of novel c-13-urea-containing capsule for more
118Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
economic and sensitive diagnosis of Helicobacter pylori
infection in human subjects. Archives of Pharmacal Research
2006;29(10):879–83.
Yoo 2007
Yoo JY, Kim N, Park YS, Hwang JH, Kim JW, Jeong
SH, et al. Detection rate of Helicobacter pylori against
a background of atrophic gastritis and/or intestinal
metaplasia. Journal of Clinical Gastroenterology 2007;41(8):
751–5.
Yoshida 1993
Yoshida J, Asaka M. 13C-urea breath test. Nippon Rinsho
[Japanese Journal of Clinical Medicine] 1993;51(12):
3196–200.
Yoshida 2000
Yoshida H, Hirota K, Ogura K, Maeda S, Shiratori Y, Sasaki
Y, et al. Determination of the optimal cut-off value for the
c-13 -urea breath test based on a Helicobacter pylori-specific
polymerase chain reaction assay. Journal of Gastroenterology
and Hepatology 2000;15(2):155–60.
Young 1995
Young EL, Cutler AF. Use of the c-13 urea breath test to
evaluate a new rapid urease test for Helicobacter-pylori.
Gastroenterology 1995;108(4 (suppl)):A265.
Young 1996
Young EL, Sharma TK, Cutler AF. Prospective evaluation of
a new urea-membrane test for the detection of Helicobacter
pylori in gastric antral tissue. Gastrointestinal Endoscopy
1996;44(5):527–31.
Zagari 1998
Zagari RM, Pozzato P, Bazzoli F, Fossi S, Ricciardiello
L, Nicolini G, et al. A comparative trial to optimize the
protocol of the c-13 urea breath test for the diagnosis of
Helicobacter pylori infection. Gastroenterology 1998;114
(4):A344.
Zagari 2003
Zagari RM, Bazzoli F. Helicobacter pylori testing in patients
with peptic ulcer bleeding. Digestive & Liver Disease 2003;
35(4):215–6.
Zagari 2005
Zagari RM, Pozzato P, Martuzzi C, Fuccio L, Martinelli G,
Roda E, et al. C-13-urea breath test to assess Helicobacter
pylori bacterial load. Helicobacter 2005;10(6):615–9.
Zagari 2012
Zagari RM, Eusebi LH, Rabitti S, Bazzoli F. 13C-urea
breath-id system for the real-time diagnosis of Helicobacter
pylori infection. Digestive and Liver Disease 2012;44:S208.
Zalabska 2010
Zalabska E. The evidence of Helicobacter pylori in gastric
biopsy and stool samples. Klinicka Mikrobiologie a Infekcni
Lekarstvi 2010;16(6):203–5.
Zambon 2004
Zambon CF, Basso D, Navaglia F, Mazza S, Razetti M,
Fogar P, et al. Non-invasive diagnosis of Helicobacter pylori
infection: Simplified c-13-urea breath test, stool antigen
testing, or DNA PCR in human feces in a clinical laboratory
setting?. Clinical Biochemistry 2004;37(4):261–7.
Zanetti 2002
Zanetti M, Vendramin R, Pieramico O. Stool antigen
test for non-invasive post-treatment assessment of
Helicobacter pylori infection: A comparative study between
immunoenzymatic and immunochromatographic tests. Gut
2002;51(Suppl):A111.
Zaremba 1995
Zaremba M, Rozkiewicz M, Pydzinska J, Stasiewicz J, Szalaj
W, Musiatowicz B, et al. Diagnostic value of the latex test
(Pyloriset) for detection of Helicobacter pylori antibodies in
adult patients with upper digestive tract diseases. Medycyna
Doswiadczalna i Mikrobiologia 1995;47(1-2):11–6.
Zawadzka-Gralec 2009
Zawadzka-Gralec A,Wroblewska M, Szaflarska PA,Mierzwa
G, Parzecka M, Bala G, et al. The analysis of usefulness
different diagnostic methods in children and adolescents
with Helicobacter pylori infection. Polski Merkuriusz
Lekarski 2009;26(151):24–8.
Zhang 1990
Zhang QB, Zhang SJ, Jia BQ. Enzyme-linked
immunosorbent assay for the serodiagnosis of campylobacter
pylori infection. Zhonghua Nei Ke Za Zhi [Chinese Journal
of Internal Medicine] 1990;29(8):457-60, 509.
Zhang 2002
Zhang WD, Xu ZM. Immunophenotyping of Helicobacter
pylori. World Chinese Journal of Digestology 2002;10(5):
509–12.
Zhang 2006
Zhang C, Guan Y, Yuan Z, Wu Y, Yamada N, Wen M,
et al. Analysis of histological detection of Helicobacter
pylori before and after eradication therapy: Compared
with the results of 13C-urea breath test. Chinese Journal of
Gastroenterology 2006;11(4):215–8.
Zhang 2007
Zhang L, Zhang JZ. Analysis of different diagnostic
methods of Helicobacter pylori infection in China. World
Chinese Journal of Digestology 2007;15(6):649–54.
Zhelezova 2006
Zhelezova GZ, Boyanova L. Stool antigen test for diagnosis
of Helicobacter pylori infection. Problems of Infectious and
Parasitic Diseases 2006;34(2):16–8.
Zheng 2004
Zheng Q, Chen X, Pan Y, Shi Y. Comparison of reliability
of 13C-urea breath tests using two different reagents for
clinical diagnosis of Helicobacter pylori infection. Chinese
Journal of Gastroenterology 2004;9(4):210–2.
Zhou 1996
Zhou DY, Xu KQ, Yang HT, Hoffman S, Marshall B.
Microdose c-14-urea breath test for the detection of h-
pylori in Chinese patients. Gastroenterology 1996;110(4
(suppl)):A307.
119Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Zhou 2000
Zhou H, Chan KL, Chu KM, Tam PKH. Intrafamilial
spread of Helicobacter pylori: A prospective study using
urea breath test. Journal of Pediatric Surgery 2000;35(11):
1672–5.
Zhou 2014
Zhou XY, Su J, Xu GX, Zhang GX. Accuracy of stool
antigen test for the diagnosis of Helicobacter pylori
infection in children: A meta-analysis. Clinics and Research
in Hepatology and Gastroenterology 2014;38(5):629–38.
Zhou 2017
Zhou Q, Li L, Ai Y, Pan Z, Guo M, Han J. Diagnostic
accuracy of the 14c-urea breath test in Helicobacter
pylori infections: A meta-analysis. Wiener Klinische
Wochenschrift 2017; Vol. 129, issue 1–2:38–45. [DOI:
10.1007/s00508-016-1117-3
Zhu 2002a
Zhu Y, Lin J, Li D, Du Q, Qian K, Wu Q, et al.
Helicobacter pylori antigen and its igg, iga -type specific
immunocomplexes in sera from patients with Helicobacter
pylori infection. Chinese Medical Journal 2002;115(3):
381–3.
Zhu 2002b
Zhu YY, Wu JC, Zhang ZH. Emissive spectral analysis
applied in n-15 excretion test of Helicobacter pylori. Society
of Photo-optical Instrumentation Engineers (SPIE): Optics in
health care and biomedical optics: Diagnostics and treatment
2002;4916:194–6.
Zhukhovitskii 2005
Zhukhovitskii VG, Gorbacheva AP, Golovkin BA,
Gidaiatova LA. Serological diagnosis of Helicobacter
infection: Comparison of the analytical capacities of
three test systems for enzyme immunoassay. Klinicheskaia
Laboratornaia Diagnostika 2005;11:12–4.
Zhuo 2008
Zhuo XL, Wang Y, Zhuo WL, Zhang XY. Possible
association of Helicobacter pylori infection with laryngeal
cancer risk: an evidence-based meta-analysis. Archives of
Medical Research 2008;39(6):625–8.
Zipser 2000
Zipser RD, Parikh MV. Is repeat testing needed for
Helicobacter pylori?. Journal of the American Board of
Family Practice 2000;13(6):449–50.
Zubillaga 1997
Zubillaga M, Oliveri P, Calcagno ML, Goldman C, Caro
R, Mitta A, et al. Min 14c ubt: A combination of gastric
basal transit and 14c-urea breath test for the detection of
Helicobacter pylori infection in human beings. Nuclear
Medicine & Biology 1997;24(6):565–9.
Zubillaga 1999
Zubillaga M, Oliveri P, Panarello H, Buzurro M, Adami
J, Goldman C, et al. Stable isotope techniques for the
detection of Helicobacter pylori infection in clinical
practice. 13C-urea breath test in different experimental
conditions. Acta Physiologica, Pharmacologica et Therapeutica
Latinoamericana 1999;49(2):101–7.
References to other published versions of this review
Gurusamy 2016
Gurusamy KS, Yaghoobi M, Davidson BR. Non-invasive
diagnostic tests for Helicobacter pylori infection. Cochrane
Database of Systematic Reviews 2016, Issue 2. [DOI:
10.1002/14651858.CD012080
∗ Indicates the major publication for the study
120Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Adamopoulos 2009a
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 73
Female: 24 (33%)
Age: 63 years
Presentation:
1. People who had undergone endoscopy (for various indications)
Setting: secondary care, Greece
Index tests Index test: urea breath test -13C
Further details:
Technical specifications: manufacturer - Infai Institut für Biomedizinische; Analytik & NMR-
Imaging GmbH, Bochum
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and histopathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Adamopoulos 2009a (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
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Adamopoulos 2009b
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 31
Female: 8 (25.8%)
Age: 71 years
Presentation:
1. People who had undergone Billroth II gastrectomy and endoscopy (for various indications)
Setting: secondary, Greece
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: manufacturer - Infai Institut für Biomedizinische; Analytik & NMR-
Imaging GmbH, Bochum
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and histopathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low High
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Adamopoulos 2009b (Continued)
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Aguilar 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 31
Female: 5 (16.1%)
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Aguilar 2007 (Continued)
Age: not stated
Presentation:
1. Dyspepsia
Setting: secondary care, Peru
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: Not stated
Performed by: Not stated
Criteria for positive diagnosis: disintegrations per minute > 200 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Low
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Aguilar 2007 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Al-Fadda 2000
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 64
Female: not stated
Age: not stated
Presentation:
1. Patients with upper gastroinstestinal symptoms
Setting: secondary care, Peru
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Al-Fadda 2000 (Continued)
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: Not stated
Performed by: Not stated
Criteria for positive diagnosis: CO2 recovery > 0.55 (20 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Low
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
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Al-Fadda 2000 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Allardyce 1997
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 63
Female: 26 (41.3%)
Age: not stated
Presentation:
1. Dyspepsia
Setting: secondary care, New Zealand
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: Not stated
Performed by: Not stated
Criteria for positive diagnosis: disintegrations per minute > 49 (time not stated)
128Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Allardyce 1997 (Continued)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Low
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
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Allardyce 1997 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
No
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Argentieri 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 215
Female: not stated
Age: not stated
Presentation:
1. Children undergoing upper gastrointestinal endoscopy
Exclusion:
1. Recent H pylori treatment
Setting: secondary care, Italy
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA
Performed by: Not stated
Criteria for positive diagnosis: Not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
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Argentieri 2007 (Continued)
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Argentieri 2007 (Continued)
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Arikan 2004
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion:
1. Malignancy
2. Taken antibiotics or proton pump inhibitors in last 2 weeks
Setting: secondary care, Turkey
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA
Performed by: Not stated
Criteria for positive diagnosis: Not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: Not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
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Arikan 2004 (Continued)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
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Arikan 2004 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Atli 2012
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 57 (57%)
Age: 71 years
Presentation:
1. Patients with dyspepsia and symptoms or signs related to peptic ulcer > 65 years of age
Exclusion:
1. Patients who had taken antibiotics or anti-ulcer treatment in the past 2 weeks
2. Advanced dementia
3. Cerbrovascular disease
4. Advanced respiratory problems
5. Alarm symptoms for malignancy
Setting: secondary setting, Turkey
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: counts per minute > 50 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
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Atli 2012 (Continued)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
135Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Atli 2012 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Behrens 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 252
Female: not stated
Age: not stated
Presentation:
1. Children (3 years to 18 years) with abdominal pain, nausea, or vomiting
Exclusion criteria:
1. Previous treatment with antibiotics or proton pump inhibitors
2. WBC < 3500/microlitre or platelets < 100,000/microlitre
Setting: secondary setting, Germany
Index tests Index test: urea breath test -13C
Further details:
Technical specifications: Promochem, Wesel
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5.0% (30 minutes and 60 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
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Behrens 1999 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Behrens 1999 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Bosso 2000
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 95
Female: not stated
Age: not stated
Presentation:
1. Patients with upper abdominal symptoms
Exclusion:
1. Patients with previous gastric surgery
Setting: secondary care, France
Index tests Index test: urea breath test -13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Bosso 2000 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Bosso 2000 (Continued)
Unclear
Ceken 2011
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 67 (67%)
Age: 48 years
Presentation:
1. Patients with dyspepsia
Exclusion:
1. Antibiotics or anti-ulcer treatment within last 4 weeks
2. Gastric surgery
Setting: secondary care, France
Index tests Index test: stool antigen test
Further details:
Technical specifications: Helicobacter Antigen Quick Castte
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Ceken 2011 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Chen 1991
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 96
Female: not stated
Age: not stated
Presentation:
1. Adult patients with dyspepsia
Setting: secondary care, China
Index tests Index test: serology
Further details:
Technical specifications: Pyloriset
Performed by: not stated
Criteria for positive diagnosis: presence of agglutination (within 3 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
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Chen 1991 (Continued)
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Chey 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
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Chey 1998 (Continued)
Patient characteristics and set-
ting
Sample size: 287
Female: 140 (48.8%)
Age: 53 years
Presentation:
1. People undergoing endoscopy
Exclusion:
1. Recent treatment for H pylori or anti-ulcer treatment
Setting: Variable settings, USA
Index tests Index test 1a: serology
Further details:
Technical specifications: HM-CAP (Enteric Products Inc.)
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 1b: serology (serum)
Further details:
Technical specifications: Hp Chek (Chem Trak)
Performed by: not stated
Criteria for positive diagnosis: 2 red lines
Index test 1c: serology (whole blood)
Further details: same as for index test 2
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Chey 1998 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
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Czerwionka-Szaflarska 2007
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 66 (66%)
Age: 13 years
Presentation:
1. Children with gastrointestinal disorders
Setting: secondary care, Poland
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0 % (time not stated)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
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Czerwionka-Szaflarska 2007 (Continued)
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
D’Elios 2000
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 256
Female: not stated
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D’Elios 2000 (Continued)
Age: not stated
Presentation:
1. Patients with dyspepsia
Exlusion:
1. Gastric surgery
2. Recent treatment for ulcer or H pylori
3. Pulmonary failure
Setting: secondary care, Italy
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: AB Analitica
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
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D’Elios 2000 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Debongnie 1991
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with previous gastric surgery excluded
Patient characteristics and set-
ting
Sample size: 230
Female: not stated
Age: not stated
Presentation:
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Debongnie 1991 (Continued)
1. Patients referred for upper gastrointestinal surgery
Excluded:
1. Gastric surgery
2. Haematologic disease
3. Immunodeficiency
4. Gastric cancer
5. Recent treatment for ulcer or H pylori
6. Atrophic gastritis
Setting: secondary care, Belgium
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: specific activity > 0.3% (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Cresyl Violet stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 27 (11.7%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Urea breath test-14C
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Debongnie 1991 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Dede 2015
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 30
Female: 8 (26.7%)
Age: 55 years
Presentation:
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Dede 2015 (Continued)
1. Patients who had undergone partial gastrectomy
Setting: secondary care, Turkey
Index tests Index test 1: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 2: urea breath test-14C
Further details:
Technical specifications: Heliprobe System, Kibion AB
Performed by: not stated
Different criteria for positive diagnosis:
• Counts per minute > 23 (10 minutes)
• Counts per minute > 29 (30 minutes)
• Counts per minute > 35 (20 minutes)
• Counts per minute > 50 (10 minutes)
• Counts per minute > 50 (20 minutes)
• Counts per minute > 50 (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and modified Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Dede 2015 (Continued)
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
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Dede 2015 (Continued)
Were all patients included in the
analysis?
Unclear
High
Delvin 1999
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 79
Female: not stated
Age: not stated
Presentation:
1. Children with gastrointestinal symptoms
Exclusion:
1. Chilren with functional abdominal pain
2. Anti-ulcer or H pylori treatment in last 6 weeks
Setting: secondary care, Canada
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: Dia 13-Helico; Dianatec iso
Performed by: not stated
Different criteria for positive diagnosis:
• Delta over baseline > 2.0% (30 minutes)
• Delta over baseline > 2.5% (30 minutes)
• Delta over baseline > 3.0% (30 minutes)
• Delta over baseline > 3.5% (30 minutes)
• Delta over baseline > 4.0% (30 minutes)
• Delta over baseline > 4.5% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
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Delvin 1999 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Delvin 1999 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Dinler 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 77
Female: 48 (62.3%)
Age: 13 years
Presentation:
1. Children with recurrent abdominal pain
Setting: secondary care, Turkey
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Dinler 1999 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Dinler 1999 (Continued)
Unclear
Duan 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 149
Female: 35 (23.5%)
Age: 44 years
Presentation:
1. Patients with gastritis or gastric ulcer
Exclusion:
1. Treatment with antibiotics or bismuth in the previous 2 months
2. Previous gastric surgery or gastric cancer
Setting: secondary care, China
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: Finniga, MAT-252, USA
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5 per thousand (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Duan 1999 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Eggers 1990
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Setting: secondary care, Germany
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 8 (7.4%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
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Eggers 1990 (Continued)
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Ekesbo 2006
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with previous gastric surgery excluded
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Ekesbo 2006 (Continued)
Patient characteristics and set-
ting
Sample size: 126
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing gastroscopy for dyspepsia or gastrointestinal bleeding
Setting: primary care, Sweden
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: staining of a 120 kilodalton protein gel band and/or at least 2 of 5
proteins between 28 - 33 kilodaltons
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with immunostaining
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 40 (24.1%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Serology
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Ekesbo 2006 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
El-Din 2013
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients without pathologic data excluded
Patient characteristics and set-
ting
Sample size: 19
Female: 6 (31.6%)
Age: 47 years
Presentation:
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El-Din 2013 (Continued)
1. Patients with upper gastrointestinal disorders
Setting: secondary care, Egypt
Index tests Index test 1: serology
Further details:
Technical specifications: Ridascreen
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 2: stool antigen test
Further details:
Technical specifications: Immunodiagnostik AG
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 33 (63.5%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Stool Antigen Test
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El-Din 2013 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
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El-Mekki 2011
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 55
Female: 35 (63.6%)
Age: 37 years
Presentation:
1. Patients with dyspepsia
Setting: secondary care, Saudi Arabia
Index tests Index test: serology
Further details:
Technical specifications: HeliSAL TM serum
Performed by: not stated
Criteria for positive diagnosis: > 1 units/ml
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
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El-Mekki 2011 (Continued)
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
El-Nasr 2003
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 50
Female: 16 (32%)
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El-Nasr 2003 (Continued)
Age: 36 years
Presentation:
1. Patients with dyspepsia
Setting: secondary care, Egypt
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA, Meridien Diagnostics
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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El-Nasr 2003 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Eltumi 1999
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 50
Female: 17 (34%)
Age: 11 years
Presentation:
1. Children referred for endoscopy
Exclusion:
1. Recent treatment for H pylori
Setting: Tertiary care, UK
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Eltumi 1999 (Continued)
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5 units/ml (40 minutes)
Index test 2: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Eltumi 1999 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Epple 1997
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 126
Female: 70 (55.6%)
Age: 48 years
Presentation:
1. Patients undergoing routine endoscopy
Exclusion:
1. Gastric cancer
2. Previous gastric surgery
Setting: secondary care, Germany
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > Mean + 2 standard deviations above normal level (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
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Epple 1997 (Continued)
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Fallone 1995
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: consecutive patients
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Fallone 1995 (Continued)
Patient characteristics and set-
ting
Sample size: 50
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion
1. Conditions that would make gastric biopsy dangerous
2. Lactating
3. Pregnant or women of child-bearing potential who were not using adequate control
Setting: secondary care, Canada
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 1.5% excretion (15 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Silver stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 4 (7.4%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
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Fallone 1995 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Fallone 1996
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 106
Female: 51 (48.1%)
Age: 54 years
Presentation:
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Fallone 1996 (Continued)
1. Patients undergoing endoscopy
Exclusion:
1. Recent treatment for H pylori
Setting: secondary care, Canada
Index tests Index test: serology
Further details:
Technical specifications: HeliSAL TM serum
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Fallone 1996 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Fanti 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 84
Female: 45 (53.6%)
Age: 50 years
Presentation:
1. Patients with dyspepsia
2. Not on current treatment for H pylori or ulcers
Setting: secondary care, Italy
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Fanti 1999 (Continued)
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450/630 nm > 0.150
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
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Fanti 1999 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Faruqui 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 50
Female: 26 (52%)
Age: 36 years
Presentation:
1. Patients with dyspepsia despite anti-ulcer treatment
Exclusion:
1. Myocardial infarction in the last 6 months
2. Cardiac failure
3. Bleeding diathesis
Setting: secondary care, Pakistan
Index tests Index test: stool antigen test
Further details:
Technical specifications: not stated
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Faruqui 2007 (Continued)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
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Faruqui 2007 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Ferrara 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 56 (56%)
Age: not stated
Presentation:
1. Patients with dyspepsia
2. Not on current treatment for H pylori
Setting: secondary care, Italy
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
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Ferrara 1998 (Continued)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
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Ferrara 1998 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Formichella 2013
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 500
Female: 263 (52.6%)
Age: 50 years
Presentation:
1. Patients undergoing routine endoscopy
Exclusion:
1. Undergone H pylori eradication therapy
2. Active immunosuppressive therapy
3. Suffering from malignant diseases
Setting: secondary care, Germany
Index tests Index test 1a: serology
Further details:
Technical specifications: recomWell ELISA (Mikrogen)
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 1b: serology
Further details:
Technical specifications: not stated
Performed by: not stated
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Formichella 2013 (Continued)
Criteria for positive diagnosis: 2 or more antigens
Index test 1c: serology
Further details:
Technical specifications: Immunoblot Helicobacter (Mikrogen)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain, Warthin-Starry stain, and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
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Formichella 2013 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Germana 2001
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 52 (52%)
Age: 51 years
Presentation:
1. Patients with dyspepsia
2. Not on current treatment for H pylori
Setting: secondary care, Italy
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: Wagner Analysen - Tecturik
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
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Germana 2001 (Continued)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and immunohistochemical stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
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Germana 2001 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Graham 1996a
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 75
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing screening for H pylori and who underwent endoscopy
Setting: secondary care, USA
Index tests Index test: serology
Further details:
Technical specifications: FlexSure HP
Performed by: not stated
Criteria for positive diagnosis: pink line
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
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Graham 1996a (Continued)
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 476 (86.4%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
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Graham 1996a (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Gramley 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 22
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Setting: secondary care, USA
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
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Gramley 1999 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Gramley 1999 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Guo 2011
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 328
Female: 90 (27.4%)
Age: 47 years
Presentation:
1. Patients with gastrointestinal symptoms
2. No previous treatment or stopped treatment for H pylori
Setting: secondary care, China
Index tests Index test: stool antigen test
Further details:
Technical specifications: Kyowa pharmaceutical
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with silver stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Guo 2011 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Gurbuz 2005
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with previous gastric surgery excluded
Patient characteristics and set-
ting
Sample size: 65
Female: 45 (69.2%)
Age: not stated
Presentation:
1. Patients undergoing routine endoscopy
Exclusion:
1. Undergone H pylori eradication therapy
2. Pregnancy or lactation
3. Prior gastric surgery
Setting: secondary care, Turkey
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: Heliprobe system
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 3 (4.4%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
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Gurbuz 2005 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
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Hafeez 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with inadequate breath samples excluded
Patient characteristics and set-
ting
Sample size: 60
Female: not stated
Age: not stated
Presentation:
1. Children with gastrointestinal symptoms
Setting: secondary care, Pakistan
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (10 minutes, 20 minutes, and 30 minutes)
Index test 2: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 6 (10%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
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Hafeez 2007 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Hafeez 2007 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Han 2012
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 99
Female: not stated
Age: not stated
Presentation:
1. Patients who had undergone urea breath tests and endoscopy
Setting: secondary care, South Korea
Index tests Index test: urea breath test - unknown isotope
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Han 2012 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test - unknown isotope
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Inelmen 2004
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 122
Female: 81 (66.4%)
Age: 80 years
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Setting: secondary care, Italy
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: BreathQuality-UBT 13C-Urea Kit, Zeta Farmaceutici SpA
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5.0% (30 minutes)
Index test 2: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: not stated
Criteria for positive diagnosis: definite yellow colour
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Inelmen 2004 (Continued)
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Inelmen 2004 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Iqbal 2013
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 50
Female: 19 (38%)
Age: 41 years
Presentation:
1. Patients who underwent upper gastrointestinal endoscopy
Setting: secondary care, Pakistan
Index tests Index test: serology
Further details:
Technical specifications: HpG screen ELISA kit
Performed by: not stated
Criteria for positive diagnosis: > 7 units/ml
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Iqbal 2013 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Islam 2005
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: neither - patients without stool samples excluded
Patient characteristics and set-
ting
Sample size: 112
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Setting: secondary care, New Zealand
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: pathologists
Criteria for positive diagnosis: Absorbance 450/630 nm > 0.120
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Immunoperoxidase stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 15 (11.8%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
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Islam 2005 (Continued)
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Ivanova 2010
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
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Ivanova 2010 (Continued)
Patient characteristics and set-
ting
Sample size: 33
Female: 16 (48.5%)
Age: 42 years
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Setting: secondary care, Bulgaria
Index tests Index test: serology
Further details:
Technical specifications: Rapid HP, US Meds
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
Unclear
205Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ivanova 2010 (Continued)
dard?
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Jekarl 2013
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with a recent antibiotic treatment were excluded
Patient characteristics and set-
ting
Sample size: 209
Female: 85 (40.7%)
Age: not stated
Presentation:
1. Patients undergoing routine health check-up and upper gastrointestinal endoscopy
Exclusion:
1. Recent ulcer or H pylori treatment
2. Previous gastric surgery
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Jekarl 2013 (Continued)
3. Previous gastric cancer
Setting: secondary care, Korea
Index tests Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: Absence of yellow
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 57 (21.4%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
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Jekarl 2013 (Continued)
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Jensen 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear
Patient characteristics and set-
ting
Sample size: 35
Female: not stated
Age: not stated
Presentation:
1. Patients referred for endoscopy
Exclusion:
Recent H pylori treatment
Setting: secondary care, USA
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
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Jensen 1998 (Continued)
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 200 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 7 (16.7%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
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Jensen 1998 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Jordaan 2008
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with previous gastrointestinal surgery excluded
Patient characteristics and set-
ting
Sample size: 103
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Exclusion criteria:
1. Recent H pylori therapy
2. Major gastrointestinal surgery
Setting: secondary care, South Africa
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.5% (time not stated)
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Jordaan 2008 (Continued)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 8 (7.2%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
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Jordaan 2008 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Kalach 1998a
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 35 (35%)
Age: 11 years
Presentation:
1. Children undergoing upper gastrointestinal endoscopy for recurrent epigastric pain or upper GI
tract disorders
Exclusion:
1. Recent H pylori treatment
Setting: secondary care, France
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 6 IU /ml
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
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Kalach 1998a (Continued)
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
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Kalach 1998a (Continued)
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Kamel 2011
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 55
Female: not stated
Age: 67 years
Presentation:
1. Older adults with dyspepsia and no gastrointestinal bleeding
Setting: secondary care, Egypt
Index tests Index test: stool antigen test
Further details:
Technical specifications: CerTest H pylori Card
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
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Kamel 2011 (Continued)
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Kamel 2011 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Kim 2016
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 107
Female: 56 (52.3%)
Age: 41 years
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Exclusion:
1. Recent H pylori treatment
Setting: secondary care, South Korea
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: UbiT-IR300 apparatus
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 2.5% (20 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
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Kim 2016 (Continued)
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
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Kim 2016 (Continued)
Unclear
Korstanje 2006
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 20
Female: 9 (45%)
Age: 68 years
Presentation:
1. Patients with atrophic gastritis
Setting: primary care, Netherlands
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: INFAI, Bochum, Germany
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
Index test 2: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: Absorbance (wavelength not stated) > 0.320
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Korstanje 2006 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear High
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
219Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Korstanje 2006 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Kuloglu 2008
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: neither - patients without a either a stool sample or a breath sample
excluded
Patient characteristics and set-
ting
Sample size: 109
Female: 58 (53.2%)
Age: 12 years
Presentation:
1. Children with symptoms suggestive of H pylori infection
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Turkey
Index tests Index test 1: urea breath test-14C
Further details:
Technical specifications: Heliprobe BreathCard
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (10 minutes)
Index test 2: stool antigen test
Further details:
Technical specifications: Rapid HpSA test (L NEAR Chemical)
Performed by: not stated
Criteria for positive diagnosis: pinkish red band (within 10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
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Kuloglu 2008 (Continued)
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 16 (12.8%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
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Kuloglu 2008 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Ladas 2002a
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 130
Female: 48 (36.9%)
Age: 50 years
Presentation:
1. Patients with dyspepsia
Exclusion:
1. Recent H pylori therapy
2. Malignancy
3. Pregnancy
4. Gastric surgery
Setting: secondary care, Greece
Index tests Index test 1a: serology
Further details:
Technical specifications: Pyloriset EIA-G
Performed by: not stated
222Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ladas 2002a (Continued)
Criteria for positive diagnosis: ≥ 300
Index test 1b: serology
Further details:
Technical specifications: Milenia H Pylori IgG
Performed by: not stated
Criteria for positive diagnosis: ≥ 44
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
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Ladas 2002a (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Lahner 2004
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 27
Female: 19 (70.4%)
Age: 52 years
Presentation:
1. Patients with atrophic gastritis
Exclusion criteria:
1. Gastric surgery
2. Gastric malignancy
3. Recent H pylori treatment
4. Diarrhoea
5. Constipation
Setting: not stated
224Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lahner 2004 (Continued)
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.5% (15 minutes and 30 minutes)
Index test 2: stool antigen test
Further details:
Technical specifications: HpSA, Meridian
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450 nm ≥ 0.160
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Lahner 2004 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
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Lee 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 71
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy for duodenitis, gastritis, duodenal ulcer, gastric ulcer
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Singapore
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 6% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
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Lee 1998 (Continued)
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Logan 1991a
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
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Logan 1991a (Continued)
Patient characteristics and set-
ting
Sample size: 50
Female: 24 (48%)
Age: 51 years
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Exclusion criteria:
1. Recent H pylori infection
2. Previous gastric surgery
Setting: secondary care, UK
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > Mean + 3 standard deviations above normal level (60 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
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Logan 1991a (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
No
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Lombardo 2003
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - histology performed in a subset of patients
Patient characteristics and set-
ting
Sample size: 28
Female: not stated
Age: not stated
Presentation:
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Lombardo 2003 (Continued)
1. Patients who had undergone gastrectomy
Setting: secondary care, Italy
Index tests Index test: urea breath test - unknown isotope
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4 perml (at 5-minute intervals up to 30minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 72 (72%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High High
DOMAIN 2: Index Test Urea breath test - unknown isotope
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Lombardo 2003 (Continued)
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
No
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Lottspeich 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with recent antibiotic treatment were excluded
Patient characteristics and set-
ting
Sample size: 56 for urea breath test, 100 for stool antigen test
Female: not stated
Age: 10 years
Presentation:
1. Children with abdominal symptoms undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Germany
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
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Lottspeich 2007 (Continued)
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 5.0% (30 minutes)
Index test 2: stool antigen test
Further details:
Technical specifications: IDEIA HpStAR assay (DakoCytomation)
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450/620 nm to 650 nm ≥ 0.150
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain or Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 44 (44%) for urea breath test; 0 (0%) for
stool antigen test
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Lottspeich 2007 (Continued)
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Luthra 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
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Luthra 1998 (Continued)
Patient characteristics and set-
ting
Sample size: 240
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing upper gastrointestinal endoscopy
Excluded:
1. People with upper GI bleeding
2. People with coagulation abnormalities
Setting: not stated
Index tests Index test: serology
Further details:
Technical specifications: Pyloristat (BioWhittaker)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain, immunostain, or Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
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Luthra 1998 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Mana 2001a
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 182
Female: not stated
Age: not stated
Presentation:
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Mana 2001a (Continued)
1. Patients undergoing upper gastrointestinal endoscopy
2. People not taking H pylori medication
Setting: secondary care, Belgium
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Multiple criteria for positive diagnosis:
• Delta over baseline > 3.0% (10 minutes)
• Delta over baseline > 3.0% (20 minutes)
• Delta over baseline > 3.0% (30 minutes)
• Delta over baseline > 3.5% (10 minutes)
• Delta over baseline > 3.5% (20 minutes)
• Delta over baseline > 3.5% (30 minutes)
• Delta over baseline > 4.0% (10 minutes)
• Delta over baseline > 4.0% (20 minutes)
• Delta over baseline > 4.0% (30 minutes)
• Delta over baseline > 4.5% (10 minutes)
• Delta over baseline > 4.5% (20 minutes)
• Delta over baseline > 4.5% (30 minutes)
• Delta over baseline > 5.0% (10 minutes)
• Delta over baseline > 5.0% (20 minutes)
• Delta over baseline > 5.0% (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with immunohistochemistry and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
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Mana 2001a (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
238Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mansour-Ghanaei 2011
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 125
Female: 65 (52%)
Age: 36 years
Presentation:
1. Patients with dyspepsia
Exclusion:
1. Recent or past H pylori eradication
2. Pregnancy
3. Severe cardiopulmonary disorders or other life-threatening illnesses
Setting: secondary care, Iran
Index tests Index test 1: urea breath test-14C
Further details:
Technical specifications: Heliprobe BreathCard
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (15 minutes)
Index test 2: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 11 IU
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
239Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Mansour-Ghanaei 2011 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
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Mansour-Ghanaei 2011 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Low
Mion 1994
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 95
Female: not stated
Age: not stated
Presentation:
1. Patients with upper abdominal symptoms
Exclusion:
1. Patients with previous gastric surgery
Setting: secondary care, France
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > + 3 delta 0/00 (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
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Mion 1994 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
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Mion 1994 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Misawa 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 114
Female: 46 (40.4%)
Age: not stated
Presentation:
1. Patients with gastritis, gastric, or duodenal ulcers
Setting: secondary care, Japan
Index tests Index test 1a: serology (IgA)
Further details:
Technical specifications: GAP-IgA (BioMerica)
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 1b: serology (IgG)
Further details:
Technical specifications: GAP-IgG (BioMerica)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with immunostaining (Carnoy’s solution)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
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Misawa 1998 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Misawa 1998 (Continued)
Were all patients included in the
analysis?
Unclear
Unclear
Mohammadian 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 179
Female: 108 (60.3%)
Age: 54 years
Presentation:
1. Patients undergoing endoscopy for gastrointestinal problems
Setting: secondary care, Iran
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Mohammadian 2007 (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Monteiro 2001a
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 104
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori therapy
2. Bleeding disorders or other conditions with contraindication for endoscopy or biopsy
Setting: secondary care, France
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: ABCA, Europa Scientific
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 2a: serology
Further details:
Technical specifications: Pyloriset EIA Kit (Orion Diagnostica)
Performed by: not stated
Criteria for positive diagnosis: > = 300
Index test 2b: serology
Further details:
Technical specifications: Helicoblot Immunoblot kit
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 3: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA, Meridian
Performed by: not stated
Criteria for positive diagnosis: Absorbance (wavelength not reported) > = 0.160
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
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Monteiro 2001a (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Monteiro 2001a (Continued)
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Morales 1995
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 104
Female: 52 (50%)
Age: 50 years
Presentation:
1. Patients with upper abdominal symptoms
Setting: Outpatients, Mexico
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Morales 1995 (Continued)
Index tests Index test 1: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Multiple criteria for positive diagnosis:
First criterion: ≥ 1.6% excretion (time not stated)
Second criterion: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
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Morales 1995 (Continued)
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Noguera 1998
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear
Patient characteristics and set-
ting
Sample size: 38
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing urea breath tests and endoscopic biopsy
Setting: secondary care, Argentina
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Multiple criteria for positive diagnosis:
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Noguera 1998 (Continued)
• > 1% excretion (10 minutes)
• > 1% excretion (20 minutes)
• > 1% excretion (30 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 87 (69.6%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
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Noguera 1998 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Novis 1991
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 76
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy for gastrointestinal symptoms
Setting: secondary care, Israel
Index tests Index test 1: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Multiple criteria for positive diagnosis:
• > 4.7% excretion (5 minutes)
• > 4.7% excretion (10 minutes)
• > 4.7% excretion (15 minutes)
• > 4.7% excretion (20 minutes)
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Novis 1991 (Continued)
• > 4.7% excretion (25 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
Yes
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Novis 1991 (Continued)
condition?
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Ogata 2001
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 47
Female: 27 (57.4%)
Age: 12 years
Presentation:
1. Children with dyspepsia undergoing endoscopy
Exclusion:
1. Recent H pylori treatment
2. Immunosuppressive treatment or chemotherapy
3. Extradigestive disease
Setting: secondary care, Brazil
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: Isomed
Performed by: not stated
Criteria for positive diagnosis: > 3% excretion (time not stated)
Index test 2: serology
Further details:
Technical specifications: Cobas Core II (Roche)
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Ogata 2001 (Continued)
Performed by: not stated
Criteria for positive diagnosis: > 7 U/ml
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear High
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Serology
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Ogata 2001 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Ozturk 2003
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 73
Female: 56 (74.6%)
Age: 41 years
Presentation:
257Non-invasive diagnostic tests for Helicobacter pylori infection (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ozturk 2003 (Continued)
1. Patients with dyspepsia
Setting: secondary care, Turkey
Index tests Index test 1a: urea breath test-14C
Further details:
Technical specifications: Heliprobe BreathCard
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (10 minutes)
Index test 1b: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 100 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
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Ozturk 2003 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Peitz 2001
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 145
Female: 87 (60%)
Age: 59 years
Presentation:
1. Patients with dyspepsia
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Peitz 2001 (Continued)
Exclusion criteria:
1. Recent H pylori treatment
2. Recent NSAID treatment
3. Previous gastric surgery
4. Clotting disorders
Setting: secondary care, Germany
Index tests Index test: serology
Further details:
Technical specifications: Helisa Rapid Whole Blood Test (Cortecs Diagnostics Ltd)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
Unclear
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Peitz 2001 (Continued)
dard?
If a threshold was used, was it
pre-specified?
Yes
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Peura 1996
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 200
Female: 118 (59%)
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
2. Gastric surgery
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Peura 1996 (Continued)
Setting: secondary care, USA
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 200 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
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Peura 1996 (Continued)
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Puspok 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 72
Female: 42 (58.3%)
Age: 55 years
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Austria
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
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Puspok 1999 (Continued)
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450/620 nm ≥ 0.100
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
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Puspok 1999 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Qadeer 2009
Study characteristics
Patient sampling Type of study: prospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 50 (50%)
Age: 39 years
Presentation:
1. Patients with dyspepsia
Exlusion criteria:
1. Recent H pylori therapy
2. Not on anti-coagulant therapy
3. Oral anticoagulants or NSAID treatment
Setting: secondary care, Pakistan
Index tests Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: pink-red band
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Qadeer 2009 (Continued)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Qadeer 2009 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Rafeey 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 96
Female: 31 (32.3%)
Age: 8 years
Presentation:
1. Children with dyspepsia or abdominal pain
Exclusion criteria:
1. Recent H pylori treatment
2. Diarrhoea
Setting: secondary care, Iran
Index tests Index test: stool antigen test
Further details:
Technical specifications: Equipar HPSA test
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
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Rafeey 2007 (Continued)
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
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Rafeey 2007 (Continued)
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Rasool 2007
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 94
Female: 34 (36.2%)
Age: 41 years
Presentation:
1. Patients with dyspepsia
Exclusion criteria:
1. Recent H pylori treatment
2. Pregnancy
3. Gastric surgery
Setting: secondary care, Pakistan
Index tests Index test: urea breath test
Further details:
Technical specifications: Heliprobe BreathCard
Performed by: not stated
Criteria for positive diagnosis: Counts per minute > 50 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
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Rasool 2007 (Continued)
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
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Rasool 2007 (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Rathbone 1986
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 73
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Setting: secondary care, UK
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > Mean + 2 standard deviations above normal level
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
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Rathbone 1986 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Rathbone 1986 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Safe 1993
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 59 (59%)
Age: 72 years
Presentation:
1. Elderly dyspeptic patients
Setting: secondary care, UK
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 10 units/ml
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Safe 1993 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Yes
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Salles-Montaudon 2002
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 107
Female: 71 (66.4%)
Age: 85 years
Presentation:
1. Adults > 75 years
Exclusion criteria:
1. Contraindication to biopsy
Setting: secondary care, Switzerland
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: ABCA, Europa Scientific
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 3.5% (30 minutes)
Index test 2: serology
Further details:
Technical specifications: Pyloriset EIA Kit (Orion Diagnostica)
Performed by: not stated
Criteria for positive diagnosis: > 300 Units
Index test 3: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA, Meridian
Performed by: not stated
Criteria for positive diagnosis: Absorbance (wavelength not reported) > 0.160
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
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Salles-Montaudon 2002 (Continued)
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
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Salles-Montaudon 2002 (Continued)
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Schilling 2001
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 68
Female: 20 (29.4%)
Age: 62 years
Presentation:
1. Patients with partial gastric resection
Exclusion criteria:
Recent H pylori treatment
Setting: secondary care, Germany
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 4.0% (30 minutes)
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Schilling 2001 (Continued)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear High
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
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Schilling 2001 (Continued)
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Scuderi 2000
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 250
Female: 127 (50.8%)
Age: 58 years
Presentation:
1. Patients with dyspeptic symptoms
Setting: secondary care, Italy
Index tests Index test: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA (Meridian Diagnostics)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
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Scuderi 2000 (Continued)
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
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Scuderi 2000 (Continued)
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Segamwenge 2014
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with recent antibiotic treatment were excluded
Patient characteristics and set-
ting
Sample size: 160
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Exclusion criteria
1. Could not tolerate endoscopy
2. Recent H pylori treatment
3. Pain attributable to pancreas or liver
4. NSAID-related dyspepsia
Setting: secondary care, Italy
Index tests Index test: stool antigen test
Further details:
Technical specifications: Rapid strip HPSA (Meridian Bioscience)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
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Segamwenge 2014 (Continued)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
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Segamwenge 2014 (Continued)
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Selcukcan 2011
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 47 (47%)
Age: not stated
Presentation:
1. Infants undergoing endoscopy
Exclusion criteria:
1. No recent H pylori treatment
Setting: secondary care, Turkey
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
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Selcukcan 2011 (Continued)
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Selcukcan 2011 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Sharbatdaran 2013
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 61
Female: 36 (59%)
Age: 31 years
Presentation:
1. Patients with dyspepsia
Exclusion criteria:
1. Recent H pylori infection
2. Gastric cancer
3. Bleeding during endoscopy
Setting: secondary care, Iran
Index tests Index test: stool antigen test
Further details:
Technical specifications: GA Generic Assay
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450 nm > + 0.1 of negative control
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
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Sharbatdaran 2013 (Continued)
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
If a threshold was used, was it
pre-specified?
Yes
Low Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Yes
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
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Sharbatdaran 2013 (Continued)
Were all patients included in the
analysis?
Yes
Unclear
Sheu 1998a
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 135
Female: not stated
Age: not stated
Presentation:
1. Patients with dyspepsia
Setting: secondary care, Mexico
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not clearly stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
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Sheu 1998a (Continued)
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Sheu 1998b
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 66
Female: not stated
Age: not stated
Presentation:
1. Patients with gastrectomy
Setting: secondary care, Mexico
Index tests Index test: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not clearly stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear High
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Sheu 1998b (Continued)
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Shin 2009
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 651
Female: 254 (39%)
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Shin 2009 (Continued)
Age: 58 years
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
2. Chronic medication
3. Gastric surgery
Setting: secondary care, South Korea
Index tests Index test: serology
Further details:
Technical specifications: Genedia H pylori
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450 nm > 0.406
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
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Shin 2009 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Soomro 2012
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 100
Female: 44 (44%)
Age: not stated
Presentation:
1. Patients undergoing endoscopic biopsy for dyspepsia or gastritis
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Soomro 2012 (Continued)
Setting: secondary care, Pakistan
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
Unclear
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Soomro 2012 (Continued)
dard?
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Surveyor 1989
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 63
Female: 30 (47.8%)
Age: 59 years
Presentation:
1. Patients with symptoms related to upper gastrointestinal tract undergoing endoscopy
Setting: secondary care, Australia
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain, Warthin-Starry stain, and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
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Surveyor 1989 (Continued)
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
Thobani 1995
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 26
Female: not stated
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Thobani 1995 (Continued)
Age: not stated
Presentation:
1. Patients with upper gastrointestinal symptoms
Setting: secondary care, Pakistan
Index tests Index test: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: > 2
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Thobani 1995 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Tiwari 2014
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 30
Female: 25 (83.3%)
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, India
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Tiwari 2014 (Continued)
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 200 (10 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy (staining not reported, probably H & E)
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
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Tiwari 2014 (Continued)
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Trevisani 2005
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 105
Female: 50 (47.6%)
Age: 58 years
Presentation:
1. Patients referred to endoscopy centre
Exclusion criteria:
1. Recent H pylori treatment
2. Pregnancy or lactation
3. Steroids or NSAID treatment
4. Prior gastric surgery
5. Bleeding peptic ulcer
6. Severe concomitant diseases
Setting: secondary care, Italy
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Trevisani 2005 (Continued)
Index tests Index test 1a: stool antigen test
Further details:
Technical specifications: Amplified IDEA Hp StAR
Performed by: doctor
Criteria for positive diagnosis: Absorbance 450 nm ≥ 0.190
Index test 1b: stool antigen test
Further details:
Technical specifications: Immunocard Stat
Performed by: doctor
Criteria for positive diagnosis: pink red band (5 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Yes
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Trevisani 2005 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Vandenplas 1992
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: consecutive patients
Patient characteristics and set-
ting
Sample size: 95
Female: 50 (52.6%)
Age: 9 years
Presentation:
1. Children with chronic abdominal pain
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Belgium
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Vandenplas 1992 (Continued)
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not clearly stated
Index test 2: serology
Further details:
Technical specifications: Malakit Helicobacter pylori (Biolab)
Performed by: not stated
Criteria for positive diagnosis: > Mean + 3 standard deviations above normal level
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
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Vandenplas 1992 (Continued)
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
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Villalobos 1992
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 105
Female: 69 (65.7%)
Age: not stated
Presentation:
1. Patients with dyspepsia
Excluded:
1. Recent H pylori treatment
2. Patients taking steroids
3. Patients with coagulopathy
4. Patients allergic to penicillin
5. Pregnancy or lactation
Setting: secondary care, Mexico
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: disintegrations per minute > 1.6% (60 minutes)
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
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Villalobos 1992 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Wang 2008
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with recent antibiotic treatment were excluded
Patient characteristics and set-
ting
Sample size: 123
Female: 69 (56.1%)
Age: 48 years
Presentation:
1. Asymptomatic individuals
Exclusion criteria:
1. Recent H pylori therapy
2. Gastric surgery
Setting: secondary care, Italy
Index tests Index test: serology
Further details:
Technical specifications: Assure H pylori Rapid Test (CIM-test, Genelabs Diagnostics Ltd)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain, Warthin-Starry stain, and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 214 (63.5%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Wang 2008 (Continued)
High Unclear
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
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Wardi 2012
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 76
Female: 15 (19.7%)
Age: 70 years
Presentation:
1. Patients with partial gastrectomy
Setting: secondary care, Israel
Index tests Index test: urea breath test - C13
Further details:
Technical specifications: BreathID
Performed by: not stated
Criteria for positive diagnosis: not clearly stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear High
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Wardi 2012 (Continued)
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
No
High High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Weiss 1994
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 95
Female: not stated
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Weiss 1994 (Continued)
Age: not stated
Presentation:
1. Patients with abdominal pain
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, USA
Index tests Index test 1a: serology
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Index test 1b: serology
Further details:
Technical specifications: Cobas Core anti-H pylori (Roche)
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
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Weiss 1994 (Continued)
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
Yan 2003
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with recent antibiotic treatment were excluded
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Yan 2003 (Continued)
Patient characteristics and set-
ting
Sample size: 31
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, China
Index tests Index test: stool antigen test
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: Absorbance 450/630 nm ≥ 0.120
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 32 (50.8%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
High Unclear
DOMAIN 2: Index Test Stool Antigen Test
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Yan 2003 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
Unclear Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Yoshimura 2001
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: unclear sampling process
Patient characteristics and set-
ting
Sample size: 72
Female: 34 (47.2%)
Age: 13 years
Presentation:
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Yoshimura 2001 (Continued)
1. Children undergoing endoscopy for symptoms such as anaemia and abdominal pain
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Japan
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 3.0% (20 minutes and 30 minutes)
Index test 2: serology
Further details:
Technical specifications: HM-CAP Anti-H pylori-EIA; Kyowa Medics
Performed by: not stated
Criteria for positive diagnosis: ≥ 1.8
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Giemsa stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: not stated
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Unclear
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test Urea breath test-13C
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Yoshimura 2001 (Continued)
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 2: Index Test Serology
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Unclear
Unclear
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Yu 1999
Study characteristics
Patient sampling Type of study: unclear whether prospective or retrospective study
Consecutive or random sample: neither - patients with recent antibiotic treatment were excluded
Patient characteristics and set-
ting
Sample size: 88
Female: not stated
Age: not stated
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
Setting: secondary care, Singapore
Index tests Index test: urea breath test-14C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: not stated
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain and Warthin-Starry stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 16 (16.5%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
No
Was a case-control design
avoided?
Yes
Did the study avoid inappropri-
ate exclusions?
Unclear
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Yu 1999 (Continued)
High Unclear
DOMAIN 2: Index Test Urea breath test-14C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear High
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
No
High
Yu 2001
Study characteristics
Patient sampling Type of study: retrospective study
Consecutive or random sample: consecutive patients
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Yu 2001 (Continued)
Patient characteristics and set-
ting
Sample size: 32
Female: 14 (43.8%)
Age: 51 years
Presentation:
1. Patients undergoing endoscopy
Exclusion criteria:
1. Recent H pylori treatment
2. Gastric surgery
Setting: secondary care, Taiwan, China
Index tests Index test 1: urea breath test-13C
Further details:
Technical specifications: not stated
Performed by: not stated
Criteria for positive diagnosis: delta over baseline > 2.8% (15 minutes)
Index test 2: stool antigen test
Further details:
Technical specifications: Premier Platinum HpSA, Meridian
Performed by: not stated
Multiple criteria for positive diagnosis:
• Absorbance 450 nm > 0.140
• Visual assessment by gastroenterologists
Target condition and reference
standard(s)
Target condition: H pylori infection
Reference standard: endoscopic biopsy with H & E stain
Further details:
Technical specifications: not stated
Performed by: endoscopist and pathologist
Criteria for positive diagnosis: presence of H pylori in biopsy
Flow and timing Number of indeterminates for whom the results of reference standard was available: not stated
Number of patients who were excluded from the analysis: 0 (0%)
Comparative
Notes
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Yu 2001 (Continued)
Did the study avoid inappropri-
ate exclusions?
Yes
Low Low
DOMAIN 2: Index Test Urea breath test-13C
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Yes
Unclear Low
DOMAIN 2: Index Test Stool Antigen Test
Were the index test results in-
terpreted without knowledge of
the results of the reference stan-
dard?
Unclear
If a threshold was used, was it
pre-specified?
Unclear
Unclear Low
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
No
Were the reference standard re-
sults
interpreted without knowledge
of the results of the index tests?
Unclear
High Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
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Yu 2001 (Continued)
Did all patients receive the same
reference standard?
Yes
Were all patients included in the
analysis?
Yes
Unclear
CO2 - carbon dioxide;
H & E stain - haematoxylin and eosin stain;
HpSA - H pylori stool antigen;
IgA - immunoglobulin A;
IgG - immunoglobulin G;
NMR - nuclear magnetic resonance;
NSAID - non-steroidal anti-inflammatory
WBC - white blood cell
All other acronyms and abbreviations are the full title of either products or companies producing products included in the study.
Characteristics of studies awaiting classification [ordered by study ID]
Buhigas-Garcia 2008
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests urea breath test-13C
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
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Fazeli 2004
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests salivary test, potential index tests of interest
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Fuke 2009
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests serology
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Glupczynski 1991
Study characteristics
Patient sampling
Patient characteristics and set-
ting
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Glupczynski 1991 (Continued)
Index tests urea breath test-13C
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Karczewska 1997
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests serology
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Kushch 2014
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests unclear
Target condition and reference
standard(s)
Flow and timing
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Kushch 2014 (Continued)
Comparative
Notes
Lappas 1997
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests salivary test, potential index tests of interest
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Lee 1999a
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests urea breath test-13C
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
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Martin-de-Argila 1997
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests serology
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Mason 1997
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests urea breath test
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Thong-Ngam 2011
Study characteristics
Patient sampling
Patient characteristics and set-
ting
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Thong-Ngam 2011 (Continued)
Index tests serology
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Tokunaga 2005a
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests urea breath test
Target condition and reference
standard(s)
Flow and timing
Comparative
Notes
Xu 1995
Study characteristics
Patient sampling
Patient characteristics and set-
ting
Index tests urea breath test-13C
Target condition and reference
standard(s)
Flow and timing
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Xu 1995 (Continued)
Comparative
Notes
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